data_2m6x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m6x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 27.0 m120 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.56 ' HD1' ' N ' ' A' ' 60' ' ' ARG . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.56 ' N ' ' HD1' ' A' ' 59' ' ' HIS . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.682 ' H ' ' ND2' ' B' ' 4' ' ' ASN . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' B' ' 2' ' ' ALA . 3.2 p30 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' B' ' 12' ' ' SER . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.516 HD21 ' N ' ' B' ' 16' ' ' ASN . 1.1 m120 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.489 ' N ' ' HG1' ' B' ' 27' ' ' THR . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.617 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' B' ' 59' ' ' HIS . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 36.5 m-70 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' C' ' 12' ' ' SER . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.617 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.451 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . 0.648 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.465 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 2.9 t-80 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' D' ' 5' ' ' VAL . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' SER . . . . . 0.519 ' HG ' ' N ' ' D' ' 13' ' ' ALA . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.519 ' N ' ' HG ' ' D' ' 12' ' ' SER . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . 0.408 ' O ' ' OG1' ' D' ' 27' ' ' THR . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.648 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' D' ' 59' ' ' HIS . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' E' ' 12' ' ' SER . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' E' ' 33' ' ' LYS . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' C' ' 59' ' ' HIS . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.586 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.586 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.533 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.674 ' ND1' ' H ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.674 ' H ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.467 ' CD2' ' O ' ' D' ' 61' ' ' ALA . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 62.7 m-80 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.644 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.644 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' B' ' 33' ' ' LYS . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 31' ' ' HIS . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.59 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' B' ' 44' ' ' SER . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' E' ' 63' ' ' ALA . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.59 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.477 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.435 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.404 ' CD2' ' H ' ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.452 ' CA ' HD21 ' D' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.452 HD21 ' CA ' ' D' ' 1' ' ' GLY . 82.8 m-20 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' D' ' 18' ' ' GLY . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.576 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.711 HD22 ' HE1' ' E' ' 21' ' ' TRP . 16.0 t-20 -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.711 ' HE1' HD22 ' E' ' 16' ' ' ASN . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.429 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.485 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . 0.68 ' HE2' HH22 ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . 0.68 HH22 ' HE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . 0.403 ' CD2' ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' F' ' 57' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' H ' ' HG1' ' A' ' 27' ' ' THR . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HD1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.661 ' N ' ' HD1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.713 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.713 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . 0.402 ' HE2' ' NH2' ' B' ' 35' ' ' ARG . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH2' ' HE2' ' B' ' 31' ' ' HIS . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.603 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' B' ' 59' ' ' HIS . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' C' ' 5' ' ' VAL . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.603 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.447 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' C' ' 43' ' ' LEU . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.67 ' H ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . 0.403 ' N ' ' CG2' ' D' ' 7' ' ' VAL . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.562 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.427 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.707 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' E' ' 44' ' ' SER . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' E' ' 43' ' ' LEU . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.489 ' O ' ' CG2' ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.707 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' F' ' 33' ' ' LYS . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.474 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . 0.527 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 34.2 m-70 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.536 ' N ' ' ND2' ' A' ' 4' ' ' ASN . 0.5 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.491 ' N ' ' CD ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.673 ' ND1' ' H ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.673 ' H ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' ND2' ' B' ' 4' ' ' ASN . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' B' ' 3' ' ' LYS . 23.4 m120 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.679 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 6.3 t-160 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.679 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.57 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.57 ' N ' ' HG1' ' B' ' 27' ' ' THR . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' B' ' 33' ' ' LYS . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' B' ' 31' ' ' HIS . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.592 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.592 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' C' ' 33' ' ' LYS . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.441 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.604 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.604 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' D' ' 27' ' ' THR . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . 0.406 ' H ' ' CG2' ' E' ' 7' ' ' VAL . 9.2 t30 . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.428 ' N ' HD21 ' E' ' 16' ' ' ASN . 1.8 m120 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' E' ' 29' ' ' ALA . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' E' ' 32' ' ' VAL . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' E' ' 41' ' ' THR . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' E' ' 58' ' ' PRO . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' F' ' 5' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.414 HD11 ' H ' ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . 0.511 ' OD1' ' CZ2' ' F' ' 21' ' ' TRP . 0.5 OUTLIER -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.511 ' CZ2' ' OD1' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 17' ' ' HIS . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.6 m170 -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' OG1' ' A' ' 27' ' ' THR . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' CE1' ' A' ' 31' ' ' HIS . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.642 ' HD1' ' H ' ' A' ' 60' ' ' ARG . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.642 ' H ' ' HD1' ' A' ' 59' ' ' HIS . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 72.3 m-80 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.721 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.69 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.721 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.596 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.449 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . 0.641 ' N ' ' HD1' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.532 ' N ' ' CD2' ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.422 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.422 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.3 m120 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . 0.662 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.69 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . 0.429 ' C ' HD21 ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . 0.429 HD21 ' C ' ' F' ' 1' ' ' GLY . 78.6 m-20 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . 0.417 ' O ' ' OG ' ' F' ' 12' ' ' SER . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 12' ' ' SER . . . . . 0.568 ' HG ' ' N ' ' F' ' 13' ' ' ALA . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . 0.568 ' N ' ' HG ' ' F' ' 12' ' ' SER . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 81.3 m-20 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.69 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . 0.662 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' F' ' 48' ' ' TRP . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.515 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . 0.469 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.406 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 9.5 m-70 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 60' ' ' ARG . 2.5 t-80 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.765 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.723 ' H ' ' HD1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.765 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.567 ' N ' ' HG1' ' B' ' 27' ' ' THR . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' B' ' 33' ' ' LYS . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' B' ' 41' ' ' THR . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.618 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' THR . . . . . 0.494 ' H ' ' HG1' ' B' ' 41' ' ' THR . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.625 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.564 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.0 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.594 ' HZ2' ' CB ' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.618 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.625 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.3 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.594 ' CB ' ' HZ2' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 24' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.454 ' O ' ' NZ ' ' E' ' 33' ' ' LYS . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 42' ' ' TYR . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.187 0.517 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 27' ' ' THR . . . . . 0.575 ' HG1' ' N ' ' E' ' 28' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . 0.575 ' N ' ' HG1' ' E' ' 27' ' ' THR . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . 0.454 ' NZ ' ' O ' ' D' ' 39' ' ' GLY . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' E' ' 41' ' ' THR . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.493 ' HD1' ' H ' ' F' ' 60' ' ' ARG . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . 0.493 ' H ' ' HD1' ' F' ' 59' ' ' HIS . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.645 HD22 ' HE1' ' A' ' 21' ' ' TRP . 23.5 t-20 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.645 ' HE1' HD22 ' A' ' 16' ' ' ASN . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.776 HH21 ' NE2' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.423 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.685 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.685 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . 0.776 ' NE2' HH21 ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . 0.576 HH21 ' HE2' ' C' ' 31' ' ' HIS . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.415 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.508 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.433 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 60.5 m-70 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . 0.487 ' C ' ' HZ2' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.536 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.628 ' ND2' HD22 ' D' ' 9' ' ' ASN . 42.8 t30 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' C' ' 21' ' ' TRP . 2.8 t-20 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' ND2' ' C' ' 16' ' ' ASN . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.418 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.576 ' HE2' HH21 ' B' ' 35' ' ' ARG . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.631 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.426 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' HE2' ' C' ' 59' ' ' HIS . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.541 ' HE2' ' CD1' ' C' ' 56' ' ' LEU . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.423 ' OXT' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.54 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' D' ' 5' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . 0.628 HD22 ' ND2' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.416 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.464 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.43 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 CA--C 1.517 -0.292 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.4 ' N ' ' CG2' ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . 0.421 ' O ' ' OG ' ' E' ' 12' ' ' SER . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 12' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 2.6 m120 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.417 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' E' ' 41' ' ' THR . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 44' ' ' SER . . . . . 0.509 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' F' ' 12' ' ' SER . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 12' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 11.8 m120 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 27' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' F' ' 28' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . 0.633 ' N ' ' HG1' ' F' ' 27' ' ' THR . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' F' ' 33' ' ' LYS . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.657 ' HG ' ' H ' ' F' ' 45' ' ' LEU . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . 0.657 ' H ' ' HG ' ' F' ' 44' ' ' SER . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.588 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . 0.67 ' H ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.604 ' HG1' ' N ' ' A' ' 28' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.604 ' N ' ' HG1' ' A' ' 27' ' ' THR . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.807 ' NE2' HH22 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.807 HH22 ' NE2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.489 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 60' ' ' ARG . 1.8 t-160 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' B' ' 17' ' ' HIS . 16.3 t-20 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.69 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.535 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' B' ' 45' ' ' LEU . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.535 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.43 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . 0.411 ' N ' ' HD1' ' D' ' 17' ' ' HIS . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.821 HH21 ' NE2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' D' ' 45' ' ' LEU . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . 0.509 ' H ' ' HG ' ' D' ' 44' ' ' SER . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' D' ' 60' ' ' ARG . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 121.413 0.625 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' E' ' 26' ' ' VAL . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . 0.821 ' NE2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.501 ' CD1' ' C ' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . 0.401 ' H ' HD23 ' E' ' 50' ' ' LEU . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.618 ' HD1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.618 ' N ' ' HD1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 27.9 m-70 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.448 ' HZ2' ' C ' ' B' ' 1' ' ' GLY . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 27' ' ' THR . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 33' ' ' LYS . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 6.1 t-80 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.589 ' HZ2' ' CA ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' B' ' 13' ' ' ALA . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . 0.423 ' N ' ' HG ' ' B' ' 12' ' ' SER . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.541 ' C ' ' HE2' ' E' ' 59' ' ' HIS . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.531 ' N ' ' HE2' ' E' ' 59' ' ' HIS . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.671 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.671 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . 0.432 ' O ' ' OG1' ' B' ' 27' ' ' THR . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 23' ' ' LEU . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.584 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' B' ' 59' ' ' HIS . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.589 ' CA ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.584 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' C' ' 33' ' ' LYS . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.451 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.451 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.463 ' CE1' HH12 ' D' ' 35' ' ' ARG . 23.6 t-160 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.463 HH12 ' CE1' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.652 ' CD2' ' HE2' ' F' ' 17' ' ' HIS . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' E' ' 12' ' ' SER . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 12' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . 0.47 ' CD2' ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' E' ' 44' ' ' SER . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 44' ' ' SER . . . . . 0.526 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.541 ' HE2' ' C ' ' B' ' 14' ' ' ALA . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . 0.441 ' H ' ' C ' ' F' ' 1' ' ' GLY . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . 0.652 ' HE2' ' CD2' ' D' ' 59' ' ' HIS . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' B' ' 4' ' ' ASN . 0.4 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.635 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.525 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . 0.468 ' H ' ' CD1' ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . 0.405 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.635 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.422 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.537 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 42' ' ' TYR . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' C' ' 59' ' ' HIS . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.633 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . 0.413 ' N ' ' CG1' ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . 0.433 ' N ' ' CG1' ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.537 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.607 ' HD1' ' N ' ' D' ' 60' ' ' ARG . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.607 ' N ' ' HD1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . 0.575 ' N ' ' HD1' ' E' ' 17' ' ' HIS . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.435 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.504 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . 0.411 ' O ' ' OG ' ' F' ' 12' ' ' SER . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 12' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.415 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.504 ' O ' ' ND2' ' B' ' 16' ' ' ASN . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 12' ' ' SER . 5.7 m-80 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.654 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.654 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.517 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . 0.448 ' CA ' ' HZ2' ' B' ' 3' ' ' LYS . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.517 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' C' ' 33' ' ' LYS . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.44 ' C ' ' O ' ' C' ' 40' ' ' ALA . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.1 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . 0.419 ' O ' ' OG ' ' D' ' 12' ' ' SER . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' D' ' 9' ' ' ASN . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . 0.691 ' HE1' ' HZ2' ' D' ' 33' ' ' LYS . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . 0.691 ' HZ2' ' HE1' ' D' ' 30' ' ' TRP . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 12' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' E' ' 13' ' ' ALA . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . 0.439 ' N ' ' HG ' ' E' ' 12' ' ' SER . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' E' ' 59' ' ' HIS . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . 0.403 HD13 ' H ' ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' F' ' 33' ' ' LYS . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 12.5 m-70 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.421 ' O ' ' OG ' ' A' ' 12' ' ' SER . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' A' ' 13' ' ' ALA . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.639 ' N ' ' HG ' ' A' ' 12' ' ' SER . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 27' ' ' THR . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.565 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.565 ' H ' ' HG1' ' A' ' 27' ' ' THR . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.495 ' C ' ' H ' ' A' ' 62' ' ' LEU . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.6 ' ND2' ' CD1' ' B' ' 21' ' ' TRP . 16.4 t30 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.6 ' CD1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' CE2' ' A' ' 42' ' ' TYR . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.65 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . 0.445 ' N ' ' CG2' ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' C' ' 33' ' ' LYS . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.65 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.428 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' C' ' 59' ' ' HIS . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.574 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.574 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.404 ' H2 ' ' H ' ' D' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.404 ' H ' ' H2 ' ' D' ' 1' ' ' GLY . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' D' ' 4' ' ' ASN . 1.7 m120 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.437 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 39.0 t30 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.437 ' CE2' ' OD1' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' E' ' 4' ' ' ASN . 5.3 p-10 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.591 HD22 ' HE1' ' E' ' 21' ' ' TRP . 13.0 t-20 -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.591 ' HE1' HD22 ' E' ' 16' ' ' ASN . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 27' ' ' THR . . . . . 0.61 ' HG1' ' N ' ' E' ' 28' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . 0.61 ' N ' ' HG1' ' E' ' 27' ' ' THR . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.472 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.592 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' E' ' 59' ' ' HIS . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.629 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.629 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' F' ' 44' ' ' SER . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.616 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.616 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.433 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.433 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' N ' ' CG1' ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.5 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.488 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 t-160 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.416 ' O ' ' OG ' ' B' ' 12' ' ' SER . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.686 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.686 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 33' ' ' LYS . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' B' ' 31' ' ' HIS . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.589 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' B' ' 44' ' ' SER . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . 0.4 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.426 ' O ' ' OG ' ' C' ' 12' ' ' SER . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' C' ' 28' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.407 ' N ' ' HG1' ' C' ' 27' ' ' THR . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.589 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' C' ' 34' ' ' GLY . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' C' ' 33' ' ' LYS . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 59.5 m-70 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.427 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 11.7 t30 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . 0.492 ' CD1' ' H ' ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.926 0.394 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.485 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.423 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' F' ' 12' ' ' SER . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.455 ' O ' ' OG ' ' F' ' 44' ' ' SER . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.601 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.497 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HZ1' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.592 ' N ' HD21 ' A' ' 4' ' ' ASN . 1.1 m120 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' OD1' ' B' ' 9' ' ' ASN . 0.5 OUTLIER -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.581 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.452 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' HIS . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.512 ' C ' ' HZ1' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . 0.527 ' N ' ' HZ1' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.403 ' OD1' ' ND2' ' A' ' 9' ' ' ASN . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.405 ' CE2' ' CH2' ' A' ' 30' ' ' TRP . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.495 ' H ' ' NE2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.486 ' CA ' ' CD2' ' C' ' 31' ' ' HIS . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 37.5 m-70 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' C' ' 12' ' ' SER . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' F' ' 59' ' ' HIS . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' THR . . . . . 0.487 ' HG1' ' H ' ' C' ' 28' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . 0.487 ' H ' ' HG1' ' C' ' 27' ' ' THR . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.622 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 44' ' ' SER . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' C' ' 59' ' ' HIS . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.61 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . 0.415 ' CD2' ' H ' ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' D' ' 12' ' ' SER . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' SER . . . . . 0.462 ' HG ' ' N ' ' D' ' 13' ' ' ALA . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' D' ' 12' ' ' SER . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.665 HD22 ' HE1' ' D' ' 21' ' ' TRP . 25.1 t-20 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.665 ' HE1' HD22 ' D' ' 16' ' ' ASN . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . 0.778 HH21 ' NE2' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . 0.778 ' NE2' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . 0.484 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' HE2' ' C' ' 59' ' ' HIS . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . 0.609 ' ND2' ' NE1' ' F' ' 21' ' ' TRP . 6.8 t-20 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.609 ' NE1' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 27' ' ' THR . . . . . 0.467 ' HG1' ' N ' ' F' ' 28' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . 0.467 ' N ' ' HG1' ' F' ' 27' ' ' THR . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . 0.484 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.423 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.515 ' O ' ' CE3' ' F' ' 48' ' ' TRP . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' F' ' 50' ' ' LEU . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.408 ' HE2' ' CA ' ' C' ' 15' ' ' GLY . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' F' ' 62' ' ' LEU . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' D' ' 8' ' ' LEU . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.606 ' H ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.2 t30 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.552 ' HG ' ' N ' ' A' ' 13' ' ' ALA . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.552 ' N ' ' HG ' ' A' ' 12' ' ' SER . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.46 ' N ' ' O ' ' A' ' 18' ' ' GLY . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.732 ' HD1' ' H ' ' A' ' 60' ' ' ARG . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.732 ' H ' ' HD1' ' A' ' 59' ' ' HIS . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ASN . . . . . 0.422 ' O ' ' OG ' ' B' ' 12' ' ' SER . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' HIS . . . . . 0.668 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.668 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLY . . . . . 0.551 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' TRP . . . . . 0.551 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' C' ' 33' ' ' LYS . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.44 ' O ' ' OG1' ' C' ' 41' ' ' THR . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' THR . . . . . 0.535 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' HIS . . . . . 0.656 ' HE2' ' N ' ' F' ' 15' ' ' GLY . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 1' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' VAL . . . . . 0.429 ' N ' ' C ' ' D' ' 3' ' ' LYS . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' D' ' 18' ' ' GLY . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' VAL . . . . . 0.418 ' H ' HG11 ' D' ' 53' ' ' VAL . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 8' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 16' ' ' ASN . . . . . 0.549 ' ND2' ' NE1' ' E' ' 21' ' ' TRP . 15.7 t-20 -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 21' ' ' TRP . . . . . 0.549 ' NE1' ' ND2' ' E' ' 16' ' ' ASN . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 38' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 41' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 51' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 56' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 58' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' E' ' 59' ' ' HIS . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 59' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 39.1 m-70 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 3' ' ' LYS . . . . . 0.606 ' NZ ' ' H ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 8' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 14' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 15' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 17' ' ' HIS . . . . . 0.416 ' HD1' ' N ' ' F' ' 18' ' ' GLY . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 43' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' F' ' 44' ' ' SER . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 44' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 48' ' ' TRP . . . . . 0.589 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 49' ' ' PRO . . . . . 0.589 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 55' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.76 -57.85 3.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.406 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 27.0 m120 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.56 ' HD1' ' N ' ' A' ' 60' ' ' ARG . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.56 ' N ' ' HD1' ' A' ' 59' ' ' HIS . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.682 ' H ' ' ND2' ' B' ' 4' ' ' ASN . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' B' ' 2' ' ' ALA . 3.2 p30 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . 0.404 ' H ' ' H ' ' B' ' 4' ' ' ASN . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.437 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' B' ' 12' ' ' SER . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.516 HD21 ' N ' ' B' ' 16' ' ' ASN . 1.1 m120 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.685 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.685 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.489 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.489 ' N ' ' HG1' ' B' ' 27' ' ' THR . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.617 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.469 ' O ' ' O ' ' B' ' 59' ' ' HIS . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 36.5 m-70 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' C' ' 12' ' ' SER . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.617 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.451 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . 0.648 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.465 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.477 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 2.9 t-80 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' D' ' 5' ' ' VAL . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.519 ' HG ' ' N ' ' D' ' 13' ' ' ALA . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.519 ' N ' ' HG ' ' D' ' 12' ' ' SER . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . 0.408 ' O ' ' OG1' ' D' ' 27' ' ' THR . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.648 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' D' ' 59' ' ' HIS . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.79 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.746 0.308 . . . . 0.0 110.495 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.488 ' C ' ' H ' ' E' ' 5' ' ' VAL . 9.7 mmtp -87.84 -176.44 5.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' E' ' 3' ' ' LYS . 0.2 OUTLIER 75.95 -41.8 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.804 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.488 ' H ' ' C ' ' E' ' 3' ' ' LYS . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' E' ' 12' ' ' SER . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.4 ' O ' ' C ' ' E' ' 33' ' ' LYS . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.443 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' C' ' 59' ' ' HIS . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.586 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.586 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.0 17.02 0.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.533 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.674 ' ND1' ' H ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.674 ' H ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.467 ' CD2' ' O ' ' D' ' 61' ' ' ALA . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 62.7 m-80 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.644 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.644 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . 0.436 ' C ' ' H ' ' B' ' 33' ' ' LYS . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 31' ' ' HIS . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.59 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.448 ' O ' ' OG ' ' B' ' 44' ' ' SER . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.408 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . 0.426 ' CD2' ' O ' ' E' ' 63' ' ' ALA . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.59 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.477 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.435 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.54 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.404 ' CD2' ' H ' ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.415 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.452 ' CA ' HD21 ' D' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.452 HD21 ' CA ' ' D' ' 1' ' ' GLY . 82.8 m-20 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.404 ' N ' ' O ' ' D' ' 18' ' ' GLY . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.576 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.03 16.77 0.09 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' E' ' 1' ' ' GLY . 36.4 mmtt -137.25 72.9 1.43 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.149 0.5 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -159.45 -28.37 0.07 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.711 HD22 ' HE1' ' E' ' 21' ' ' TRP . 16.0 t-20 -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.412 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.711 ' HE1' HD22 ' E' ' 16' ' ' ASN . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.429 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . 0.49 ' CD2' ' N ' ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.474 ' CD1' ' N ' ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.485 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.546 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . 0.432 ' CG2' ' HZ2' ' E' ' 3' ' ' LYS . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . 0.68 ' HE2' HH22 ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . 0.68 HH22 ' HE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . 0.403 ' CD2' ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' F' ' 57' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.02 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.42 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' H ' ' HG1' ' A' ' 27' ' ' THR . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.661 ' HD1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.661 ' N ' ' HD1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.713 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.713 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . 0.402 ' HE2' ' NH2' ' B' ' 35' ' ' ARG . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.402 ' NH2' ' HE2' ' B' ' 31' ' ' HIS . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.603 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' B' ' 59' ' ' HIS . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' C' ' 5' ' ' VAL . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.603 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.447 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' C' ' 43' ' ' LEU . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.454 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.67 ' H ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.409 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . 0.403 ' CG2' ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . 0.403 ' N ' ' CG2' ' D' ' 7' ' ' VAL . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.562 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.427 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' E' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.82 40.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.423 ' O ' ' CG2' ' E' ' 7' ' ' VAL . 0.1 OUTLIER -75.21 -46.1 36.16 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 -73.4 52.98 0.39 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' E' ' 1' ' ' GLY . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . 0.423 ' CG2' ' O ' ' E' ' 3' ' ' LYS . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.455 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.707 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.428 ' O ' ' OG ' ' E' ' 44' ' ' SER . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 44' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' E' ' 43' ' ' LEU . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.489 ' O ' ' CG2' ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.707 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.449 ' O ' ' C ' ' F' ' 33' ' ' LYS . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.407 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.474 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . 0.527 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 34.2 m-70 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.18 86.21 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.536 ' N ' ' ND2' ' A' ' 4' ' ' ASN . 0.5 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' N ' ' CD ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.429 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.673 ' ND1' ' H ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.673 ' H ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.536 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' ND2' ' B' ' 4' ' ' ASN . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' B' ' 3' ' ' LYS . 23.4 m120 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.679 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 6.3 t-160 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.679 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.57 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.57 ' N ' ' HG1' ' B' ' 27' ' ' THR . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' B' ' 33' ' ' LYS . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' B' ' 31' ' ' HIS . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.428 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.592 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.507 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.592 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' C' ' 33' ' ' LYS . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.441 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.447 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.604 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.604 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . 0.415 ' O ' ' OG1' ' D' ' 27' ' ' THR . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.05 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' E' ' 1' ' ' GLY . 30.6 mmtt -77.94 -162.08 0.3 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.432 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.452 ' CB ' ' O ' ' E' ' 3' ' ' LYS . 9.2 t30 78.31 -47.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . 0.406 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.428 ' N ' HD21 ' E' ' 16' ' ' ASN . 1.8 m120 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.414 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . 0.407 ' O ' ' CG2' ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' E' ' 29' ' ' ALA . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' E' ' 32' ' ' VAL . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' E' ' 41' ' ' THR . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' E' ' 58' ' ' PRO . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . 0.478 ' C ' ' H ' ' F' ' 5' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.414 HD11 ' H ' ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . 0.511 ' OD1' ' CZ2' ' F' ' 21' ' ' TRP . 0.5 OUTLIER -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.511 ' CZ2' ' OD1' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.481 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.4 139.15 57.98 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 17' ' ' HIS . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.6 m170 -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.401 ' O ' ' OG1' ' A' ' 27' ' ' THR . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.518 ' O ' ' CE1' ' A' ' 31' ' ' HIS . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.487 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.642 ' HD1' ' H ' ' A' ' 60' ' ' ARG . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.642 ' H ' ' HD1' ' A' ' 59' ' ' HIS . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 72.3 m-80 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.721 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.69 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.721 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.596 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' THR . . . . . 0.432 ' O ' ' CG2' ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.449 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.546 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.559 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.559 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . 0.641 ' N ' ' HD1' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.532 ' N ' ' CD2' ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.459 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.472 ' CD2' ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.422 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . 0.489 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.422 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . 0.489 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.82 160.81 22.74 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.482 ' O ' ' ND2' ' E' ' 4' ' ' ASN . 13.9 tptt 51.24 51.06 17.7 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' E' ' 3' ' ' LYS . 29.3 m120 -149.6 13.44 0.83 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.08 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . 0.662 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.69 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . 0.429 ' C ' HD21 ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . 0.429 HD21 ' C ' ' F' ' 1' ' ' GLY . 78.6 m-20 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . 0.417 ' O ' ' OG ' ' F' ' 12' ' ' SER . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 12' ' ' SER . . . . . 0.568 ' HG ' ' N ' ' F' ' 13' ' ' ALA . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . 0.568 ' N ' ' HG ' ' F' ' 12' ' ' SER . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 81.3 m-20 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.69 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . 0.662 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . 0.445 ' O ' ' CG2' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' F' ' 48' ' ' TRP . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.515 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . 0.469 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.406 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.406 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 9.5 m-70 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.98 -73.01 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 60' ' ' ARG . 2.5 t-80 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.765 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.723 ' H ' ' HD1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.765 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.567 ' HG1' ' N ' ' B' ' 28' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.567 ' N ' ' HG1' ' B' ' 27' ' ' THR . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.42 ' O ' ' C ' ' B' ' 33' ' ' LYS . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' B' ' 41' ' ' THR . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.618 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' THR . . . . . 0.494 ' H ' ' HG1' ' B' ' 41' ' ' THR . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.625 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.564 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.564 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.535 ' H ' ' CD2' ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.0 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.463 ' O ' ' CB ' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.594 ' HZ2' ' CB ' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.618 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.625 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.431 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.3 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.594 ' CB ' ' HZ2' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.626 ' NZ ' ' N ' ' E' ' 2' ' ' ALA . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . 0.412 ' O ' ' CE1' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 24' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.454 ' O ' ' NZ ' ' E' ' 33' ' ' LYS . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 42' ' ' TYR . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . 0.523 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . 0.58 ' N ' ' HZ1' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.626 ' N ' ' NZ ' ' D' ' 3' ' ' LYS . . . 70.05 -39.09 0.43 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.693 0.283 . . . . 0.0 110.913 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' E' ' 1' ' ' GLY . 1.9 mptm? -91.54 -171.79 3.03 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.795 0.331 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 m120 70.81 1.61 3.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.165 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.508 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 27' ' ' THR . . . . . 0.575 ' HG1' ' N ' ' E' ' 28' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . 0.575 ' N ' ' HG1' ' E' ' 27' ' ' THR . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . 0.454 ' NZ ' ' O ' ' D' ' 39' ' ' GLY . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.437 ' O ' ' OG1' ' E' ' 41' ' ' THR . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.51 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.493 ' HD1' ' H ' ' F' ' 60' ' ' ARG . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . 0.493 ' H ' ' HD1' ' F' ' 59' ' ' HIS . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.449 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.21 12.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.645 HD22 ' HE1' ' A' ' 21' ' ' TRP . 23.5 t-20 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.645 ' HE1' HD22 ' A' ' 16' ' ' ASN . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.776 HH21 ' NE2' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.423 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.536 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.685 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.685 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . 0.776 ' NE2' HH21 ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . 0.576 HH21 ' HE2' ' C' ' 31' ' ' HIS . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.415 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.533 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.508 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.433 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 60.5 m-70 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.487 ' C ' ' HZ2' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.536 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.628 ' ND2' HD22 ' D' ' 9' ' ' ASN . 42.8 t30 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' C' ' 21' ' ' TRP . 2.8 t-20 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' ND2' ' C' ' 16' ' ' ASN . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.418 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.576 ' HE2' HH21 ' B' ' 35' ' ' ARG . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.631 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.426 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.541 ' CD1' ' HE2' ' C' ' 59' ' ' HIS . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.541 ' HE2' ' CD1' ' C' ' 56' ' ' LEU . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.423 ' OXT' ' O ' ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.54 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' D' ' 5' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . 0.628 HD22 ' ND2' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.416 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.464 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.43 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . 0.512 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.63 -98.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.681 0.276 . . . . 0.0 110.602 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.42 ' HZ2' ' N ' ' F' ' 2' ' ' ALA . 1.8 mptm? -79.41 65.11 4.48 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.285 0.564 . . . . 0.0 110.145 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -154.03 34.2 0.43 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . 0.4 ' CG2' ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.4 ' N ' ' CG2' ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . 0.421 ' O ' ' OG ' ' E' ' 12' ' ' SER . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 12' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 2.6 m120 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.417 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.49 ' CG2' ' O ' ' E' ' 41' ' ' THR . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.509 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 44' ' ' SER . . . . . 0.509 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . 0.42 ' N ' ' HZ2' ' E' ' 3' ' ' LYS . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . 0.414 ' O ' ' OG ' ' F' ' 12' ' ' SER . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 12' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 11.8 m120 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 27' ' ' THR . . . . . 0.633 ' HG1' ' N ' ' F' ' 28' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . 0.633 ' N ' ' HG1' ' F' ' 27' ' ' THR . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.447 ' O ' ' C ' ' F' ' 33' ' ' LYS . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.657 ' HG ' ' H ' ' F' ' 45' ' ' LEU . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . 0.657 ' H ' ' HG ' ' F' ' 44' ' ' SER . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.588 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.588 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.67 ' ND1' ' H ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . 0.67 ' H ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.73 -88.57 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.604 ' HG1' ' N ' ' A' ' 28' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.604 ' N ' ' HG1' ' A' ' 27' ' ' THR . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.807 ' NE2' HH22 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.807 HH22 ' NE2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.516 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.489 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.431 ' O ' ' O ' ' A' ' 60' ' ' ARG . 1.8 t-160 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' B' ' 17' ' ' HIS . 16.3 t-20 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.69 ' HD1' ' H ' ' B' ' 19' ' ' PHE . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.69 ' H ' ' HD1' ' B' ' 17' ' ' HIS . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.535 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' B' ' 45' ' ' LEU . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.544 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.462 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.533 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.533 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . 0.411 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.535 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.43 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.434 ' CD1' ' N ' ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.469 ' CD2' ' N ' ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.456 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . 0.411 ' N ' ' HD1' ' D' ' 17' ' ' HIS . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.821 HH21 ' NE2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.443 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.509 ' HG ' ' H ' ' D' ' 45' ' ' LEU . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . 0.509 ' H ' ' HG ' ' D' ' 44' ' ' SER . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.422 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.413 ' O ' ' O ' ' D' ' 60' ' ' ARG . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . 0.667 ' H3 ' HD21 ' E' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.2 -79.55 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.83 76.25 10.26 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.419 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.667 HD21 ' H3 ' ' E' ' 1' ' ' GLY . 63.8 m-80 -162.84 2.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.468 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.536 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.536 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' E' ' 26' ' ' VAL . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . 0.821 ' NE2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.501 ' CD1' ' C ' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . 0.401 ' H ' HD23 ' E' ' 50' ' ' LEU . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.618 ' HD1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.618 ' N ' ' HD1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . 0.415 ' CG2' ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.415 ' N ' ' CG2' ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 27.9 m-70 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.482 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.526 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.01 83.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.448 ' HZ2' ' C ' ' B' ' 1' ' ' GLY . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 27' ' ' THR . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 23' ' ' LEU . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 ' O ' ' C ' ' A' ' 33' ' ' LYS . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 6.1 t-80 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.454 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.589 ' HZ2' ' CA ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' B' ' 13' ' ' ALA . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . 0.423 ' N ' ' HG ' ' B' ' 12' ' ' SER . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.541 ' C ' ' HE2' ' E' ' 59' ' ' HIS . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.531 ' N ' ' HE2' ' E' ' 59' ' ' HIS . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.671 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.671 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . 0.432 ' O ' ' OG1' ' B' ' 27' ' ' THR . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' B' ' 23' ' ' LEU . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.584 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.547 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.417 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.461 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.436 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' B' ' 59' ' ' HIS . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.589 ' CA ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.584 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.407 ' C ' ' H ' ' C' ' 33' ' ' LYS . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.407 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.451 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.469 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.466 ' NZ ' ' H ' ' E' ' 2' ' ' ALA . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.451 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.463 ' CE1' HH12 ' D' ' 35' ' ' ARG . 23.6 t-160 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.463 HH12 ' CE1' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.5 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.409 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.652 ' CD2' ' HE2' ' F' ' 17' ' ' HIS . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.526 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.526 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . 0.466 ' H ' ' NZ ' ' D' ' 3' ' ' LYS . . . 47.26 89.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.733 0.301 . . . . 0.0 110.599 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -154.72 -56.71 0.1 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -43.14 -29.74 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' E' ' 12' ' ' SER . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 12' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' E' ' 9' ' ' ASN . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . 0.47 ' CD2' ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.424 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.526 ' C ' ' H ' ' E' ' 44' ' ' SER . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.456 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 44' ' ' SER . . . . . 0.526 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . 0.433 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.541 ' HE2' ' C ' ' B' ' 14' ' ' ALA . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . 0.527 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . 0.652 ' HE2' ' CD2' ' D' ' 59' ' ' HIS . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.459 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . 0.532 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.532 ' H ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . 60.33 142.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' CB ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.493 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' B' ' 4' ' ' ASN . 0.4 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.479 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.635 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.525 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.448 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . 0.53 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . 0.468 ' H ' ' CD1' ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . 0.405 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . 0.405 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.531 ' C ' ' H ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.635 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.422 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.537 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 42' ' ' TYR . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.445 ' O ' ' O ' ' C' ' 59' ' ' HIS . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.633 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.633 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.536 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . 0.413 ' N ' ' CG1' ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . 0.433 ' CG1' ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . 0.433 ' N ' ' CG1' ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.537 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.607 ' HD1' ' N ' ' D' ' 60' ' ' ARG . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.607 ' N ' ' HD1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.14 59.93 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.783 0.325 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -91.05 -169.56 2.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.563 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 73.56 2.34 4.24 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . 0.575 ' N ' ' HD1' ' E' ' 17' ' ' HIS . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.435 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . 0.422 ' N ' ' CD1' ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.504 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . 0.411 ' O ' ' OG ' ' F' ' 12' ' ' SER . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 12' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.415 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.65 62.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.412 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.483 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.504 ' O ' ' ND2' ' B' ' 16' ' ' ASN . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 12' ' ' SER . 5.7 m-80 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.654 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.654 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.517 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.584 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.492 ' CD1' ' N ' ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.448 ' CA ' ' HZ2' ' B' ' 3' ' ' LYS . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.517 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.423 ' C ' ' H ' ' C' ' 33' ' ' LYS . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.44 ' C ' ' O ' ' C' ' 40' ' ' ALA . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.1 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.534 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . 0.419 ' O ' ' OG ' ' D' ' 12' ' ' SER . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' D' ' 9' ' ' ASN . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . 0.691 ' HE1' ' HZ2' ' D' ' 33' ' ' LYS . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . 0.691 ' HZ2' ' HE1' ' D' ' 30' ' ' TRP . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.44 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.63 138.89 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.498 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' E' ' 5' ' ' VAL . 0.4 OUTLIER 49.27 -171.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.049 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 42.07 22.0 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.046 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' E' ' 3' ' ' LYS . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 12' ' ' SER . . . . . 0.439 ' HG ' ' N ' ' E' ' 13' ' ' ALA . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . 0.439 ' N ' ' HG ' ' E' ' 12' ' ' SER . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.433 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.434 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' E' ' 59' ' ' HIS . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . 0.403 HD13 ' H ' ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . 0.426 ' O ' ' C ' ' F' ' 33' ' ' LYS . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.438 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.477 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 12.5 m-70 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -55.6 32.92 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.421 ' O ' ' OG ' ' A' ' 12' ' ' SER . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' A' ' 13' ' ' ALA . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.639 ' N ' ' HG ' ' A' ' 12' ' ' SER . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.441 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.429 ' O ' ' OG1' ' A' ' 27' ' ' THR . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.565 ' HG1' ' H ' ' A' ' 28' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.565 ' H ' ' HG1' ' A' ' 27' ' ' THR . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.495 ' C ' ' H ' ' A' ' 62' ' ' LEU . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.6 ' ND2' ' CD1' ' B' ' 21' ' ' TRP . 16.4 t30 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.6 ' CD1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' CE2' ' A' ' 42' ' ' TYR . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.65 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.497 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . 0.445 ' N ' ' CG2' ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.403 ' O ' ' C ' ' C' ' 33' ' ' LYS . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.65 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.428 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.453 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.441 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.451 ' O ' ' O ' ' C' ' 59' ' ' HIS . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.574 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.574 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.404 ' H2 ' ' H ' ' D' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.404 ' H ' ' H2 ' ' D' ' 1' ' ' GLY . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' D' ' 4' ' ' ASN . 1.7 m120 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.437 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 39.0 t30 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.437 ' CE2' ' OD1' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.71 -17.06 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -79.64 64.92 4.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' E' ' 4' ' ' ASN . 5.3 p-10 -138.44 22.02 2.74 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.591 HD22 ' HE1' ' E' ' 21' ' ' TRP . 13.0 t-20 -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.591 ' HE1' HD22 ' E' ' 16' ' ' ASN . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 27' ' ' THR . . . . . 0.61 ' HG1' ' N ' ' E' ' 28' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . 0.61 ' N ' ' HG1' ' E' ' 27' ' ' THR . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.434 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.472 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.592 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . 0.485 ' N ' ' CD2' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . 0.449 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.446 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' E' ' 59' ' ' HIS . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.629 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.629 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.425 ' O ' ' OG ' ' F' ' 44' ' ' SER . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.616 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.616 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.433 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.433 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.9 30.66 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' N ' ' CG1' ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.5 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.488 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 t-160 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.416 ' O ' ' OG ' ' B' ' 12' ' ' SER . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.686 ' ND1' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.686 ' H ' ' ND1' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . 0.45 ' C ' ' H ' ' B' ' 33' ' ' LYS . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' B' ' 31' ' ' HIS . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.589 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.442 ' O ' ' OG ' ' B' ' 44' ' ' SER . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . 0.4 ' N ' ' CG1' ' C' ' 7' ' ' VAL . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.426 ' O ' ' OG ' ' C' ' 12' ' ' SER . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' THR . . . . . 0.407 ' HG1' ' N ' ' C' ' 28' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.407 ' N ' ' HG1' ' C' ' 27' ' ' THR . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.589 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.429 ' CG ' ' H ' ' C' ' 34' ' ' GLY . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . 0.429 ' H ' ' CG ' ' C' ' 33' ' ' LYS . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . 0.44 ' CD2' ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 59.5 m-70 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.5 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.427 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 11.7 t30 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . 0.492 ' CD1' ' H ' ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.408 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.534 ' N ' ' CD2' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.28 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.785 0.326 . . . . 0.0 110.476 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.87 -177.49 5.24 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.01 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 70.11 11.41 7.6 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.083 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . 0.47 ' CD2' ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.436 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.485 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.423 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . 0.425 ' O ' ' OG ' ' F' ' 12' ' ' SER . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 12' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . 0.485 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.455 ' O ' ' OG ' ' F' ' 44' ' ' SER . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.601 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.601 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' N ' ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.497 ' N ' ' CD2' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.08 21.21 1.69 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HZ1' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.592 ' N ' HD21 ' A' ' 4' ' ' ASN . 1.1 m120 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' OD1' ' B' ' 9' ' ' ASN . 0.5 OUTLIER -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.581 ' N ' ' HD1' ' A' ' 17' ' ' HIS . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.452 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 59' ' ' HIS . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.512 ' C ' ' HZ1' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.527 ' N ' ' HZ1' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.403 ' OD1' ' ND2' ' A' ' 9' ' ' ASN . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.405 ' CE2' ' CH2' ' A' ' 30' ' ' TRP . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.495 ' H ' ' NE2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.486 ' CA ' ' CD2' ' C' ' 31' ' ' HIS . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.458 ' CD1' ' N ' ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 37.5 m-70 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.482 ' CG ' ' N ' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.482 ' N ' ' CG ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . 0.428 ' O ' ' OG ' ' C' ' 12' ' ' SER . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 9' ' ' ASN . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' F' ' 59' ' ' HIS . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' THR . . . . . 0.487 ' HG1' ' H ' ' C' ' 28' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . 0.487 ' H ' ' HG1' ' C' ' 27' ' ' THR . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.512 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.622 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' C' ' 44' ' ' SER . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' C' ' 59' ' ' HIS . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.61 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.61 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . 0.415 ' CD2' ' H ' ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' D' ' 12' ' ' SER . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' SER . . . . . 0.462 ' HG ' ' N ' ' D' ' 13' ' ' ALA . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' D' ' 12' ' ' SER . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.665 HD22 ' HE1' ' D' ' 21' ' ' TRP . 25.1 t-20 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.665 ' HE1' HD22 ' D' ' 16' ' ' ASN . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . 0.778 HH21 ' NE2' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.439 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . 0.482 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 -46.98 70.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.641 0.257 . . . . 0.0 110.782 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . 0.555 ' HZ1' ' CA ' ' F' ' 2' ' ' ALA . 29.2 mmtt -102.98 62.57 0.81 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.084 0.468 . . . . 0.0 110.761 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -156.15 15.35 0.33 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.489 ' N ' ' CD1' ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . 0.778 ' NE2' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . 0.484 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . 0.401 ' C ' ' CD1' ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . 0.555 ' CA ' ' HZ1' ' E' ' 3' ' ' LYS . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' HE2' ' C' ' 59' ' ' HIS . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . 0.609 ' ND2' ' NE1' ' F' ' 21' ' ' TRP . 6.8 t-20 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.609 ' NE1' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 27' ' ' THR . . . . . 0.467 ' HG1' ' N ' ' F' ' 28' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . 0.467 ' N ' ' HG1' ' F' ' 27' ' ' THR . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . 0.484 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.423 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.515 ' O ' ' CE3' ' F' ' 48' ' ' TRP . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' F' ' 50' ' ' LEU . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' CD ' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.408 ' HE2' ' CA ' ' C' ' 15' ' ' GLY . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' F' ' 62' ' ' LEU . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . 0.435 ' O ' ' CD2' ' D' ' 8' ' ' LEU . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.606 ' H ' ' NZ ' ' F' ' 3' ' ' LYS . . . 54.95 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 1' ' ' GLY . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.527 ' N ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.43 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.2 t30 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.552 ' HG ' ' N ' ' A' ' 13' ' ' ALA . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.552 ' N ' ' HG ' ' A' ' 12' ' ' SER . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.46 ' N ' ' O ' ' A' ' 18' ' ' GLY . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.438 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.732 ' HD1' ' H ' ' A' ' 60' ' ' ARG . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.732 ' H ' ' HD1' ' A' ' 59' ' ' HIS . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ASN . . . . . 0.422 ' O ' ' OG ' ' B' ' 12' ' ' SER . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' B' ' 9' ' ' ASN . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' HIS . . . . . 0.668 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.668 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.442 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLY . . . . . 0.551 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' TRP . . . . . 0.551 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' C' ' 33' ' ' LYS . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' LYS . . . . . 0.478 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.44 ' O ' ' OG1' ' C' ' 41' ' ' THR . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' THR . . . . . 0.535 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' N ' ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' LEU . . . . . 0.449 ' CD1' ' N ' ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' HIS . . . . . 0.656 ' HE2' ' N ' ' F' ' 15' ' ' GLY . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . 0.515 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' GLY . . . . . 0.506 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' VAL . . . . . 0.429 ' N ' ' C ' ' D' ' 3' ' ' LYS . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' D' ' 18' ' ' GLY . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' LYS . . . . . 0.535 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' VAL . . . . . 0.418 ' H ' HG11 ' D' ' 53' ' ' VAL . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' LEU . . . . . 0.412 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' LEU . . . . . 0.522 ' CD2' ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.61 19.51 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -92.52 51.7 1.78 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -143.9 33.84 1.25 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . 0.402 ' CG2' ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 8' ' ' LEU . . . . . 0.402 ' N ' ' CG2' ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 16' ' ' ASN . . . . . 0.549 ' ND2' ' NE1' ' E' ' 21' ' ' TRP . 15.7 t-20 -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 21' ' ' TRP . . . . . 0.549 ' NE1' ' ND2' ' E' ' 16' ' ' ASN . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 27' ' ' THR . . . . . . . . . . . . . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 36' ' ' LEU . . . . . . . . . . . . . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 38' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' E' ' 41' ' ' THR . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 41' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 51' ' ' LEU . . . . . 0.479 ' N ' ' CD2' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 56' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 57' ' ' ARG . . . . . 0.442 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 58' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' E' ' 59' ' ' HIS . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 59' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 39.1 m-70 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 3' ' ' LYS . . . . . 0.606 ' NZ ' ' H ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 8' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 14' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 15' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 17' ' ' HIS . . . . . 0.416 ' HD1' ' N ' ' F' ' 18' ' ' GLY . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 37' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 43' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' F' ' 44' ' ' SER . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 44' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 48' ' ' TRP . . . . . 0.589 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 49' ' ' PRO . . . . . 0.589 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 55' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 57' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' A' ' 8' ' ' LEU . 76.7 m-20 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.602 HG21 ' HB ' ' F' ' 32' ' ' VAL . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 29' ' ' ALA . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.632 HD23 ' CB ' ' A' ' 48' ' ' TRP . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.632 ' CB ' HD23 ' A' ' 45' ' ' LEU . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PRO . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.508 ' O ' HD13 ' B' ' 8' ' ' LEU . 2.2 p-10 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.508 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.646 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.646 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.761 ' O ' HG23 ' B' ' 27' ' ' THR . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.402 ' H ' HG22 ' B' ' 25' ' ' VAL . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.761 HG23 ' O ' ' B' ' 23' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' C' ' 24' ' ' LEU . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.65 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.411 HD22 ' N ' ' B' ' 50' ' ' LEU . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.7 m80 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.429 HG23 ' H ' ' C' ' 5' ' ' VAL . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 28' ' ' LEU . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.65 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.43 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ARG . . . . . 0.661 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.566 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' E' ' 19' ' ' PHE . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.517 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.556 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' C' ' 60' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 12.1 t60 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' E' ' 5' ' ' VAL . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.434 HG13 ' N ' ' D' ' 8' ' ' LEU . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.434 ' N ' HG13 ' D' ' 7' ' ' VAL . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' D' ' 17' ' ' HIS . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 27' ' ' THR . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.402 HG12 ' H ' ' D' ' 25' ' ' VAL . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.661 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.559 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.527 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' D' ' 62' ' ' LEU . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.473 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.438 HG22 ' CG1' ' F' ' 5' ' ' VAL . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.517 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.411 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.476 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.411 HG22 ' O ' ' E' ' 22' ' ' GLY . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.476 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' F' ' 27' ' ' THR . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.571 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.514 ' CZ3' HD13 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.466 ' N ' HD12 ' E' ' 51' ' ' LEU . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' E' ' 48' ' ' TRP . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.559 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' E' ' 6' ' ' ILE . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 5' ' ' VAL . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.401 HG23 ' H ' ' F' ' 7' ' ' VAL . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 24' ' ' LEU . . . . . 0.469 HD12 HG11 ' E' ' 32' ' ' VAL . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.517 HG21 ' HB ' ' E' ' 32' ' ' VAL . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.437 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 27' ' ' THR . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.595 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.658 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.718 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.641 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.499 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t60 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' HD13 ' A' ' 8' ' ' LEU . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 61' ' ' ALA . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' F' ' 32' ' ' VAL . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.638 HG21 ' HB ' ' F' ' 32' ' ' VAL . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' C ' ' A' ' 43' ' ' LEU . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.527 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.521 ' O ' HD13 ' B' ' 8' ' ' LEU . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 6' ' ' ILE . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' C' ' 5' ' ' VAL . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 22.7 m120 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 25' ' ' VAL . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 32' ' ' VAL . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.625 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.436 ' H ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.512 HG13 ' O ' ' B' ' 47' ' ' VAL . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.605 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.412 ' O ' HG12 ' C' ' 7' ' ' VAL . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' B' ' 10' ' ' ALA . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.477 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.477 ' N ' HG13 ' C' ' 7' ' ' VAL . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.552 ' O ' HG23 ' C' ' 27' ' ' THR . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' C' ' 23' ' ' LEU . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.563 ' O ' HD13 ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.625 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.416 ' H ' HG22 ' C' ' 32' ' ' VAL . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.41 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.582 ' O ' HD23 ' C' ' 56' ' ' LEU . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' C' ' 58' ' ' PRO . 0.1 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.55 HD23 ' H ' ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.53 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 15.6 m120 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' E' ' 5' ' ' VAL . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.518 ' O ' HG23 ' D' ' 27' ' ' THR . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' D' ' 23' ' ' LEU . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.521 ' O ' HD13 ' D' ' 28' ' ' LEU . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.497 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.497 HG22 ' O ' ' D' ' 29' ' ' ALA . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.589 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.543 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.542 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.43 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' CD1' ' E' ' 21' ' ' TRP . 0.5 OUTLIER -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.422 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.501 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.407 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.655 ' O ' HG23 ' E' ' 27' ' ' THR . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 24' ' ' LEU . . . . . 0.43 ' CD1' HG11 ' D' ' 32' ' ' VAL . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.407 HG12 ' O ' ' E' ' 22' ' ' GLY . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.655 HG23 ' O ' ' E' ' 23' ' ' LEU . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 28' ' ' LEU . . . . . 0.462 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.442 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.471 ' HB ' HG21 ' F' ' 27' ' ' THR . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.624 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 47' ' ' VAL . . . . . 0.409 ' O ' HG12 ' E' ' 47' ' ' VAL . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 55' ' ' LEU . . . . . 0.546 ' N ' HD22 ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.62 HD12 ' N ' ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' E' ' 61' ' ' ALA . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.444 ' O ' HD13 ' F' ' 8' ' ' LEU . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' E' ' 6' ' ' ILE . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.444 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.471 HG21 ' HB ' ' E' ' 32' ' ' VAL . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 31' ' ' HIS . . . . . 0.404 ' NE2' ' NH2' ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 27' ' ' THR . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 35' ' ' ARG . . . . . 0.404 ' NH2' ' NE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.627 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.603 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 45' ' ' LEU . . . . . 0.553 HD22 ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.553 ' CE3' HD22 ' F' ' 45' ' ' LEU . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' B' ' 5' ' ' VAL . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 27' ' ' THR . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 23' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 29' ' ' ALA . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' A' ' 51' ' ' LEU . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 47' ' ' VAL . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.523 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.466 ' O ' HD13 ' B' ' 8' ' ' LEU . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.446 HG23 ' H ' ' B' ' 5' ' ' VAL . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.419 HG22 ' CG1' ' C' ' 5' ' ' VAL . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.466 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.613 ' N ' HD12 ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 47' ' ' VAL . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.605 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.425 HG11 ' CE1' ' D' ' 19' ' ' PHE . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' C' ' 4' ' ' ASN . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.46 HD21 ' C ' ' E' ' 63' ' ' ALA . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' O ' ' ND1' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' ALA . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.64 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.435 ' C ' ' O ' ' C' ' 40' ' ' ALA . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.522 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.514 HD13 ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.485 HG23 ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' C' ' 10' ' ' ALA . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' D' ' 25' ' ' VAL . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG21 ' E' ' 27' ' ' THR . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.547 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.562 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.573 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.57 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.562 ' N ' HD12 ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.606 ' N ' HD12 ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.635 HG21 ' HB ' ' D' ' 32' ' ' VAL . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.428 ' H ' HG22 ' E' ' 32' ' ' VAL . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.697 HD23 ' O ' ' E' ' 36' ' ' LEU . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.48 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.573 ' H ' HD23 ' E' ' 43' ' ' LEU . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' E' ' 44' ' ' SER . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.877 ' O ' HG22 ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.877 HG22 ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 55' ' ' LEU . . . . . 0.509 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.536 HD23 ' O ' ' E' ' 56' ' ' LEU . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.609 ' O ' ' HB3' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.512 HD23 ' O ' ' E' ' 62' ' ' LEU . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.46 ' C ' HD21 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.44 HG23 ' H ' ' F' ' 5' ' ' VAL . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.684 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.455 ' O ' HG22 ' F' ' 27' ' ' THR . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 25' ' ' VAL . . . . . 0.444 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.455 HG22 ' O ' ' F' ' 23' ' ' LEU . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.726 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.48 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.726 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.608 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.543 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.596 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.508 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 m80 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' C' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 0.9 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 8' ' ' LEU . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.498 ' N ' HG13 ' A' ' 7' ' ' VAL . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 19' ' ' PHE . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.491 ' CD ' ' N ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.49 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' C' ' 19' ' ' PHE . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.404 ' O ' HD13 ' B' ' 8' ' ' LEU . 79.6 m-20 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 6' ' ' ILE . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' C' ' 5' ' ' VAL . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.404 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' E' ' 59' ' ' HIS . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.1 t-80 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.63 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.731 ' O ' HG23 ' B' ' 27' ' ' THR . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 23' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.401 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.537 ' N ' HD12 ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.561 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.445 HG13 ' N ' ' C' ' 8' ' ' LEU . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.445 ' N ' HG13 ' C' ' 7' ' ' VAL . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.406 HG12 ' H ' ' C' ' 25' ' ' VAL . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.401 HG23 ' CZ2' ' C' ' 30' ' ' TRP . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.536 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.569 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.428 ' O ' HD13 ' D' ' 8' ' ' LEU . 88.5 m-20 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.557 ' H ' HD12 ' D' ' 6' ' ' ILE . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 4' ' ' ASN . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.408 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.485 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.557 HD23 ' O ' ' D' ' 28' ' ' LEU . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.453 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' E' ' 27' ' ' THR . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.59 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.575 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.648 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.504 ' N ' HD22 ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' E' ' 19' ' ' PHE . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.616 HG21 ' HB ' ' D' ' 32' ' ' VAL . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' E' ' 33' ' ' LYS . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.612 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' B' ' 14' ' ' ALA . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 3' ' ' LYS . . . . . 0.48 ' O ' HG23 ' F' ' 7' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.639 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.48 HG23 ' O ' ' F' ' 3' ' ' LYS . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' C' ' 63' ' ' ALA . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 21.5 t-20 -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.66 ' CZ2' ' ND2' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' E' ' 32' ' ' VAL . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.4 HG22 ' H ' ' F' ' 32' ' ' VAL . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.612 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.56 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 47' ' ' VAL . . . . . 0.461 ' O ' HG12 ' F' ' 47' ' ' VAL . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.686 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.567 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.535 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 56' ' ' LEU . . . . . 0.526 ' N ' HD12 ' F' ' 56' ' ' LEU . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' HD13 ' A' ' 8' ' ' LEU . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' THR . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 23' ' ' LEU . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.525 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 52' ' ' LEU . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 55' ' ' LEU . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 58' ' ' PRO . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.575 ' H ' HD12 ' B' ' 6' ' ' ILE . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.5 m120 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 27' ' ' THR . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.708 HG23 ' O ' ' B' ' 23' ' ' LEU . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 32' ' ' VAL . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.637 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' THR . . . . . 0.483 HG23 ' O ' ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' B' ' 55' ' ' LEU . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.563 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' C' ' 27' ' ' THR . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.416 ' H ' HG12 ' C' ' 25' ' ' VAL . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' C' ' 23' ' ' LEU . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.637 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.567 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.587 ' O ' HD13 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.502 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' E' ' 19' ' ' PHE . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' E' ' 5' ' ' VAL . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.404 HG23 ' O ' ' D' ' 3' ' ' LYS . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' HIS . . . . . 0.525 ' N ' ' ND1' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.533 ' O ' HG23 ' D' ' 27' ' ' THR . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.533 HG23 ' O ' ' D' ' 23' ' ' LEU . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' E' ' 27' ' ' THR . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.582 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.564 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.553 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.601 ' N ' HD12 ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' F' ' 19' ' ' PHE . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.514 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.441 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.441 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.479 ' O ' HD13 ' E' ' 8' ' ' LEU . 29.3 m120 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.603 ' H ' HD12 ' E' ' 6' ' ' ILE . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.523 HD22 ' HB1' ' D' ' 10' ' ' ALA . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' E' ' 21' ' ' TRP . 10.6 t-20 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.53 HG21 ' HB ' ' D' ' 32' ' ' VAL . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 28' ' ' LEU . . . . . 0.525 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.511 ' HB ' HG21 ' F' ' 27' ' ' THR . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 35' ' ' ARG . . . . . 0.699 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.637 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' E' ' 40' ' ' ALA . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.577 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.54 ' N ' HD12 ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 55' ' ' LEU . . . . . 0.524 HD12 ' N ' ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.61 ' N ' HD12 ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 3' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' F' ' 4' ' ' ASN . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' F' ' 3' ' ' LYS . 31.3 m120 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.417 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.403 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.438 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 29.4 m120 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.479 ' CE1' HG11 ' D' ' 53' ' ' VAL . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 24' ' ' LEU . . . . . 0.41 ' CD1' HG11 ' E' ' 32' ' ' VAL . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.511 HG21 ' HB ' ' E' ' 32' ' ' VAL . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.466 ' CH2' ' CE1' ' A' ' 20' ' ' PHE . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 31' ' ' HIS . . . . . 0.699 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 27' ' ' THR . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.585 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 47' ' ' VAL . . . . . 0.683 HG22 ' O ' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.605 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.613 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 m80 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 8' ' ' LEU . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG22 ' CG1' ' B' ' 5' ' ' VAL . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 25' ' ' VAL . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 23' ' ' LEU . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.609 ' CD2' ' HB1' ' D' ' 11' ' ' ALA . 9.2 t60 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.484 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 6' ' ' ILE . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 18' ' ' GLY . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.436 ' N ' ' ND1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.877 ' O ' HG23 ' B' ' 27' ' ' THR . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 23' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.822 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.822 HG12 ' O ' ' B' ' 29' ' ' ALA . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' THR . . . . . 0.476 ' C ' ' O ' ' B' ' 40' ' ' ALA . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' B' ' 41' ' ' THR . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.54 ' O ' HD23 ' B' ' 50' ' ' LEU . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.651 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.54 HD23 ' O ' ' B' ' 46' ' ' GLY . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.681 ' N ' HD22 ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.605 ' CG2' HD21 ' D' ' 23' ' ' LEU . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.525 HD23 ' O ' ' B' ' 55' ' ' LEU . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.3 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.547 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.513 ' HZ1' ' HB2' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' C' ' 5' ' ' VAL . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' F' ' 59' ' ' HIS . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' GLY . . . . . 0.432 ' O ' HG12 ' C' ' 25' ' ' VAL . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 22' ' ' GLY . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.532 HG22 ' CH2' ' C' ' 30' ' ' TRP . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.449 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.556 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.603 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.415 ' H ' HG13 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.495 ' CD2' ' HA2' ' F' ' 15' ' ' GLY . 0.1 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.513 ' HB2' ' HZ1' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.425 ' O ' HD13 ' D' ' 8' ' ' LEU . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' C' ' 6' ' ' ILE . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.474 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 4' ' ' ASN . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.609 ' HB1' ' CD2' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.605 HD21 ' CG2' ' B' ' 53' ' ' VAL . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.417 HG22 ' H ' ' D' ' 25' ' ' VAL . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 23' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.491 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.491 HG22 ' O ' ' D' ' 29' ' ' ALA . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.552 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.502 ' C ' HD22 ' D' ' 43' ' ' LEU . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.502 HD22 ' C ' ' D' ' 42' ' ' TYR . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.561 ' N ' HD12 ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 49' ' ' PRO . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.556 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.549 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.534 ' N ' HD12 ' D' ' 62' ' ' LEU . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.46 ' O ' HD13 ' E' ' 8' ' ' LEU . 2.2 m120 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.187 0.517 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.411 HG23 ' H ' ' E' ' 7' ' ' VAL . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.564 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.718 ' O ' HG23 ' E' ' 27' ' ' THR . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.718 HG23 ' O ' ' E' ' 23' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.412 ' C ' ' O ' ' E' ' 40' ' ' ALA . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 45' ' ' LEU . . . . . 0.473 HD13 ' HZ2' ' F' ' 33' ' ' LYS . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.543 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.427 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 13' ' ' ALA . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 10' ' ' ALA . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 15' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' C' ' 59' ' ' HIS . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 16' ' ' ASN . . . . . 0.487 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 23.8 t-20 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.551 HG21 ' HB ' ' E' ' 32' ' ' VAL . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.426 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.426 HG22 ' O ' ' F' ' 29' ' ' ALA . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.473 ' HZ2' HD13 ' E' ' 45' ' ' LEU . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.584 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 53' ' ' VAL . . . . . 0.426 ' H ' HG13 ' F' ' 53' ' ' VAL . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' F' F ' 56' ' ' LEU . . . . . 0.586 HD23 ' O ' ' F' ' 56' ' ' LEU . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.424 ' CE1' ' HB1' ' C' ' 11' ' ' ALA . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' F' F ' 60' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 61' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.408 HG22 ' CG1' ' B' ' 5' ' ' VAL . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.542 HG21 HG22 ' F' ' 32' ' ' VAL . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' ALA . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.893 HD12 HG22 ' B' ' 27' ' ' THR . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HZ3' ' C ' ' C' ' 1' ' ' GLY . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' E' ' 63' ' ' ALA . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.855 ' O ' HG23 ' B' ' 27' ' ' THR . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.893 HG22 HD12 ' A' ' 36' ' ' LEU . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.451 HD12 HG21 ' C' ' 27' ' ' THR . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.443 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.58 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.563 ' O ' HG22 ' B' ' 53' ' ' VAL . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.563 HG22 ' O ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' B' ' 58' ' ' PRO . 29.6 m80 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HZ3' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' D' ' 5' ' ' VAL . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.45 ' H ' HG22 ' C' ' 7' ' ' VAL . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' ASN . . . . . 0.426 ' OD1' ' ND2' ' D' ' 9' ' ' ASN . 3.9 t-20 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.582 ' O ' HG23 ' C' ' 27' ' ' THR . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' C' ' 23' ' ' LEU . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.505 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' C' ' 33' ' ' LYS . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.505 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.611 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.43 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 40' ' ' ALA . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.659 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.481 HD23 ' C ' ' C' ' 43' ' ' LEU . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' E' ' 19' ' ' PHE . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' C' ' 59' ' ' HIS . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.538 ' C ' HD12 ' C' ' 62' ' ' LEU . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.519 ' N ' HD12 ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 1' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.473 ' O ' HG13 ' D' ' 7' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.572 HG22 HG11 ' E' ' 5' ' ' VAL . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.473 HG13 ' O ' ' D' ' 3' ' ' LYS . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.453 ' N ' HG23 ' D' ' 7' ' ' VAL . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 9' ' ' ASN . . . . . 0.426 ' ND2' ' OD1' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.474 ' O ' HD13 ' D' ' 23' ' ' LEU . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.52 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' D' ' 24' ' ' LEU . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.409 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.52 HG23 ' O ' ' D' ' 23' ' ' LEU . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.659 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.516 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.572 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 CA--C 1.517 -0.292 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.572 HG11 HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' F' ' 5' ' ' VAL . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.475 HG23 ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' HG23 ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 41.1 m-20 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.485 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.424 ' H ' HG13 ' E' ' 25' ' ' VAL . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.449 ' H ' HG23 ' E' ' 27' ' ' THR . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' E' ' 29' ' ' ALA . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.582 HD23 ' O ' ' E' ' 36' ' ' LEU . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.403 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.697 ' O ' HG22 ' E' ' 41' ' ' THR . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.697 HG22 ' O ' ' E' ' 38' ' ' PRO . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 3' ' ' LYS . . . . . 0.42 ' O ' HG23 ' F' ' 5' ' ' VAL . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.42 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' F' ' 4' ' ' ASN . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.549 ' N ' HD12 ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.441 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 16.9 m-80 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.421 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.763 ' O ' HG23 ' F' ' 27' ' ' THR . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.763 HG23 ' O ' ' F' ' 23' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.806 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.806 HG12 ' O ' ' F' ' 29' ' ' ALA . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 27' ' ' THR . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.662 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.735 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.64 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 60' ' ' ARG . . . . . 0.599 ' N ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.595 ' N ' HD22 ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' A' ' 8' ' ' LEU . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 27' ' ' THR . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' GLY . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 23' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.688 ' CD2' HH12 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 29' ' ' ALA . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.688 HH12 ' CD2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.875 HD12 HG22 ' B' ' 27' ' ' THR . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.543 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' HB1' ' D' ' 11' ' ' ALA . 5.0 t60 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' B' ' 5' ' ' VAL . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.468 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' C' ' 5' ' ' VAL . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.42 HG23 ' H ' ' B' ' 7' ' ' VAL . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.554 ' N ' HD12 ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.496 ' ND2' ' CD2' ' B' ' 21' ' ' TRP . 7.1 t30 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 16' ' ' ASN . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.496 ' CD2' ' ND2' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.862 ' O ' HG23 ' B' ' 27' ' ' THR . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.875 HG22 HD12 ' A' ' 36' ' ' LEU . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 29' ' ' ALA . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.557 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 46' ' ' GLY . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.616 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.4 ' H ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.511 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.455 ' CE1' ' HB1' ' E' ' 11' ' ' ALA . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 1' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.489 HG12 ' O ' ' C' ' 3' ' ' LYS . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.456 ' N ' HG13 ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.463 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.461 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.557 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.581 ' HA ' ' HZ2' ' C' ' 33' ' ' LYS . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' HA ' ' C' ' 31' ' ' HIS . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.587 ' N ' HD12 ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.513 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' LEU . . . . . 0.507 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' E' ' 5' ' ' VAL . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.43 HG23 ' H ' ' D' ' 7' ' ' VAL . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.545 ' HB1' ' CD2' ' A' ' 59' ' ' HIS . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.55 ' O ' HG23 ' D' ' 27' ' ' THR . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.414 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 23' ' ' LEU . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' E' ' 27' ' ' THR . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.537 HH21 ' CD2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.578 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' LEU . . . . . 0.461 HD12 ' N ' ' D' ' 45' ' ' LEU . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' F' ' 19' ' ' PHE . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.543 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.448 ' ND1' ' HB1' ' A' ' 11' ' ' ALA . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' D' ' 62' ' ' LEU . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.491 ' O ' HD13 ' E' ' 8' ' ' LEU . 63.8 m-80 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 121.413 0.625 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.413 HG23 ' H ' ' E' ' 7' ' ' VAL . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.496 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 10' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' F' ' 5' ' ' VAL . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' B' ' 59' ' ' HIS . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.438 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 24' ' ' LEU . . . . . 0.502 ' CD1' HG11 ' D' ' 32' ' ' VAL . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.438 HG12 ' O ' ' E' ' 22' ' ' GLY . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.6 HG21 ' HB ' ' D' ' 32' ' ' VAL . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.534 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 31' ' ' HIS . . . . . 0.537 ' CD2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.534 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.576 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.501 ' C ' ' CD1' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.615 ' O ' HG22 ' E' ' 53' ' ' VAL . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.615 HG22 ' O ' ' E' ' 50' ' ' LEU . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 55' ' ' LEU . . . . . 0.557 HD12 ' N ' ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.551 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.551 ' N ' HD12 ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' E' ' 10' ' ' ALA . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.47 HG22 ' CG1' ' A' ' 5' ' ' VAL . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.511 HG23 ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.511 ' N ' HG23 ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' D' ' 53' ' ' VAL . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.429 ' N ' HD12 ' F' ' 23' ' ' LEU . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 24' ' ' LEU . . . . . 0.558 HD23 ' O ' ' F' ' 24' ' ' LEU . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.447 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.447 HG22 ' O ' ' F' ' 29' ' ' ALA . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.554 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.557 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.567 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.553 ' N ' HD12 ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' F' ' 58' ' ' PRO . 10.1 m80 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.572 ' N ' HD12 ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HG2' ' HZ2' ' A' ' 3' ' ' LYS . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' B' ' 5' ' ' VAL . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' E' ' 53' ' ' VAL . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.62 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 47' ' ' VAL . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 5.6 t60 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.434 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.453 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 6' ' ' ILE . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' C' ' 20' ' ' PHE . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 29' ' ' ALA . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' N ' ' B' ' 35' ' ' ARG . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.615 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.58 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 45' ' ' LEU . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.434 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.439 ' O ' HD13 ' C' ' 8' ' ' LEU . 23.1 m120 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.406 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 10' ' ' ALA . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' F' ' 63' ' ' ALA . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.413 ' O ' HG13 ' C' ' 32' ' ' VAL . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.642 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.615 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.642 HG22 ' O ' ' C' ' 29' ' ' ALA . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.588 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.426 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.596 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' VAL . . . . . 0.476 ' O ' HG12 ' C' ' 47' ' ' VAL . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' E' ' 19' ' ' PHE . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.527 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 t60 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.468 HG23 ' H ' ' D' ' 5' ' ' VAL . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.453 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.717 HD13 ' HB1' ' F' ' 63' ' ' ALA . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 25' ' ' VAL . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.58 ' CD2' HH12 ' D' ' 35' ' ' ARG . 1.7 t60 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.58 HH12 ' CD2' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' E' ' 27' ' ' THR . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.481 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.723 ' HE1' HD22 ' E' ' 36' ' ' LEU . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' D' ' 56' ' ' LEU . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.497 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' E' ' 8' ' ' LEU . 59.6 m-80 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' E' ' 4' ' ' ASN . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.48 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.648 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' D' ' 36' ' ' LEU . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.433 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.433 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.723 HD22 ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.52 ' OH ' ' NE1' ' F' ' 30' ' ' TRP . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.533 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 44' ' ' SER . . . . . 0.491 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.516 HD13 ' O ' ' E' ' 56' ' ' LEU . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' F' F ' 1' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.431 HG22 ' CG1' ' A' ' 5' ' ' VAL . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' F' ' 23' ' ' LEU . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.66 ' O ' HG23 ' F' ' 27' ' ' THR . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' E' ' 36' ' ' LEU . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.508 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.508 HG22 ' O ' ' F' ' 29' ' ' ALA . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.474 HG23 ' H ' ' F' ' 37' ' ' VAL . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.667 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.625 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' F' F ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.736 ' C ' HD22 ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 27' ' ' THR . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' LEU . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.967 ' O ' HG22 ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.474 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.7 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.46 HG23 ' H ' ' B' ' 7' ' ' VAL . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.407 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 29' ' ' ALA . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.61 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.554 ' H ' ' HD2' ' B' ' 49' ' ' PRO . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.639 HD12 ' N ' ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.526 HG23 HD12 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.677 ' H ' HD12 ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.443 HG12 ' O ' ' C' ' 3' ' ' LYS . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.406 ' N ' HG13 ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.429 ' O ' HG23 ' C' ' 27' ' ' THR . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.433 ' H ' HG22 ' C' ' 25' ' ' VAL . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 23' ' ' LEU . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.574 HD23 ' O ' ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.794 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.515 ' O ' ' N ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.794 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.61 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.602 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.455 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.413 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.53 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.529 ' N ' HD12 ' C' ' 43' ' ' LEU . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.554 ' N ' HD12 ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' C' ' 10' ' ' ALA . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.483 HG22 ' CG1' ' E' ' 5' ' ' VAL . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.447 HG13 ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.447 ' N ' HG13 ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' D' ' 19' ' ' PHE . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.449 HG13 ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 26' ' ' VAL . . . . . 0.449 ' N ' HG13 ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.433 HG21 ' HB ' ' C' ' 32' ' ' VAL . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.53 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 29' ' ' ALA . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.588 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 44' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.555 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.549 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' D' ' 58' ' ' PRO . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.429 ' N ' ' ND1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.478 ' O ' HD13 ' E' ' 8' ' ' LEU . 1.9 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.425 ' H ' HG23 ' E' ' 7' ' ' VAL . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.571 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 17' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' E' ' 13' ' ' ALA . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.599 ' O ' HG23 ' E' ' 27' ' ' THR . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 24' ' ' LEU . . . . . 0.575 HD23 ' O ' ' E' ' 24' ' ' LEU . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.599 HG23 ' O ' ' E' ' 23' ' ' LEU . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.459 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.632 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.412 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.401 ' C ' ' O ' ' E' ' 40' ' ' ALA . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 50' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 53' ' ' VAL . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.56 ' N ' HD12 ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.539 ' N ' HD22 ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.424 HG22 ' O ' ' E' ' 50' ' ' LEU . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.472 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.428 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.565 HG21 ' HB ' ' E' ' 32' ' ' VAL . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' F' ' 29' ' ' ALA . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.561 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.56 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.692 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.576 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.54 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' F' ' 56' ' ' LEU . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.568 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' O ' HD13 ' A' ' 8' ' ' LEU . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' B' ' 5' ' ' VAL . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.476 HG21 ' HB ' ' F' ' 32' ' ' VAL . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 29' ' ' ALA . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' B' ' 5' ' ' VAL . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.594 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 32' ' ' VAL . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.552 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.856 ' O ' HG22 ' B' ' 53' ' ' VAL . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' VAL . . . . . 0.856 HG22 ' O ' ' B' ' 50' ' ' LEU . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.54 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.454 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.52 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.552 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.52 HG22 ' O ' ' C' ' 29' ' ' ALA . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.691 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.705 ' O ' HG22 ' C' ' 41' ' ' THR . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.705 HG22 ' O ' ' C' ' 38' ' ' PRO . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.485 ' O ' HD13 ' D' ' 8' ' ' LEU . 82.6 m-20 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' E' ' 5' ' ' VAL . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.485 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' E' ' 5' ' ' VAL . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' B' ' 53' ' ' VAL . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.41 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' TRP . . . . . 0.51 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.592 ' HB ' HG21 ' E' ' 27' ' ' THR . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.609 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.629 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 6' ' ' ILE . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.41 HG23 ' H ' ' E' ' 7' ' ' VAL . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.441 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.592 HG21 ' HB ' ' D' ' 32' ' ' VAL . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.424 ' H ' HG22 ' E' ' 32' ' ' VAL . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.631 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 47' ' ' VAL . . . . . 0.487 HG22 ' O ' ' E' ' 47' ' ' VAL . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.493 HD13 ' O ' ' E' ' 51' ' ' LEU . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 3' ' ' LYS . . . . . 0.412 ' O ' HG23 ' F' ' 5' ' ' VAL . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' F' ' 4' ' ' ASN . 0.6 OUTLIER 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.604 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.412 ' H ' HG23 ' F' ' 7' ' ' VAL . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.587 ' N ' HD12 ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.564 ' O ' HG22 ' F' ' 27' ' ' THR . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.564 HG22 ' O ' ' F' ' 23' ' ' LEU . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 28' ' ' LEU . . . . . 0.483 ' N ' HG23 ' F' ' 27' ' ' THR . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 27' ' ' THR . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.405 HD12 ' OG1' ' A' ' 27' ' ' THR . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.46 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.721 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.574 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' NZ ' HG21 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' HD13 ' A' ' 8' ' ' LEU . 68.6 m-80 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 17' ' ' HIS . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' HG11 ' E' ' 53' ' ' VAL . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 27' ' ' THR . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 23' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.554 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.554 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 48' ' ' TRP . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 53' ' ' VAL . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ARG . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' O ' HD11 ' E' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.44 ' O ' HD13 ' B' ' 8' ' ' LEU . 30.1 m120 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.443 HG21 ' NZ ' ' A' ' 3' ' ' LYS . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.44 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.673 ' ND2' ' NE1' ' B' ' 21' ' ' TRP . 11.4 t-20 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.673 ' NE1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 36' ' ' LEU . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 29' ' ' ALA . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.68 HD23 ' O ' ' B' ' 36' ' ' LEU . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.411 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' B' ' 43' ' ' LEU . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.589 HD13 ' O ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.54 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.536 HH21 HD11 ' B' ' 50' ' ' LEU . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' C' ' 8' ' ' LEU . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.407 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.419 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.452 HG23 ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.452 ' N ' HG23 ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.495 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.492 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.576 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.603 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 37' ' ' VAL . . . . . 0.438 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' C' ' 51' ' ' LEU . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.511 HG11 ' CE2' ' E' ' 19' ' ' PHE . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.565 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.423 ' O ' HD13 ' D' ' 8' ' ' LEU . 4.2 m-20 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.439 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 6' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' E' ' 5' ' ' VAL . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.423 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ASN . . . . . 0.587 ' ND2' ' CE2' ' D' ' 21' ' ' TRP . 16.6 t-20 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.587 ' CE2' ' ND2' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.556 ' O ' HG23 ' D' ' 27' ' ' THR . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.556 HG23 ' O ' ' D' ' 23' ' ' LEU . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.583 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.482 HG23 ' H ' ' D' ' 37' ' ' VAL . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' LEU . . . . . 0.487 ' O ' HD12 ' D' ' 43' ' ' LEU . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.471 ' N ' HD12 ' D' ' 51' ' ' LEU . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' D' ' 55' ' ' LEU . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.926 HD21 ' N ' ' E' ' 4' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.552 ' H ' HD12 ' E' ' 6' ' ' ILE . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 63' ' ' ALA . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.484 ' C ' HD21 ' E' ' 16' ' ' ASN . 0.4 OUTLIER -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' E' ' 18' ' ' GLY . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 22' ' ' GLY . . . . . 0.404 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.456 ' O ' HG23 ' E' ' 27' ' ' THR . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.413 HG13 ' H ' ' E' ' 25' ' ' VAL . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.636 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.459 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.572 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.507 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 52' ' ' LEU . . . . . 0.453 ' N ' HD22 ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 19' ' ' PHE . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.507 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.48 HG23 ' H ' ' F' ' 5' ' ' VAL . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.429 HG22 ' CG1' ' A' ' 5' ' ' VAL . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.438 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 22' ' ' GLY . . . . . 0.403 ' O ' HG12 ' F' ' 25' ' ' VAL . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' F' ' 19' ' ' PHE . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.618 HG22 HD12 ' E' ' 36' ' ' LEU . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.586 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.654 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.586 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.654 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.566 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.441 ' H ' HG23 ' F' ' 37' ' ' VAL . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.468 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.693 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.72 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.58 HD22 ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.461 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.567 ' N ' HD22 ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 7' ' ' VAL . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.512 ' N ' HG13 ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 23' ' ' LEU . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 19' ' ' PHE . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HG ' ' F' ' 36' ' ' LEU . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 32' ' ' VAL . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 36' ' ' LEU . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.488 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 52' ' ' LEU . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 3.4 t60 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.413 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 5' ' ' VAL . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.413 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.537 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.537 HG22 ' O ' ' B' ' 29' ' ' ALA . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' C' ' 27' ' ' THR . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.504 ' O ' HG22 ' B' ' 47' ' ' VAL . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LEU . . . . . 0.656 HD13 ' O ' ' B' ' 50' ' ' LEU . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.604 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 3' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 7' ' ' VAL . . . . . 0.472 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' E' ' 63' ' ' ALA . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.63 ' O ' HG23 ' C' ' 27' ' ' THR . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.465 ' CD1' HG11 ' B' ' 32' ' ' VAL . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 23' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' D' ' 24' ' ' LEU . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.62 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 52' ' ' LEU . . . . . 0.501 HD22 ' N ' ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' C' ' 49' ' ' PRO . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' C' ' 58' ' ' PRO . 29.0 m80 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' VAL . . . . . 0.433 HG13 ' N ' ' D' ' 8' ' ' LEU . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.434 HD21 ' N ' ' F' ' 63' ' ' ALA . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ASN . . . . . 0.564 ' ND2' ' CE2' ' D' ' 21' ' ' TRP . 28.7 t-20 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' LEU . . . . . 0.715 ' H ' HD12 ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 25' ' ' VAL . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' E' ' 24' ' ' LEU . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.648 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' D' ' 58' ' ' PRO . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.577 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 4' ' ' ASN . . . . . 0.48 ' O ' HD13 ' E' ' 8' ' ' LEU . 7.5 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.926 0.394 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.566 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' E' ' 27' ' ' THR . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 24' ' ' LEU . . . . . 0.495 HD22 ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' E' ' 23' ' ' LEU . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.46 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.548 ' HB ' HG21 ' F' ' 27' ' ' THR . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.587 HD23 ' O ' ' E' ' 36' ' ' LEU . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 41' ' ' THR . . . . . 0.449 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.554 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.543 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' E' E ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.55 ' HB3' HD22 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.424 ' H ' HG23 ' F' ' 7' ' ' VAL . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.476 HG23 ' H ' ' F' ' 5' ' ' VAL . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.436 HG22 ' CG1' ' A' ' 5' ' ' VAL . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 7' ' ' VAL . . . . . 0.424 HG23 ' H ' ' F' ' 4' ' ' ASN . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.548 HG21 ' HB ' ' E' ' 32' ' ' VAL . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.451 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.451 HG22 ' O ' ' F' ' 29' ' ' ALA . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.651 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.679 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 51' ' ' LEU . . . . . 0.638 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 60' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' F' ' 60' ' ' ARG . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' F' F ' 63' ' ' ALA . . . . . 0.434 ' N ' HD21 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.473 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.8 m-20 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' B' ' 5' ' ' VAL . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' E' ' 53' ' ' VAL . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' F' ' 32' ' ' VAL . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' F' ' 32' ' ' VAL . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' ALA . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.48 ' CB ' HD23 ' A' ' 45' ' ' LEU . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 3.0 t60 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.444 ' C ' ' HZ2' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' ALA . . . . . 0.513 ' N ' ' NZ ' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 5' ' ' VAL . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.476 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.447 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' H ' ' B' ' 4' ' ' ASN . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' E' ' 63' ' ' ALA . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.426 ' HB3' ' H ' ' B' ' 20' ' ' PHE . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.426 ' H ' ' HB3' ' B' ' 19' ' ' PHE . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.429 ' H ' ' CD2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 25' ' ' VAL . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' LEU . . . . . 0.812 ' O ' HG23 ' B' ' 27' ' ' THR . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 22' ' ' GLY . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 23' ' ' LEU . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 29' ' ' ALA . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HG21 ' C' ' 27' ' ' THR . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.512 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.492 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 17.7 m80 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.631 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.492 HD22 ' N ' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 5' ' ' VAL . . . . . 0.445 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.401 HD13 ' O ' ' C' ' 4' ' ' ASN . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' LEU . . . . . 0.624 ' O ' HG23 ' C' ' 27' ' ' THR . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 27' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 23' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.559 HD23 ' O ' ' C' ' 28' ' ' LEU . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.512 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.6 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.725 ' O ' HD23 ' C' ' 36' ' ' LEU . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.491 ' O ' HG23 ' C' ' 41' ' ' THR . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.478 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' E' ' 19' ' ' PHE . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.583 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' LEU . . . . . 0.661 HD23 ' H ' ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 8' ' ' LEU . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.421 HG23 ' H ' ' D' ' 5' ' ' VAL . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' THR . . . . . 0.402 HG23 ' N ' ' D' ' 28' ' ' LEU . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.402 ' N ' HG23 ' D' ' 27' ' ' THR . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.488 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ARG . . . . . 0.474 HH21 ' CE1' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.633 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.466 HG23 ' H ' ' D' ' 37' ' ' VAL . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.523 HD23 ' O ' ' D' ' 51' ' ' LEU . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 56' ' ' LEU . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 63' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' D' ' 10' ' ' ALA . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 7' ' ' VAL . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.579 ' N ' HD12 ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' C' ' 53' ' ' VAL . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' E' ' 27' ' ' THR . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' E' ' 23' ' ' LEU . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 29' ' ' ALA . . . . . 0.516 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 31' ' ' HIS . . . . . 0.474 ' CE1' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' E' ' 29' ' ' ALA . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.676 ' C ' HD13 ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 53' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' E' E ' 63' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' B' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.425 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 16' ' ' ASN . . . . . 0.668 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 36.4 t30 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.668 ' CZ2' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.487 ' O ' HG23 ' F' ' 27' ' ' THR . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.487 HG23 ' O ' ' F' ' 23' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 29' ' ' ALA . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.565 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.55 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.55 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' F' ' 53' ' ' VAL . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' F' F ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' F' F ' 60' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 61' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 62' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.795 ' N ' ' HZ1' ' F' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' HD13 ' A' ' 8' ' ' LEU . 8.2 p-10 -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' HG21 ' A' ' 25' ' ' VAL . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 19' ' ' PHE . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.472 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.505 HG21 ' HB ' ' F' ' 32' ' ' VAL . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ALA . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 36' ' ' LEU . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ASN . . . . . 0.445 ' O ' HD13 ' B' ' 8' ' ' LEU . 13.0 m120 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' F' ' 50' ' ' LEU . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.477 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.56 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 29' ' ' ALA . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.554 HD23 ' O ' ' B' ' 36' ' ' LEU . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.552 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 4' ' ' ASN . . . . . 0.403 ' O ' HD13 ' C' ' 8' ' ' LEU . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' LEU . . . . . 0.403 HD13 ' O ' ' C' ' 4' ' ' ASN . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' B' ' 32' ' ' VAL . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 31' ' ' HIS . . . . . 0.428 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 33' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 36' ' ' LEU . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' THR . . . . . 0.49 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.591 ' N ' HD12 ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' E' ' 19' ' ' PHE . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' LEU . . . . . 0.535 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' HIS . . . . . 0.676 ' NE2' ' HB3' ' F' ' 14' ' ' ALA . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' F' ' 11' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 3' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 5' ' ' VAL . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' ALA . . . . . 0.405 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' D' ' 23' ' ' LEU . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' LEU . . . . . 0.481 HD11 ' CZ ' ' D' ' 19' ' ' PHE . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' VAL . . . . . 0.435 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' LEU . . . . . 0.554 HD23 ' O ' ' D' ' 28' ' ' LEU . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' D' ' 29' ' ' ALA . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 50' ' ' LEU . . . . . 0.63 ' O ' HG22 ' D' ' 53' ' ' VAL . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' VAL . . . . . 0.63 HG22 ' O ' ' D' ' 50' ' ' LEU . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' LEU . . . . . 0.533 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 56' ' ' LEU . . . . . 0.545 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' E' E ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 6' ' ' ILE . . . . . 0.416 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 7' ' ' VAL . . . . . 0.486 HG23 ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 8' ' ' LEU . . . . . 0.486 ' N ' HG23 ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 19' ' ' PHE . . . . . 0.452 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' E' ' 18' ' ' GLY . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 23' ' ' LEU . . . . . 0.594 ' O ' HG23 ' E' ' 27' ' ' THR . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 27' ' ' THR . . . . . 0.594 HG23 ' O ' ' E' ' 23' ' ' LEU . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 36' ' ' LEU . . . . . 0.714 HD23 ' O ' ' E' ' 36' ' ' LEU . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 51' ' ' LEU . . . . . 0.49 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 56' ' ' LEU . . . . . 0.516 ' HG ' ' CE1' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 59' ' ' HIS . . . . . 0.516 ' CE1' ' HG ' ' E' ' 56' ' ' LEU . 14.3 m80 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 3' ' ' LYS . . . . . 0.795 ' HZ1' ' N ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 4' ' ' ASN . . . . . 0.45 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 5' ' ' VAL . . . . . 0.416 ' CG1' HG22 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' F' F ' 6' ' ' ILE . . . . . 0.619 ' H ' HD12 ' F' ' 6' ' ' ILE . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 8' ' ' LEU . . . . . 0.536 ' N ' HD12 ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 10' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' C' ' 61' ' ' ALA . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 14' ' ' ALA . . . . . 0.676 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 15' ' ' GLY . . . . . 0.507 ' N ' ' NE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 23' ' ' LEU . . . . . 0.471 ' O ' HG22 ' F' ' 27' ' ' THR . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 27' ' ' THR . . . . . 0.471 HG22 ' O ' ' F' ' 23' ' ' LEU . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 28' ' ' LEU . . . . . 0.429 ' N ' HG23 ' F' ' 27' ' ' THR . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 29' ' ' ALA . . . . . 0.411 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 32' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 27' ' ' THR . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 36' ' ' LEU . . . . . 0.623 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 43' ' ' LEU . . . . . 0.552 HD12 ' N ' ' F' ' 43' ' ' LEU . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 44' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 48' ' ' TRP . . . . . 0.663 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 49' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 50' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' B' ' 19' ' ' PHE . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 55' ' ' LEU . . . . . 0.549 ' N ' HD12 ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.76 -57.85 3.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' A' ' 8' ' ' LEU . 27.0 m120 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.602 HG21 ' HB ' ' F' ' 32' ' ' VAL . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 29' ' ' ALA . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.632 HD23 ' CB ' ' A' ' 48' ' ' TRP . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.632 ' CB ' HD23 ' A' ' 45' ' ' LEU . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PRO . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.508 ' O ' HD13 ' B' ' 8' ' ' LEU . 2.2 p-10 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.508 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.646 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.646 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.761 ' O ' HG23 ' B' ' 27' ' ' THR . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.402 ' H ' HG22 ' B' ' 25' ' ' VAL . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.761 HG23 ' O ' ' B' ' 23' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' C' ' 24' ' ' LEU . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.65 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.471 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.411 HD22 ' N ' ' B' ' 50' ' ' LEU . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.469 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.7 m80 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.429 HG23 ' H ' ' C' ' 5' ' ' VAL . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 28' ' ' LEU . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.65 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.43 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ARG . . . . . 0.661 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.566 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' E' ' 19' ' ' PHE . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.517 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.556 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' C' ' 60' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 12.1 t60 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' E' ' 5' ' ' VAL . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.434 HG13 ' N ' ' D' ' 8' ' ' LEU . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.434 ' N ' HG13 ' D' ' 7' ' ' VAL . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' D' ' 17' ' ' HIS . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 27' ' ' THR . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.402 HG12 ' H ' ' D' ' 25' ' ' VAL . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.661 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.559 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.527 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' D' ' 62' ' ' LEU . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.79 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.746 0.308 . . . . 0.0 110.495 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' E' ' 5' ' ' VAL . 9.7 mmtp -87.84 -176.44 5.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' E' ' 3' ' ' LYS . 0.2 OUTLIER 75.95 -41.8 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.804 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.473 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.438 HG22 ' CG1' ' F' ' 5' ' ' VAL . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.517 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.411 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.476 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.411 HG22 ' O ' ' E' ' 22' ' ' GLY . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.476 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' F' ' 27' ' ' THR . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.571 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.514 ' CZ3' HD13 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.466 ' N ' HD12 ' E' ' 51' ' ' LEU . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' E' ' 48' ' ' TRP . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.559 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' E' ' 6' ' ' ILE . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 5' ' ' VAL . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.401 HG23 ' H ' ' F' ' 7' ' ' VAL . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' LEU . . . . . 0.469 HD12 HG11 ' E' ' 32' ' ' VAL . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.517 HG21 ' HB ' ' E' ' 32' ' ' VAL . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.437 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 27' ' ' THR . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.595 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.658 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.718 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.641 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.499 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 16.1 t60 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.0 17.02 0.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' HD13 ' A' ' 8' ' ' LEU . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 61' ' ' ALA . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' F' ' 32' ' ' VAL . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.638 HG21 ' HB ' ' F' ' 32' ' ' VAL . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 HD23 ' C ' ' A' ' 43' ' ' LEU . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.527 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.521 ' O ' HD13 ' B' ' 8' ' ' LEU . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 6' ' ' ILE . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' C' ' 5' ' ' VAL . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 22.7 m120 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 25' ' ' VAL . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 32' ' ' VAL . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.431 HD23 ' O ' ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.625 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.436 ' H ' HD12 ' B' ' 43' ' ' LEU . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.512 HG13 ' O ' ' B' ' 47' ' ' VAL . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.605 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.412 ' O ' HG12 ' C' ' 7' ' ' VAL . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' B' ' 10' ' ' ALA . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.477 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.477 ' N ' HG13 ' C' ' 7' ' ' VAL . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.552 ' O ' HG23 ' C' ' 27' ' ' THR . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' C' ' 23' ' ' LEU . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.563 ' O ' HD13 ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.625 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.416 ' H ' HG22 ' C' ' 32' ' ' VAL . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.41 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.582 ' O ' HD23 ' C' ' 56' ' ' LEU . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' C' ' 58' ' ' PRO . 0.1 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.55 HD23 ' H ' ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.53 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 15.6 m120 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' E' ' 5' ' ' VAL . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.518 ' O ' HG23 ' D' ' 27' ' ' THR . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' D' ' 23' ' ' LEU . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.521 ' O ' HD13 ' D' ' 28' ' ' LEU . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.497 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.497 HG22 ' O ' ' D' ' 29' ' ' ALA . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.62 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.589 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.543 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.542 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.423 ' HB2' ' HZ1' ' D' ' 3' ' ' LYS . . . 48.03 16.77 0.09 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' E' ' 1' ' ' GLY . 36.4 mmtt -137.25 72.9 1.43 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.149 0.5 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -159.45 -28.37 0.07 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.43 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' CD1' ' E' ' 21' ' ' TRP . 0.5 OUTLIER -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.422 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.501 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.407 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.655 ' O ' HG23 ' E' ' 27' ' ' THR . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 24' ' ' LEU . . . . . 0.43 ' CD1' HG11 ' D' ' 32' ' ' VAL . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.407 HG12 ' O ' ' E' ' 22' ' ' GLY . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.655 HG23 ' O ' ' E' ' 23' ' ' LEU . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 28' ' ' LEU . . . . . 0.462 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.442 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.471 ' HB ' HG21 ' F' ' 27' ' ' THR . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.624 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 47' ' ' VAL . . . . . 0.409 ' O ' HG12 ' E' ' 47' ' ' VAL . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 55' ' ' LEU . . . . . 0.546 ' N ' HD22 ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.62 HD12 ' N ' ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.485 ' C ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' E' ' 61' ' ' ALA . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.444 ' O ' HD13 ' F' ' 8' ' ' LEU . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' E' ' 6' ' ' ILE . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.444 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.471 HG21 ' HB ' ' E' ' 32' ' ' VAL . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 31' ' ' HIS . . . . . 0.404 ' NE2' ' NH2' ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 27' ' ' THR . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 35' ' ' ARG . . . . . 0.404 ' NH2' ' NE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.627 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.603 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 45' ' ' LEU . . . . . 0.553 HD22 ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.553 ' CE3' HD22 ' F' ' 45' ' ' LEU . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.02 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' B' ' 5' ' ' VAL . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 27' ' ' THR . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 23' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 29' ' ' ALA . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' A' ' 51' ' ' LEU . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 47' ' ' VAL . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 55' ' ' LEU . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.523 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.466 ' O ' HD13 ' B' ' 8' ' ' LEU . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.446 HG23 ' H ' ' B' ' 5' ' ' VAL . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.419 HG22 ' CG1' ' C' ' 5' ' ' VAL . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.466 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.613 ' N ' HD12 ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 47' ' ' VAL . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.605 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.425 HG11 ' CE1' ' D' ' 19' ' ' PHE . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' C' ' 4' ' ' ASN . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.46 HD21 ' C ' ' E' ' 63' ' ' ALA . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' O ' ' ND1' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' ALA . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.64 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.435 ' C ' ' O ' ' C' ' 40' ' ' ALA . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.522 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.514 HD13 ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.485 HG23 ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' C' ' 10' ' ' ALA . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' D' ' 25' ' ' VAL . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 48.3 t-80 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG21 ' E' ' 27' ' ' THR . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.547 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.562 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.573 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.57 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.562 ' N ' HD12 ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' E' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.82 40.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.6 ' O ' HG23 ' E' ' 7' ' ' VAL . 0.1 OUTLIER -75.21 -46.1 36.16 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 -73.4 52.98 0.39 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' E' ' 1' ' ' GLY . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.6 HG23 ' O ' ' E' ' 3' ' ' LYS . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.606 ' N ' HD12 ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.635 HG21 ' HB ' ' D' ' 32' ' ' VAL . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.428 ' H ' HG22 ' E' ' 32' ' ' VAL . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.697 HD23 ' O ' ' E' ' 36' ' ' LEU . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.48 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.573 ' H ' HD23 ' E' ' 43' ' ' LEU . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' E' ' 44' ' ' SER . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.877 ' O ' HG22 ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.877 HG22 ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 55' ' ' LEU . . . . . 0.509 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.536 HD23 ' O ' ' E' ' 56' ' ' LEU . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.609 ' O ' ' HB3' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.512 HD23 ' O ' ' E' ' 62' ' ' LEU . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.46 ' C ' HD21 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.44 HG23 ' H ' ' F' ' 5' ' ' VAL . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.684 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.455 ' O ' HG22 ' F' ' 27' ' ' THR . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 25' ' ' VAL . . . . . 0.444 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.455 HG22 ' O ' ' F' ' 23' ' ' LEU . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.726 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.48 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.726 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.608 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.543 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.596 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.508 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 14.1 m80 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' C' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.18 86.21 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.43 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 0.9 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 8' ' ' LEU . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.498 ' N ' HG13 ' A' ' 7' ' ' VAL . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 19' ' ' PHE . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' CD ' ' N ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.553 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.49 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' C' ' 19' ' ' PHE . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.404 ' O ' HD13 ' B' ' 8' ' ' LEU . 79.6 m-20 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 6' ' ' ILE . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' C' ' 5' ' ' VAL . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.404 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' E' ' 59' ' ' HIS . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.1 t-80 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.63 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.731 ' O ' HG23 ' B' ' 27' ' ' THR . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 23' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.401 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.537 ' N ' HD12 ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.561 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.445 HG13 ' N ' ' C' ' 8' ' ' LEU . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.445 ' N ' HG13 ' C' ' 7' ' ' VAL . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.406 HG12 ' H ' ' C' ' 25' ' ' VAL . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.401 HG23 ' CZ2' ' C' ' 30' ' ' TRP . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.536 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.569 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.428 ' O ' HD13 ' D' ' 8' ' ' LEU . 88.5 m-20 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.557 ' H ' HD12 ' D' ' 6' ' ' ILE . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 4' ' ' ASN . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.408 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.485 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.557 HD23 ' O ' ' D' ' 28' ' ' LEU . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.453 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' E' ' 27' ' ' THR . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.59 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.575 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.648 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.504 ' N ' HD22 ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.05 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' E' ' 1' ' ' GLY . 30.6 mmtt -77.94 -162.08 0.3 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.432 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' E' ' 7' ' ' VAL . 9.2 t30 78.31 -47.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 21.4 m-20 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' E' ' 19' ' ' PHE . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.616 HG21 ' HB ' ' D' ' 32' ' ' VAL . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' E' ' 33' ' ' LYS . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.612 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' B' ' 14' ' ' ALA . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.48 ' O ' HG23 ' F' ' 7' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.639 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.48 HG23 ' O ' ' F' ' 3' ' ' LYS . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' C' ' 63' ' ' ALA . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 16' ' ' ASN . . . . . 0.66 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 21.5 t-20 -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.66 ' CZ2' ' ND2' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' E' ' 32' ' ' VAL . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.4 HG22 ' H ' ' F' ' 32' ' ' VAL . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.612 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.56 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 47' ' ' VAL . . . . . 0.461 ' O ' HG12 ' F' ' 47' ' ' VAL . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.686 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.567 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.535 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 56' ' ' LEU . . . . . 0.526 ' N ' HD12 ' F' ' 56' ' ' LEU . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.4 139.15 57.98 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' HD13 ' A' ' 8' ' ' LEU . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' THR . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 23' ' ' LEU . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.525 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.525 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 52' ' ' LEU . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD23 ' O ' ' A' ' 55' ' ' LEU . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 58' ' ' PRO . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.575 ' H ' HD12 ' B' ' 6' ' ' ILE . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.5 m120 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 27' ' ' THR . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.708 HG23 ' O ' ' B' ' 23' ' ' LEU . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 32' ' ' VAL . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.445 HD23 ' O ' ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.637 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.483 HG23 ' O ' ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.54 ' N ' HD12 ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' B' ' 55' ' ' LEU . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.563 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' C' ' 27' ' ' THR . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.416 ' H ' HG12 ' C' ' 25' ' ' VAL . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' C' ' 23' ' ' LEU . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.637 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.567 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.587 ' O ' HD13 ' C' ' 50' ' ' LEU . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.502 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' E' ' 19' ' ' PHE . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' E' ' 5' ' ' VAL . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.404 HG23 ' O ' ' D' ' 3' ' ' LYS . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' HIS . . . . . 0.525 ' N ' ' ND1' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.533 ' O ' HG23 ' D' ' 27' ' ' THR . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.533 HG23 ' O ' ' D' ' 23' ' ' LEU . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' E' ' 27' ' ' THR . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.582 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.564 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.553 ' N ' HD22 ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.601 ' N ' HD12 ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' F' ' 19' ' ' PHE . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.514 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.441 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.441 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.82 160.81 22.74 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.482 ' O ' ' ND2' ' E' ' 4' ' ' ASN . 13.9 tptt 51.24 51.06 17.7 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' E' ' 3' ' ' LYS . 29.3 m120 -149.6 13.44 0.83 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.08 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.603 ' H ' HD12 ' E' ' 6' ' ' ILE . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.523 HD22 ' HB1' ' D' ' 10' ' ' ALA . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.457 ' ND2' ' CE2' ' E' ' 21' ' ' TRP . 10.6 t-20 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.53 HG21 ' HB ' ' D' ' 32' ' ' VAL . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 28' ' ' LEU . . . . . 0.525 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.511 ' HB ' HG21 ' F' ' 27' ' ' THR . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 35' ' ' ARG . . . . . 0.699 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.637 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' E' ' 40' ' ' ALA . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.577 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.54 ' N ' HD12 ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 55' ' ' LEU . . . . . 0.524 HD12 ' N ' ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.435 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.61 ' N ' HD12 ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.531 ' O ' ' ND2' ' F' ' 4' ' ' ASN . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' F' ' 3' ' ' LYS . 31.3 m120 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.417 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.403 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.438 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 29.4 m120 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.479 ' CE1' HG11 ' D' ' 53' ' ' VAL . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 24' ' ' LEU . . . . . 0.41 ' CD1' HG11 ' E' ' 32' ' ' VAL . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.511 HG21 ' HB ' ' E' ' 32' ' ' VAL . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.466 ' CH2' ' CE1' ' A' ' 20' ' ' PHE . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 31' ' ' HIS . . . . . 0.699 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 27' ' ' THR . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.585 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 47' ' ' VAL . . . . . 0.683 HG22 ' O ' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.605 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.613 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 15.0 m80 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.98 -73.01 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 8' ' ' LEU . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG22 ' CG1' ' B' ' 5' ' ' VAL . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 25' ' ' VAL . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 23' ' ' LEU . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.609 ' CD2' ' HB1' ' D' ' 11' ' ' ALA . 9.2 t60 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.484 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.534 ' H ' HD12 ' B' ' 6' ' ' ILE . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 18' ' ' GLY . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.436 ' N ' ' ND1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.877 ' O ' HG23 ' B' ' 27' ' ' THR . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 23' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.822 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.822 HG12 ' O ' ' B' ' 29' ' ' ALA . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' THR . . . . . 0.476 ' C ' ' O ' ' B' ' 40' ' ' ALA . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' B' ' 41' ' ' THR . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.54 ' O ' HD23 ' B' ' 50' ' ' LEU . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.651 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.54 HD23 ' O ' ' B' ' 46' ' ' GLY . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.681 ' N ' HD22 ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.605 ' CG2' HD21 ' D' ' 23' ' ' LEU . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.525 HD23 ' O ' ' B' ' 55' ' ' LEU . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.3 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.547 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.513 ' HZ1' ' HB2' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.496 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' C' ' 5' ' ' VAL . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' F' ' 59' ' ' HIS . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' GLY . . . . . 0.432 ' O ' HG12 ' C' ' 25' ' ' VAL . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 22' ' ' GLY . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.532 HG22 ' CH2' ' C' ' 30' ' ' TRP . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.449 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.556 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.603 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.415 ' H ' HG13 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.495 ' CD2' ' HA2' ' F' ' 15' ' ' GLY . 0.1 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.513 ' HB2' ' HZ1' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.707 ' HZ2' ' CA ' ' E' ' 1' ' ' GLY . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.425 ' O ' HD13 ' D' ' 8' ' ' LEU . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' C' ' 6' ' ' ILE . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.474 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 4' ' ' ASN . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.609 ' HB1' ' CD2' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.605 HD21 ' CG2' ' B' ' 53' ' ' VAL . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.417 HG22 ' H ' ' D' ' 25' ' ' VAL . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 23' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.491 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.491 HG22 ' O ' ' D' ' 29' ' ' ALA . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.552 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.502 ' C ' HD22 ' D' ' 43' ' ' LEU . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.502 HD22 ' C ' ' D' ' 42' ' ' TYR . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.477 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.561 ' N ' HD12 ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 49' ' ' PRO . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.556 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.549 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.534 ' N ' HD12 ' D' ' 62' ' ' LEU . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.707 ' CA ' ' HZ2' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.626 ' N ' ' NZ ' ' D' ' 3' ' ' LYS . . . 70.05 -39.09 0.43 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.693 0.283 . . . . 0.0 110.913 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' E' ' 1' ' ' GLY . 1.9 mptm? -91.54 -171.79 3.03 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.795 0.331 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.461 ' H ' ' CG2' ' E' ' 7' ' ' VAL . 2.2 m120 70.81 1.61 3.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.564 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.718 ' O ' HG23 ' E' ' 27' ' ' THR . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.718 HG23 ' O ' ' E' ' 23' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.412 ' C ' ' O ' ' E' ' 40' ' ' ALA . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 45' ' ' LEU . . . . . 0.473 HD13 ' HZ2' ' F' ' 33' ' ' LYS . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.543 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.427 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 13' ' ' ALA . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 10' ' ' ALA . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 15' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' C' ' 59' ' ' HIS . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 16' ' ' ASN . . . . . 0.487 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 23.8 t-20 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.551 HG21 ' HB ' ' E' ' 32' ' ' VAL . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.426 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.426 HG22 ' O ' ' F' ' 29' ' ' ALA . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.473 ' HZ2' HD13 ' E' ' 45' ' ' LEU . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.584 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 53' ' ' VAL . . . . . 0.426 ' H ' HG13 ' F' ' 53' ' ' VAL . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 56' ' ' LEU . . . . . 0.586 HD23 ' O ' ' F' ' 56' ' ' LEU . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.424 ' CE1' ' HB1' ' C' ' 11' ' ' ALA . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 60' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 61' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.449 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.21 12.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 HG22 ' CG1' ' B' ' 5' ' ' VAL . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.542 HG21 HG22 ' F' ' 32' ' ' VAL . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' ALA . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.893 HD12 HG22 ' B' ' 27' ' ' THR . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HZ3' ' C ' ' C' ' 1' ' ' GLY . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' E' ' 63' ' ' ALA . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.855 ' O ' HG23 ' B' ' 27' ' ' THR . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.893 HG22 HD12 ' A' ' 36' ' ' LEU . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.451 HD12 HG21 ' C' ' 27' ' ' THR . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.443 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.58 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.563 ' O ' HG22 ' B' ' 53' ' ' VAL . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.563 HG22 ' O ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.4 ' O ' ' O ' ' B' ' 58' ' ' PRO . 29.6 m80 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HZ3' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' D' ' 5' ' ' VAL . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.45 ' H ' HG22 ' C' ' 7' ' ' VAL . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' ASN . . . . . 0.426 ' OD1' ' ND2' ' D' ' 9' ' ' ASN . 3.9 t-20 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.582 ' O ' HG23 ' C' ' 27' ' ' THR . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' C' ' 23' ' ' LEU . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.505 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.485 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' C' ' 33' ' ' LYS . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.505 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.611 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.43 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 40' ' ' ALA . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.659 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.481 HD23 ' C ' ' C' ' 43' ' ' LEU . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' E' ' 19' ' ' PHE . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' C' ' 59' ' ' HIS . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.538 ' C ' HD12 ' C' ' 62' ' ' LEU . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.519 ' N ' HD12 ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.473 ' O ' HG13 ' D' ' 7' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.572 HG22 HG11 ' E' ' 5' ' ' VAL . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.473 HG13 ' O ' ' D' ' 3' ' ' LYS . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.453 ' N ' HG23 ' D' ' 7' ' ' VAL . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' ASN . . . . . 0.426 ' ND2' ' OD1' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.474 ' O ' HD13 ' D' ' 23' ' ' LEU . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.52 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' D' ' 24' ' ' LEU . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.409 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.52 HG23 ' O ' ' D' ' 23' ' ' LEU . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.659 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.516 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.572 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.464 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.63 -98.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.681 0.276 . . . . 0.0 110.602 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -79.41 65.11 4.48 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.285 0.564 . . . . 0.0 110.145 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -154.03 34.2 0.43 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.572 HG11 HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' F' ' 5' ' ' VAL . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.475 HG23 ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' HG23 ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 41.1 m-20 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.485 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.424 ' H ' HG13 ' E' ' 25' ' ' VAL . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.449 ' H ' HG23 ' E' ' 27' ' ' THR . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' E' ' 29' ' ' ALA . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.582 HD23 ' O ' ' E' ' 36' ' ' LEU . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.403 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.697 ' O ' HG22 ' E' ' 41' ' ' THR . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.697 HG22 ' O ' ' E' ' 38' ' ' PRO . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.42 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' F' ' 4' ' ' ASN . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.549 ' N ' HD12 ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.441 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 16.9 m-80 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.421 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.763 ' O ' HG23 ' F' ' 27' ' ' THR . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.763 HG23 ' O ' ' F' ' 23' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.806 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.806 HG12 ' O ' ' F' ' 29' ' ' ALA . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 27' ' ' THR . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.662 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.735 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.64 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 60' ' ' ARG . . . . . 0.599 ' N ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.595 ' N ' HD22 ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.73 -88.57 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' A' ' 8' ' ' LEU . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 27' ' ' THR . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' GLY . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 23' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.688 ' CD2' HH12 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 29' ' ' ALA . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.688 HH12 ' CD2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.875 HD12 HG22 ' B' ' 27' ' ' THR . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.543 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' HB1' ' D' ' 11' ' ' ALA . 5.0 t60 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' B' ' 5' ' ' VAL . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.468 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' C' ' 5' ' ' VAL . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.42 HG23 ' H ' ' B' ' 7' ' ' VAL . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.554 ' N ' HD12 ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.496 ' ND2' ' CD2' ' B' ' 21' ' ' TRP . 7.1 t30 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 16' ' ' ASN . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.496 ' CD2' ' ND2' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.862 ' O ' HG23 ' B' ' 27' ' ' THR . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.875 HG22 HD12 ' A' ' 36' ' ' LEU . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 29' ' ' ALA . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.557 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 46' ' ' GLY . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.616 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.4 ' H ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.511 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.455 ' CE1' ' HB1' ' E' ' 11' ' ' ALA . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.489 HG12 ' O ' ' C' ' 3' ' ' LYS . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.456 ' N ' HG13 ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.463 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.461 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.557 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.581 ' HA ' ' HZ2' ' C' ' 33' ' ' LYS . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' HA ' ' C' ' 31' ' ' HIS . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.587 ' N ' HD12 ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.513 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' LEU . . . . . 0.507 ' N ' HD22 ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' E' ' 5' ' ' VAL . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.43 HG23 ' H ' ' D' ' 7' ' ' VAL . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.545 ' HB1' ' CD2' ' A' ' 59' ' ' HIS . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.55 ' O ' HG23 ' D' ' 27' ' ' THR . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.414 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 23' ' ' LEU . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' E' ' 27' ' ' THR . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.537 HH21 ' CD2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.564 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.578 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' LEU . . . . . 0.461 HD12 ' N ' ' D' ' 45' ' ' LEU . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.617 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' F' ' 19' ' ' PHE . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.543 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.448 ' ND1' ' HB1' ' A' ' 11' ' ' ALA . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' D' ' 62' ' ' LEU . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.2 -79.55 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.83 76.25 10.26 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.419 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.491 ' O ' HD13 ' E' ' 8' ' ' LEU . 23.4 m120 -162.84 2.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.468 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.413 HG23 ' H ' ' E' ' 7' ' ' VAL . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.496 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 10' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' F' ' 5' ' ' VAL . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' B' ' 59' ' ' HIS . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.438 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 24' ' ' LEU . . . . . 0.502 ' CD1' HG11 ' D' ' 32' ' ' VAL . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.438 HG12 ' O ' ' E' ' 22' ' ' GLY . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.6 HG21 ' HB ' ' D' ' 32' ' ' VAL . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.534 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 31' ' ' HIS . . . . . 0.537 ' CD2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.534 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.576 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.501 ' C ' ' CD1' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.615 ' O ' HG22 ' E' ' 53' ' ' VAL . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.615 HG22 ' O ' ' E' ' 50' ' ' LEU . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 55' ' ' LEU . . . . . 0.557 HD12 ' N ' ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.551 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.551 ' N ' HD12 ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' E' ' 10' ' ' ALA . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.47 HG22 ' CG1' ' A' ' 5' ' ' VAL . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.511 HG23 ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.511 ' N ' HG23 ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' D' ' 53' ' ' VAL . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.429 ' N ' HD12 ' F' ' 23' ' ' LEU . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 24' ' ' LEU . . . . . 0.558 HD23 ' O ' ' F' ' 24' ' ' LEU . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.447 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.447 HG22 ' O ' ' F' ' 29' ' ' ALA . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.554 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.557 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.567 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.553 ' N ' HD12 ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.437 ' O ' ' O ' ' F' ' 58' ' ' PRO . 10.1 m80 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.572 ' N ' HD12 ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.526 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.01 83.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HG2' ' HZ2' ' A' ' 3' ' ' LYS . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' B' ' 5' ' ' VAL . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' E' ' 53' ' ' VAL . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.62 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 47' ' ' VAL . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 5.6 t60 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.434 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.453 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 6' ' ' ILE . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' C' ' 20' ' ' PHE . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 29' ' ' ALA . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' N ' ' B' ' 35' ' ' ARG . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.615 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.58 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.479 ' N ' HD12 ' B' ' 45' ' ' LEU . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.647 HD12 ' N ' ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.579 ' N ' HD12 ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.434 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.439 ' O ' HD13 ' C' ' 8' ' ' LEU . 23.1 m120 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.406 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 10' ' ' ALA . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' F' ' 63' ' ' ALA . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.413 ' O ' HG13 ' C' ' 32' ' ' VAL . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.642 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.615 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.642 HG22 ' O ' ' C' ' 29' ' ' ALA . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.588 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.426 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.596 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' VAL . . . . . 0.476 ' O ' HG12 ' C' ' 47' ' ' VAL . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' E' ' 19' ' ' PHE . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.527 ' N ' HD22 ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 18.2 t60 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.55 ' NZ ' ' H ' ' E' ' 2' ' ' ALA . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.468 HG23 ' H ' ' D' ' 5' ' ' VAL . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.453 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.717 HD13 ' HB1' ' F' ' 63' ' ' ALA . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 25' ' ' VAL . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.58 ' CD2' HH12 ' D' ' 35' ' ' ARG . 1.7 t60 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.58 HH12 ' CD2' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' E' ' 27' ' ' THR . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.481 HG23 ' H ' ' D' ' 37' ' ' VAL . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.543 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.723 ' HE1' HD22 ' E' ' 36' ' ' LEU . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' D' ' 56' ' ' LEU . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.497 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.55 ' H ' ' NZ ' ' D' ' 3' ' ' LYS . . . 47.26 89.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.733 0.301 . . . . 0.0 110.599 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -154.72 -56.71 0.1 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' E' ' 8' ' ' LEU . 59.6 m-80 -43.14 -29.74 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' E' ' 4' ' ' ASN . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.48 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.648 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' D' ' 36' ' ' LEU . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.433 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.433 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.723 HD22 ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.52 ' OH ' ' NE1' ' F' ' 30' ' ' TRP . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.533 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 44' ' ' SER . . . . . 0.491 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.516 HD13 ' O ' ' E' ' 56' ' ' LEU . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.48 ' C ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 1' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.431 HG22 ' CG1' ' A' ' 5' ' ' VAL . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' F' ' 23' ' ' LEU . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.66 ' O ' HG23 ' F' ' 27' ' ' THR . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' E' ' 36' ' ' LEU . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.508 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.508 HG22 ' O ' ' F' ' 29' ' ' ALA . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.458 ' CB ' ' NZ ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.474 HG23 ' H ' ' F' ' 37' ' ' VAL . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.667 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.625 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.736 ' C ' HD22 ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . 60.33 142.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 27' ' ' THR . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' LEU . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.967 ' O ' HG22 ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.468 ' N ' HD12 ' A' ' 56' ' ' LEU . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.474 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.7 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.46 HG23 ' H ' ' B' ' 7' ' ' VAL . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.509 ' N ' HD12 ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.407 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 29' ' ' ALA . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.61 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.554 ' H ' ' HD2' ' B' ' 49' ' ' PRO . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.639 HD12 ' N ' ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.526 HG23 HD12 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.677 ' H ' HD12 ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.443 HG12 ' O ' ' C' ' 3' ' ' LYS . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.406 ' N ' HG13 ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.429 ' O ' HG23 ' C' ' 27' ' ' THR . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.433 ' H ' HG22 ' C' ' 25' ' ' VAL . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 23' ' ' LEU . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.574 HD23 ' O ' ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.794 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.511 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.515 ' O ' ' N ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.794 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.61 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.602 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.455 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.413 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.53 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.529 ' N ' HD12 ' C' ' 43' ' ' LEU . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.554 ' N ' HD12 ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' C' ' 10' ' ' ALA . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.483 HG22 ' CG1' ' E' ' 5' ' ' VAL . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.447 HG13 ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.447 ' N ' HG13 ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' D' ' 19' ' ' PHE . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.449 HG13 ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 26' ' ' VAL . . . . . 0.449 ' N ' HG13 ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.433 HG21 ' HB ' ' C' ' 32' ' ' VAL . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.53 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 29' ' ' ALA . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.588 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 44' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.475 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.555 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.549 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' D' ' 58' ' ' PRO . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.429 ' N ' ' ND1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.14 59.93 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.783 0.325 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.439 ' O ' HG23 ' E' ' 5' ' ' VAL . 38.1 mmtm -91.05 -169.56 2.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.478 ' O ' HD13 ' E' ' 8' ' ' LEU . 1.9 m-20 73.56 2.34 4.24 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.428 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.571 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 17' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' E' ' 13' ' ' ALA . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.599 ' O ' HG23 ' E' ' 27' ' ' THR . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 24' ' ' LEU . . . . . 0.575 HD23 ' O ' ' E' ' 24' ' ' LEU . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.599 HG23 ' O ' ' E' ' 23' ' ' LEU . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.459 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.632 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.412 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.401 ' C ' ' O ' ' E' ' 40' ' ' ALA . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 50' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 53' ' ' VAL . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.56 ' N ' HD12 ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.539 ' N ' HD22 ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.424 HG22 ' O ' ' E' ' 50' ' ' LEU . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.472 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.428 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.565 HG21 ' HB ' ' E' ' 32' ' ' VAL . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' F' ' 29' ' ' ALA . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.561 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.56 ' N ' HD22 ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.692 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.576 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.54 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 56' ' ' LEU . . . . . 0.48 ' N ' HD12 ' F' ' 56' ' ' LEU . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.568 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.65 62.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' O ' HD13 ' A' ' 8' ' ' LEU . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' B' ' 5' ' ' VAL . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.476 HG21 ' HB ' ' F' ' 32' ' ' VAL . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 29' ' ' ALA . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' B' ' 5' ' ' VAL . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.594 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 32' ' ' VAL . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.552 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.601 HD22 ' N ' ' B' ' 43' ' ' LEU . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.856 ' O ' HG22 ' B' ' 53' ' ' VAL . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' VAL . . . . . 0.856 HG22 ' O ' ' B' ' 50' ' ' LEU . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.54 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.454 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.52 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.552 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.52 HG22 ' O ' ' C' ' 29' ' ' ALA . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.691 ' O ' HD23 ' C' ' 36' ' ' LEU . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.705 ' O ' HG22 ' C' ' 41' ' ' THR . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.705 HG22 ' O ' ' C' ' 38' ' ' PRO . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.485 ' O ' HD13 ' D' ' 8' ' ' LEU . 82.6 m-20 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' E' ' 5' ' ' VAL . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.485 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' E' ' 5' ' ' VAL . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' B' ' 53' ' ' VAL . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.41 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' TRP . . . . . 0.51 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.592 ' HB ' HG21 ' E' ' 27' ' ' THR . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.609 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.629 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' E' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' E' ' 1' ' ' GLY . . . 65.63 138.89 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.498 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.496 ' O ' HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER 49.27 -171.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.049 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 42.07 22.0 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.046 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 6' ' ' ILE . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.41 HG23 ' H ' ' E' ' 7' ' ' VAL . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.46 ' C ' ' CD1' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.441 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.592 HG21 ' HB ' ' D' ' 32' ' ' VAL . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.424 ' H ' HG22 ' E' ' 32' ' ' VAL . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.631 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 47' ' ' VAL . . . . . 0.487 HG22 ' O ' ' E' ' 47' ' ' VAL . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.493 HD13 ' O ' ' E' ' 51' ' ' LEU . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.412 ' O ' HG23 ' F' ' 5' ' ' VAL . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.493 ' O ' ' ND2' ' F' ' 4' ' ' ASN . 0.6 OUTLIER 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.604 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.412 ' H ' HG23 ' F' ' 7' ' ' VAL . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.587 ' N ' HD12 ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.564 ' O ' HG22 ' F' ' 27' ' ' THR . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.564 HG22 ' O ' ' F' ' 23' ' ' LEU . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 28' ' ' LEU . . . . . 0.483 ' N ' HG23 ' F' ' 27' ' ' THR . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 27' ' ' THR . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.405 HD12 ' OG1' ' A' ' 27' ' ' THR . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.46 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.721 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.574 ' N ' HD12 ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 m80 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -55.6 32.92 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' NZ ' HG21 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' HD13 ' A' ' 8' ' ' LEU . 27.8 m120 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 17' ' ' HIS . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' HG11 ' E' ' 53' ' ' VAL . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 27' ' ' THR . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 23' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 36' ' ' LEU . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.554 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.554 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 48' ' ' TRP . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 53' ' ' VAL . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ARG . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' O ' HD11 ' E' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.44 ' O ' HD13 ' B' ' 8' ' ' LEU . 30.1 m120 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.443 HG21 ' NZ ' ' A' ' 3' ' ' LYS . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.44 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.673 ' ND2' ' NE1' ' B' ' 21' ' ' TRP . 11.4 t-20 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.673 ' NE1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 36' ' ' LEU . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 29' ' ' ALA . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.68 HD23 ' O ' ' B' ' 36' ' ' LEU . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.411 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' B' ' 43' ' ' LEU . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.589 HD13 ' O ' ' B' ' 50' ' ' LEU . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.54 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.536 HH21 HD11 ' B' ' 50' ' ' LEU . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' C' ' 8' ' ' LEU . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.407 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.419 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.452 HG23 ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.452 ' N ' HG23 ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.495 ' C ' ' CD1' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.492 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.576 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.603 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 37' ' ' VAL . . . . . 0.438 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' C' ' 51' ' ' LEU . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.511 HG11 ' CE2' ' E' ' 19' ' ' PHE . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.565 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.423 ' O ' HD13 ' D' ' 8' ' ' LEU . 4.2 m-20 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.439 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' E' ' 5' ' ' VAL . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.423 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ASN . . . . . 0.587 ' ND2' ' CE2' ' D' ' 21' ' ' TRP . 16.6 t-20 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.587 ' CE2' ' ND2' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.556 ' O ' HG23 ' D' ' 27' ' ' THR . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.556 HG23 ' O ' ' D' ' 23' ' ' LEU . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.583 HD23 ' O ' ' D' ' 36' ' ' LEU . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.482 HG23 ' H ' ' D' ' 37' ' ' VAL . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.542 ' CD1' ' O ' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' LEU . . . . . 0.487 ' O ' HD12 ' D' ' 43' ' ' LEU . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.471 ' N ' HD12 ' D' ' 51' ' ' LEU . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' D' ' 55' ' ' LEU . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.71 -17.06 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -79.64 64.92 4.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' E' ' 4' ' ' ASN . 5.3 p-10 -138.44 22.02 2.74 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.552 ' H ' HD12 ' E' ' 6' ' ' ILE . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 63' ' ' ALA . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.484 ' C ' HD21 ' E' ' 16' ' ' ASN . 0.4 OUTLIER -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' E' ' 18' ' ' GLY . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 22' ' ' GLY . . . . . 0.404 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.456 ' O ' HG23 ' E' ' 27' ' ' THR . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.413 HG13 ' H ' ' E' ' 25' ' ' VAL . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.636 HD23 ' O ' ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.459 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.572 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.507 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 52' ' ' LEU . . . . . 0.453 ' N ' HD22 ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 19' ' ' PHE . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.507 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.48 HG23 ' H ' ' F' ' 5' ' ' VAL . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.429 HG22 ' CG1' ' A' ' 5' ' ' VAL . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.438 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 22' ' ' GLY . . . . . 0.403 ' O ' HG12 ' F' ' 25' ' ' VAL . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' F' ' 19' ' ' PHE . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.618 HG22 HD12 ' E' ' 36' ' ' LEU . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.586 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.654 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.586 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.654 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.566 HD23 ' O ' ' F' ' 36' ' ' LEU . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.441 ' H ' HG23 ' F' ' 37' ' ' VAL . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.468 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.693 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.72 ' O ' HD13 ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.58 HD22 ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.461 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.567 ' N ' HD22 ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.9 30.66 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 7' ' ' VAL . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.512 ' N ' HG13 ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 23' ' ' LEU . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 19' ' ' PHE . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HG ' ' F' ' 36' ' ' LEU . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 32' ' ' VAL . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.671 HD23 ' O ' ' A' ' 36' ' ' LEU . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.488 ' C ' ' CD1' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 52' ' ' LEU . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD22 ' N ' ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 3.4 t60 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.413 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 5' ' ' VAL . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.413 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.537 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.537 HG22 ' O ' ' B' ' 29' ' ' ALA . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' C' ' 27' ' ' THR . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.504 ' O ' HG22 ' B' ' 47' ' ' VAL . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LEU . . . . . 0.656 HD13 ' O ' ' B' ' 50' ' ' LEU . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.604 HD12 ' N ' ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 7' ' ' VAL . . . . . 0.472 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' E' ' 63' ' ' ALA . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.63 ' O ' HG23 ' C' ' 27' ' ' THR . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.465 ' CD1' HG11 ' B' ' 32' ' ' VAL . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 23' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' D' ' 24' ' ' LEU . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.62 ' O ' HD23 ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 52' ' ' LEU . . . . . 0.501 HD22 ' N ' ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' C' ' 49' ' ' PRO . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' C' ' 58' ' ' PRO . 29.0 m80 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' VAL . . . . . 0.433 HG13 ' N ' ' D' ' 8' ' ' LEU . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.434 HD21 ' N ' ' F' ' 63' ' ' ALA . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ASN . . . . . 0.564 ' ND2' ' CE2' ' D' ' 21' ' ' TRP . 28.7 t-20 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' LEU . . . . . 0.715 ' H ' HD12 ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 25' ' ' VAL . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' E' ' 24' ' ' LEU . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.648 HD13 ' O ' ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' D' ' 58' ' ' PRO . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.577 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.28 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.785 0.326 . . . . 0.0 110.476 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.4 ' O ' HG23 ' E' ' 5' ' ' VAL . 0.6 OUTLIER -89.87 -177.49 5.24 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.01 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 4' ' ' ASN . . . . . 0.48 ' O ' HD13 ' E' ' 8' ' ' LEU . 7.5 t-20 70.11 11.41 7.6 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.083 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.4 HG23 ' O ' ' E' ' 3' ' ' LYS . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.566 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' E' ' 27' ' ' THR . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 24' ' ' LEU . . . . . 0.495 HD22 ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' E' ' 23' ' ' LEU . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.46 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.548 ' HB ' HG21 ' F' ' 27' ' ' THR . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.587 HD23 ' O ' ' E' ' 36' ' ' LEU . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 41' ' ' THR . . . . . 0.449 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.554 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.543 ' N ' HD22 ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 62' ' ' LEU . . . . . 0.539 ' N ' HD22 ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.55 ' HB3' HD22 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.424 ' H ' HG23 ' F' ' 7' ' ' VAL . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.476 HG23 ' H ' ' F' ' 5' ' ' VAL . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.436 HG22 ' CG1' ' A' ' 5' ' ' VAL . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 7' ' ' VAL . . . . . 0.424 HG23 ' H ' ' F' ' 4' ' ' ASN . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.548 HG21 ' HB ' ' E' ' 32' ' ' VAL . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.451 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.451 HG22 ' O ' ' F' ' 29' ' ' ALA . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.651 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.679 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 51' ' ' LEU . . . . . 0.638 ' N ' HD12 ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 60' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' F' ' 60' ' ' ARG . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 63' ' ' ALA . . . . . 0.434 ' N ' HD21 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.08 21.21 1.69 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.473 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.8 m-20 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' B' ' 5' ' ' VAL . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' E' ' 53' ' ' VAL . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' F' ' 32' ' ' VAL . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' F' ' 32' ' ' VAL . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' ALA . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.587 HD23 ' O ' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.44 ' O ' ' OG1' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.48 ' CB ' HD23 ' A' ' 45' ' ' LEU . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 3.0 t60 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.444 ' C ' ' HZ2' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.513 ' N ' ' NZ ' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 5' ' ' VAL . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.476 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.447 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' H ' ' B' ' 4' ' ' ASN . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.563 ' N ' HD12 ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' E' ' 63' ' ' ALA . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.426 ' HB3' ' H ' ' B' ' 20' ' ' PHE . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.426 ' H ' ' HB3' ' B' ' 19' ' ' PHE . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.429 ' H ' ' CD2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 25' ' ' VAL . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' LEU . . . . . 0.812 ' O ' HG23 ' B' ' 27' ' ' THR . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 22' ' ' GLY . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 23' ' ' LEU . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 29' ' ' ALA . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HG21 ' C' ' 27' ' ' THR . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.512 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.492 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 17.7 m80 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.631 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.492 HD22 ' N ' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.499 ' N ' ' OD1' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' VAL . . . . . 0.445 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.401 HD13 ' O ' ' C' ' 4' ' ' ASN . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' LEU . . . . . 0.624 ' O ' HG23 ' C' ' 27' ' ' THR . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 27' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 23' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.559 HD23 ' O ' ' C' ' 28' ' ' LEU . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.512 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.6 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.725 ' O ' HD23 ' C' ' 36' ' ' LEU . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.491 ' O ' HG23 ' C' ' 41' ' ' THR . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.478 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' E' ' 19' ' ' PHE . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.583 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' LEU . . . . . 0.661 HD23 ' H ' ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 8' ' ' LEU . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.421 HG23 ' H ' ' D' ' 5' ' ' VAL . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' THR . . . . . 0.402 HG23 ' N ' ' D' ' 28' ' ' LEU . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.402 ' N ' HG23 ' D' ' 27' ' ' THR . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.488 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ARG . . . . . 0.474 HH21 ' CE1' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.633 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.466 HG23 ' H ' ' D' ' 37' ' ' VAL . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.523 HD23 ' O ' ' D' ' 51' ' ' LEU . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.58 HD23 ' O ' ' D' ' 56' ' ' LEU . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 63' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 -46.98 70.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.641 0.257 . . . . 0.0 110.782 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 3' ' ' LYS . . . . . 0.431 ' HZ1' ' C ' ' F' ' 2' ' ' ALA . 29.2 mmtt -102.98 62.57 0.81 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.084 0.468 . . . . 0.0 110.761 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -156.15 15.35 0.33 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' D' ' 10' ' ' ALA . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 7' ' ' VAL . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.579 ' N ' HD12 ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' C' ' 53' ' ' VAL . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' E' ' 27' ' ' THR . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' E' ' 23' ' ' LEU . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 29' ' ' ALA . . . . . 0.516 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 31' ' ' HIS . . . . . 0.474 ' CE1' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' E' ' 29' ' ' ALA . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.676 ' C ' HD13 ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 53' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 63' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' B' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 2' ' ' ALA . . . . . 0.431 ' C ' ' HZ1' ' E' ' 3' ' ' LYS . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.425 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 16' ' ' ASN . . . . . 0.668 ' ND2' ' CZ2' ' F' ' 21' ' ' TRP . 36.4 t30 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.668 ' CZ2' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.487 ' O ' HG23 ' F' ' 27' ' ' THR . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.487 HG23 ' O ' ' F' ' 23' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 29' ' ' ALA . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.565 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.55 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.55 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' F' ' 53' ' ' VAL . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 60' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 61' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 62' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' H ' ' NZ ' ' F' ' 3' ' ' LYS . . . 54.95 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 1' ' ' GLY . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' HD13 ' A' ' 8' ' ' LEU . 8.2 p-10 -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' HG21 ' A' ' 25' ' ' VAL . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 19' ' ' PHE . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.472 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.505 HG21 ' HB ' ' F' ' 32' ' ' VAL . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ALA . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 36' ' ' LEU . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.492 ' N ' HD22 ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.594 ' O ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ASN . . . . . 0.445 ' O ' HD13 ' B' ' 8' ' ' LEU . 13.0 m120 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' F' ' 50' ' ' LEU . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.477 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.56 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 29' ' ' ALA . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.554 HD23 ' O ' ' B' ' 36' ' ' LEU . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 ' N ' HD22 ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.552 ' N ' HD22 ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' ASN . . . . . 0.403 ' O ' HD13 ' C' ' 8' ' ' LEU . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' LEU . . . . . 0.403 HD13 ' O ' ' C' ' 4' ' ' ASN . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' B' ' 32' ' ' VAL . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 31' ' ' HIS . . . . . 0.428 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 33' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.715 ' O ' HD23 ' C' ' 36' ' ' LEU . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' THR . . . . . 0.49 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.591 ' N ' HD12 ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' E' ' 19' ' ' PHE . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' LEU . . . . . 0.535 ' N ' HD12 ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' HIS . . . . . 0.676 ' NE2' ' HB3' ' F' ' 14' ' ' ALA . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' F' ' 11' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' D' ' 5' ' ' VAL . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' ALA . . . . . 0.405 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' D' ' 23' ' ' LEU . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' LEU . . . . . 0.481 HD11 ' CZ ' ' D' ' 19' ' ' PHE . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' VAL . . . . . 0.435 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' LEU . . . . . 0.554 HD23 ' O ' ' D' ' 28' ' ' LEU . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' D' ' 29' ' ' ALA . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' LEU . . . . . 0.57 HD23 ' O ' ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 50' ' ' LEU . . . . . 0.63 ' O ' HG22 ' D' ' 53' ' ' VAL . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' VAL . . . . . 0.63 HG22 ' O ' ' D' ' 50' ' ' LEU . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' LEU . . . . . 0.533 ' N ' HD12 ' D' ' 55' ' ' LEU . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 56' ' ' LEU . . . . . 0.545 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.61 19.51 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -92.52 51.7 1.78 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -143.9 33.84 1.25 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 6' ' ' ILE . . . . . 0.416 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 7' ' ' VAL . . . . . 0.486 HG23 ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 8' ' ' LEU . . . . . 0.486 ' N ' HG23 ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 19' ' ' PHE . . . . . 0.452 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' E' ' 18' ' ' GLY . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 23' ' ' LEU . . . . . 0.594 ' O ' HG23 ' E' ' 27' ' ' THR . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 27' ' ' THR . . . . . 0.594 HG23 ' O ' ' E' ' 23' ' ' LEU . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 36' ' ' LEU . . . . . 0.714 HD23 ' O ' ' E' ' 36' ' ' LEU . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 51' ' ' LEU . . . . . 0.49 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 56' ' ' LEU . . . . . 0.516 ' HG ' ' CE1' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 59' ' ' HIS . . . . . 0.516 ' CE1' ' HG ' ' E' ' 56' ' ' LEU . 14.3 m80 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 3' ' ' LYS . . . . . 0.689 ' NZ ' ' H ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 4' ' ' ASN . . . . . 0.45 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 5' ' ' VAL . . . . . 0.416 ' CG1' HG22 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 6' ' ' ILE . . . . . 0.619 ' H ' HD12 ' F' ' 6' ' ' ILE . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 8' ' ' LEU . . . . . 0.536 ' N ' HD12 ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 10' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' C' ' 61' ' ' ALA . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 14' ' ' ALA . . . . . 0.676 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 15' ' ' GLY . . . . . 0.507 ' N ' ' NE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 23' ' ' LEU . . . . . 0.471 ' O ' HG22 ' F' ' 27' ' ' THR . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 27' ' ' THR . . . . . 0.471 HG22 ' O ' ' F' ' 23' ' ' LEU . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 28' ' ' LEU . . . . . 0.429 ' N ' HG23 ' F' ' 27' ' ' THR . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 29' ' ' ALA . . . . . 0.411 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 32' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 27' ' ' THR . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 36' ' ' LEU . . . . . 0.623 HD23 ' O ' ' F' ' 36' ' ' LEU . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 43' ' ' LEU . . . . . 0.552 HD12 ' N ' ' F' ' 43' ' ' LEU . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 44' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 48' ' ' TRP . . . . . 0.663 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 49' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 50' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' B' ' 19' ' ' PHE . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 55' ' ' LEU . . . . . 0.549 ' N ' HD12 ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' A' ' 8' ' ' LEU . 27.0 m120 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.602 HG21 ' HB ' ' F' ' 32' ' ' VAL . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 29' ' ' ALA . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.632 HD23 ' CB ' ' A' ' 48' ' ' TRP . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.632 ' CB ' HD23 ' A' ' 45' ' ' LEU . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PRO . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.698 ' H ' ' ND2' ' B' ' 4' ' ' ASN . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' B' ' 2' ' ' ALA . 3.2 p30 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.508 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.541 HD22 ' N ' ' B' ' 16' ' ' ASN . 1.1 m120 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.646 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.646 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.761 ' O ' HG23 ' B' ' 27' ' ' THR . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.402 ' H ' HG22 ' B' ' 25' ' ' VAL . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.761 HG23 ' O ' ' B' ' 23' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' C' ' 24' ' ' LEU . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.65 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.411 HD22 ' N ' ' B' ' 50' ' ' LEU . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 36.5 m-70 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.429 HG23 ' H ' ' C' ' 5' ' ' VAL . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 28' ' ' LEU . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.65 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.43 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . 0.661 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.566 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' E' ' 19' ' ' PHE . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.517 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.556 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' C' ' 60' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 2.9 t-80 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' E' ' 5' ' ' VAL . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.434 HG13 ' N ' ' D' ' 8' ' ' LEU . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.434 ' N ' HG13 ' D' ' 7' ' ' VAL . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' D' ' 17' ' ' HIS . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 27' ' ' THR . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.402 HG12 ' H ' ' D' ' 25' ' ' VAL . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.661 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.559 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.527 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' D' ' 62' ' ' LEU . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.46 0.075 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.473 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.438 HG22 ' CG1' ' F' ' 5' ' ' VAL . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.517 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.411 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.476 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.411 HG22 ' O ' ' E' ' 22' ' ' GLY . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.476 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' F' ' 27' ' ' THR . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.571 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.514 ' CZ3' HD13 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.466 HD12 ' N ' ' E' ' 51' ' ' LEU . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' E' ' 48' ' ' TRP . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.559 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' E' ' 6' ' ' ILE . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 5' ' ' VAL . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.401 HG23 ' H ' ' F' ' 7' ' ' VAL . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.418 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' C' ' 59' ' ' HIS . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . 0.469 HD12 HG11 ' E' ' 32' ' ' VAL . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.517 HG21 ' HB ' ' E' ' 32' ' ' VAL . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.437 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 27' ' ' THR . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.595 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.658 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.718 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.641 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.499 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' HD13 ' A' ' 8' ' ' LEU . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 61' ' ' ALA . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' F' ' 32' ' ' VAL . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.638 HG21 ' HB ' ' F' ' 32' ' ' VAL . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.478 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 43' ' ' LEU . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.527 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.521 ' O ' HD13 ' B' ' 8' ' ' LEU . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.534 HD12 ' H ' ' B' ' 6' ' ' ILE . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' C' ' 5' ' ' VAL . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 62.7 m-80 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 25' ' ' VAL . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 32' ' ' VAL . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.431 ' O ' HD23 ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.625 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.436 HD12 ' H ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.512 ' O ' HG13 ' B' ' 47' ' ' VAL . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.605 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.412 ' O ' HG12 ' C' ' 7' ' ' VAL . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' C' ' 8' ' ' LEU . 0.2 OUTLIER -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' B' ' 10' ' ' ALA . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.477 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.518 HD11 ' ND2' ' C' ' 4' ' ' ASN . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.552 ' O ' HG23 ' C' ' 27' ' ' THR . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' C' ' 23' ' ' LEU . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.563 HD13 ' O ' ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.625 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.416 ' H ' HG22 ' C' ' 32' ' ' VAL . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.41 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.582 ' O ' HD23 ' C' ' 56' ' ' LEU . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.55 ' H ' HD23 ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . 0.485 ' CA ' HD22 ' D' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.485 HD22 ' CA ' ' D' ' 1' ' ' GLY . 82.8 m-20 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' E' ' 5' ' ' VAL . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.518 ' O ' HG23 ' D' ' 27' ' ' THR . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' D' ' 23' ' ' LEU . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.521 ' O ' HD13 ' D' ' 28' ' ' LEU . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.497 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.497 HG22 ' O ' ' D' ' 29' ' ' ALA . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.62 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.589 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.543 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.542 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 CA--C 1.521 -0.143 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.43 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.757 HD21 ' HE1' ' E' ' 21' ' ' TRP . 16.0 t-20 -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.422 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.757 ' HE1' HD21 ' E' ' 16' ' ' ASN . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.407 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.655 ' O ' HG23 ' E' ' 27' ' ' THR . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . 0.43 ' CD1' HG11 ' D' ' 32' ' ' VAL . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.407 HG12 ' O ' ' E' ' 22' ' ' GLY . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.655 HG23 ' O ' ' E' ' 23' ' ' LEU . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . 0.462 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.442 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.471 ' HB ' HG21 ' F' ' 27' ' ' THR . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.624 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . 0.409 HG12 ' O ' ' E' ' 47' ' ' VAL . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . 0.546 HD22 ' N ' ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.62 ' N ' HD12 ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.485 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' E' ' 61' ' ' ALA . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.444 ' O ' HD13 ' F' ' 8' ' ' LEU . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' E' ' 6' ' ' ILE . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.444 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.471 HG21 ' HB ' ' E' ' 32' ' ' VAL . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . 0.404 ' NE2' ' NH2' ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 27' ' ' THR . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . 0.404 ' NH2' ' NE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.627 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.603 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . 0.553 HD22 ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.553 ' CE3' HD22 ' F' ' 45' ' ' LEU . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 4' ' ' ASN . 12.9 m-80 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' B' ' 5' ' ' VAL . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 27' ' ' THR . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 23' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 29' ' ' ALA . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' A' ' 51' ' ' LEU . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 47' ' ' VAL . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.523 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.466 ' O ' HD13 ' B' ' 8' ' ' LEU . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.446 HG23 ' H ' ' B' ' 5' ' ' VAL . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.419 HG22 ' CG1' ' C' ' 5' ' ' VAL . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.466 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.613 HD12 ' N ' ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.499 ' O ' HG13 ' B' ' 47' ' ' VAL . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.605 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.425 HG11 ' CE1' ' D' ' 19' ' ' PHE . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' C' ' 4' ' ' ASN . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.46 HD21 ' C ' ' E' ' 63' ' ' ALA . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' ALA . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.64 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.435 ' C ' ' O ' ' C' ' 40' ' ' ALA . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.522 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.514 HD13 ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.485 HG23 ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' C' ' 10' ' ' ALA . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' D' ' 25' ' ' VAL . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG21 ' E' ' 27' ' ' THR . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.547 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.562 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.573 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.57 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.562 HD12 ' N ' ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 . . . . . 0 CA--C 1.527 0.081 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.606 ' N ' HD12 ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.635 HG21 ' HB ' ' D' ' 32' ' ' VAL . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.428 ' H ' HG22 ' E' ' 32' ' ' VAL . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.697 ' O ' HD23 ' E' ' 36' ' ' LEU . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.48 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.573 ' H ' HD23 ' E' ' 43' ' ' LEU . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' E' ' 44' ' ' SER . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.877 ' O ' HG22 ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.877 HG22 ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . 0.509 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.536 ' O ' HD23 ' E' ' 56' ' ' LEU . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.609 ' O ' ' HB3' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.512 ' O ' HD23 ' E' ' 62' ' ' LEU . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.46 ' C ' HD21 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.44 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.684 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.455 ' O ' HG22 ' F' ' 27' ' ' THR . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . 0.444 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.455 HG22 ' O ' ' F' ' 23' ' ' LEU . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.726 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.48 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.726 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.608 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.543 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.508 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.527 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 34.2 m-70 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' C' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.536 ' N ' ' ND2' ' A' ' 4' ' ' ASN . 0.5 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 8' ' ' LEU . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.498 ' N ' HG13 ' A' ' 7' ' ' VAL . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 19' ' ' PHE . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.491 ' N ' ' CD ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.49 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' C' ' 19' ' ' PHE . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' ND2' ' B' ' 4' ' ' ASN . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' B' ' 3' ' ' LYS . 23.4 m120 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 6' ' ' ILE . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' C' ' 5' ' ' VAL . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.404 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' E' ' 59' ' ' HIS . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' B' ' 18' ' ' GLY . 6.3 t-160 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.652 ' H ' ' CD2' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.731 ' O ' HG23 ' B' ' 27' ' ' THR . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 23' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.401 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.537 HD12 ' N ' ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.561 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.445 HG13 ' N ' ' C' ' 8' ' ' LEU . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.445 ' N ' HG13 ' C' ' 7' ' ' VAL . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.406 HG12 ' H ' ' C' ' 25' ' ' VAL . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.401 HG23 ' CZ2' ' C' ' 30' ' ' TRP . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.536 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.569 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.428 ' O ' HD13 ' D' ' 8' ' ' LEU . 18.7 m120 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.557 ' H ' HD12 ' D' ' 6' ' ' ILE . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 4' ' ' ASN . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.408 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.485 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.557 ' O ' HD23 ' D' ' 28' ' ' LEU . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.453 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' E' ' 27' ' ' THR . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.59 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.575 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.648 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.504 HD22 ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 1.9 t-80 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 9.2 t30 . . . . . 0 N--CA 1.463 0.181 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.454 ' N ' HD22 ' E' ' 16' ' ' ASN . 1.8 m120 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' E' ' 19' ' ' PHE . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.616 HG21 ' HB ' ' D' ' 32' ' ' VAL . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' E' ' 33' ' ' LYS . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.612 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' B' ' 14' ' ' ALA . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . 0.48 ' O ' HG23 ' F' ' 7' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.639 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.48 HG23 ' O ' ' F' ' 3' ' ' LYS . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' C' ' 63' ' ' ALA . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . 0.511 ' OD1' ' CZ2' ' F' ' 21' ' ' TRP . 0.5 OUTLIER -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.511 ' CZ2' ' OD1' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' E' ' 32' ' ' VAL . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.4 HG22 ' H ' ' F' ' 32' ' ' VAL . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.612 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . 0.461 ' O ' HG12 ' F' ' 47' ' ' VAL . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.686 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.567 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.535 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' F' ' 56' ' ' LEU . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' HD13 ' A' ' 8' ' ' LEU . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 17' ' ' HIS . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.6 m170 -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' THR . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 23' ' ' LEU . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.525 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.525 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 52' ' ' LEU . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 58' ' ' PRO . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.575 HD12 ' H ' ' B' ' 6' ' ' ILE . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 72.3 m-80 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 27' ' ' THR . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.708 HG23 ' O ' ' B' ' 23' ' ' LEU . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 32' ' ' VAL . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.445 ' O ' HD23 ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.637 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . 0.483 ' O ' HG23 ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' B' ' 55' ' ' LEU . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.563 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' C' ' 27' ' ' THR . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.416 ' H ' HG12 ' C' ' 25' ' ' VAL . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' C' ' 23' ' ' LEU . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.637 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.567 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.587 HD13 ' O ' ' C' ' 50' ' ' LEU . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.502 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' E' ' 19' ' ' PHE . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' E' ' 5' ' ' VAL . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.404 HG23 ' O ' ' D' ' 3' ' ' LYS . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . 0.525 ' ND1' ' N ' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.533 ' O ' HG23 ' D' ' 27' ' ' THR . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.533 HG23 ' O ' ' D' ' 23' ' ' LEU . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' E' ' 27' ' ' THR . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.582 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.553 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.601 ' N ' HD12 ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' F' ' 19' ' ' PHE . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.514 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.441 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.441 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.479 ' O ' HD13 ' E' ' 8' ' ' LEU . 29.3 m120 . . . . . 0 CA--C 1.519 -0.216 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.603 ' H ' HD12 ' E' ' 6' ' ' ILE . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.523 HD22 ' HB1' ' D' ' 10' ' ' ALA . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.53 HG21 ' HB ' ' D' ' 32' ' ' VAL . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . 0.525 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.511 ' HB ' HG21 ' F' ' 27' ' ' THR . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . 0.699 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.637 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' E' ' 40' ' ' ALA . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.577 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.54 HD12 ' N ' ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . 0.524 ' N ' HD12 ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.61 HD12 ' N ' ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . 0.459 ' C ' HD22 ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.459 HD22 ' C ' ' F' ' 1' ' ' GLY . 78.6 m-20 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.417 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.403 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.438 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 81.3 m-20 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.479 ' CE1' HG11 ' D' ' 53' ' ' VAL . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . 0.41 ' CD1' HG11 ' E' ' 32' ' ' VAL . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.511 HG21 ' HB ' ' E' ' 32' ' ' VAL . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.466 ' CH2' ' CE1' ' A' ' 20' ' ' PHE . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . 0.699 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 27' ' ' THR . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.585 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . 0.683 HG22 ' O ' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.605 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.613 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 9.5 m-70 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 8' ' ' LEU . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.484 HG22 ' CG1' ' B' ' 5' ' ' VAL . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 25' ' ' VAL . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 23' ' ' LEU . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.496 ' CE1' ' HB1' ' D' ' 11' ' ' ALA . 2.5 t-80 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.484 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.534 HD12 ' H ' ' B' ' 6' ' ' ILE . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 18' ' ' GLY . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.436 ' N ' ' ND1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.877 ' O ' HG23 ' B' ' 27' ' ' THR . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 23' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.822 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.822 HG12 ' O ' ' B' ' 29' ' ' ALA . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . 0.476 ' C ' ' O ' ' B' ' 40' ' ' ALA . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' B' ' 41' ' ' THR . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.54 ' O ' HD23 ' B' ' 50' ' ' LEU . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.651 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.54 HD23 ' O ' ' B' ' 46' ' ' GLY . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.681 HD22 ' N ' ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.605 ' CG2' HD21 ' D' ' 23' ' ' LEU . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.525 ' O ' HD23 ' B' ' 55' ' ' LEU . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.0 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.547 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.513 ' HZ1' ' HB2' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' C' ' 5' ' ' VAL . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' F' ' 59' ' ' HIS . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . 0.432 ' O ' HG12 ' C' ' 25' ' ' VAL . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 22' ' ' GLY . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.532 HG22 ' CH2' ' C' ' 30' ' ' TRP . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.449 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.449 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.556 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.603 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.415 ' H ' HG13 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.3 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.513 ' HB2' ' HZ1' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.425 ' O ' HD13 ' D' ' 8' ' ' LEU . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' C' ' 6' ' ' ILE . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.474 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 4' ' ' ASN . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.605 HD21 ' CG2' ' B' ' 53' ' ' VAL . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.417 ' H ' HG22 ' D' ' 25' ' ' VAL . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 23' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.491 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.491 HG22 ' O ' ' D' ' 29' ' ' ALA . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.552 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.502 ' C ' HD22 ' D' ' 43' ' ' LEU . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.502 HD22 ' C ' ' D' ' 42' ' ' TYR . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.561 ' N ' HD12 ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 49' ' ' PRO . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.556 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.549 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.534 HD12 ' N ' ' D' ' 62' ' ' LEU . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.46 ' O ' HD13 ' E' ' 8' ' ' LEU . 2.2 m120 . . . . . 0 N--CA 1.462 0.131 0 CA-C-O 121.187 0.517 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.411 HG23 ' H ' ' E' ' 7' ' ' VAL . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.564 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.718 ' O ' HG23 ' E' ' 27' ' ' THR . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.718 HG23 ' O ' ' E' ' 23' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.412 ' C ' ' O ' ' E' ' 40' ' ' ALA . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . 0.473 HD13 ' HZ2' ' F' ' 33' ' ' LYS . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.543 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.427 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 13' ' ' ALA . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 10' ' ' ALA . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.551 HG21 ' HB ' ' E' ' 32' ' ' VAL . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.426 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.426 HG22 ' O ' ' F' ' 29' ' ' ALA . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.473 ' HZ2' HD13 ' E' ' 45' ' ' LEU . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.584 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . 0.426 ' H ' HG13 ' F' ' 53' ' ' VAL . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.586 ' O ' HD23 ' F' ' 56' ' ' LEU . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.424 ' CE1' ' HB1' ' C' ' 11' ' ' ALA . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.408 HG22 ' CG1' ' B' ' 5' ' ' VAL . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.699 HD21 ' HE1' ' A' ' 21' ' ' TRP . 23.5 t-20 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.699 ' HE1' HD21 ' A' ' 16' ' ' ASN . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.542 HG21 HG22 ' F' ' 32' ' ' VAL . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' ALA . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.893 HD12 HG22 ' B' ' 27' ' ' THR . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HZ3' ' C ' ' C' ' 1' ' ' GLY . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' E' ' 63' ' ' ALA . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.855 ' O ' HG23 ' B' ' 27' ' ' THR . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.893 HG22 HD12 ' A' ' 36' ' ' LEU . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.451 HD12 HG21 ' C' ' 27' ' ' THR . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.443 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.58 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.563 ' O ' HG22 ' B' ' 53' ' ' VAL . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.55 HD22 ' N ' ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.563 HG22 ' O ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.508 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 60.5 m-70 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HZ3' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' D' ' 5' ' ' VAL . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.45 ' H ' HG22 ' C' ' 7' ' ' VAL . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . 0.645 ' ND2' HD21 ' D' ' 9' ' ' ASN . 42.8 t30 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' C' ' 21' ' ' TRP . 2.8 t-20 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' ND2' ' C' ' 16' ' ' ASN . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.582 ' O ' HG23 ' C' ' 27' ' ' THR . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' C' ' 23' ' ' LEU . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.505 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' C' ' 33' ' ' LYS . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.505 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.611 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.43 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 40' ' ' ALA . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.659 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 43' ' ' LEU . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' E' ' 19' ' ' PHE . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' C' ' 59' ' ' HIS . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.538 HD12 ' C ' ' C' ' 62' ' ' LEU . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.519 ' N ' HD12 ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . 0.473 ' O ' HG13 ' D' ' 7' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.572 HG22 HG11 ' E' ' 5' ' ' VAL . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.473 HG13 ' O ' ' D' ' 3' ' ' LYS . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.453 ' N ' HG23 ' D' ' 7' ' ' VAL . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . 0.645 HD21 ' ND2' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.474 ' O ' HD13 ' D' ' 23' ' ' LEU . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.52 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' D' ' 24' ' ' LEU . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.409 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.52 HG23 ' O ' ' D' ' 23' ' ' LEU . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.659 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.516 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.464 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 CA--C 1.517 -0.292 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.572 HG11 HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' F' ' 5' ' ' VAL . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.475 HG23 ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' HG23 ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 2.6 m120 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.485 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.424 ' H ' HG13 ' E' ' 25' ' ' VAL . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.449 ' H ' HG23 ' E' ' 27' ' ' THR . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' E' ' 29' ' ' ALA . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.582 ' O ' HD23 ' E' ' 36' ' ' LEU . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.403 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.697 ' O ' HG22 ' E' ' 41' ' ' THR . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.697 HG22 ' O ' ' E' ' 38' ' ' PRO . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . 0.42 ' O ' HG23 ' F' ' 5' ' ' VAL . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.42 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' F' ' 4' ' ' ASN . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.549 HD12 ' N ' ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.441 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 11.8 m120 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.421 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.763 ' O ' HG23 ' F' ' 27' ' ' THR . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.763 HG23 ' O ' ' F' ' 23' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.806 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.806 HG12 ' O ' ' F' ' 29' ' ' ALA . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 27' ' ' THR . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.662 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.735 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.64 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . 0.599 ' N ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.595 HD22 ' N ' ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' A' ' 8' ' ' LEU . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 27' ' ' THR . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' GLY . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 23' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.688 ' CD2' HH12 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 29' ' ' ALA . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.688 HH12 ' CD2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.875 HD12 HG22 ' B' ' 27' ' ' THR . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.543 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.447 ' CE1' ' HB1' ' D' ' 11' ' ' ALA . 1.8 t-160 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' B' ' 5' ' ' VAL . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.468 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' C' ' 5' ' ' VAL . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 7' ' ' VAL . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.554 HD12 ' N ' ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' B' ' 17' ' ' HIS . 16.3 t-20 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 16' ' ' ASN . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.862 ' O ' HG23 ' B' ' 27' ' ' THR . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.875 HG22 HD12 ' A' ' 36' ' ' LEU . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 29' ' ' ALA . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.557 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 46' ' ' GLY . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.616 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.4 ' H ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.511 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.455 ' CE1' ' HB1' ' E' ' 11' ' ' ALA . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.489 HG12 ' O ' ' C' ' 3' ' ' LYS . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.456 ' N ' HG13 ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.463 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.461 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.557 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.581 ' HA ' ' HZ2' ' C' ' 33' ' ' LYS . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' HA ' ' C' ' 31' ' ' HIS . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.587 HD12 ' N ' ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.513 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.507 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' E' ' 5' ' ' VAL . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.43 ' H ' HG23 ' D' ' 7' ' ' VAL . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' CE1' ' A' ' 59' ' ' HIS . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.55 ' O ' HG23 ' D' ' 27' ' ' THR . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG22 ' D' ' 25' ' ' VAL . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 23' ' ' LEU . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' E' ' 27' ' ' THR . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.537 HH21 ' CD2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.564 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . 0.461 HD12 ' N ' ' D' ' 45' ' ' LEU . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.617 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' F' ' 19' ' ' PHE . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.543 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.448 ' ND1' ' HB1' ' A' ' 11' ' ' ALA . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' D' ' 62' ' ' LEU . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.491 ' O ' HD13 ' E' ' 8' ' ' LEU . 63.8 m-80 . . . . . 0 CA--C 1.522 -0.105 0 CA-C-O 121.413 0.625 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.413 HG23 ' H ' ' E' ' 7' ' ' VAL . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.496 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' F' ' 5' ' ' VAL . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' B' ' 59' ' ' HIS . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.438 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . 0.502 ' CD1' HG11 ' D' ' 32' ' ' VAL . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.438 HG12 ' O ' ' E' ' 22' ' ' GLY . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.6 HG21 ' HB ' ' D' ' 32' ' ' VAL . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.534 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . 0.537 ' CD2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.534 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.576 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.501 ' CD1' ' C ' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.615 ' O ' HG22 ' E' ' 53' ' ' VAL . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.615 HG22 ' O ' ' E' ' 50' ' ' LEU . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . 0.557 ' N ' HD12 ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.551 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.551 HD12 ' N ' ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' E' ' 10' ' ' ALA . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.47 HG22 ' CG1' ' A' ' 5' ' ' VAL . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.511 HG23 ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.511 ' N ' HG23 ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' D' ' 53' ' ' VAL . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.429 ' N ' HD12 ' F' ' 23' ' ' LEU . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . 0.558 ' O ' HD23 ' F' ' 24' ' ' LEU . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.447 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.447 HG22 ' O ' ' F' ' 29' ' ' ALA . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.554 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.557 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.567 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.553 HD12 ' N ' ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 27.9 m-70 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.572 ' N ' HD12 ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HG2' ' HZ2' ' A' ' 3' ' ' LYS . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' B' ' 5' ' ' VAL . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' E' ' 53' ' ' VAL . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.62 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 47' ' ' VAL . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 6.1 t-80 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.434 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.453 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 6' ' ' ILE . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' C' ' 20' ' ' PHE . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.501 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 29' ' ' ALA . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' N ' ' B' ' 35' ' ' ARG . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.615 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.58 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.479 HD12 ' N ' ' B' ' 45' ' ' LEU . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.647 ' N ' HD12 ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.434 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.439 ' O ' HD13 ' C' ' 8' ' ' LEU . 46.6 m-80 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.406 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 10' ' ' ALA . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' F' ' 63' ' ' ALA . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.413 ' O ' HG13 ' C' ' 32' ' ' VAL . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.642 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.615 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.642 HG22 ' O ' ' C' ' 29' ' ' ALA . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.588 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.426 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.596 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . 0.476 HG12 ' O ' ' C' ' 47' ' ' VAL . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' E' ' 19' ' ' PHE . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.527 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.453 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.717 HD13 ' HB1' ' F' ' 63' ' ' ALA . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 25' ' ' VAL . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.48 ' CE1' HH12 ' D' ' 35' ' ' ARG . 23.6 t-160 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.48 HH12 ' CE1' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' E' ' 27' ' ' THR . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.481 ' H ' HG23 ' D' ' 37' ' ' VAL . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.723 ' HE1' HD22 ' E' ' 36' ' ' LEU . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' D' ' 56' ' ' LEU . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.497 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' E' ' 8' ' ' LEU . 59.6 m-80 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' E' ' 4' ' ' ASN . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.48 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.648 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' D' ' 36' ' ' LEU . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.433 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.433 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.723 HD22 ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.52 ' OH ' ' NE1' ' F' ' 30' ' ' TRP . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.533 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . 0.491 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.516 ' O ' HD13 ' E' ' 56' ' ' LEU . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.431 HG22 ' CG1' ' A' ' 5' ' ' VAL . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' F' ' 23' ' ' LEU . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.66 ' O ' HG23 ' F' ' 27' ' ' THR . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' E' ' 36' ' ' LEU . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.508 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.508 HG22 ' O ' ' F' ' 29' ' ' ALA . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.474 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.667 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.625 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.736 HD22 ' C ' ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 27' ' ' THR . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' LEU . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.616 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.967 ' O ' HG22 ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' B' ' 4' ' ' ASN . 0.4 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.46 ' H ' HG23 ' B' ' 7' ' ' VAL . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.407 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 29' ' ' ALA . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.61 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.554 ' H ' ' HD2' ' B' ' 49' ' ' PRO . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.639 ' N ' HD12 ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.526 HG23 HD12 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.677 ' H ' HD12 ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.443 HG12 ' O ' ' C' ' 3' ' ' LYS . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.406 ' N ' HG13 ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.429 ' O ' HG23 ' C' ' 27' ' ' THR . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.433 ' H ' HG22 ' C' ' 25' ' ' VAL . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 23' ' ' LEU . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.574 ' O ' HD23 ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.794 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.515 ' O ' ' N ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.794 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.61 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.602 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.455 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.413 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.53 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.529 ' N ' HD12 ' C' ' 43' ' ' LEU . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.554 HD12 ' N ' ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' C' ' 10' ' ' ALA . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.483 HG22 ' CG1' ' E' ' 5' ' ' VAL . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.447 HG13 ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.447 ' N ' HG13 ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' D' ' 19' ' ' PHE . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.449 HG13 ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . 0.449 ' N ' HG13 ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.433 HG21 ' HB ' ' C' ' 32' ' ' VAL . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.53 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 29' ' ' ALA . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.588 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.555 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.549 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' D' ' 58' ' ' PRO . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.429 ' N ' ' ND1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.478 ' O ' HD13 ' E' ' 8' ' ' LEU . 1.9 m-20 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.425 ' H ' HG23 ' E' ' 7' ' ' VAL . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.571 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' E' ' 13' ' ' ALA . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.599 ' O ' HG23 ' E' ' 27' ' ' THR . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . 0.575 ' O ' HD23 ' E' ' 24' ' ' LEU . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.599 HG23 ' O ' ' E' ' 23' ' ' LEU . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.459 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.632 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.412 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.401 ' C ' ' O ' ' E' ' 40' ' ' ALA . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 53' ' ' VAL . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.56 HD12 ' N ' ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.539 HD22 ' N ' ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.424 HG22 ' O ' ' E' ' 50' ' ' LEU . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.472 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.428 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.565 HG21 ' HB ' ' E' ' 32' ' ' VAL . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' F' ' 29' ' ' ALA . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.561 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.692 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.576 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.54 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.48 HD12 ' N ' ' F' ' 56' ' ' LEU . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.568 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' O ' HD13 ' A' ' 8' ' ' LEU . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' B' ' 5' ' ' VAL . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.476 HG21 ' HB ' ' F' ' 32' ' ' VAL . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 29' ' ' ALA . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.583 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' B' ' 5' ' ' VAL . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.504 ' O ' ' ND2' ' B' ' 16' ' ' ASN . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 12' ' ' SER . 5.7 m-80 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.594 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 32' ' ' VAL . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.552 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.601 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.856 ' O ' HG22 ' B' ' 53' ' ' VAL . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . 0.856 HG22 ' O ' ' B' ' 50' ' ' LEU . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.55 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.529 HD12 ' N ' ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.454 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.52 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.552 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.52 HG22 ' O ' ' C' ' 29' ' ' ALA . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.691 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.705 ' O ' HG22 ' C' ' 41' ' ' THR . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.705 HG22 ' O ' ' C' ' 38' ' ' PRO . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.1 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.485 ' O ' HD13 ' D' ' 8' ' ' LEU . 14.6 m120 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' E' ' 5' ' ' VAL . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.485 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' E' ' 5' ' ' VAL . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' B' ' 53' ' ' VAL . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.41 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . 0.51 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.592 ' HB ' HG21 ' E' ' 27' ' ' THR . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.609 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.629 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 . . . . . 0 N--CA 1.465 0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 6' ' ' ILE . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.41 HG23 ' H ' ' E' ' 7' ' ' VAL . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.441 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.592 HG21 ' HB ' ' D' ' 32' ' ' VAL . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.424 ' H ' HG22 ' E' ' 32' ' ' VAL . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.631 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . 0.487 HG22 ' O ' ' E' ' 47' ' ' VAL . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.493 HD13 ' O ' ' E' ' 51' ' ' LEU . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . 0.412 ' O ' HG23 ' F' ' 5' ' ' VAL . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.416 ' O ' HD13 ' F' ' 8' ' ' LEU . 8.8 t-20 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.604 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.412 ' H ' HG23 ' F' ' 7' ' ' VAL . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.587 HD12 ' N ' ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.564 ' O ' HG22 ' F' ' 27' ' ' THR . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.564 HG22 ' O ' ' F' ' 23' ' ' LEU . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . 0.483 ' N ' HG23 ' F' ' 27' ' ' THR . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 27' ' ' THR . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.405 HD12 ' OG1' ' A' ' 27' ' ' THR . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.46 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.721 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.574 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 12.5 m-70 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.443 ' NZ ' HG21 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' HD13 ' A' ' 8' ' ' LEU . 68.6 m-80 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 17' ' ' HIS . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' HG11 ' E' ' 53' ' ' VAL . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 27' ' ' THR . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 23' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.554 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.554 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 48' ' ' TRP . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 53' ' ' VAL . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ARG . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' O ' HD11 ' E' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.44 ' O ' HD13 ' B' ' 8' ' ' LEU . 71.6 m-80 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.443 HG21 ' NZ ' ' A' ' 3' ' ' LYS . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.44 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.6 ' ND2' ' CD1' ' B' ' 21' ' ' TRP . 16.4 t30 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.6 ' CD1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 36' ' ' LEU . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 29' ' ' ALA . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.68 ' O ' HD23 ' B' ' 36' ' ' LEU . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.411 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' B' ' 43' ' ' LEU . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.589 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.536 HH21 HD11 ' B' ' 50' ' ' LEU . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' C' ' 8' ' ' LEU . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.407 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.419 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.452 HG23 ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.452 ' N ' HG23 ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.492 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.576 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.603 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . 0.438 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' C' ' 51' ' ' LEU . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.511 HG11 ' CE2' ' E' ' 19' ' ' PHE . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.565 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' D' ' 4' ' ' ASN . 1.7 m120 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.439 ' H ' HG23 ' D' ' 5' ' ' VAL . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' E' ' 5' ' ' VAL . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.423 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.437 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 39.0 t30 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.437 ' CE2' ' OD1' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.556 ' O ' HG23 ' D' ' 27' ' ' THR . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.556 HG23 ' O ' ' D' ' 23' ' ' LEU . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.583 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.482 ' H ' HG23 ' D' ' 37' ' ' VAL . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . 0.487 ' O ' HD12 ' D' ' 43' ' ' LEU . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.595 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.471 ' N ' HD12 ' D' ' 51' ' ' LEU . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.508 HD12 ' N ' ' D' ' 55' ' ' LEU . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' E' ' 4' ' ' ASN . 5.3 p-10 . . . . . 0 N--CA 1.465 0.283 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.552 ' H ' HD12 ' E' ' 6' ' ' ILE . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 63' ' ' ALA . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.644 HD21 ' HE1' ' E' ' 21' ' ' TRP . 13.0 t-20 -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.644 ' HE1' HD21 ' E' ' 16' ' ' ASN . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . 0.404 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.456 ' O ' HG23 ' E' ' 27' ' ' THR . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.413 HG13 ' H ' ' E' ' 25' ' ' VAL . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.636 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.459 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.572 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.507 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . 0.453 HD22 ' N ' ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 19' ' ' PHE . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.507 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.48 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.429 HG22 ' CG1' ' A' ' 5' ' ' VAL . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.438 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . 0.403 ' O ' HG12 ' F' ' 25' ' ' VAL . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' F' ' 19' ' ' PHE . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.618 HG22 HD12 ' E' ' 36' ' ' LEU . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.586 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.654 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.586 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.654 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.566 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.441 ' H ' HG23 ' F' ' 37' ' ' VAL . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.693 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.72 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.58 HD22 ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.461 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.567 HD22 ' N ' ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 7' ' ' VAL . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.512 ' N ' HG13 ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 23' ' ' LEU . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 19' ' ' PHE . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HG ' ' F' ' 36' ' ' LEU . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 32' ' ' VAL . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.488 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 52' ' ' LEU . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 t-160 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.413 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 5' ' ' VAL . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.413 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.537 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.537 HG22 ' O ' ' B' ' 29' ' ' ALA . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' C' ' 27' ' ' THR . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.504 HG22 ' O ' ' B' ' 47' ' ' VAL . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . 0.656 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.604 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . 0.472 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' E' ' 63' ' ' ALA . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.63 ' O ' HG23 ' C' ' 27' ' ' THR . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.465 ' CD1' HG11 ' B' ' 32' ' ' VAL . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 23' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' D' ' 24' ' ' LEU . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.62 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . 0.501 ' N ' HD22 ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' C' ' 49' ' ' PRO . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 59.5 m-70 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . 0.433 HG13 ' N ' ' D' ' 8' ' ' LEU . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.434 HD21 ' N ' ' F' ' 63' ' ' ALA . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.427 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 11.7 t30 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . 0.715 ' H ' HD12 ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 25' ' ' VAL . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' E' ' 24' ' ' LEU . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.648 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' D' ' 58' ' ' PRO . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.577 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . 0.48 ' O ' HD13 ' E' ' 8' ' ' LEU . 7.5 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.926 0.394 . . . . 0.0 110.083 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.566 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' E' ' 27' ' ' THR . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . 0.495 HD22 ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' E' ' 23' ' ' LEU . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.46 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.548 ' HB ' HG21 ' F' ' 27' ' ' THR . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.587 ' O ' HD23 ' E' ' 36' ' ' LEU . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . 0.449 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.554 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.543 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . 0.539 HD22 ' N ' ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.55 ' HB3' HD22 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.424 ' H ' HG23 ' F' ' 7' ' ' VAL . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.476 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.436 HG22 ' CG1' ' A' ' 5' ' ' VAL . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . 0.424 HG23 ' H ' ' F' ' 4' ' ' ASN . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.548 HG21 ' HB ' ' E' ' 32' ' ' VAL . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.451 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.451 HG22 ' O ' ' F' ' 29' ' ' ALA . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.651 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.679 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . 0.638 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' F' ' 60' ' ' ARG . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . 0.434 ' N ' HD21 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.602 HD22 ' N ' ' A' ' 4' ' ' ASN . 1.1 m120 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' B' ' 5' ' ' VAL . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' OD1' ' B' ' 9' ' ' ASN . 0.5 OUTLIER -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' E' ' 53' ' ' VAL . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' F' ' 32' ' ' VAL . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' F' ' 32' ' ' VAL . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' ALA . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.48 ' CB ' HD23 ' A' ' 45' ' ' LEU . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.444 ' C ' ' HZ2' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . 0.513 ' N ' ' NZ ' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 5' ' ' VAL . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.476 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.447 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' H ' ' B' ' 4' ' ' ASN . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . 0.403 ' OD1' ' ND2' ' A' ' 9' ' ' ASN . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' E' ' 63' ' ' ALA . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.426 ' HB3' ' H ' ' B' ' 20' ' ' PHE . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.426 ' H ' ' HB3' ' B' ' 19' ' ' PHE . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.429 ' H ' ' CD2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 25' ' ' VAL . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . 0.812 ' O ' HG23 ' B' ' 27' ' ' THR . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 22' ' ' GLY . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 23' ' ' LEU . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 29' ' ' ALA . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HG21 ' C' ' 27' ' ' THR . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.512 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.492 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 37.5 m-70 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.631 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.492 HD22 ' N ' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . 0.445 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.401 HD13 ' O ' ' C' ' 4' ' ' ASN . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . 0.624 ' O ' HG23 ' C' ' 27' ' ' THR . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 23' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.559 ' O ' HD23 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.512 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.6 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.725 HD23 ' O ' ' C' ' 36' ' ' LEU . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.491 ' O ' HG23 ' C' ' 41' ' ' THR . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.478 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' E' ' 19' ' ' PHE . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.583 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . 0.661 ' H ' HD23 ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 8' ' ' LEU . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.421 HG23 ' H ' ' D' ' 5' ' ' VAL . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.723 HD21 ' HE1' ' D' ' 21' ' ' TRP . 25.1 t-20 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.723 ' HE1' HD21 ' D' ' 16' ' ' ASN . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . 0.402 HG23 ' N ' ' D' ' 28' ' ' LEU . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.402 ' N ' HG23 ' D' ' 27' ' ' THR . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.488 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . 0.474 HH21 ' CE1' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.633 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.466 ' H ' HG23 ' D' ' 37' ' ' VAL . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.523 ' O ' HD23 ' D' ' 51' ' ' LEU . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.58 ' O ' HD23 ' D' ' 56' ' ' LEU . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . 0.422 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 . . . . . 0 CA--C 1.517 -0.295 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' D' ' 10' ' ' ALA . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 7' ' ' VAL . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.579 ' N ' HD12 ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' C' ' 53' ' ' VAL . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' E' ' 27' ' ' THR . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' E' ' 23' ' ' LEU . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . 0.516 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . 0.474 ' CE1' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' E' ' 29' ' ' ALA . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.676 HD13 ' C ' ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' B' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.425 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . 0.609 ' ND2' ' NE1' ' F' ' 21' ' ' TRP . 6.8 t-20 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.609 ' NE1' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.487 ' O ' HG23 ' F' ' 27' ' ' THR . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.487 HG23 ' O ' ' F' ' 23' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 29' ' ' ALA . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.565 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.55 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.55 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' F' ' 53' ' ' VAL . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.795 ' N ' ' HZ1' ' F' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' HG21 ' A' ' 25' ' ' VAL . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 19' ' ' PHE . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.472 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.505 HG21 ' HB ' ' F' ' 32' ' ' VAL . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ALA . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ASN . . . . . 0.445 ' O ' HD13 ' B' ' 8' ' ' LEU . 29.2 m-80 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' F' ' 50' ' ' LEU . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.477 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.56 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 29' ' ' ALA . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.554 ' O ' HD23 ' B' ' 36' ' ' LEU . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.552 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' ASN . . . . . 0.403 ' O ' HD13 ' C' ' 8' ' ' LEU . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' LEU . . . . . 0.403 HD13 ' O ' ' C' ' 4' ' ' ASN . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' B' ' 32' ' ' VAL . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' LEU . . . . . 0.538 HD13 ' O ' ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' HIS . . . . . 0.428 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.715 HD23 ' O ' ' C' ' 36' ' ' LEU . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' THR . . . . . 0.49 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.591 HD12 ' N ' ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' E' ' 19' ' ' PHE . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' LEU . . . . . 0.535 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' HIS . . . . . 0.676 ' NE2' ' HB3' ' F' ' 14' ' ' ALA . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' F' ' 11' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' ALA . . . . . 0.405 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' D' ' 23' ' ' LEU . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' LEU . . . . . 0.481 HD11 ' CZ ' ' D' ' 19' ' ' PHE . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' VAL . . . . . 0.435 ' H ' HG22 ' D' ' 25' ' ' VAL . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' LEU . . . . . 0.554 ' O ' HD23 ' D' ' 28' ' ' LEU . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' D' ' 29' ' ' ALA . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' LEU . . . . . 0.63 ' O ' HG22 ' D' ' 53' ' ' VAL . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' VAL . . . . . 0.63 HG22 ' O ' ' D' ' 50' ' ' LEU . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' LEU . . . . . 0.533 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' LEU . . . . . 0.545 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' E' E ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 6' ' ' ILE . . . . . 0.416 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 7' ' ' VAL . . . . . 0.486 HG23 ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 8' ' ' LEU . . . . . 0.486 ' N ' HG23 ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 16' ' ' ASN . . . . . 0.549 ' ND2' ' NE1' ' E' ' 21' ' ' TRP . 15.7 t-20 -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 19' ' ' PHE . . . . . 0.452 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 21' ' ' TRP . . . . . 0.549 ' NE1' ' ND2' ' E' ' 16' ' ' ASN . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 23' ' ' LEU . . . . . 0.594 ' O ' HG23 ' E' ' 27' ' ' THR . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 27' ' ' THR . . . . . 0.594 HG23 ' O ' ' E' ' 23' ' ' LEU . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 36' ' ' LEU . . . . . 0.714 ' O ' HD23 ' E' ' 36' ' ' LEU . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 51' ' ' LEU . . . . . 0.49 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 56' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 59' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 39.1 m-70 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 3' ' ' LYS . . . . . 0.795 ' HZ1' ' N ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 4' ' ' ASN . . . . . 0.45 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 5' ' ' VAL . . . . . 0.416 ' CG1' HG22 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' F' F ' 6' ' ' ILE . . . . . 0.619 ' H ' HD12 ' F' ' 6' ' ' ILE . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 8' ' ' LEU . . . . . 0.536 HD12 ' N ' ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 10' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' C' ' 61' ' ' ALA . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 14' ' ' ALA . . . . . 0.676 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 15' ' ' GLY . . . . . 0.507 ' N ' ' NE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 23' ' ' LEU . . . . . 0.471 ' O ' HG22 ' F' ' 27' ' ' THR . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 27' ' ' THR . . . . . 0.471 HG22 ' O ' ' F' ' 23' ' ' LEU . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 28' ' ' LEU . . . . . 0.429 ' N ' HG23 ' F' ' 27' ' ' THR . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 29' ' ' ALA . . . . . 0.411 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 32' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 27' ' ' THR . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 36' ' ' LEU . . . . . 0.623 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 43' ' ' LEU . . . . . 0.552 ' N ' HD12 ' F' ' 43' ' ' LEU . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 44' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 48' ' ' TRP . . . . . 0.663 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 49' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 50' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' B' ' 19' ' ' PHE . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 55' ' ' LEU . . . . . 0.549 HD12 ' N ' ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.76 -57.85 3.99 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 120.715 0.293 . . . . 0.0 110.589 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.406 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 18.7 mmtp -87.55 77.52 8.76 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.199 0.523 . . . . 0.0 110.632 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' A' ' 8' ' ' LEU . 27.0 m120 -159.34 -46.86 0.05 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.106 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG23 ' H ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -62.6 -58.19 8.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.0 mt -58.78 -34.59 52.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.741 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.52 -40.17 77.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.318 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -59.54 -40.31 86.82 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.018 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.94 -41.6 96.55 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.219 0.533 . . . . 0.0 110.261 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.55 -39.8 77.47 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.278 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -58.16 -39.82 79.82 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.387 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.0 t -60.67 -42.16 96.51 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.008 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.85 -37.49 73.96 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.585 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.34 -39.93 84.74 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.67 -41.81 95.94 Favored Glycine 0 C--N 1.305 -1.19 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 18' ' ' GLY . 97.1 m-20 -60.74 -40.64 93.17 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.888 0.375 . . . . 0.0 110.618 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.3 m170 -52.54 86.98 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.876 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -163.92 118.9 0.84 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 110.368 -1.093 . . . . 0.0 110.368 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 2.1 p90 -47.63 -36.41 10.84 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 122.808 -0.231 . . . . 0.0 111.409 -178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.1 p90 -59.45 -42.4 91.9 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.515 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.627 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 63.8 t-105 -60.3 -40.25 89.85 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.314 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.0 -39.13 95.25 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.75 -38.95 83.19 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 122.784 -0.245 . . . . 0.0 111.044 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 47.6 tp -61.14 -44.72 96.88 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 1.5 p -63.35 -44.28 98.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.246 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 15.5 m -64.11 -41.26 91.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.097 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.602 HG21 ' HB ' ' F' ' 32' ' ' VAL . 56.4 m -61.11 -43.68 98.51 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.567 -178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.1 mt -62.01 -42.43 99.14 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.162 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.44 -42.78 99.7 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.326 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.03 -42.19 94.55 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 -41.57 98.12 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 29' ' ' ALA . 13.7 m -62.42 -15.99 15.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -46.38 -57.33 4.74 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.884 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.32 85.3 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.61 -36.81 81.77 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.915 0.388 . . . . 0.0 111.542 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.534 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -59.64 -44.95 93.33 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -176.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.473 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -63.97 -45.05 80.25 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 -177.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.25 -34.9 76.89 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.243 1.962 . . . . 0.0 111.372 178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.15 95.62 Favored Glycine 0 C--N 1.302 -1.316 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.487 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.51 -41.73 86.09 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.702 -0.249 . . . . 0.0 111.196 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.2 p -94.73 108.97 20.96 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 120.84 0.352 . . . . 0.0 111.721 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.497 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.6 p90 -148.17 -123.25 0.06 Allowed 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.646 179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 26.7 mt -114.34 177.81 4.51 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 66.5 m -114.4 97.42 6.3 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.336 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.632 HD23 ' CB ' ' A' ' 48' ' ' TRP . 9.8 mp -95.44 -74.01 0.57 Allowed 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 -34.92 2.13 Favored Glycine 0 C--N 1.307 -1.075 0 CA-C-N 116.419 -0.355 . . . . 0.0 113.319 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 18.7 t -108.24 -26.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 117.47 0.635 . . . . 0.0 111.613 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.632 ' CB ' HD23 ' A' ' 45' ' ' LEU . 2.2 t90 -59.47 -41.58 87.6 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 53' ' ' VAL . 71.8 Cg_endo -76.75 -52.47 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.316 0 CA-C-N 120.355 1.163 . . . . 0.0 111.947 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.1 mt -52.91 -37.06 60.31 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.817 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 47.9 mt -59.1 -44.57 91.95 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 117.761 -1.576 . . . . 0.0 108.849 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.54 -47.02 83.34 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.489 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 49' ' ' PRO . 1.0 OUTLIER -62.95 -32.48 56.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 CA-C-O 120.884 0.373 . . . . 0.0 110.895 179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.55 -41.59 69.95 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.928 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.8 tp -59.44 -43.68 93.08 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.79 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.67 -33.74 75.53 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 124.489 1.115 . . . . 0.0 113.23 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.467 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 66.5 ttp85 -55.51 -43.82 99.34 Favored Pre-proline 0 C--N 1.305 -1.335 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -173.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.6 Cg_endo -60.16 -40.48 59.77 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 CA-C-N 121.859 1.7 . . . . 0.0 110.879 178.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.425 ' O ' ' O ' ' A' ' 58' ' ' PRO . 5.5 t-80 58.41 152.68 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.573 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.463 ' C ' ' H ' ' A' ' 62' ' ' LEU . 5.2 ptp180 -161.4 75.57 0.5 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.004 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' A' ' 63' ' ' ALA . . . -50.98 -10.38 0.07 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.708 -179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.463 ' H ' ' C ' ' A' ' 60' ' ' ARG . 16.7 mt -76.59 21.81 0.19 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.138 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' H ' ' C ' ' A' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.28 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.526 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.698 ' H ' ' ND2' ' B' ' 4' ' ' ASN . . . -158.85 -77.57 0.07 Allowed 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.805 0.336 . . . . 0.0 110.347 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -78.46 71.82 4.95 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.092 0.472 . . . . 0.0 110.092 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.698 ' ND2' ' H ' ' B' ' 2' ' ' ALA . 3.2 p30 -156.32 -0.75 0.13 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.354 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.3 t -112.59 -64.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.304 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.5 mt -58.42 -34.33 50.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.148 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 16.8 t -58.3 -41.2 80.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.153 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.508 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.11 -40.6 85.87 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -60.96 -39.08 88.18 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.491 0.662 . . . . 0.0 109.367 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.66 -41.55 77.44 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.632 -178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.41 -39.81 80.74 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.686 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 55.9 p -61.11 -42.77 99.13 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.395 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.61 81.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.344 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.83 95.82 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.23 97.52 Favored Glycine 0 C--N 1.304 -1.217 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.075 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.541 HD22 ' N ' ' B' ' 16' ' ' ASN . 1.1 m120 -60.59 -42.01 95.88 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 117.401 0.601 . . . . 0.0 110.67 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.646 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 49.77 -168.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.785 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.646 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -130.37 -2.43 4.99 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.12 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 4.3 t80 -75.13 -96.2 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 117.173 0.486 . . . . 0.0 110.764 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 0.9 OUTLIER -60.34 -42.75 96.33 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.427 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 65.3 t90 -60.42 -40.38 90.79 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.351 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.63 -40.37 97.83 Favored Glycine 0 C--N 1.305 -1.165 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.761 ' O ' HG23 ' B' ' 27' ' ' THR . 4.7 mt -61.26 -39.52 90.68 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 120.638 0.256 . . . . 0.0 111.104 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.82 -45.83 91.14 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.402 ' H ' HG22 ' B' ' 25' ' ' VAL . 6.6 m -64.06 -43.76 97.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.35 -43.51 97.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.74 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.761 HG23 ' O ' ' B' ' 23' ' ' LEU . 79.6 p -62.79 -43.44 98.8 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.098 -178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' C' ' 24' ' ' LEU . 0.1 OUTLIER -61.18 -41.91 97.64 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.864 -178.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -61.9 -42.05 98.62 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.606 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.47 -40.5 95.81 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -59.4 -41.72 90.07 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.465 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -65.05 0.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 C-N-CA 119.745 -0.782 . . . . 0.0 111.787 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -50.54 -65.42 0.56 Allowed 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.51 86.5 Favored Glycine 0 C--N 1.303 -1.267 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 -60.31 -36.85 78.87 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.322 0.582 . . . . 0.0 110.438 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.6 tt -59.54 -42.43 92.33 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 -176.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.87 -47.42 87.08 Favored Pre-proline 0 C--N 1.306 -1.296 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -176.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.1 Cg_endo -64.09 -36.49 47.72 Favored 'Trans proline' 0 N--CA 1.502 2.014 0 C-N-CA 122.308 2.005 . . . . 0.0 111.101 177.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.65 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -38.01 93.82 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.138 -1.392 . . . . 0.0 110.99 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.426 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -58.92 -40.57 84.97 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -177.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 62.2 p -75.04 123.98 26.17 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.631 -178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.1 p90 176.85 116.18 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.809 0 O-C-N 123.459 0.475 . . . . 0.0 110.492 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.471 ' N ' ' CD2' ' B' ' 43' ' ' LEU . 3.6 mm? -97.31 -178.84 4.3 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' B' ' 44' ' ' SER . 50.3 p 53.46 72.42 0.43 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.625 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.55 34.91 0.19 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.02 0.438 . . . . 0.0 109.914 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.94 -60.2 7.14 Favored Glycine 0 C--N 1.303 -1.264 0 CA-C-N 115.688 -0.687 . . . . 0.0 113.25 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -133.66 -7.8 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 117.206 0.503 . . . . 0.0 111.24 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.417 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 6.2 t-105 -48.97 -45.52 74.09 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-O 119.341 -0.361 . . . . 0.0 110.844 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 36.9 Cg_endo -71.93 -37.33 5.06 Favored 'Trans proline' 0 N--CA 1.487 1.129 0 CA-C-N 120.038 1.049 . . . . 0.0 110.995 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.411 HD22 ' N ' ' B' ' 50' ' ' LEU . 4.4 mm? -55.65 -36.24 66.83 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.153 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 16.2 mt -56.74 -44.02 81.27 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.446 -1.302 . . . . 0.0 109.044 -178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -60.28 -42.3 95.13 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.345 -0.984 . . . . 0.0 108.345 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -60.08 -31.49 48.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.409 178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.92 -40.89 67.1 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.555 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.9 mp -60.2 -44.88 94.77 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.066 -1.053 . . . . 0.0 108.675 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.2 tp -67.62 -33.93 75.97 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 124.518 1.127 . . . . 0.0 113.723 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 10.9 ttm180 -55.68 -43.79 99.35 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.41 -41.21 51.24 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 CA-C-N 121.798 1.678 . . . . 0.0 112.021 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 36.5 m-70 55.15 160.09 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.945 0.402 . . . . 0.0 110.147 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.52 113.68 0.36 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.407 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.38 -60.71 3.02 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.287 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.421 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 15.6 mt -71.73 48.86 0.16 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.641 -0.423 . . . . 0.0 110.427 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 117.931 -1.033 . . . . 0.0 110.617 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.91 -92.4 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.817 0.341 . . . . 0.0 110.447 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -74.55 75.36 1.98 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.21 0.529 . . . . 0.0 110.622 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -151.1 -36.93 0.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.389 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.429 HG23 ' H ' ' C' ' 5' ' ' VAL . 0.4 OUTLIER -72.49 -56.17 10.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.194 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.444 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.3 mt -58.83 -36.28 60.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.488 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.45 -41.53 84.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.425 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.9 -39.93 87.04 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.602 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -60.74 -41.43 95.35 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.338 0.589 . . . . 0.0 109.467 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.95 -40.91 81.71 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.97 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.06 79.73 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.591 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 56.1 p -60.09 -41.56 92.74 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.544 -0.462 . . . . 0.0 109.852 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -38.76 79.29 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.795 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.01 94.43 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.68 -41.57 97.49 Favored Glycine 0 C--N 1.304 -1.227 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.601 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -60.99 -41.63 96.86 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.876 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -61.86 119.03 8.0 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.525 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.32 168.1 40.67 Favored Glycine 0 C--N 1.306 -1.136 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.548 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -80.93 -64.52 1.17 Allowed 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.508 -0.346 . . . . 0.0 111.217 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -58.83 -40.95 85.71 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 81.2 t90 -60.04 -40.84 90.74 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.946 -178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.36 -40.72 99.41 Favored Glycine 0 C--N 1.306 -1.124 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.945 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 51.6 mt -60.37 -39.51 87.49 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' B' ' 28' ' ' LEU . 3.1 tt -59.85 -42.2 93.12 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 74.7 t -63.02 -44.5 99.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.9 t -64.72 -43.09 96.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-O 121.045 0.45 . . . . 0.0 111.874 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 96.1 m -62.56 -43.55 98.53 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.064 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 34.1 mt -62.41 -41.77 98.93 Favored 'General case' 0 C--N 1.295 -1.789 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.279 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.43 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.14 -48.17 81.28 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.401 -0.92 . . . . 0.0 113.07 -177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.65 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.5 -37.53 80.15 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.691 -0.804 . . . . 0.0 111.778 178.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.402 ' C ' ' H ' ' C' ' 33' ' ' LYS . 83.8 t60 -58.9 -41.69 87.83 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.43 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -58.53 -5.62 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.963 -178.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' C' ' 31' ' ' HIS . 17.9 pttp -42.44 -57.48 2.61 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.144 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.07 -38.36 89.12 Favored Glycine 0 C--N 1.302 -1.311 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.047 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . 0.661 ' NH2' HH22 ' D' ' 35' ' ' ARG . 41.4 mtp180 -59.3 -36.06 74.9 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.87 0.367 . . . . 0.0 110.657 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.566 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.46 -43.35 99.03 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 -177.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.402 ' H ' HG23 ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.67 -46.21 88.6 Favored Pre-proline 0 N--CA 1.483 1.201 0 C-N-CA 119.41 -0.916 . . . . 0.0 113.375 -176.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.31 -35.78 96.11 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.629 2.219 . . . . 0.0 111.438 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.61 -37.89 94.14 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.243 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.43 78.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 121.099 -0.24 . . . . 0.0 111.616 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 38.0 p -43.5 111.36 0.27 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.013 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -96.76 70.8 2.54 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.653 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -84.74 100.98 11.86 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.257 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t 60.5 58.5 2.49 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.445 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.8 mt -144.94 23.02 1.56 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.253 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.6 -70.98 0.65 Allowed Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.42 -15.19 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.505 0.558 . . . . 0.0 112.505 -178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.429 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.6 OUTLIER -47.56 -48.54 58.28 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.798 -179.05 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.429 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 50.1 Cg_exo -54.35 -37.59 88.93 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.232 1.955 . . . . 0.0 112.645 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.7 mt -55.55 -35.3 65.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -56.12 -43.33 78.08 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.545 -1.262 . . . . 0.0 109.309 -178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.07 -40.62 90.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' E' ' 19' ' ' PHE . 21.5 t -58.12 -30.16 38.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.385 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 44.9 mmm-85 -54.04 -39.3 66.07 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.955 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.517 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.6 mm? -58.65 -44.17 90.03 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.434 -0.907 . . . . 0.0 108.808 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.556 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.4 mm? -67.22 -32.74 74.0 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.353 1.061 . . . . 0.0 112.927 177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 71.3 ttt180 -55.2 -43.41 99.08 Favored Pre-proline 0 C--N 1.307 -1.243 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 -174.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' C' ' 60' ' ' ARG . 18.5 Cg_endo -58.87 -39.73 78.68 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 CA-C-N 121.874 1.705 . . . . 0.0 110.875 178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.41 ' O ' ' O ' ' C' ' 60' ' ' ARG . 2.9 t-80 64.7 -66.31 0.13 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.078 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' C' ' 58' ' ' PRO . 28.9 ttm-85 59.82 116.27 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.21 -179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.67 -4.05 57.05 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.037 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 6.6 tp -66.87 -40.32 87.82 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 120.915 0.388 . . . . 0.0 110.312 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.648 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.2 -54.08 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.782 0.325 . . . . 0.0 110.595 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -86.07 -15.3 41.72 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.003 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -83.14 40.4 0.7 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.193 0.521 . . . . 0.0 110.036 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.444 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.6 OUTLIER -144.12 -68.39 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.782 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.473 HG22 ' CG1' ' E' ' 5' ' ' VAL . 43.6 mt -57.42 -36.03 51.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.434 HG13 ' N ' ' D' ' 8' ' ' LEU . 9.5 p -60.16 -40.72 84.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.61 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.434 ' N ' HG13 ' D' ' 7' ' ' VAL . 1.8 mp -58.86 -40.74 85.22 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.753 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -61.72 -41.18 97.29 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.238 0.542 . . . . 0.0 110.116 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.24 -40.74 78.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.538 -178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 -38.63 74.91 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.254 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 25.3 p -60.48 -41.9 95.17 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.468 -0.493 . . . . 0.0 109.76 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.489 ' O ' ' CD2' ' D' ' 17' ' ' HIS . . . -58.06 -38.89 77.16 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.754 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -40.49 91.08 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.08 -42.02 94.87 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.541 ' O ' ' N ' ' D' ' 18' ' ' GLY . 78.7 m-20 -60.56 -40.57 92.11 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.817 0.342 . . . . 0.0 110.228 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . 0.489 ' CD2' ' O ' ' D' ' 13' ' ' ALA . 19.8 m170 -55.01 80.69 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.862 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -153.91 125.19 1.69 Allowed Glycine 0 C--N 1.304 -1.218 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -39.12 23.29 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 120.69 0.281 . . . . 0.0 111.169 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.557 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 30.4 p90 -60.79 -44.15 97.18 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.436 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.9 t-105 -61.58 -43.26 99.18 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.317 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.63 -40.59 98.96 Favored Glycine 0 C--N 1.303 -1.273 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.448 ' O ' HG23 ' D' ' 27' ' ' THR . 3.6 tp -61.32 -40.4 94.06 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 -179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.3 tp -61.26 -45.36 94.82 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.402 HG12 ' H ' ' D' ' 25' ' ' VAL . 2.4 p -63.57 -43.67 98.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.787 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.8 t -63.75 -42.13 94.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 CA-C-O 121.145 0.498 . . . . 0.0 110.765 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 20.1 p -62.74 -42.95 99.91 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.99 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 15.4 mt -60.04 -41.83 93.11 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.364 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.61 -42.61 97.17 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.003 -0.679 . . . . 0.0 111.326 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.598 ' CD1' ' NZ ' ' D' ' 33' ' ' LYS . 0.0 OUTLIER -63.7 -39.13 93.54 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.547 ' CE1' ' O ' ' D' ' 27' ' ' THR . 3.6 m-70 -58.89 -42.07 88.68 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.76 -1.31 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.834 -0.746 . . . . 0.0 112.023 -177.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.598 ' NZ ' ' CD1' ' D' ' 30' ' ' TRP . 18.1 mmtp -47.47 -64.85 0.67 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.401 -0.52 . . . . 0.0 110.364 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.27 -37.79 88.16 Favored Glycine 0 C--N 1.301 -1.361 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.661 HH22 ' NH2' ' C' ' 35' ' ' ARG . 81.0 mtt85 -60.94 -36.94 80.66 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.048 0.452 . . . . 0.0 111.169 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.559 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -59.8 -42.33 93.17 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -177.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.1 t -62.37 -46.56 90.12 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.9 Cg_endo -62.34 -34.73 76.39 Favored 'Trans proline' 0 N--CA 1.501 1.949 0 C-N-CA 122.376 2.051 . . . . 0.0 111.461 177.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.42 -40.23 97.33 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.468 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -41.26 87.03 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.337 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 31.1 p -88.19 114.53 24.91 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 120.943 0.401 . . . . 0.0 111.343 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.573 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 36.1 p90 -163.63 -55.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.456 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.573 ' N ' ' CG ' ' D' ' 42' ' ' TYR . 18.7 mt 58.91 81.66 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.563 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' D' ' 45' ' ' LEU . 11.1 t -178.81 -177.39 0.5 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.638 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . 0.53 ' N ' ' OG ' ' D' ' 44' ' ' SER . 7.4 mt 58.36 46.75 14.89 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.84 -63.8 4.64 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.266 -178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.43 -15.88 9.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 117.051 0.425 . . . . 0.0 111.708 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 30.5 t-105 -57.13 -41.66 92.33 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 41.9 Cg_endo -71.43 -45.0 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.393 0 CA-C-N 120.574 1.241 . . . . 0.0 112.296 -178.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 11.8 mt -54.07 -37.31 64.07 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 mp -58.18 -44.25 87.92 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.557 -1.257 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.6 mt -61.04 -42.25 98.11 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.093 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.416 ' O ' ' N ' ' D' ' 57' ' ' ARG . 92.7 t -58.8 -31.36 44.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.311 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.3 tpp180 -54.19 -40.95 68.05 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 120.272 -0.571 . . . . 0.0 109.888 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 45.1 tp -61.46 -45.88 92.4 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 118.968 -1.093 . . . . 0.0 108.437 178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -66.59 -34.18 77.31 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 12.9 ttm180 -57.05 -44.5 99.79 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 25.7 Cg_endo -61.14 -42.05 38.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 CA-C-N 121.442 1.551 . . . . 0.0 111.618 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.527 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.1 OUTLIER 54.39 161.61 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.414 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -174.11 138.66 0.6 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.477 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.03 53.15 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.762 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.477 HD13 ' O ' ' D' ' 62' ' ' LEU . 0.2 OUTLIER -64.71 -53.44 47.23 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.987 0.422 . . . . 0.0 109.883 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.734 179.841 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.37 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.79 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.746 0.308 . . . . 0.0 110.495 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.449 ' C ' ' H ' ' E' ' 5' ' ' VAL . 9.7 mmtp -87.84 -176.44 5.49 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.574 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' E' ' 3' ' ' LYS . 0.2 OUTLIER 75.95 -41.8 0.44 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.804 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.473 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.1 OUTLIER -65.5 -63.4 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.683 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.438 HG22 ' CG1' ' F' ' 5' ' ' VAL . 37.6 mt -59.37 -35.65 59.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.571 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 t -59.16 -40.65 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.398 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.1 -40.17 88.71 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.287 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -61.25 -41.82 97.56 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.102 0.477 . . . . 0.0 110.003 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.79 -39.0 76.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.941 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.0 -38.95 73.79 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.817 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.8 p -60.19 -41.42 92.92 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.88 -38.41 78.77 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.453 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.02 86.46 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.01 96.52 Favored Glycine 0 C--N 1.304 -1.202 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.52 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 10.0 t30 -60.66 -40.88 93.7 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 120.746 0.308 . . . . 0.0 110.711 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -53.4 98.51 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.967 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 104.13 0.2 Allowed Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.517 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -33.12 -40.75 0.06 Allowed 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -59.7 -42.7 93.58 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.952 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.533 ' N ' ' O ' ' E' ' 18' ' ' GLY . 54.3 t-105 -60.77 -40.67 93.4 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.644 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.411 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.31 -39.08 96.73 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.476 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -59.63 -37.2 78.01 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 111.514 0.19 . . . . 0.0 111.514 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.8 tp -57.03 -42.23 80.05 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.411 HG22 ' O ' ' E' ' 22' ' ' GLY . 1.3 m -59.77 -41.44 85.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 119.624 -0.831 . . . . 0.0 111.897 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 5.0 t -62.93 -42.91 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.476 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.4 p -62.53 -44.19 96.96 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.274 -0.57 . . . . 0.0 112.065 -178.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 59.0 mt -61.96 -42.68 99.4 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 120.178 -0.609 . . . . 0.0 110.621 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.8 -42.3 99.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.133 -0.485 . . . . 0.0 112.176 -179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -65.86 -42.91 89.84 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -62.04 -42.37 99.1 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.517 ' HB ' HG21 ' F' ' 27' ' ' THR . 12.5 m -58.83 -18.59 13.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' E' ' 32' ' ' VAL . 48.5 mttm -43.98 -61.19 1.54 Allowed 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.168 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.422 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.28 -37.72 87.96 Favored Glycine 0 C--N 1.299 -1.511 0 N-CA-C 111.424 -0.67 . . . . 0.0 111.424 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 40.0 mmm-85 -60.3 -37.27 80.03 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 117.039 0.42 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.571 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.1 tt -61.64 -43.87 98.04 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -46.33 83.19 Favored Pre-proline 0 N--CA 1.484 1.234 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.422 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.6 Cg_exo -59.99 -36.59 89.28 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.941 2.427 . . . . 0.0 111.636 177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.0 -38.77 96.06 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 115.036 -0.983 . . . . 0.0 111.112 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.59 -41.26 80.82 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 25.2 p -42.25 116.19 0.79 Allowed 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.8 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' E' ' 43' ' ' LEU . 63.9 m-85 -88.83 73.57 8.4 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.692 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.442 ' O ' ' O ' ' E' ' 42' ' ' TYR . 26.6 mt -59.94 -128.57 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.341 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m -96.38 86.43 4.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.548 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.88 48.59 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.046 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.76 -60.43 5.75 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 121.377 -0.44 . . . . 0.0 112.927 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 72.5 t -110.99 -20.3 6.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 117.131 0.466 . . . . 0.0 112.232 -178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.514 ' CZ3' HD13 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -46.5 -48.04 47.71 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.737 -179.458 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 49.5 Cg_exo -57.05 -47.91 20.69 Favored 'Trans proline' 0 N--CA 1.501 1.962 0 C-N-CA 122.261 1.974 . . . . 0.0 112.702 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.26 -37.17 64.39 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.466 HD12 ' N ' ' E' ' 51' ' ' LEU . 11.0 mp -57.63 -43.01 84.51 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.267 -1.373 . . . . 0.0 108.502 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.514 HD13 ' CZ3' ' E' ' 48' ' ' TRP . 3.9 mp -61.07 -41.3 96.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 61.5 t -57.46 -34.56 46.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 80.0 ttt-85 -55.32 -40.62 71.38 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.947 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 21.5 mt -60.82 -44.93 96.26 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.501 -0.88 . . . . 0.0 108.825 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.559 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.14 -33.93 76.49 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.412 1.085 . . . . 0.0 113.498 178.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.489 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 45.7 ttp180 -55.8 -43.52 99.23 Favored Pre-proline 0 C--N 1.308 -1.199 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.2 Cg_endo -58.68 -39.77 79.39 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 CA-C-N 121.558 1.592 . . . . 0.0 110.574 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 53.92 54.68 9.4 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.509 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' E' ' 61' ' ' ALA . 23.6 ttp180 -46.95 160.17 0.09 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.315 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' E' ' 60' ' ' ARG . . . -140.16 0.41 1.72 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.749 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 32.0 mt -72.54 -43.83 62.97 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.763 179.508 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.14 -64.88 0.79 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.788 0.328 . . . . 0.0 110.561 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -89.75 72.77 7.65 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.139 0.495 . . . . 0.0 110.046 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -158.1 -31.09 0.08 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.147 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.438 ' CG1' HG22 ' E' ' 6' ' ' ILE . 1.5 t -77.01 -61.33 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.188 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' A' ' 5' ' ' VAL . 43.3 mt -59.58 -35.13 57.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.137 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.401 HG23 ' H ' ' F' ' 7' ' ' VAL . 8.1 t -58.7 -40.61 79.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.197 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.81 -40.66 89.14 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.513 -0.475 . . . . 0.0 110.088 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -61.41 -41.45 97.18 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.291 0.567 . . . . 0.0 109.976 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.418 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.32 -40.37 77.78 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.704 -178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . 0.4 ' O ' ' CE1' ' C' ' 59' ' ' HIS . . . -58.32 -40.49 82.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.279 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 39.1 t -61.67 -43.09 99.53 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.77 178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.22 90.2 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.595 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.33 -42.53 98.84 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.35 -41.87 97.14 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.921 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 24.0 m-20 -61.46 -41.74 97.71 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.471 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -70.53 132.15 45.08 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.457 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.27 -174.88 47.26 Favored Glycine 0 C--N 1.305 -1.193 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.593 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -82.8 -64.01 1.26 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.498 -0.351 . . . . 0.0 111.739 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -58.79 -40.89 85.34 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.553 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 78.3 t90 -59.7 -39.74 85.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.16 -39.56 96.04 Favored Glycine 0 C--N 1.305 -1.181 0 N-CA-C 111.589 -0.604 . . . . 0.0 111.589 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 41.9 mt -59.65 -37.52 78.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . 0.469 HD12 HG11 ' E' ' 32' ' ' VAL . 5.7 tp -58.47 -43.31 88.89 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 -177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 13.6 t -62.74 -44.19 99.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.886 -0.726 . . . . 0.0 112.426 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -64.53 -43.93 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.517 HG21 ' HB ' ' E' ' 32' ' ' VAL . 86.1 m -63.51 -43.5 97.02 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -178.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.81 -42.66 98.08 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.458 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.437 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.22 -43.89 96.82 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.704 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.99 -41.81 95.08 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -61.15 -42.27 98.26 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.602 ' HB ' HG21 ' A' ' 27' ' ' THR . 18.2 m -65.82 -6.68 4.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.265 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -48.92 -63.66 1.03 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.054 -0.658 . . . . 0.0 109.382 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.95 -36.99 83.3 Favored Glycine 0 C--N 1.301 -1.394 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -59.67 -38.14 80.68 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.134 0.492 . . . . 0.0 110.828 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.595 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -41.7 94.29 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -61.63 -46.18 93.58 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.058 1.503 . . . . 0.0 115.058 -176.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.24 -34.68 77.56 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.346 2.031 . . . . 0.0 111.428 177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -40.18 96.93 Favored Glycine 0 C--N 1.301 -1.396 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.475 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.05 -41.44 83.3 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.851 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 76.1 p -78.86 110.1 13.74 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.783 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 34.1 p90 -160.18 119.39 2.76 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.254 0.55 . . . . 0.0 109.789 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 23.1 mt -78.54 145.46 34.85 Favored 'General case' 0 C--N 1.296 -1.717 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.865 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 65.65 -178.43 0.19 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.804 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 10.8 mt 69.49 35.05 2.63 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.781 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.41 -47.43 2.17 Favored Glycine 0 C--N 1.307 -1.072 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.224 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.7 m -141.77 72.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.658 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -164.0 -42.62 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.104 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.5 Cg_exo -71.49 -29.53 16.35 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.03 1.82 . . . . 0.0 110.686 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.718 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.6 OUTLIER -56.43 -36.46 69.02 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.061 -0.972 . . . . 0.0 111.9 -178.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.641 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.96 -44.02 82.19 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.845 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -61.16 -41.56 96.99 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 40.6 t -60.06 -30.89 46.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.472 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -53.75 -38.99 64.95 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.698 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.499 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -57.46 -42.83 83.3 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.001 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 tp -67.39 -34.11 76.58 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 124.169 0.988 . . . . 0.0 113.558 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.541 ' NH2' ' CD1' ' B' ' 19' ' ' PHE . 18.6 mmt180 -55.32 -44.13 99.47 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -174.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 19.2 Cg_endo -59.75 -40.44 64.11 Favored 'Trans proline' 0 N--CA 1.496 1.645 0 CA-C-N 121.739 1.657 . . . . 0.0 110.957 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 55.67 165.89 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.633 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 34.5 ptt-85 -155.84 179.4 9.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.053 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -146.71 3.58 0.85 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 120.81 0.338 . . . . 0.0 110.529 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' F' ' 63' ' ' ALA . 16.3 mt -83.61 22.5 1.07 Allowed 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.22 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.592 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.0 17.02 0.81 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.712 0.292 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.3 mmtt -133.93 77.86 1.73 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.204 0.526 . . . . 0.0 110.32 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.441 ' O ' HD13 ' A' ' 8' ' ' LEU . 48.5 m-80 -158.53 -49.88 0.06 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.258 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.5 OUTLIER -63.1 -57.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.674 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.3 mt -58.21 -35.37 52.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.939 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -58.64 -41.16 81.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.959 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -59.27 -40.35 85.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.401 -0.52 . . . . 0.0 109.839 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -61.19 -41.14 96.28 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.144 0.497 . . . . 0.0 110.224 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' HB3' ' HB1' ' D' ' 61' ' ' ALA . . . -57.58 -41.21 80.68 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.391 -178.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.08 -39.76 79.36 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.22 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.2 p -60.99 -42.06 97.68 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.69 -38.05 74.53 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.713 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.95 91.2 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.24 -42.8 95.58 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -61.25 -40.67 94.91 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.877 0.37 . . . . 0.0 110.423 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -56.17 93.11 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.762 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.63 120.51 0.92 Allowed Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -48.92 -36.52 17.45 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.165 -179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 43.2 p90 -59.75 -42.39 93.1 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.791 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.623 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 62.9 t-105 -60.42 -40.43 90.99 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.055 0.455 . . . . 0.0 110.353 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.36 -38.97 94.15 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 111.226 -0.75 . . . . 0.0 111.226 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.77 -39.27 88.19 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.239 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' CD1' HG11 ' F' ' 32' ' ' VAL . 41.3 tp -60.67 -45.67 93.25 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -64.1 -43.61 97.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.559 -178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 79.3 t -63.88 -42.81 97.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.933 0.397 . . . . 0.0 110.932 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.638 HG21 ' HB ' ' F' ' 32' ' ' VAL . 26.7 m -63.01 -42.09 99.74 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.82 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.08 -42.29 94.26 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.0 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.486 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.88 -42.38 97.83 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.478 ' CD1' ' NZ ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -63.73 -39.87 95.35 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -179.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.3 t60 -59.95 -41.96 92.99 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -177.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.3 m -64.62 -5.32 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.533 -177.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.478 ' NZ ' ' CD1' ' A' ' 30' ' ' TRP . 18.3 mmtp -45.03 -62.7 1.14 Allowed 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.442 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.48 85.69 Favored Glycine 0 C--N 1.303 -1.271 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -59.83 -37.55 79.53 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-O 121.075 0.464 . . . . 0.0 111.067 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.4 tt -59.78 -42.32 93.06 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -176.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.1 t -62.48 -46.46 89.6 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.9 Cg_endo -62.23 -35.01 76.78 Favored 'Trans proline' 0 N--CA 1.504 2.101 0 C-N-CA 122.465 2.11 . . . . 0.0 111.829 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.58 96.2 Favored Glycine 0 C--N 1.301 -1.403 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.572 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.83 80.49 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.655 -0.272 . . . . 0.0 111.01 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.9 p -94.99 107.72 19.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.735 0.302 . . . . 0.0 111.036 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.521 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.5 p90 -133.45 -121.08 0.18 Allowed 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' C ' HD23 ' A' ' 43' ' ' LEU . 1.6 tt -145.89 105.7 3.99 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.6 t -39.16 116.79 0.62 Allowed 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.693 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.32 -69.37 0.75 Allowed 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.542 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.53 -54.12 0.58 Allowed Glycine 0 C--N 1.309 -0.945 0 N-CA-C 111.881 -0.488 . . . . 0.0 111.881 178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.6 p -153.03 -11.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 16.0 t-105 -46.77 -46.8 51.7 Favored Pre-proline 0 C--N 1.307 -1.261 0 C-N-CA 120.014 -0.674 . . . . 0.0 112.409 -177.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.41 -37.24 0.53 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 121.067 1.178 . . . . 0.0 112.701 -178.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.05 -36.07 67.63 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.49 -44.09 84.68 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.267 -1.373 . . . . 0.0 110.146 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.32 -40.73 91.62 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 43.2 t -58.91 -30.38 42.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.029 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 ttp85 -53.84 -41.01 66.96 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.882 -178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD13 ' O ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -60.51 -45.43 93.84 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -66.94 -33.19 75.05 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 124.747 1.219 . . . . 0.0 113.733 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.48 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 54.9 ttp180 -55.51 -44.06 99.46 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.4 Cg_endo -59.74 -40.72 61.6 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 CA-C-N 121.627 1.617 . . . . 0.0 111.012 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.527 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 36.7 t-80 51.4 168.08 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.15 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.527 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 19.2 ptt180 -174.58 162.01 3.34 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.265 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -126.07 10.11 7.51 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.363 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 5.0 tp -80.87 2.9 24.58 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.878 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.896 -179.869 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.26 -70.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 120.82 0.343 . . . . 0.0 110.585 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.61 76.3 7.48 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.817 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.521 ' O ' HD13 ' B' ' 8' ' ' LEU . 72.7 m-80 -149.47 3.52 0.57 Allowed 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.38 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.96 -63.0 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.534 HD12 ' H ' ' B' ' 6' ' ' ILE . 2.5 mp -58.93 -34.16 51.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.82 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -57.32 -42.0 79.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.749 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.5 mp -59.22 -39.99 84.43 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.842 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -61.58 -41.46 97.44 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.192 0.52 . . . . 0.0 110.151 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.48 ' HB2' HG12 ' C' ' 5' ' ' VAL . . . -56.92 -39.98 75.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.483 -178.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' E' ' 60' ' ' ARG . . . -57.21 -37.02 71.59 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.41 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 28.2 t -58.88 -40.98 86.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.36 -37.92 73.35 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.775 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.2 84.72 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.67 -40.44 92.67 Favored Glycine 0 C--N 1.303 -1.253 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.851 -178.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.411 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 62.7 m-80 -59.81 -41.21 90.75 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 117.415 0.607 . . . . 0.0 110.824 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.59 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 54.94 -177.74 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.577 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.59 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -131.11 -11.09 2.33 Favored Glycine 0 N--CA 1.472 1.057 0 CA-C-N 116.303 -0.408 . . . . 0.0 112.442 -179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -71.42 -95.13 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 117.223 0.511 . . . . 0.0 110.805 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -60.87 -42.19 97.4 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.826 0.346 . . . . 0.0 110.851 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.411 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 64.7 t-105 -61.08 -41.56 96.86 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.723 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.66 -41.52 99.81 Favored Glycine 0 C--N 1.308 -1.025 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 17.7 mt -60.77 -38.92 86.9 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 120.682 0.277 . . . . 0.0 111.286 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.33 -42.14 90.74 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.539 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG23 ' H ' ' B' ' 25' ' ' VAL . 4.3 t -62.34 -44.16 98.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 120.287 -0.565 . . . . 0.0 112.034 -179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -64.3 -43.3 97.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 120.604 -0.438 . . . . 0.0 111.585 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.42 HG21 ' HB ' ' A' ' 32' ' ' VAL . 22.0 m -62.79 -43.34 99.06 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.624 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 tp -60.78 -42.56 97.78 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.909 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.8 98.85 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.427 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.71 -41.29 92.49 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -59.79 -41.72 91.82 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 7.5 m -63.98 0.04 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.26 -178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -47.82 -66.53 0.39 Allowed 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 120.333 -0.547 . . . . 0.0 109.531 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -37.47 86.15 Favored Glycine 0 C--N 1.303 -1.269 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 55.5 ttt85 -60.33 -37.31 80.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.238 0.542 . . . . 0.0 110.463 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.431 ' O ' HD23 ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.78 -41.84 92.01 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.4 OUTLIER -62.38 -47.36 89.44 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 -176.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.3 Cg_endo -63.53 -36.21 55.32 Favored 'Trans proline' 0 N--CA 1.502 2.028 0 C-N-CA 122.518 2.145 . . . . 0.0 111.7 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.625 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.31 -40.02 96.89 Favored Glycine 0 C--N 1.3 -1.419 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.551 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.439 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.04 -40.52 85.32 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 74.9 p -75.96 121.32 22.53 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.548 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 48.2 p90 179.45 113.68 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.16 178.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.436 HD12 ' H ' ' B' ' 43' ' ' LEU . 0.3 OUTLIER -105.11 76.59 1.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.082 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 3.4 m 177.62 -173.59 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.527 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.3 mt 65.81 45.34 2.59 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.858 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.77 -39.75 3.53 Favored Glycine 0 C--N 1.309 -0.95 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.512 ' O ' HG13 ' B' ' 47' ' ' VAL . 6.0 p -152.96 80.25 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.551 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.4 OUTLIER -169.07 -53.55 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.075 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.498 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 84.0 Cg_endo -81.98 -35.5 0.37 Allowed 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 121.723 1.616 . . . . 0.0 111.887 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 15.8 mt -56.52 -35.5 68.14 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.149 -178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.605 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.5 mp -56.68 -43.6 80.63 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.709 -1.196 . . . . 0.0 109.394 -178.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.58 -41.72 95.23 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.13 -29.34 43.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.666 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -52.89 -39.49 62.72 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.697 -177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 19.2 mt -58.77 -44.36 90.62 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.293 -0.963 . . . . 0.0 108.63 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 tp -67.39 -33.34 75.0 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.556 1.142 . . . . 0.0 113.435 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.4 ttp180 -55.49 -43.48 99.16 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 17.8 Cg_endo -58.91 -39.22 83.15 Favored 'Trans proline' 0 N--CA 1.497 1.705 0 CA-C-N 121.785 1.673 . . . . 0.0 111.186 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 57.34 60.68 2.8 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.682 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 10.8 ptt-85 -61.65 140.03 58.21 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.351 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -104.96 9.95 34.37 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.832 0.348 . . . . 0.0 110.449 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.8 mt -81.85 5.84 17.57 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.269 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.696 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.72 29.09 3.96 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.774 0.321 . . . . 0.0 110.521 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.412 ' O ' HG12 ' C' ' 7' ' ' VAL . 26.7 mmtt -140.8 -26.23 0.74 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.518 ' ND2' HD11 ' C' ' 8' ' ' LEU . 0.2 OUTLIER -78.57 51.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.163 0.506 . . . . 0.0 109.773 179.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.48 HG12 ' HB2' ' B' ' 10' ' ' ALA . 0.0 OUTLIER -153.01 -67.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.274 -0.876 . . . . 0.0 108.776 -179.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 36.7 mt -59.07 -37.79 70.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.477 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.0 p -60.9 -41.25 88.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.119 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.518 HD11 ' ND2' ' C' ' 4' ' ' ASN . 10.1 mt -60.4 -40.09 89.7 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.057 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.19 -42.65 98.96 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.35 -40.79 87.55 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.75 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -39.63 84.82 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.643 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 16.1 t -60.2 -41.34 92.75 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.155 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.86 -39.92 86.85 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.392 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.0 98.39 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.406 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.74 -41.2 99.58 Favored Glycine 0 C--N 1.306 -1.095 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.426 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -60.49 -41.91 95.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.704 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -49.03 112.12 0.58 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.211 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.8 154.27 25.39 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -80.18 -67.5 0.76 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.5 0.191 . . . . 0.0 111.242 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -58.78 -40.2 83.3 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.343 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 59.8 t-105 -59.01 -40.68 85.66 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.426 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.85 -39.85 98.06 Favored Glycine 0 C--N 1.302 -1.323 0 C-N-CA 121.402 -0.428 . . . . 0.0 112.521 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.552 ' O ' HG23 ' C' ' 27' ' ' THR . 8.9 mt -60.26 -38.95 85.09 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tt -59.56 -42.13 91.7 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -63.44 -44.77 99.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 112.851 0.686 . . . . 0.0 112.851 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -65.3 -43.74 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.002 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.552 HG23 ' O ' ' C' ' 23' ' ' LEU . 77.4 p -63.48 -42.83 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.99 -178.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.563 HD13 ' O ' ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.36 -41.67 98.8 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.147 -178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.4 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -60.68 -47.21 87.26 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.625 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.8 OUTLIER -68.39 -37.33 80.28 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.786 178.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.446 ' C ' ' H ' ' C' ' 33' ' ' LYS . 24.4 t60 -58.73 -42.25 88.34 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.416 ' H ' HG22 ' C' ' 32' ' ' VAL . 3.6 m -58.77 -5.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.62 -178.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.446 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.1 pttp -41.65 -53.41 3.57 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.995 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.92 -38.16 87.78 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 112.017 -0.433 . . . . 0.0 112.017 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 80.6 mtt-85 -58.66 -35.74 73.04 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.965 0.412 . . . . 0.0 110.622 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.565 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.7 OUTLIER -60.88 -43.84 97.91 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -177.149 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -46.27 87.02 Favored Pre-proline 0 N--CA 1.483 1.211 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -175.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.28 -35.96 95.86 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.66 2.24 . . . . 0.0 111.42 176.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.37 -37.28 92.89 Favored Glycine 0 C--N 1.302 -1.332 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.482 179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.39 -40.81 75.23 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.41 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.9 p -39.13 106.41 0.05 Allowed 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.859 0.361 . . . . 0.0 111.458 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -97.14 73.88 2.53 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.526 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mt -83.99 102.04 12.17 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.29 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 36.5 t 49.38 78.74 0.09 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.681 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 96.8 mt -151.08 31.75 0.61 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.027 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.26 -70.79 0.82 Allowed Glycine 0 C--N 1.301 -1.369 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.46 -10.14 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.446 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.8 OUTLIER -47.85 -47.8 62.33 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.406 -179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 54.2 Cg_exo -53.99 -38.05 86.47 Favored 'Trans proline' 0 N--CA 1.502 1.986 0 C-N-CA 122.269 1.979 . . . . 0.0 112.917 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 81.3 mt -55.56 -34.54 64.84 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.531 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.8 mm? -55.65 -43.12 75.95 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 118.442 -1.303 . . . . 0.0 109.18 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -60.13 -41.82 93.49 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -59.4 -31.43 46.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.692 178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -53.99 -38.48 65.12 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.05 -178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 49.2 tp -55.96 -41.3 74.5 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 120.084 -0.646 . . . . 0.0 109.334 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.582 ' O ' HD23 ' C' ' 56' ' ' LEU . 0.8 OUTLIER -66.86 -34.62 78.19 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 124.078 0.951 . . . . 0.0 112.919 177.863 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 8.6 mmt85 -56.94 -43.19 99.3 Favored Pre-proline 0 N--CA 1.486 1.328 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 -174.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.3 Cg_endo -58.79 -38.96 86.03 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 CA-C-N 121.877 1.706 . . . . 0.0 112.227 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.54 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -39.39 162.98 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 120.758 0.314 . . . . 0.0 111.118 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.78 -149.87 0.42 Allowed 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -110.25 -20.22 12.73 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 120.51 0.195 . . . . 0.0 110.972 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.55 ' H ' HD23 ' C' ' 62' ' ' LEU . 0.1 OUTLIER -79.96 17.16 1.01 Allowed 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.99 179.814 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . 0.485 ' CA ' HD22 ' D' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.15 -105.77 0.15 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.754 0.312 . . . . 0.0 110.645 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.423 ' HZ1' ' HB2' ' E' ' 2' ' ' ALA . 20.6 mmtp -67.84 77.48 0.21 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.018 0.437 . . . . 0.0 110.567 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.485 HD22 ' CA ' ' D' ' 1' ' ' GLY . 82.8 m-20 -156.43 -45.48 0.07 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.739 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 1.6 t -65.46 -56.32 15.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.418 HG22 ' CG1' ' E' ' 5' ' ' VAL . 50.4 mt -59.3 -34.54 54.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.622 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.0 t -58.42 -40.43 78.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.206 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.475 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.9 mp -59.26 -40.33 85.66 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.259 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -61.17 -41.72 97.27 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.36 80.23 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.617 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.15 -39.94 80.07 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.344 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.9 -42.02 97.23 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 120.392 -0.523 . . . . 0.0 109.744 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -38.76 79.04 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.644 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.65 95.4 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.96 -43.08 98.46 Favored Glycine 0 C--N 1.305 -1.161 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -61.77 -41.65 97.97 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 120.924 0.392 . . . . 0.0 110.803 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -51.68 101.88 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.827 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.1 119.26 0.8 Allowed Glycine 0 C--N 1.304 -1.248 0 N-CA-C 110.284 -1.127 . . . . 0.0 110.284 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.74 -35.91 1.28 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.662 0.268 . . . . 0.0 110.683 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.84 -43.66 97.99 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.983 -0.687 . . . . 0.0 109.742 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 t90 -61.02 -42.06 97.75 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.876 0.369 . . . . 0.0 111.526 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.78 -39.5 96.85 Favored Glycine 0 C--N 1.304 -1.237 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.518 ' O ' HG23 ' D' ' 27' ' ' THR . 4.2 tp -59.66 -39.24 83.76 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -178.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.49 -43.37 93.34 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 13.2 t -61.99 -44.01 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 120.162 -0.615 . . . . 0.0 112.111 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -63.96 -43.16 97.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 CA-C-O 121.081 0.467 . . . . 0.0 111.374 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.518 HG23 ' O ' ' D' ' 23' ' ' LEU . 77.9 p -63.73 -43.79 95.47 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.529 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.521 ' O ' HD13 ' D' ' 28' ' ' LEU . 0.2 OUTLIER -61.36 -43.22 99.25 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.367 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.497 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.68 -42.51 99.03 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.331 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.565 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -64.32 -40.91 96.85 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -61.06 -42.19 98.02 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.497 HG22 ' O ' ' D' ' 29' ' ' ALA . 20.9 m -64.52 -7.94 4.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.381 -0.527 . . . . 0.0 112.332 -177.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 3.5 tppt? -46.35 -59.51 2.9 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.204 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.72 -38.04 91.07 Favored Glycine 0 C--N 1.303 -1.289 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -60.3 -37.1 79.49 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.967 0.413 . . . . 0.0 111.055 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.62 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -59.63 -41.92 91.55 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.448 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.9 t -62.22 -46.6 90.88 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -61.9 -34.63 81.16 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.434 2.089 . . . . 0.0 111.688 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.534 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.89 95.17 Favored Glycine 0 C--N 1.301 -1.388 0 CA-C-N 114.794 -1.093 . . . . 0.0 110.548 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -39.91 77.38 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.633 -0.283 . . . . 0.0 111.514 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 39.4 p -90.32 113.99 25.97 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 120.866 0.365 . . . . 0.0 111.251 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.576 ' CG ' ' N ' ' D' ' 43' ' ' LEU . 11.0 p90 -162.74 -54.73 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.647 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.589 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.1 mm? 55.93 77.94 0.22 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.632 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 34.7 m -171.68 170.4 5.65 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.256 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.6 mt 55.75 53.18 9.77 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.051 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.53 -55.28 4.68 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 121.362 -0.446 . . . . 0.0 113.2 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.93 -25.22 3.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 117.345 0.573 . . . . 0.0 112.033 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.502 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 20.6 t-105 -53.19 -38.83 65.56 Favored Pre-proline 0 C--N 1.298 -1.669 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.643 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.502 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 26.8 Cg_exo -62.0 -55.74 0.96 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.285 1.323 . . . . 0.0 112.343 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 47.1 mt -54.96 -38.74 68.14 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 9.2 mp -59.35 -44.37 92.67 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.345 -1.342 . . . . 0.0 109.265 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 11.8 mt -61.02 -41.1 95.92 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.48 -32.56 45.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.285 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -54.96 -40.82 70.4 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.138 -178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.543 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.52 -44.77 95.68 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.868 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -67.49 -31.29 71.33 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.659 1.584 . . . . 0.0 115.128 179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.41 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 28.4 ttt-85 -54.4 -39.98 79.19 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -172.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' D' ' 59' ' ' HIS . 26.7 Cg_exo -61.24 -40.79 47.2 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 C-N-CA 121.847 1.698 . . . . 0.0 111.449 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' D' ' 58' ' ' PRO . 0.2 OUTLIER 55.07 155.35 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.383 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -173.96 135.13 0.47 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.383 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . 0.467 ' O ' ' CD2' ' B' ' 8' ' ' LEU . . . -81.1 -18.39 46.69 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.605 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.542 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.4 mm? -66.84 -28.92 68.74 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.238 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.661 179.821 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.432 ' C ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.423 ' HB2' ' HZ1' ' D' ' 3' ' ' LYS . . . 48.03 16.77 0.09 Allowed 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.432 ' N ' ' C ' ' E' ' 1' ' ' GLY . 36.4 mmtt -137.25 72.9 1.43 Allowed 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.149 0.5 . . . . 0.0 110.498 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -159.45 -28.37 0.07 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.079 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.418 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.5 OUTLIER -81.02 -61.1 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.01 179.22 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.43 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.9 mt -59.95 -35.34 60.26 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.2 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 t -58.67 -40.76 80.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.143 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 11.0 mt -60.23 -39.99 88.63 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.116 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.12 -41.99 97.71 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.196 0.522 . . . . 0.0 109.674 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.96 -39.76 78.89 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.664 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.86 81.04 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.253 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 43.3 t -60.45 -41.56 94.33 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.66 -37.89 76.95 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.815 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -40.81 91.41 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.09 -41.54 96.59 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.757 HD21 ' HE1' ' E' ' 21' ' ' TRP . 16.0 t-20 -60.93 -41.4 96.14 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.695 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -57.84 110.87 0.99 Allowed 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.842 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.501 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.8 112.25 0.34 Allowed Glycine 0 C--N 1.305 -1.179 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.422 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -33.86 -44.42 0.16 Allowed 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 122.476 0.31 . . . . 0.0 111.67 -179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -59.9 -43.26 94.94 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.046 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.757 ' HE1' HD21 ' E' ' 16' ' ' ASN . 64.7 t-105 -60.75 -40.99 94.53 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.887 0.375 . . . . 0.0 110.976 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.407 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.15 -39.86 97.73 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.655 ' O ' HG23 ' E' ' 27' ' ' THR . 7.9 mp -60.47 -37.36 80.79 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . 0.43 ' CD1' HG11 ' D' ' 32' ' ' VAL . 35.2 tp -57.19 -43.34 82.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -176.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.407 HG12 ' O ' ' E' ' 22' ' ' GLY . 1.9 p -60.62 -42.13 90.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 C-N-CA 119.529 -0.868 . . . . 0.0 111.363 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.21 -42.85 98.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.655 HG23 ' O ' ' E' ' 23' ' ' LEU . 7.0 p -62.79 -44.67 95.55 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.329 -0.548 . . . . 0.0 112.074 -178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . 0.462 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.1 OUTLIER -61.91 -43.13 99.48 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.29 -178.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.442 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.78 -41.87 99.44 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.776 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.534 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.38 -42.33 92.81 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.53 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -62.08 -41.8 98.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.471 ' HB ' HG21 ' F' ' 27' ' ' THR . 17.8 m -63.69 -7.33 3.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 28.3 mmtt -45.49 -59.34 2.77 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.447 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.61 -37.51 89.33 Favored Glycine 0 C--N 1.303 -1.274 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -58.75 -36.03 73.7 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 120.837 0.351 . . . . 0.0 110.667 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.624 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.96 -43.44 98.83 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 115.416 1.635 . . . . 0.0 115.416 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.4 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -45.86 88.05 Favored Pre-proline 0 N--CA 1.484 1.234 0 CA-C-N 119.186 0.903 . . . . 0.0 113.231 -176.231 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.38 -35.49 96.38 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.913 2.408 . . . . 0.0 111.252 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.51 -37.85 93.96 Favored Glycine 0 C--N 1.301 -1.374 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.192 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.87 79.88 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -177.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -43.86 112.24 0.37 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.717 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.427 ' O ' ' O ' ' E' ' 43' ' ' LEU . 62.4 m-85 -91.36 69.42 5.96 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.987 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' E' ' 42' ' ' TYR . 8.7 tp -58.09 -113.7 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.177 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 13.6 t -103.71 79.06 1.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.907 179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 21.3 mt -133.85 21.15 3.84 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.299 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.4 -67.81 1.95 Allowed Glycine 0 C--N 1.302 -1.361 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.152 -179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . 0.409 HG12 ' O ' ' E' ' 47' ' ' VAL . 63.2 t -129.09 -18.35 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.483 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 4.0 t-105 -51.57 -43.82 88.21 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.892 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.483 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 26.1 Cg_exo -61.36 -47.43 11.94 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.847 1.698 . . . . 0.0 112.077 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -55.23 -36.46 66.03 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -176.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.1 mt -57.26 -44.35 83.86 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.154 -1.419 . . . . 0.0 109.254 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.36 -41.56 93.91 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 47.0 t -59.24 -32.6 48.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.023 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 70.0 ttp85 -55.22 -41.39 72.0 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.303 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . 0.546 HD22 ' N ' ' E' ' 55' ' ' LEU . 3.7 mm? -59.69 -43.79 93.92 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 119.419 -0.912 . . . . 0.0 109.058 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.62 ' N ' HD12 ' E' ' 56' ' ' LEU . 9.1 mp -67.42 -33.1 74.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 124.479 1.111 . . . . 0.0 113.405 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 60.6 ttt-85 -56.82 -44.42 99.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -174.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 27.7 Cg_endo -60.41 -41.18 51.48 Favored 'Trans proline' 0 N--CA 1.5 1.892 0 CA-C-N 121.542 1.586 . . . . 0.0 113.056 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.485 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -58.61 155.82 11.82 Favored 'General case' 0 C--N 1.307 -1.247 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.103 -178.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' E' ' 61' ' ' ALA . 0.0 OUTLIER -170.75 -15.42 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.509 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' E' ' 60' ' ' ARG . . . 163.59 -175.33 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.86 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 3.8 tp 67.97 5.12 4.37 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.426 ' O ' ' CD2' ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 -93.94 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.83 0.347 . . . . 0.0 110.582 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -75.95 73.7 2.85 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.508 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.444 ' O ' HD13 ' F' ' 8' ' ' LEU . 69.5 m-80 -155.08 -42.73 0.08 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.87 179.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.43 ' CG1' HG22 ' E' ' 6' ' ' ILE . 2.2 t -67.48 -54.7 21.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.36 -34.58 58.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.672 178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 61.2 t -57.99 -40.42 76.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.934 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.444 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.53 -40.29 86.7 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.57 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -61.19 -41.48 96.88 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.142 0.496 . . . . 0.0 109.979 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.14 -39.09 74.51 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.486 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.12 77.75 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.346 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -61.29 -42.48 98.72 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 120.195 -0.602 . . . . 0.0 109.656 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -39.72 85.08 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.321 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.14 -42.08 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.95 -42.61 98.36 Favored Glycine 0 C--N 1.305 -1.155 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.027 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -61.66 -41.71 97.9 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.453 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -65.86 123.36 19.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.142 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.35 -179.99 48.8 Favored Glycine 0 C--N 1.305 -1.185 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.5 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -81.15 -61.7 1.88 Allowed 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.886 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -58.83 -40.92 85.61 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.558 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 82.0 t90 -59.04 -40.28 84.58 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 120.672 0.272 . . . . 0.0 111.393 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.31 -39.49 96.16 Favored Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -59.91 -39.22 84.65 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 120.51 0.195 . . . . 0.0 111.29 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.09 -44.47 94.78 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -177.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.4 t -63.07 -45.19 99.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 40.8 t -64.83 -42.89 96.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 120.401 -0.52 . . . . 0.0 111.935 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.471 HG21 ' HB ' ' E' ' 32' ' ' VAL . 83.6 m -62.91 -43.31 99.14 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.63 -43.1 97.93 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.443 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.13 -43.31 98.74 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.25 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -65.54 -42.09 92.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . 0.404 ' NE2' ' NH2' ' F' ' 35' ' ' ARG . 70.5 t60 -60.64 -42.05 96.16 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 27' ' ' THR . 19.8 m -65.74 -5.02 2.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -177.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -48.45 -63.2 1.15 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.764 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.94 -36.95 83.11 Favored Glycine 0 C--N 1.3 -1.434 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . 0.404 ' NH2' ' NE2' ' F' ' 31' ' ' HIS . 48.0 mmt-85 -61.2 -38.38 86.35 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 120.912 0.387 . . . . 0.0 111.615 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.627 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.37 -44.6 95.44 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -176.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.475 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -64.09 -45.01 79.48 Favored Pre-proline 0 C--N 1.304 -1.388 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 36.1 Cg_endo -62.14 -34.83 78.2 Favored 'Trans proline' 0 N--CA 1.503 2.049 0 C-N-CA 122.501 2.134 . . . . 0.0 111.692 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.474 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.29 -41.13 98.23 Favored Glycine 0 C--N 1.3 -1.428 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.29 -41.48 84.48 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.966 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 69.2 p -73.44 110.87 8.06 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.474 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.555 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 12.6 p90 -171.42 118.79 0.46 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 121.041 0.448 . . . . 0.0 110.255 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.603 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.5 mm? -88.96 161.22 16.74 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.26 176.13 0.27 Allowed 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.034 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . 0.553 HD22 ' CE3' ' F' ' 48' ' ' TRP . 12.1 mt 60.97 43.63 11.36 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.148 -178.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.93 -65.16 3.28 Favored Glycine 0 CA--C 1.534 1.23 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.457 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 18.4 m -109.63 -8.19 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 CA-C-N 117.151 0.475 . . . . 0.0 111.204 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.553 ' CE3' HD22 ' F' ' 45' ' ' LEU . 8.9 t90 -58.43 -39.66 76.82 Favored Pre-proline 0 C--N 1.298 -1.641 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.316 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.6 Cg_exo -54.59 -50.44 13.4 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 120.939 1.093 . . . . 0.0 110.752 178.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 2.2 mt -54.87 -36.49 65.16 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.454 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 20.6 mt -57.49 -44.41 84.92 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.469 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.63 -41.63 95.25 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.07 -31.6 46.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.532 178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.419 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.2 ttm180 -53.69 -40.34 65.91 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -178.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -60.37 -44.13 95.9 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.629 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 56' ' ' LEU . 3.5 mm? -68.32 -34.03 75.38 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 115.174 1.546 . . . . 0.0 115.174 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' F' ' 58' ' ' PRO . 2.4 ttt-85 -56.07 -43.49 99.27 Favored Pre-proline 0 N--CA 1.483 1.178 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -172.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 31.5 Cg_exo -56.52 -41.09 79.68 Favored 'Trans proline' 0 C--N 1.299 -2.067 0 C-N-CA 121.685 1.59 . . . . 0.0 110.855 177.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.427 ' O ' ' O ' ' F' ' 60' ' ' ARG . 23.3 t-80 44.27 48.28 7.88 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.73 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' F' ' 59' ' ' HIS . 30.5 ptt180 -53.71 -170.78 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.178 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -157.9 91.92 1.16 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.945 0.402 . . . . 0.0 110.743 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 7.2 tp -167.01 -28.13 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.175 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 117.972 -1.013 . . . . 0.0 111.057 179.719 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -177.02 -94.51 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.689 0.281 . . . . 0.0 110.424 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.5 mttp -104.81 -32.96 8.58 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.654 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 4' ' ' ASN . 12.9 m-80 -45.98 -27.32 0.88 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.329 0.585 . . . . 0.0 109.716 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.684 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -69.82 -56.7 10.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.437 HG22 ' CG1' ' B' ' 5' ' ' VAL . 40.0 mt -57.64 -36.6 54.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 90.3 t -59.81 -41.79 86.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.173 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.67 -40.42 92.06 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.689 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -60.74 -42.17 96.81 Favored 'General case' 0 C--N 1.308 -1.211 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.726 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.99 -40.0 79.61 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.535 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.25 83.42 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.52 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.9 t -61.05 -42.56 98.72 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.313 -0.555 . . . . 0.0 109.773 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.43 79.61 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.443 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.09 -40.83 90.99 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.07 -41.94 96.76 Favored Glycine 0 C--N 1.306 -1.135 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' GLY . 16.7 m120 -60.95 -40.53 93.69 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.835 0.35 . . . . 0.0 110.222 178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -45.94 88.8 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.807 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.89 111.68 0.49 Allowed Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.092 -1.203 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -45.29 -38.04 5.29 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.591 0.234 . . . . 0.0 111.192 -179.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.583 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 50.4 p90 -61.2 -43.91 98.12 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.886 -0.726 . . . . 0.0 110.037 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.583 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 68.2 t-105 -61.47 -42.81 99.35 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.062 0.458 . . . . 0.0 111.003 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.11 -39.43 97.11 Favored Glycine 0 C--N 1.302 -1.31 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.717 ' O ' HG23 ' A' ' 27' ' ' THR . 46.9 mt -60.59 -39.08 86.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.855 -0.173 . . . . 0.0 111.454 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.48 -43.34 93.31 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 43.5 t -62.74 -44.46 99.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 120.028 -0.669 . . . . 0.0 111.741 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -64.24 -42.35 95.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.273 0.558 . . . . 0.0 110.793 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 23' ' ' LEU . 64.5 p -62.17 -42.79 99.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.469 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.6 tp -61.05 -41.36 96.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.935 0.398 . . . . 0.0 110.298 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.67 -40.59 88.29 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.066 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -62.92 -41.22 99.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.3 t-80 -61.33 -42.04 98.02 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -177.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 29' ' ' ALA . 25.4 m -64.45 -13.36 14.05 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -45.29 -56.73 4.58 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.443 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.83 88.72 Favored Glycine 0 C--N 1.302 -1.336 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.03 -36.55 77.53 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.93 0.395 . . . . 0.0 111.211 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.609 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -59.92 -42.12 93.24 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.7 t -61.91 -46.58 92.34 Favored Pre-proline 0 C--N 1.306 -1.32 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -176.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.7 Cg_endo -62.21 -34.28 78.99 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.329 2.019 . . . . 0.0 111.121 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.02 -38.95 95.01 Favored Glycine 0 C--N 1.3 -1.445 0 CA-C-N 114.691 -1.14 . . . . 0.0 110.573 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.12 -40.92 82.44 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.142 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -79.06 115.89 19.01 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.869 0.366 . . . . 0.0 111.122 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.547 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 39.7 p90 -171.7 118.53 0.43 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.115 0.484 . . . . 0.0 110.284 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 43' ' ' LEU . 4.0 mm? -40.43 114.27 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.59 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.7 p -38.86 130.55 1.44 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.434 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 26.9 mt -88.2 -71.79 0.56 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.863 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.12 -53.77 0.6 Allowed Glycine 0 C--N 1.308 -0.981 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.11 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.491 ' CG2' HD21 ' A' ' 51' ' ' LEU . 7.1 p -148.84 -13.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 13.4 t-105 -47.42 -45.51 56.57 Favored Pre-proline 0 C--N 1.307 -1.271 0 C-N-CA 120.021 -0.672 . . . . 0.0 112.365 -178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.5 -37.87 0.34 Allowed 'Trans proline' 0 N--CA 1.489 1.216 0 C-N-CA 121.192 1.261 . . . . 0.0 112.589 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.4 mt -55.29 -37.52 67.42 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.491 HD21 ' CG2' ' A' ' 47' ' ' VAL . 19.0 mt -58.39 -44.52 88.96 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.206 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp -60.83 -42.26 97.4 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.46 -31.07 45.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.918 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -54.25 -40.99 68.27 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.049 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 55' ' ' LEU . 11.0 mp -60.43 -44.7 95.53 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.349 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.98 -33.55 75.82 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 124.569 1.148 . . . . 0.0 113.578 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 72.0 ttt180 -56.07 -44.16 99.58 Favored Pre-proline 0 C--N 1.307 -1.254 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -174.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 21.7 Cg_endo -60.19 -41.06 54.43 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 CA-C-N 121.657 1.628 . . . . 0.0 111.155 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.523 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 27.1 t-80 54.9 159.73 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.869 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.523 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 6.8 ptp180 -165.99 121.94 1.3 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.223 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.32 2.99 29.52 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.842 0.353 . . . . 0.0 110.674 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 58.0 tp -70.82 -38.98 73.28 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.047 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.659 -179.95 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -100.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.771 0.319 . . . . 0.0 110.292 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 56.2 mttp -78.72 -33.89 46.37 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.301 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.466 ' O ' HD13 ' B' ' 8' ' ' LEU . 11.1 m120 -45.28 -34.04 2.7 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.446 HG23 ' H ' ' B' ' 5' ' ' VAL . 2.4 t -64.69 -54.73 26.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.419 HG22 ' CG1' ' C' ' 5' ' ' VAL . 41.5 mt -58.27 -36.46 58.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.053 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 92.7 t -59.73 -41.01 83.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.298 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.466 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.4 mp -57.29 -39.43 75.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.35 -39.64 87.88 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 121.221 0.534 . . . . 0.0 109.619 178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.26 -42.2 81.09 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.699 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.36 -39.1 78.62 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 36.2 p -60.5 -42.65 96.8 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.964 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.98 -40.04 83.58 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.138 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.35 -40.51 94.56 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.7 -41.34 95.76 Favored Glycine 0 C--N 1.305 -1.186 0 CA-C-N 114.726 -1.124 . . . . 0.0 112.346 -178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -60.45 -42.12 95.5 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.681 0.741 . . . . 0.0 110.984 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 56.06 174.43 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.722 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -123.0 -7.43 7.18 Favored Glycine 0 N--CA 1.472 1.098 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.532 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.612 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.7 t80 -73.25 -94.23 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 117.244 0.522 . . . . 0.0 110.599 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.612 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 38.6 p90 -60.23 -42.05 94.38 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.941 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.557 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 52.5 t90 -60.77 -40.55 92.95 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.37 97.63 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.45 -40.65 95.26 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.443 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 30.7 tp -60.78 -44.86 96.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.6 p -63.74 -43.62 98.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.882 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -64.0 -42.97 97.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.194 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -62.74 -43.13 99.61 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.828 -178.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 12.2 tp -60.78 -43.15 98.42 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.056 -0.658 . . . . 0.0 109.997 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -41.92 98.57 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.278 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.37 -40.78 96.52 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -59.21 -40.78 86.84 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.565 0.579 . . . . 0.0 112.565 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 15.5 m -70.36 1.18 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 C-N-CA 120.067 -0.653 . . . . 0.0 112.023 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -52.0 -62.85 1.37 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.269 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.65 -38.39 91.52 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -60.83 -35.85 77.58 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.405 0.622 . . . . 0.0 110.592 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 4.7 tt -60.21 -41.76 93.68 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 114.722 1.378 . . . . 0.0 114.722 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.453 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -63.26 -47.7 84.34 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -177.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 41.6 Cg_endo -65.07 -37.49 32.61 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.424 2.083 . . . . 0.0 111.795 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.86 -42.17 99.5 Favored Glycine 0 C--N 1.301 -1.373 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.264 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.64 86.62 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -84.89 107.72 17.18 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 111.892 0.33 . . . . 0.0 111.892 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.521 ' O ' ' CG ' ' B' ' 42' ' ' TYR . 18.8 p90 -175.85 112.59 0.12 Allowed 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.061 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.613 HD12 ' N ' ' B' ' 43' ' ' LEU . 7.1 mp -84.01 -170.8 3.26 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 1.2 t 75.61 -173.91 0.11 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.96 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 8.0 mt 63.42 45.58 4.78 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.486 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.3 -36.54 3.82 Favored Glycine 0 C--N 1.308 -1.019 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.316 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.499 ' O ' HG13 ' B' ' 47' ' ' VAL . 5.9 p -154.51 79.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.543 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.8 OUTLIER -169.04 -53.59 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.013 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.497 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 86.8 Cg_endo -82.28 -34.53 0.43 Allowed 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 121.802 1.668 . . . . 0.0 111.531 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -57.06 -35.66 69.62 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.269 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.605 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.1 mp -56.71 -44.08 81.22 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.801 -1.16 . . . . 0.0 109.396 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -60.05 -41.16 91.71 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.425 HG11 ' CE1' ' D' ' 19' ' ' PHE . 23.7 t -60.21 -29.8 44.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.688 177.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -53.75 -39.65 65.52 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.455 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 16.7 mt -58.4 -43.92 88.8 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.175 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 14.2 mt -67.77 -32.8 73.65 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.508 1.123 . . . . 0.0 112.934 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.452 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 38.0 ttp180 -55.45 -43.95 99.4 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 -174.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.9 Cg_endo -59.75 -40.55 63.1 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.777 1.67 . . . . 0.0 111.446 178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' B' ' 58' ' ' PRO . 10.4 t-80 52.64 170.19 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.398 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 ptp85 -171.92 -162.54 0.22 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.37 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.55 20.45 0.4 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.744 179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 27.0 mt -75.25 -44.01 48.31 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.139 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.209 0 CA-C-O 117.991 -1.004 . . . . 0.0 110.95 179.814 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 62.03 135.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 120.879 0.371 . . . . 0.0 110.699 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.406 ' O ' ' CB ' ' C' ' 4' ' ' ASN . 8.2 mptt 52.52 -177.63 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.028 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' C' ' 3' ' ' LYS . 13.3 t-20 74.55 -48.53 0.65 Allowed 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.419 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.0 OUTLIER -63.85 -66.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.201 179.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -59.15 -36.8 64.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.868 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 19.1 t -59.5 -41.02 83.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.028 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.46 HD21 ' C ' ' E' ' 63' ' ' ALA . 9.1 mt -59.62 -39.69 85.09 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.207 -179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . -58.31 -40.97 83.47 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.588 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.52 79.87 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.317 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 36.8 t -60.61 -42.15 96.22 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.887 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.27 82.94 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.661 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -60.99 -41.53 96.64 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.76 -41.64 97.64 Favored Glycine 0 C--N 1.305 -1.167 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.374 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 33.4 m120 -61.14 -41.74 97.29 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.9 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -55.69 115.11 2.16 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.514 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.57 161.9 34.04 Favored Glycine 0 C--N 1.308 -1.002 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.567 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -79.07 -62.79 1.59 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.422 -0.389 . . . . 0.0 111.357 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -58.68 -40.5 83.73 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.296 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -59.63 -40.5 87.81 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.796 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.64 -40.23 98.47 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 121.152 -0.547 . . . . 0.0 112.379 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 39.5 mt -60.2 -39.51 86.82 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.15 -42.74 95.54 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -177.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -63.95 -45.3 97.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 7.5 t -65.19 -43.27 95.51 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-O 121.301 0.572 . . . . 0.0 111.378 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 19.3 m -62.47 -43.29 99.18 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.812 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 37.2 tp -62.45 -42.6 99.58 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.655 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.473 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.59 -48.16 78.52 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.16 -37.24 80.79 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.849 -0.74 . . . . 0.0 112.38 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 1.5 t60 -58.48 -40.96 84.15 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.473 HG22 ' O ' ' C' ' 29' ' ' ALA . 6.7 m -61.59 -2.03 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.03 -178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.405 ' H ' ' C ' ' C' ' 31' ' ' HIS . 15.1 pttp -42.47 -56.38 3.07 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.664 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.402 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.18 -38.19 89.01 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -59.22 -36.2 75.0 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.001 0.429 . . . . 0.0 110.341 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.64 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.7 tt -61.67 -43.32 99.07 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.42 88.52 Favored Pre-proline 0 N--CA 1.483 1.179 0 C-N-CA 119.351 -0.94 . . . . 0.0 113.095 -176.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.402 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.72 -36.11 92.7 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.78 2.32 . . . . 0.0 111.453 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -38.4 95.1 Favored Glycine 0 C--N 1.304 -1.236 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.376 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.09 -40.5 77.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.435 ' C ' ' O ' ' C' ' 40' ' ' ALA . 20.1 p -37.8 112.8 0.23 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.782 0.325 . . . . 0.0 110.791 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' C' ' 43' ' ' LEU . 1.8 t80 -92.7 -74.3 0.53 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.628 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.439 ' O ' ' O ' ' C' ' 42' ' ' TYR . 6.6 tp 55.4 108.91 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 50.6 p 54.34 -152.68 0.32 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.829 0.347 . . . . 0.0 110.621 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 17.0 mt 69.24 46.93 0.74 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.003 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.02 -68.18 1.82 Allowed Glycine 0 C--N 1.306 -1.136 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.125 -178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -135.17 -7.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.5 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.5 t-105 -51.74 -45.44 91.83 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.85 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 74.3 Cg_endo -79.02 -44.03 0.14 Allowed 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 121.122 1.214 . . . . 0.0 112.102 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 88.8 mt -55.01 -35.59 64.55 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.7 mt -56.8 -42.95 80.42 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.731 -1.188 . . . . 0.0 109.913 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.24 -41.16 92.58 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.06 -32.28 47.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.094 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -54.56 -39.4 67.71 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.268 -0.424 . . . . 0.0 109.871 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.522 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.1 mp -56.87 -42.21 79.37 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.514 HD13 ' O ' ' C' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -33.81 76.41 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 124.221 1.008 . . . . 0.0 112.314 177.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.474 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 39.3 ttm180 -55.37 -43.64 99.22 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 19.1 Cg_endo -58.9 -39.19 83.49 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 CA-C-N 121.897 1.713 . . . . 0.0 111.585 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' C' ' 60' ' ' ARG . 31.3 t-80 54.01 168.34 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.551 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 21.3 ptt-85 -171.95 -173.43 1.13 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.286 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -155.14 6.71 0.25 Allowed 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.955 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.1 mt -82.09 20.31 1.03 Allowed 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.235 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.295 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.633 -179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.28 -52.53 35.68 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.838 0.351 . . . . 0.0 110.496 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.457 ' O ' ' ND2' ' D' ' 4' ' ' ASN . 0.5 OUTLIER -88.54 179.94 6.18 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.188 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.457 ' ND2' ' O ' ' D' ' 3' ' ' LYS . 1.3 m-80 73.83 31.33 1.23 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.013 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.8 -71.12 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 mt -58.37 -36.51 58.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.474 179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.485 HG23 ' N ' ' D' ' 8' ' ' LEU . 10.4 m -60.5 -41.26 87.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.201 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.523 HD13 ' HB1' ' C' ' 10' ' ' ALA . 11.8 mt -60.35 -40.16 89.75 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.605 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -61.1 -42.11 97.9 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 121.184 0.516 . . . . 0.0 109.854 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.93 -39.88 79.08 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.936 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.16 -39.93 80.08 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.328 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 47.9 t -60.98 -42.4 98.28 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.366 -0.534 . . . . 0.0 109.848 179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.09 -38.86 80.49 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.812 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.51 95.51 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -41.77 97.49 Favored Glycine 0 C--N 1.306 -1.109 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.332 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -61.02 -41.7 97.05 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.654 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -56.15 112.01 1.11 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.596 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.94 162.16 35.39 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.425 ' CE1' HG11 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -79.15 -56.97 3.97 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.86 -0.17 . . . . 0.0 111.261 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.546 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 22.7 p90 -58.42 -39.73 80.55 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.647 0.26 . . . . 0.0 110.974 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.546 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 70.4 t-105 -58.3 -40.13 81.18 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.014 -179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.84 95.97 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.81 -38.25 84.77 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.802 -0.234 . . . . 0.0 111.456 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.17 -45.11 91.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' D' ' 25' ' ' VAL . 5.5 m -62.15 -41.57 91.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.28 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 60.1 t -62.57 -41.72 93.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.491 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 57.7 m -62.2 -44.88 95.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 8.6 mp -62.4 -42.75 99.67 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.386 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.39 -43.09 98.59 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -41.98 91.43 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -61.23 -41.56 97.08 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -177.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG21 ' E' ' 27' ' ' THR . 16.9 m -64.18 -9.14 5.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.404 -177.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 31.7 mmtt -45.88 -63.55 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.005 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.28 -37.73 92.29 Favored Glycine 0 C--N 1.301 -1.402 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.348 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -60.73 -37.84 83.09 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.078 0.465 . . . . 0.0 111.081 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.547 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.07 -41.76 93.08 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -176.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.8 t -62.35 -46.8 90.3 Favored Pre-proline 0 C--N 1.305 -1.368 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 -176.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.6 Cg_endo -62.71 -35.55 68.41 Favored 'Trans proline' 0 N--CA 1.504 2.124 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 178.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.532 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.95 -42.92 99.9 Favored Glycine 0 C--N 1.303 -1.268 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.5 -41.16 93.73 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.594 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 1.1 m -85.41 113.51 21.75 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.169 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.562 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 19.9 p90 -171.98 101.78 0.17 Allowed 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.958 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 10.7 tp -79.45 58.98 2.79 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.183 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 49.5 m -163.5 163.24 24.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.366 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 38.0 mt 55.59 50.89 13.56 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.3 -61.97 5.01 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.344 -178.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.9 m -109.97 -15.72 9.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 117.177 0.488 . . . . 0.0 112.189 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' D' ' 48' ' ' TRP . 5.7 t-105 -57.3 -40.85 87.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 CA-C-O 119.378 -0.344 . . . . 0.0 111.874 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 75.8 Cg_exo -49.99 -49.77 15.2 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.286 1.324 . . . . 0.0 112.338 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.39 -35.88 63.33 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.784 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.573 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -56.78 -43.39 80.8 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.329 -1.348 . . . . 0.0 109.317 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.94 -40.82 90.28 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.2 -32.12 43.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.125 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.37 -39.96 67.67 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.091 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 60.3 tp -58.88 -43.51 90.91 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.569 -0.852 . . . . 0.0 108.91 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.57 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.4 mm? -66.96 -30.31 70.4 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 125.319 1.448 . . . . 0.0 114.715 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 23.2 mtm180 -54.32 -39.52 75.49 Favored Pre-proline 0 C--N 1.308 -1.236 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 -172.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.1 Cg_exo -60.54 -40.56 55.57 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 121.633 1.555 . . . . 0.0 111.107 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' D' ' 60' ' ' ARG . 9.6 t-80 49.78 48.63 21.39 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.837 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' D' ' 59' ' ' HIS . 65.1 mtp180 -48.52 177.93 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.349 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.83 -2.73 0.34 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.857 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.562 HD12 ' N ' ' D' ' 62' ' ' LEU . 8.0 mp -90.59 31.4 1.04 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.886 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.636 -179.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.474 ' O ' ' CG2' ' E' ' 5' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.81 -33.82 40.09 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.853 0.359 . . . . 0.0 110.616 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.6 ' O ' HG23 ' E' ' 7' ' ' VAL . 0.1 OUTLIER -75.21 -46.1 36.16 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.111 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' E' ' 4' ' ' ASN . 20.8 t30 -73.4 52.98 0.39 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.437 0.637 . . . . 0.0 110.622 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' E' ' 1' ' ' GLY . 1.5 t -145.39 -70.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.5 -34.09 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.6 HG23 ' O ' ' E' ' 3' ' ' LYS . 65.3 t -57.51 -40.61 75.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.421 -1.263 . . . . 0.0 109.778 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.606 ' N ' HD12 ' E' ' 8' ' ' LEU . 9.1 mp -60.33 -40.24 89.94 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.206 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -60.98 -42.16 97.84 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-O 121.171 0.51 . . . . 0.0 109.892 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.37 -38.55 74.38 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.53 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.53 79.37 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.409 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 46.9 t -60.41 -42.01 95.1 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.065 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.65 80.72 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.682 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -40.35 91.2 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.25 -40.99 96.56 Favored Glycine 0 C--N 1.306 -1.128 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.534 ' O ' ' N ' ' E' ' 18' ' ' GLY . 80.7 m-20 -60.22 -40.97 92.05 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.799 0.333 . . . . 0.0 110.397 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.2 t60 -45.69 88.2 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.62 112.07 0.5 Allowed Glycine 0 C--N 1.305 -1.17 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.413 ' CG ' ' N ' ' E' ' 20' ' ' PHE . 5.5 p90 -44.07 -37.7 3.19 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.508 0.194 . . . . 0.0 111.402 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 40.9 p90 -60.46 -43.19 97.16 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.651 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.588 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 64.2 t-105 -60.78 -41.34 95.35 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.81 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.54 -39.24 96.15 Favored Glycine 0 C--N 1.304 -1.242 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 5.4 mt -59.63 -38.36 81.15 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.75 -0.225 . . . . 0.0 111.468 -179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 33.9 tp -58.97 -43.94 91.42 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.993 -177.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 5.2 t -62.58 -44.22 99.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 C-N-CA 120.186 -0.605 . . . . 0.0 112.168 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -64.4 -43.31 97.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.962 -179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.635 HG21 ' HB ' ' D' ' 32' ' ' VAL . 19.7 m -63.27 -43.39 98.09 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 112.243 -178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 57.6 tp -60.48 -43.19 97.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.989 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.54 -41.9 99.18 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.742 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.14 -42.16 94.11 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 -61.88 -42.29 98.89 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.428 ' H ' HG22 ' E' ' 32' ' ' VAL . 5.9 m -62.55 -11.35 6.67 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -177.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -44.08 -60.7 1.75 Allowed 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 120.461 -0.495 . . . . 0.0 110.254 179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.43 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.23 -36.89 84.88 Favored Glycine 0 C--N 1.301 -1.368 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -58.63 -36.82 74.69 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.865 0.364 . . . . 0.0 110.818 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.697 ' O ' HD23 ' E' ' 36' ' ' LEU . 2.9 tt -61.77 -44.24 97.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.02 85.34 Favored Pre-proline 0 N--CA 1.485 1.288 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.43 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.67 -35.51 94.72 Favored 'Trans proline' 0 N--CA 1.501 1.938 0 C-N-CA 123.027 2.485 . . . . 0.0 111.484 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.62 -38.34 94.87 Favored Glycine 0 C--N 1.302 -1.355 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.263 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.11 -40.79 77.74 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -177.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 31.5 p -42.64 112.24 0.33 Allowed 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.736 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.48 ' HH ' ' HE1' ' F' ' 30' ' ' TRP . 61.1 m-85 -95.38 73.83 3.3 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.09 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.573 ' H ' HD23 ' E' ' 43' ' ' LEU . 0.2 OUTLIER -86.56 98.92 11.34 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.958 179.365 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . 0.409 ' O ' ' OG ' ' E' ' 44' ' ' SER . 11.8 p 61.06 55.71 2.99 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.363 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 79.6 mt -141.83 19.71 2.15 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.133 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.75 -69.38 1.12 Allowed Glycine 0 C--N 1.302 -1.338 0 C-N-CA 121.053 -0.594 . . . . 0.0 111.693 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.38 -17.45 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.517 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.2 t-105 -52.07 -43.32 89.53 Favored Pre-proline 0 C--N 1.304 -1.401 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.774 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.517 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 24.9 Cg_exo -63.41 -41.7 25.2 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 122.421 2.081 . . . . 0.0 112.227 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.877 ' O ' HG22 ' E' ' 53' ' ' VAL . 96.0 mt -55.0 -33.4 62.57 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.3 mt -52.88 -37.77 60.85 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.078 -178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.66 -34.07 57.4 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.877 HG22 ' O ' ' E' ' 50' ' ' LEU . 3.5 m -54.62 -29.43 20.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . 0.413 ' CG ' ' N ' ' E' ' 55' ' ' LEU . 24.4 ptt180 -54.13 -40.1 67.07 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . 0.509 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 54.4 mt -58.34 -42.83 87.71 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.11 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.536 ' O ' HD23 ' E' ' 56' ' ' LEU . 0.6 OUTLIER -65.06 -28.91 69.8 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 125.551 1.54 . . . . 0.0 113.686 178.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.43 ' N ' ' CD ' ' E' ' 58' ' ' PRO . 41.3 ttp180 -54.15 -37.23 50.82 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -173.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 29.6 Cg_exo -60.36 -39.95 62.53 Favored 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 122.109 1.873 . . . . 0.0 111.851 -177.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.456 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 2.1 t60 -29.08 135.28 0.03 OUTLIER 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.08 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.609 ' O ' ' HB3' ' E' ' 61' ' ' ALA . 0.1 OUTLIER -170.5 14.24 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.568 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' E' ' 60' ' ' ARG . . . 83.64 46.91 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.626 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.512 ' O ' HD23 ' E' ' 62' ' ' LEU . 2.7 tt -66.22 -57.29 7.9 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.621 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.46 ' C ' HD21 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.356 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.563 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.05 -60.16 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.796 0.332 . . . . 0.0 110.528 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -74.14 -42.69 59.57 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.548 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.518 ' N ' ' OD1' ' F' ' 4' ' ' ASN . 0.9 OUTLIER -42.72 -33.21 0.7 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.075 0.464 . . . . 0.0 110.062 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.44 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.1 t -69.06 -51.94 38.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.318 179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 27.0 mt -60.69 -35.41 63.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.738 178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.03 -40.53 77.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.765 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.441 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.0 mp -59.02 -40.26 84.45 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -61.36 -41.53 97.22 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.199 0.523 . . . . 0.0 110.027 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.684 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -57.39 -40.01 77.31 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.704 -178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.07 81.09 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.354 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.79 -41.84 96.42 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.404 -0.518 . . . . 0.0 109.872 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.53 79.84 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.964 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -41.8 95.0 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.57 -42.35 97.69 Favored Glycine 0 C--N 1.305 -1.143 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 21.5 m-20 -61.46 -41.53 97.37 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.937 0.398 . . . . 0.0 110.618 179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -60.85 115.86 4.01 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.536 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.43 170.75 43.91 Favored Glycine 0 C--N 1.304 -1.211 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.622 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 14.1 p90 -78.7 -52.72 8.0 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.622 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 28.8 p90 -59.17 -40.97 87.31 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.303 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.449 ' N ' ' CG ' ' F' ' 20' ' ' PHE . 73.7 t90 -59.4 -40.46 86.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 120.687 0.28 . . . . 0.0 111.325 -179.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.53 -39.31 96.23 Favored Glycine 0 C--N 1.304 -1.198 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.455 ' O ' HG22 ' F' ' 27' ' ' THR . 86.7 mt -60.17 -38.55 83.55 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 51.5 tp -59.4 -43.85 92.9 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . 0.444 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.7 m -64.89 -44.36 96.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 119.536 -0.865 . . . . 0.0 113.114 -178.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.2 -44.86 95.17 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.213 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.455 HG22 ' O ' ' F' ' 23' ' ' LEU . 5.2 t -63.67 -42.57 98.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 37.5 mt -60.85 -42.05 97.06 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.122 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.726 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -61.57 -42.49 98.92 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.331 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.48 ' HE1' ' HH ' ' E' ' 42' ' ' TYR . 0.9 OUTLIER -64.23 -41.2 97.11 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -60.18 -41.4 92.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.726 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.9 p -49.89 -20.55 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.152 -178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' F' ' 32' ' ' VAL . 52.0 mttm -40.11 -61.64 0.85 Allowed 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -38.28 88.97 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.083 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 31.2 mmm-85 -62.07 -36.74 82.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 118.134 0.967 . . . . 0.0 111.108 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.608 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.9 OUTLIER -59.01 -42.79 90.99 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -176.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 12.7 t -61.66 -46.72 93.54 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.9 Cg_endo -62.1 -34.84 78.59 Favored 'Trans proline' 0 N--CA 1.5 1.857 0 C-N-CA 121.963 1.776 . . . . 0.0 110.996 177.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.83 -37.58 92.73 Favored Glycine 0 C--N 1.302 -1.315 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.143 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.49 -41.18 80.22 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.523 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -77.99 104.95 8.87 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.446 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' F' ' 43' ' ' LEU . 39.1 p90 -145.75 -42.71 0.21 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.276 -0.42 . . . . 0.0 112.052 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD1' ' F' ' 42' ' ' TYR . 3.0 mm? 59.7 148.57 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.037 0.446 . . . . 0.0 110.398 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 67.7 -175.76 0.2 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.956 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.8 mp 63.15 39.49 9.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.992 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.24 -46.35 2.4 Favored Glycine 0 C--N 1.307 -1.038 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.93 74.97 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.543 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.4 OUTLIER -162.45 -47.67 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.543 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 24.7 Cg_exo -64.84 -31.51 57.26 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 121.999 1.799 . . . . 0.0 111.136 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.33 -35.03 67.14 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.2 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.596 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.4 mp -55.68 -42.93 75.88 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.315 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.2 mp -60.7 -40.32 91.82 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -58.56 -29.51 39.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.277 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.342 179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -53.21 -38.93 63.33 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.651 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.508 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -58.31 -44.93 88.8 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.079 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.527 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.1 tp -67.33 -34.02 76.47 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 38.8 ttt180 -55.23 -43.67 99.22 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -173.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 25.2 Cg_endo -60.42 -39.83 62.99 Favored 'Trans proline' 0 N--CA 1.498 1.737 0 CA-C-N 121.645 1.623 . . . . 0.0 111.389 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.527 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 34.2 m-70 55.98 167.06 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.446 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -174.62 135.97 0.42 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.072 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -77.82 -24.19 48.8 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.613 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 28.0 mt -65.06 -38.71 91.71 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.869 0.366 . . . . 0.0 110.164 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.442 ' HB2' ' HB2' ' C' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.481 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.18 86.21 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.848 0.356 . . . . 0.0 110.685 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mmtp -91.1 -173.56 3.69 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.667 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.536 ' N ' ' ND2' ' A' ' 4' ' ' ASN . 0.5 OUTLIER 71.7 31.89 2.08 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.386 -179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -147.25 -73.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 178.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.462 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.9 mt -57.87 -36.48 55.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.492 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.498 HG13 ' N ' ' A' ' 8' ' ' LEU . 12.5 p -60.57 -41.11 86.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.003 0.43 . . . . 0.0 110.335 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.498 ' N ' HG13 ' A' ' 7' ' ' VAL . 12.5 mt -59.71 -41.11 90.08 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.162 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -61.59 -41.41 97.38 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.277 0.56 . . . . 0.0 110.036 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.39 -42.22 86.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.431 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -59.1 -40.5 85.53 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.45 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -61.6 -43.14 99.41 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.32 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.41 -39.48 83.57 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.043 -179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.49 -42.14 95.7 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.04 -42.67 97.09 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.637 -0.985 . . . . 0.0 110.637 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.532 ' OD1' ' CG ' ' A' ' 21' ' ' TRP . 54.8 t-20 -61.72 -41.35 97.52 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.935 0.397 . . . . 0.0 110.617 179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.7 t60 -52.38 102.74 0.05 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.286 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -174.3 127.67 1.35 Allowed Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -43.86 -35.01 1.78 Allowed 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 110.285 -0.265 . . . . 0.0 110.285 -179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 19' ' ' PHE . 23.8 m-85 -60.87 -43.62 98.16 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.141 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.532 ' CG ' ' OD1' ' A' ' 16' ' ' ASN . 62.0 t90 -61.15 -41.29 96.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.021 0.439 . . . . 0.0 111.112 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.58 -39.11 94.64 Favored Glycine 0 C--N 1.303 -1.277 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 HD13 ' O ' ' A' ' 19' ' ' PHE . 7.6 mp -60.82 -40.53 93.09 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 120.754 -0.379 . . . . 0.0 111.357 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.68 -44.89 96.09 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.417 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 3.4 p -62.23 -43.32 97.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.847 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.417 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 52.2 t -63.5 -41.08 91.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 121.043 0.449 . . . . 0.0 110.353 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.0 m -61.8 -44.24 97.26 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.017 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 16.8 mt -62.44 -42.84 99.76 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.381 -0.528 . . . . 0.0 110.52 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.68 -43.28 99.21 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.089 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.45 -41.64 96.43 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -61.23 -40.96 95.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.5 m -68.37 -13.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -177.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.0 mttm -46.56 -55.96 6.78 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.779 -0.768 . . . . 0.0 110.15 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.06 -38.16 92.61 Favored Glycine 0 C--N 1.303 -1.297 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.491 ' N ' ' CD ' ' A' ' 35' ' ' ARG . 0.9 OUTLIER -60.13 -36.64 77.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.91 0.386 . . . . 0.0 111.009 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.553 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.6 OUTLIER -59.57 -41.98 91.42 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -177.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.46 -46.81 89.8 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -176.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.3 Cg_endo -62.28 -34.64 77.24 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.48 2.12 . . . . 0.0 111.439 177.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.06 96.82 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.337 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.05 -42.21 89.77 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.633 -0.284 . . . . 0.0 111.181 -178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -98.01 105.76 17.95 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-O 120.823 0.344 . . . . 0.0 111.128 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.49 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -138.1 -128.22 0.13 Allowed 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.49 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.8 mm? -109.81 -177.95 3.4 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 54.4 p -110.36 77.6 1.06 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.998 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.0 mp -66.19 -80.06 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.47 -57.48 0.42 Allowed Glycine 0 C--N 1.31 -0.912 0 N-CA-C 112.096 -0.402 . . . . 0.0 112.096 178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.9 m -151.24 -7.21 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 3.3 t-105 -49.34 -45.8 76.96 Favored Pre-proline 0 C--N 1.305 -1.348 0 C-N-CA 120.271 -0.571 . . . . 0.0 111.859 -178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 96.4 Cg_endo -80.44 -40.22 0.21 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 121.286 1.324 . . . . 0.0 112.063 -179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -55.6 -35.75 66.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -57.2 -44.64 83.86 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 118.848 -1.141 . . . . 0.0 110.079 -178.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.22 -41.75 97.41 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' C' ' 19' ' ' PHE . 24.8 t -59.69 -31.07 46.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.05 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -54.29 -40.03 67.49 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 33.8 tp -59.54 -44.94 93.07 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 tp -67.16 -33.15 74.79 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 124.645 1.178 . . . . 0.0 113.469 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.8 ttt-85 -55.35 -43.86 99.33 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -174.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 19.0 Cg_endo -59.6 -39.97 69.77 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 CA-C-N 121.711 1.647 . . . . 0.0 111.07 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 60' ' ' ARG . 47.3 t-80 52.81 167.75 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.887 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' N ' ' ND1' ' A' ' 59' ' ' HIS . 21.8 ptt180 -170.57 -169.74 0.84 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.047 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.53 7.77 0.58 Allowed 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.818 0.342 . . . . 0.0 110.598 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.571 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.3 mm? -83.5 18.68 1.78 Allowed 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.958 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.261 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.582 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.98 -63.94 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.763 0.316 . . . . 0.0 110.563 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.498 ' O ' ' ND2' ' B' ' 4' ' ' ASN . 4.2 mptp? -69.64 78.93 0.43 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.208 0.528 . . . . 0.0 110.216 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' B' ' 3' ' ' LYS . 23.4 m120 -160.42 -50.96 0.05 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.255 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.462 ' CG1' HG22 ' A' ' 6' ' ' ILE . 2.3 t -63.25 -52.29 60.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.471 HG22 ' CG1' ' C' ' 5' ' ' VAL . 34.4 mt -58.99 -35.81 58.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.896 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 21.8 t -59.13 -41.33 83.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.024 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.404 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.9 mp -57.9 -39.51 78.11 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -60.28 -39.2 86.06 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.6 -41.64 77.36 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.587 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.18 76.72 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.703 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 42.0 t -60.72 -42.84 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.869 179.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.46 -40.48 86.99 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' E' ' 59' ' ' HIS . . . -61.25 -41.31 96.68 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.54 0.686 . . . . 0.0 109.433 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.69 -41.01 95.57 Favored Glycine 0 C--N 1.301 -1.392 0 CA-C-N 114.689 -1.141 . . . . 0.0 111.976 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 52.8 m-20 -60.59 -41.85 95.54 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 117.382 0.591 . . . . 0.0 110.952 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.652 ' CD2' ' H ' ' B' ' 18' ' ' GLY . 6.3 t-160 41.19 -152.47 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.017 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.652 ' H ' ' CD2' ' B' ' 17' ' ' HIS . . . -147.42 -1.42 0.55 Allowed Glycine 0 CA--C 1.528 0.886 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.194 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.32 -103.98 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -60.56 -41.81 95.32 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.824 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 67.9 t-105 -60.55 -41.29 94.25 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.722 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.45 -40.67 98.98 Favored Glycine 0 C--N 1.305 -1.191 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.731 ' O ' HG23 ' B' ' 27' ' ' THR . 13.4 mt -60.64 -39.63 89.0 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 120.648 0.261 . . . . 0.0 111.455 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 33.4 tp -59.63 -42.81 93.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 49.0 t -61.74 -44.52 98.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.977 -0.689 . . . . 0.0 111.675 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.0 t -65.05 -42.85 95.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 120.657 -0.417 . . . . 0.0 111.596 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.731 HG23 ' O ' ' B' ' 23' ' ' LEU . 58.4 p -62.56 -44.07 97.23 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.098 -178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 5.9 tp -61.36 -43.5 98.76 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.069 -0.653 . . . . 0.0 110.032 -178.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.401 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.9 -42.83 97.35 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.555 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.18 -41.67 94.39 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.478 0.548 . . . . 0.0 112.478 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -59.43 -41.73 90.23 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.401 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.7 m -66.6 2.85 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.629 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -50.96 -65.81 0.49 Allowed 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.541 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.07 90.46 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -60.75 -36.48 79.02 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.349 0.595 . . . . 0.0 110.515 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.2 tt -60.34 -41.35 93.43 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.451 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.7 t -62.79 -47.2 87.91 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.88 -36.55 49.59 Favored 'Trans proline' 0 N--CA 1.503 2.052 0 C-N-CA 122.489 2.126 . . . . 0.0 111.768 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.5 -40.83 98.27 Favored Glycine 0 C--N 1.301 -1.395 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.65 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.53 -39.9 85.45 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 71.7 p -78.78 121.06 24.3 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.137 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.543 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 49.8 p90 179.41 117.58 0.05 OUTLIER 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.103 178.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.537 HD12 ' N ' ' B' ' 43' ' ' LEU . 7.3 mp -90.71 176.28 6.71 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.84 -170.66 0.19 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.264 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 67.74 43.15 1.84 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.58 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.0 -39.73 3.03 Favored Glycine 0 C--N 1.306 -1.083 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 t -148.83 79.63 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.535 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.3 t-105 -169.54 -52.09 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 72.1 Cg_endo -80.97 -36.27 0.41 Allowed 'Trans proline' 0 N--CA 1.485 1.025 0 C-N-CA 121.283 1.322 . . . . 0.0 110.569 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 mt -56.44 -35.07 67.45 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.74 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 6.1 mt -56.32 -43.58 79.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.965 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.75 -40.04 90.96 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 23.5 t -58.45 -29.17 37.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.352 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mmt-85 -53.67 -40.09 65.63 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.25 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 28.0 mt -60.15 -45.91 91.46 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.76 -1.176 . . . . 0.0 109.129 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 42.5 tp -67.68 -33.68 75.4 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.496 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 0.0 OUTLIER -56.26 -43.68 99.38 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -174.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.4 Cg_endo -58.64 -39.98 77.65 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 CA-C-N 121.528 1.581 . . . . 0.0 111.781 178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' B' ' 59' ' ' HIS . 46.8 t-80 47.17 54.01 9.97 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.932 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 59' ' ' HIS . 15.0 ptt-85 -50.9 -175.94 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.71 10.41 1.6 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.82 0.343 . . . . 0.0 110.638 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.561 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.3 mm? -85.78 22.41 1.65 Allowed 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.962 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.328 0 CA-C-O 117.993 -1.003 . . . . 0.0 110.64 -179.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.0 -43.32 92.94 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 120.711 0.291 . . . . 0.0 110.696 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mmtp -98.03 37.15 1.46 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.807 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -132.11 32.26 4.03 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.378 0.609 . . . . 0.0 109.421 179.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.471 ' CG1' HG22 ' B' ' 6' ' ' ILE . 0.1 OUTLIER -142.11 -67.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.474 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 50.1 mt -59.74 -36.0 63.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.445 HG13 ' N ' ' C' ' 8' ' ' LEU . 9.1 p -60.13 -41.17 85.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.255 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.445 ' N ' HG13 ' C' ' 7' ' ' VAL . 9.4 mt -59.97 -40.58 89.55 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.046 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 26.1 t30 -60.97 -40.87 95.08 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.531 0.681 . . . . 0.0 109.301 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.85 76.66 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.959 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.33 -39.53 79.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.688 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 26.7 t -60.05 -41.54 92.51 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.432 -0.507 . . . . 0.0 109.853 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.02 79.52 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.367 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -41.26 95.67 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.75 97.97 Favored Glycine 0 C--N 1.305 -1.188 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.112 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -60.92 -41.49 96.27 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.593 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -51.01 108.17 0.23 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.196 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.78 156.32 27.07 Favored Glycine 0 C--N 1.306 -1.09 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . 0.502 ' CE1' HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -80.63 -63.05 1.49 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.649 -0.276 . . . . 0.0 111.207 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -57.96 -40.37 80.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.329 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 61.1 t-105 -59.51 -40.56 87.52 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 120.615 0.245 . . . . 0.0 111.49 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.62 -40.21 98.43 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 121.415 -0.422 . . . . 0.0 112.404 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.89 -39.49 89.44 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.2 -43.58 95.82 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.406 HG12 ' H ' ' C' ' 25' ' ' VAL . 2.5 p -64.39 -44.55 97.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 119.909 -0.716 . . . . 0.0 112.559 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -65.2 -43.62 95.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-O 121.335 0.588 . . . . 0.0 111.318 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.401 HG23 ' CZ2' ' C' ' 30' ' ' TRP . 18.4 m -62.89 -43.56 98.47 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.991 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -41.69 98.88 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.434 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.06 -46.92 87.0 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -67.37 -36.49 81.47 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.115 179.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -58.05 -41.52 83.47 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.7 m -61.77 -3.48 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.337 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -42.94 -57.79 2.69 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.269 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -38.06 90.03 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 111.546 -0.622 . . . . 0.0 111.546 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -58.79 -36.5 74.55 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 120.94 0.4 . . . . 0.0 110.4 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' D' ' 30' ' ' TRP . 0.9 OUTLIER -61.63 -42.76 99.34 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 -177.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.16 -46.05 90.99 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 119.554 -0.858 . . . . 0.0 113.3 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.59 -35.65 98.37 Favored 'Trans proline' 0 N--CA 1.501 1.916 0 C-N-CA 122.65 2.233 . . . . 0.0 111.279 176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.57 -38.36 94.83 Favored Glycine 0 C--N 1.302 -1.322 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.241 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.58 -41.56 81.36 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.585 -177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 41.5 p -47.12 114.54 0.88 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.631 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -91.23 -94.13 0.13 Allowed 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 23.0 mt 62.64 107.75 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 67.37 44.73 1.74 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 97.1 mt -151.62 26.78 0.66 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.401 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.93 -70.71 0.81 Allowed Glycine 0 C--N 1.303 -1.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.766 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 m -139.77 -12.99 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.473 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -49.39 -46.75 77.96 Favored Pre-proline 0 C--N 1.302 -1.472 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.261 -179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 36.1 Cg_exo -58.09 -39.39 85.99 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 122.314 2.01 . . . . 0.0 112.692 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 3.9 mt -55.78 -36.16 67.07 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 112.843 0.682 . . . . 0.0 112.843 -176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.98 -44.64 82.88 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.93 -1.108 . . . . 0.0 110.321 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.0 mp -61.08 -42.45 98.53 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 45.4 t -60.77 -32.11 51.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.806 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -54.44 -39.7 67.63 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.794 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 48.1 tp -57.4 -43.35 83.61 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.259 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.536 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.3 mm? -67.95 -33.66 75.1 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 124.036 0.934 . . . . 0.0 112.744 177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 65.1 ttt-85 -55.08 -43.68 99.2 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.5 Cg_endo -59.76 -39.06 76.41 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 CA-C-N 121.933 1.726 . . . . 0.0 111.292 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.569 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 18.6 t-80 46.97 -175.63 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.554 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.569 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 9.4 ptp180 -178.72 -168.86 0.15 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.439 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.81 -168.77 3.07 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.4 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.424 ' O ' ' O ' ' C' ' 63' ' ' ALA . 20.9 mt 52.84 36.52 21.72 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.962 0.41 . . . . 0.0 109.993 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.517 ' HB2' ' CB ' ' F' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.41 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.42 162.36 26.46 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.625 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 40.4 mmtt 50.22 59.25 4.68 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.211 0.529 . . . . 0.0 110.394 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.428 ' O ' HD13 ' D' ' 8' ' ' LEU . 18.7 m120 -142.87 -30.53 0.52 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.003 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.424 HG23 ' H ' ' D' ' 5' ' ' VAL . 1.3 t -71.38 -57.28 7.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.211 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.557 ' H ' HD12 ' D' ' 6' ' ' ILE . 3.3 mp -58.77 -35.49 56.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 46.1 t -58.37 -40.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.991 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.428 HD13 ' O ' ' D' ' 4' ' ' ASN . 3.5 mp -59.66 -40.35 87.47 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.185 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -61.26 -42.0 97.88 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.224 0.535 . . . . 0.0 110.159 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.408 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -57.77 -40.01 78.77 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.718 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.04 -39.47 78.51 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.749 -0.381 . . . . 0.0 110.344 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 40.2 t -60.78 -42.39 97.44 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.199 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.07 -38.75 80.17 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.621 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.2 94.2 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.78 97.08 Favored Glycine 0 C--N 1.305 -1.178 0 N-CA-C 110.957 -0.857 . . . . 0.0 110.957 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -61.18 -41.1 96.2 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.784 0.326 . . . . 0.0 110.616 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 63.3 t60 -51.53 105.22 0.1 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.068 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.71 109.67 0.31 Allowed Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.453 -1.059 . . . . 0.0 110.453 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.43 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 15.7 p90 -36.8 -39.13 0.2 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.62 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 37.2 p90 -60.15 -42.39 94.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.946 -0.701 . . . . 0.0 109.467 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.62 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 56.7 t90 -60.16 -40.91 91.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.26 95.7 Favored Glycine 0 C--N 1.304 -1.218 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.485 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mt -59.39 -39.06 82.17 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.6 tp -59.33 -42.84 92.4 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.73 -0.388 . . . . 0.0 111.968 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -61.23 -43.19 95.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.284 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.33 -42.31 95.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.013 0.435 . . . . 0.0 110.841 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.536 ' O ' ' CE1' ' D' ' 31' ' ' HIS . 65.3 p -63.03 -43.67 98.06 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.041 -178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.557 ' O ' HD23 ' D' ' 28' ' ' LEU . 0.9 OUTLIER -60.81 -42.61 97.99 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.181 -178.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.453 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.01 -42.41 98.4 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.542 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' C' ' 36' ' ' LEU . 0.0 OUTLIER -63.93 -40.39 96.34 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' D' ' 27' ' ' THR . 4.1 m-70 -59.98 -42.58 94.51 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -177.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' E' ' 27' ' ' THR . 15.4 m -65.24 -10.31 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -47.66 -62.97 1.19 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.6 -37.42 89.04 Favored Glycine 0 C--N 1.301 -1.386 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -60.94 -37.07 81.05 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.044 0.449 . . . . 0.0 111.255 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.59 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.9 OUTLIER -59.89 -42.52 93.97 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.045 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.64 -46.46 88.8 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.2 Cg_endo -62.15 -34.48 79.04 Favored 'Trans proline' 0 N--CA 1.502 1.994 0 C-N-CA 122.442 2.095 . . . . 0.0 111.292 177.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.453 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.09 -39.48 95.84 Favored Glycine 0 C--N 1.301 -1.399 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.346 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.09 83.09 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.9 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 34.1 p -85.79 111.06 19.8 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.694 0.283 . . . . 0.0 110.702 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.468 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 53.2 p90 -147.51 -46.18 0.17 Allowed 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.575 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.2 mm? 59.74 159.04 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.988 0.423 . . . . 0.0 110.253 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' D' ' 43' ' ' LEU . 1.4 t 75.56 175.46 0.23 Allowed 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.319 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 21.9 mt 60.42 47.74 8.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.973 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.18 -61.91 5.09 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.386 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -113.62 -14.21 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 117.317 0.559 . . . . 0.0 112.195 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 3.7 t-105 -57.07 -41.34 90.8 Favored Pre-proline 0 C--N 1.301 -1.51 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.447 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 58.3 Cg_exo -52.59 -47.38 27.46 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 121.354 1.369 . . . . 0.0 111.844 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.648 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.38 -37.36 64.91 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.645 -176.136 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.3 mp -58.55 -44.36 89.62 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 118.794 -1.162 . . . . 0.0 110.053 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.504 HD22 ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.81 -42.7 98.17 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 87.6 t -59.62 -31.27 46.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.053 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -54.24 -40.44 67.72 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.684 -178.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.7 mm? -60.16 -44.45 95.01 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.539 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 tp -67.62 -31.44 71.47 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.402 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.9 ttp85 -54.68 -41.13 88.22 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -172.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 32.2 Cg_exo -60.36 -40.79 55.22 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.762 1.641 . . . . 0.0 111.082 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 1.9 t-80 76.47 -56.7 0.56 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.939 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 66.88 -65.77 0.2 Allowed 'General case' 0 C--N 1.309 -1.158 0 O-C-N 123.28 0.362 . . . . 0.0 111.386 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.44 177.87 0.2 Allowed 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.565 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 6.0 tp 60.59 26.32 16.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.822 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.21 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.64 -179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.519 ' O ' ' N ' ' E' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.05 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.764 0.316 . . . . 0.0 110.546 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' E' ' 1' ' ' GLY . 30.6 mmtt -77.94 -162.08 0.3 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.432 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.473 ' H ' ' CG2' ' E' ' 7' ' ' VAL . 9.2 t30 78.31 -47.51 0.45 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.476 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -64.28 -64.12 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.835 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 47.1 mt -59.5 -36.16 63.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.404 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.473 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 8.4 t -59.5 -40.64 82.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.362 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 12.2 mt -60.01 -40.02 87.81 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.98 -42.38 98.26 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.055 0.455 . . . . 0.0 109.912 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -38.92 75.95 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.911 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.36 78.49 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.119 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -60.08 -41.72 93.05 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 120.586 -0.445 . . . . 0.0 110.015 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.2 -37.94 78.66 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 120.987 0.423 . . . . 0.0 110.427 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.05 92.36 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.661 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.45 97.5 Favored Glycine 0 C--N 1.306 -1.121 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.454 ' N ' HD22 ' E' ' 16' ' ' ASN . 1.8 m120 -60.99 -41.25 96.12 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.868 0.366 . . . . 0.0 110.712 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -55.07 109.88 0.59 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.007 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -179.89 112.79 0.36 Allowed Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.457 ' CZ ' HD11 ' E' ' 23' ' ' LEU . 0.9 OUTLIER -32.2 -44.61 0.09 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 122.895 0.478 . . . . 0.0 111.895 -179.692 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -60.11 -42.84 95.6 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.914 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.544 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.7 t-105 -60.43 -39.94 89.27 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.083 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.64 -38.77 94.24 Favored Glycine 0 C--N 1.304 -1.222 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.457 HD11 ' CZ ' ' E' ' 19' ' ' PHE . 6.8 mt -59.35 -37.35 77.62 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 111.593 0.22 . . . . 0.0 111.593 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 36.2 tp -58.22 -44.17 88.07 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.12 -42.37 94.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 119.72 -0.792 . . . . 0.0 112.399 -178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -63.16 -42.99 98.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.616 HG21 ' HB ' ' D' ' 32' ' ' VAL . 28.5 m -62.92 -44.52 95.85 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 67.8 mt -62.34 -42.98 99.83 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.88 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.84 -41.59 99.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.041 -179.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.453 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -66.24 -43.43 86.61 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . 0.615 ' NE2' ' NH2' ' E' ' 35' ' ' ARG . 15.4 t60 -62.62 -42.02 99.35 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.501 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.4 m -58.46 -19.98 15.1 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . 0.443 ' HB2' ' HZ3' ' E' ' 33' ' ' LYS . 8.8 ttmm -42.08 -57.12 2.58 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.95 -0.7 . . . . 0.0 110.744 -179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.429 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.84 -38.16 91.81 Favored Glycine 0 C--N 1.301 -1.385 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' E' ' 31' ' ' HIS . 1.4 mpt_? -60.11 -36.24 77.01 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.826 0.346 . . . . 0.0 110.841 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.612 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.4 tt -61.67 -44.3 97.21 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 115.47 1.656 . . . . 0.0 115.47 -176.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.07 -46.21 80.19 Favored Pre-proline 0 N--CA 1.484 1.271 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.429 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.2 Cg_exo -60.05 -35.94 91.13 Favored 'Trans proline' 0 N--CA 1.502 2.012 0 C-N-CA 123.099 2.533 . . . . 0.0 111.76 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.533 ' O ' ' NE1' ' F' ' 30' ' ' TRP . . . -60.53 -38.38 94.82 Favored Glycine 0 C--N 1.299 -1.473 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.91 -40.96 77.28 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.697 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.9 p -46.69 111.9 0.44 Allowed 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.408 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -114.96 84.36 2.06 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.293 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.1 -149.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.074 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 36.6 p -56.95 99.17 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.582 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 67.6 mt -141.03 39.45 1.79 Allowed 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.741 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -69.16 1.35 Allowed Glycine 0 C--N 1.302 -1.333 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.565 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.3 m -136.43 -8.8 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.527 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.3 t-105 -51.61 -45.78 91.14 Favored Pre-proline 0 C--N 1.304 -1.411 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.968 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 72.8 Cg_endo -79.59 -47.31 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 121.341 1.36 . . . . 0.0 112.165 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -55.39 -35.55 65.43 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 mt -56.09 -43.94 78.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.013 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.7 mp -60.29 -41.01 92.49 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 41.3 t -58.91 -32.71 47.91 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.542 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -55.43 -39.66 70.53 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.426 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 tp -57.12 -42.06 80.15 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.454 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 tp -67.19 -33.02 74.49 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.028 0.931 . . . . 0.0 112.636 177.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 72.7 ttt180 -56.7 -43.61 99.42 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -174.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.0 Cg_endo -58.99 -40.11 74.37 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 CA-C-N 121.833 1.69 . . . . 0.0 111.692 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.501 ' CE1' ' HB1' ' B' ' 14' ' ' ALA . 84.7 t60 -36.34 151.11 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.362 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.442 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -143.5 177.77 8.23 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -81.83 -38.88 24.8 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.216 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.4 pp -46.73 -13.75 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.746 0.308 . . . . 0.0 110.864 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.246 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.646 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.335 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.56 -54.78 4.7 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.662 0.268 . . . . 0.0 110.896 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . 0.48 ' O ' HG23 ' F' ' 7' ' ' VAL . 32.0 mmtt -94.33 -21.52 18.93 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.167 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -56.75 -7.75 0.49 Allowed 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.633 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.441 ' H ' ' C ' ' F' ' 3' ' ' LYS . 1.8 t -82.06 -66.85 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.525 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.639 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -58.46 -33.78 48.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.409 0.623 . . . . 0.0 109.796 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.48 HG23 ' O ' ' F' ' 3' ' ' LYS . 48.9 t -57.17 -40.03 70.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.061 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mt -58.59 -40.61 83.65 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.616 -0.434 . . . . 0.0 109.935 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.83 -39.53 89.37 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.326 0.584 . . . . 0.0 109.491 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.435 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.89 -41.84 78.79 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.27 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.31 -40.65 86.9 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 44.9 t -61.76 -43.85 98.04 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.38 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.14 -39.62 86.98 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.859 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.517 ' CB ' ' HB2' ' C' ' 63' ' ' ALA . . . -61.09 -42.55 98.71 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.61 -42.58 97.86 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . 0.511 ' OD1' ' CZ2' ' F' ' 21' ' ' TRP . 0.5 OUTLIER -61.71 -41.65 97.89 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.476 179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -66.35 126.7 29.61 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.373 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.09 -172.33 45.06 Favored Glycine 0 C--N 1.304 -1.204 0 C-N-CA 120.832 -0.699 . . . . 0.0 111.589 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -82.78 -60.04 2.3 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -59.83 -42.31 93.29 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.511 ' CZ2' ' OD1' ' F' ' 16' ' ' ASN . 76.0 t90 -60.45 -40.24 90.45 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.76 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.48 -39.96 97.05 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.711 -0.556 . . . . 0.0 111.711 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 8.6 mp -60.41 -39.82 88.74 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 111.572 0.212 . . . . 0.0 111.572 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 tt -60.69 -43.97 97.1 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.25 -45.79 97.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 119.528 -0.869 . . . . 0.0 112.301 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 62.2 t -65.72 -44.15 93.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.969 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' E' ' 32' ' ' VAL . 87.8 m -64.11 -43.65 94.67 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.493 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 44.7 tp -61.27 -43.91 98.1 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.052 -178.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.11 98.19 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.177 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.03 -42.17 94.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -61.67 -41.81 98.05 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.4 HG22 ' H ' ' F' ' 32' ' ' VAL . 10.7 m -63.57 -11.69 9.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 11.1 ttpp -46.22 -62.59 1.28 Allowed 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.282 -0.567 . . . . 0.0 109.526 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.86 -36.74 81.5 Favored Glycine 0 C--N 1.301 -1.403 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -59.29 -37.63 78.18 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.127 0.489 . . . . 0.0 110.662 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.612 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.8 tt -59.87 -41.97 92.71 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -61.63 -46.37 93.61 Favored Pre-proline 0 C--N 1.306 -1.312 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -176.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.3 Cg_endo -61.95 -34.49 81.06 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.303 2.002 . . . . 0.0 111.232 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.91 -39.26 95.29 Favored Glycine 0 C--N 1.301 -1.368 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.506 179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -41.87 83.3 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.927 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 51.2 p -74.71 108.58 7.55 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.926 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.57 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 20.3 p90 -168.38 118.58 0.77 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.145 0.497 . . . . 0.0 110.161 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -85.12 154.12 22.24 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.485 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.0 t 72.07 171.33 0.31 Allowed 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.075 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 13.1 mt 70.82 34.05 2.07 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.569 -0.742 . . . . 0.0 109.982 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.21 -65.38 3.61 Favored Glycine 0 C--N 1.305 -1.157 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.819 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . 0.461 ' O ' HG12 ' F' ' 47' ' ' VAL . 50.4 t -131.28 -11.0 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 116.709 0.255 . . . . 0.0 111.575 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.5 OUTLIER -51.72 -44.21 89.9 Favored Pre-proline 0 C--N 1.308 -1.215 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.304 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.463 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.21 -38.28 88.06 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.217 1.278 . . . . 0.0 110.797 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.686 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.4 OUTLIER -56.41 -36.93 69.5 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 114.834 -1.076 . . . . 0.0 112.628 -177.392 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.567 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.0 mp -57.25 -44.15 83.6 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.71 -178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.2 mp -61.15 -40.89 95.56 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.116 178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.78 -32.02 48.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.581 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 21.4 mmt85 -54.73 -38.79 67.53 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.5 -0.48 . . . . 0.0 109.863 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.535 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -57.13 -43.11 82.07 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.922 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.526 HD12 ' N ' ' F' ' 56' ' ' LEU . 10.3 mp -68.16 -33.44 74.46 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 124.141 0.976 . . . . 0.0 113.618 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -55.2 -44.67 99.74 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -173.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' F' ' 59' ' ' HIS . 2.8 Cg_exo -57.1 -40.92 79.82 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 CA-C-N 121.687 1.638 . . . . 0.0 110.364 176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' F' ' 58' ' ' PRO . 0.1 OUTLIER 46.74 -175.93 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.136 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -172.28 -159.67 0.14 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.51 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.83 50.41 0.32 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.0 0.428 . . . . 0.0 110.561 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -163.87 32.31 0.08 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.856 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.359 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.548 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.4 139.15 57.98 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 3.9 mmpt? 54.29 59.89 3.91 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.722 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.435 ' O ' HD13 ' A' ' 8' ' ' LEU . 86.0 m-20 -154.4 -45.13 0.09 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' H ' HG23 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -65.92 -55.79 17.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 54.7 mt -59.07 -34.69 53.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.763 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.35 -41.01 80.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.941 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -59.23 -40.3 85.42 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.834 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -61.45 -41.33 97.05 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.142 0.496 . . . . 0.0 110.213 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.15 -40.25 76.85 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.454 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.03 74.74 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.104 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.73 -41.99 96.41 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' O ' ' CD2' ' A' ' 17' ' ' HIS . . . -58.07 -38.7 76.84 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.751 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.2 -41.22 92.53 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.63 -42.96 96.44 Favored Glycine 0 C--N 1.305 -1.15 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -61.62 -40.96 96.72 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.985 0.421 . . . . 0.0 110.651 178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.418 ' CD2' ' O ' ' A' ' 13' ' ' ALA . 16.6 m170 -58.51 103.64 0.17 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.913 -179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -175.86 115.83 0.54 Allowed Glycine 0 C--N 1.304 -1.219 0 N-CA-C 110.466 -1.054 . . . . 0.0 110.466 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.424 ' CZ ' HD11 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -39.88 -39.37 0.81 Allowed 'General case' 0 C--N 1.308 -1.224 0 O-C-N 123.003 -0.116 . . . . 0.0 110.848 -179.588 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.466 ' CE1' ' CH2' ' F' ' 30' ' ' TRP . 70.4 m-85 -60.23 -42.8 95.98 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.1 t-105 -59.76 -39.63 85.5 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.027 0.441 . . . . 0.0 110.731 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.85 -37.79 85.91 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 27' ' ' THR . 28.9 mt -59.66 -39.43 84.38 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 122.615 -0.344 . . . . 0.0 111.57 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 tp -60.13 -45.55 92.65 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.5 m -62.22 -42.96 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 C-N-CA 119.428 -0.909 . . . . 0.0 111.182 -179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.6 t -63.53 -42.0 94.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 121.076 0.465 . . . . 0.0 111.157 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 23' ' ' LEU . 36.4 p -62.31 -43.9 97.74 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.23 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.59 -42.35 98.73 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.224 -0.591 . . . . 0.0 109.924 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.38 -42.87 99.42 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.653 -179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.537 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.4 -40.74 96.38 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.518 ' CE1' ' O ' ' A' ' 27' ' ' THR . 2.3 m-70 -60.82 -41.93 96.68 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 29' ' ' ALA . 23.0 m -65.7 -8.51 6.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -46.4 -60.62 2.22 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.427 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -37.68 90.18 Favored Glycine 0 C--N 1.302 -1.323 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -60.34 -36.73 78.67 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.973 0.415 . . . . 0.0 111.119 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.73 -42.26 92.73 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -177.138 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.3 t -62.28 -46.44 90.55 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 -176.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.5 Cg_endo -62.23 -34.5 78.23 Favored 'Trans proline' 0 N--CA 1.503 2.07 0 C-N-CA 122.501 2.134 . . . . 0.0 111.436 177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.473 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.18 -39.7 96.26 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.473 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.97 89.84 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.444 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -96.92 111.91 23.9 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.883 0.373 . . . . 0.0 111.46 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.525 ' C ' HD22 ' A' ' 43' ' ' LEU . 5.0 p90 -142.67 -129.41 0.09 Allowed 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.525 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.2 mm? -115.53 -173.1 2.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 44' ' ' SER . 28.1 p -119.44 99.7 6.84 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.494 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.506 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -83.18 -75.37 0.32 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.982 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.03 -54.53 0.56 Allowed Glycine 0 CA--C 1.53 1.003 0 CA-C-N 116.401 -0.363 . . . . 0.0 112.783 178.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 t -134.2 -11.21 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 8.6 t-105 -55.3 -40.94 88.01 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 119.989 -0.684 . . . . 0.0 112.413 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.6 Cg_endo -79.64 -47.74 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.299 0 CA-C-N 120.375 1.17 . . . . 0.0 112.488 -179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -55.45 -38.75 69.45 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.1 mt -60.03 -45.81 91.56 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.711 -1.196 . . . . 0.0 110.48 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 52' ' ' LEU . 8.8 mp -61.47 -41.94 98.01 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 57' ' ' ARG . 86.0 t -59.55 -30.51 44.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.892 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -54.16 -40.74 67.75 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.137 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.0 tt -60.32 -45.43 93.42 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tp -67.13 -33.2 74.93 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 124.663 1.185 . . . . 0.0 113.706 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 62.9 ttp85 -55.65 -44.1 99.5 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -174.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.3 Cg_endo -60.22 -40.79 56.46 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 CA-C-N 121.599 1.607 . . . . 0.0 110.983 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 58' ' ' PRO . 4.4 t-80 57.03 155.39 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.644 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -157.61 -167.3 2.23 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.329 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -167.1 25.14 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.755 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.602 ' N ' HD12 ' A' ' 62' ' ' LEU . 8.8 mp -86.64 6.63 30.07 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.529 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.343 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.679 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.84 154.51 31.75 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.865 0.364 . . . . 0.0 110.652 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp 48.54 66.16 1.15 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.562 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -151.81 -27.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.48 -0.782 . . . . 0.0 108.99 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.94 -62.41 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.838 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.575 HD12 ' H ' ' B' ' 6' ' ' ILE . 2.8 mp -58.77 -34.46 52.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.217 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.433 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 5.6 t -58.31 -41.13 80.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.021 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.2 mt -58.52 -40.09 81.91 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -60.98 -39.26 88.97 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.414 0.626 . . . . 0.0 109.369 178.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.76 -41.87 78.36 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.8 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.54 -38.45 74.74 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.433 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.5 t -60.54 -42.56 96.78 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.105 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.81 -39.96 82.69 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.016 -179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.28 -40.38 93.91 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.518 0.675 . . . . 0.0 109.272 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.12 -41.23 94.55 Favored Glycine 0 C--N 1.304 -1.216 0 CA-C-N 114.799 -1.091 . . . . 0.0 111.797 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 72.3 m-80 -60.23 -41.32 92.84 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 117.344 0.572 . . . . 0.0 110.665 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 53.71 176.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.362 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -121.79 -7.76 7.83 Favored Glycine 0 N--CA 1.471 1.015 0 CA-C-N 116.238 -0.437 . . . . 0.0 112.503 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -74.1 -92.44 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 117.395 0.598 . . . . 0.0 110.995 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -60.91 -42.81 98.8 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 120.739 -0.385 . . . . 0.0 110.952 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.7 t90 -61.58 -40.59 95.3 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.748 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.02 97.45 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.708 ' O ' HG23 ' B' ' 27' ' ' THR . 10.2 mt -59.68 -39.33 84.17 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 120.752 0.311 . . . . 0.0 110.751 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.61 -42.41 92.58 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.566 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 57.6 t -61.67 -43.82 97.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.05 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -63.38 -42.01 94.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.94 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.708 HG23 ' O ' ' B' ' 23' ' ' LEU . 51.2 p -62.33 -43.24 99.27 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.755 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 10.2 mt -61.78 -43.93 97.88 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.337 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.46 -42.67 98.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 120.054 -0.659 . . . . 0.0 110.952 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . 0.473 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.3 -40.76 94.23 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -59.91 -41.3 91.39 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.409 HG22 ' H ' ' B' ' 32' ' ' VAL . 10.5 m -66.89 -1.66 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.718 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -50.7 -63.45 1.12 Allowed 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.74 -37.53 90.13 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 110.431 -1.067 . . . . 0.0 110.431 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -60.28 -36.82 78.71 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 121.348 0.594 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.445 ' O ' HD23 ' B' ' 36' ' ' LEU . 0.9 OUTLIER -59.84 -41.89 92.36 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.0 OUTLIER -62.47 -47.14 89.5 Favored Pre-proline 0 C--N 1.307 -1.255 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -176.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.3 -35.8 60.35 Favored 'Trans proline' 0 N--CA 1.501 1.948 0 C-N-CA 122.372 2.048 . . . . 0.0 111.445 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.637 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -61.21 -39.68 97.51 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.361 -1.291 . . . . 0.0 111.315 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.49 91.67 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.483 ' O ' HG23 ' B' ' 41' ' ' THR . 3.8 t -84.76 123.34 30.3 Favored 'General case' 0 C--N 1.311 -1.092 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.344 -178.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 43.3 p90 -178.59 111.74 0.06 Allowed 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.08 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.54 HD12 ' N ' ' B' ' 43' ' ' LEU . 9.9 mp -92.82 -176.28 4.18 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m 65.01 -160.02 0.28 Allowed 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.74 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 27.0 mt 65.46 47.76 2.21 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.915 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.07 -68.94 1.43 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -144.02 -7.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.658 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.0 OUTLIER -48.68 -48.64 68.96 Favored Pre-proline 0 C--N 1.308 -1.205 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.62 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 43.2 Cg_endo -77.49 -42.12 0.3 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 121.231 1.287 . . . . 0.0 111.553 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 38.1 mt -54.48 -34.8 62.24 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 5.2 tp -56.36 -43.52 79.24 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 118.052 -1.459 . . . . 0.0 109.822 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -62.98 -46.57 87.05 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.509 179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.68 -31.72 54.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.106 0.479 . . . . 0.0 110.495 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.405 ' O ' ' CD ' ' B' ' 58' ' ' PRO . 71.7 ttt-85 -53.82 -41.01 66.89 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.698 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.508 ' N ' HD12 ' B' ' 55' ' ' LEU . 11.0 mp -59.71 -44.66 93.62 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.157 -1.017 . . . . 0.0 108.596 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.563 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -68.04 -33.62 74.93 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.357 1.063 . . . . 0.0 112.964 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 67.7 ttt180 -54.75 -44.01 98.94 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 24.2 Cg_endo -60.44 -39.76 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 CA-C-N 121.841 1.693 . . . . 0.0 111.197 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 62.7 165.0 0.11 Allowed 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.117 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -176.15 -167.74 0.23 Allowed 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.418 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' B' ' 63' ' ' ALA . . . -139.92 -158.99 0.91 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.459 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 3.9 tp 72.85 -38.49 0.42 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.818 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.174 0 CA-C-O 118.03 -0.986 . . . . 0.0 111.135 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.85 142.32 53.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.976 0.417 . . . . 0.0 110.766 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm 45.71 73.17 0.18 Allowed 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.995 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -163.56 -40.1 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.014 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.56 -53.15 20.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.241 -0.891 . . . . 0.0 108.792 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 43.6 mt -59.04 -37.29 66.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.371 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 5.3 t -60.18 -41.24 86.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.518 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mt -59.45 -39.51 83.83 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.027 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -60.34 -40.49 90.89 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.05 81.27 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.047 -179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.55 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.27 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.8 t -60.74 -41.96 96.41 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.498 -0.481 . . . . 0.0 109.898 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.46 82.76 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.081 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.98 -41.39 96.36 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.38 -42.44 98.91 Favored Glycine 0 C--N 1.305 -1.16 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.94 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -61.14 -42.06 97.86 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.848 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -59.3 118.02 5.47 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.392 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.94 166.81 39.38 Favored Glycine 0 C--N 1.306 -1.084 0 C-N-CA 120.715 -0.755 . . . . 0.0 111.744 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . 0.529 ' CD2' ' N ' ' C' ' 20' ' ' PHE . 4.6 t80 -80.08 -65.82 0.96 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.42 -0.39 . . . . 0.0 110.975 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 24.3 p90 -58.54 -40.35 82.74 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.251 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . 0.569 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 65.3 t90 -59.01 -40.34 84.66 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.99 -39.56 97.23 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 121.455 -0.403 . . . . 0.0 112.551 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' C' ' 27' ' ' THR . 8.4 mp -60.2 -40.54 90.45 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 3.5 tt -60.98 -44.52 97.24 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.416 ' H ' HG12 ' C' ' 25' ' ' VAL . 2.6 p -66.77 -45.93 86.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 -179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 t -67.13 -45.62 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.204 0 CA-C-O 121.05 0.453 . . . . 0.0 112.077 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' C' ' 23' ' ' LEU . 75.2 p -63.5 -42.18 98.52 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.661 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.84 -41.18 97.49 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.87 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.99 -47.1 88.01 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.586 -0.846 . . . . 0.0 113.22 -176.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.637 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.5 OUTLIER -68.12 -37.03 80.68 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.382 178.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.478 ' C ' ' ND1' ' C' ' 31' ' ' HIS . 12.7 t-80 -58.2 -41.53 84.17 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 3.1 m -59.01 -3.83 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.914 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.434 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.9 pttp -43.72 -55.93 4.1 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 120.316 -0.553 . . . . 0.0 110.591 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.58 -38.46 91.41 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 112.008 -0.437 . . . . 0.0 112.008 -179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . 0.52 ' N ' ' NE ' ' C' ' 35' ' ' ARG . 0.0 OUTLIER -58.92 -36.15 74.25 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.912 0.387 . . . . 0.0 109.976 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.567 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.53 -43.53 98.7 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -177.226 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.57 -46.15 89.06 Favored Pre-proline 0 N--CA 1.484 1.236 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.33 -36.12 95.23 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 122.812 2.342 . . . . 0.0 111.464 176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.419 ' O ' ' CE ' ' D' ' 33' ' ' LYS . . . -60.78 -37.37 93.5 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.768 -1.106 . . . . 0.0 111.336 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.38 -41.02 75.55 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.414 ' C ' ' O ' ' C' ' 40' ' ' ALA . 25.3 p -38.7 112.23 0.22 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.871 0.367 . . . . 0.0 111.361 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -95.23 76.8 3.44 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.948 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 10.9 tp -83.79 100.49 10.96 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.614 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p 47.0 80.06 0.05 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.998 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 65.6 mt -148.44 28.76 0.88 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.0 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -49.62 -72.34 0.49 Allowed Glycine 0 C--N 1.303 -1.286 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 9.9 p -137.6 -16.7 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.441 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -44.15 -49.2 23.3 Favored Pre-proline 0 C--N 1.307 -1.249 0 C-N-CA 120.419 -0.512 . . . . 0.0 110.424 -179.312 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 26.0 Cg_exo -60.68 -40.81 52.08 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.11 1.873 . . . . 0.0 111.806 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.587 HD13 ' O ' ' C' ' 50' ' ' LEU . 0.2 OUTLIER -55.89 -38.35 70.06 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 -176.247 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.502 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.9 mm? -58.3 -44.98 88.79 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 118.53 -1.268 . . . . 0.0 110.021 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.83 -43.05 99.62 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.342 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' E' ' 19' ' ' PHE . 46.4 t -60.71 -31.16 48.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.851 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -53.64 -38.86 64.49 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.55 -178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 31.4 mt -56.93 -42.2 79.58 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 tp -67.13 -33.65 75.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.281 1.033 . . . . 0.0 112.842 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 69.7 ttt180 -55.74 -43.63 99.28 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 -174.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 20.0 Cg_endo -59.05 -39.33 81.24 Favored 'Trans proline' 0 N--CA 1.499 1.798 0 CA-C-N 121.809 1.682 . . . . 0.0 111.778 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 22.9 t-80 49.28 178.3 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.715 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.529 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 12.3 ptt180 -175.01 103.24 0.09 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.069 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.59 -7.83 50.21 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.148 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 46.2 mt -82.27 25.53 0.6 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 117.984 -1.008 . . . . 0.0 110.541 179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.54 -75.05 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.798 0.332 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' D' ' 5' ' ' VAL . 17.1 mmtp -82.17 -48.41 11.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.274 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' D' ' 4' ' ' ASN . 0.8 OUTLIER -39.82 -26.51 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.924 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.472 ' N ' ' O ' ' D' ' 3' ' ' LYS . 0.3 OUTLIER -76.95 -62.51 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.449 HG22 ' CG1' ' E' ' 5' ' ' VAL . 23.1 mt -57.85 -34.72 48.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.821 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.404 HG23 ' O ' ' D' ' 3' ' ' LYS . 79.5 t -58.84 -41.52 83.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.913 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.4 -40.17 85.79 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.374 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -61.4 -41.47 97.19 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.272 0.558 . . . . 0.0 109.896 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -57.82 -41.11 81.57 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.912 -178.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.53 79.17 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.03 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 35.4 t -60.81 -42.08 96.93 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.516 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -57.87 -38.07 75.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.897 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.21 -40.89 91.7 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.94 -41.79 94.47 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.596 -1.002 . . . . 0.0 110.596 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -60.8 -40.96 94.63 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.957 0.408 . . . . 0.0 110.285 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . 0.525 ' ND1' ' N ' ' D' ' 17' ' ' HIS . 0.2 OUTLIER -58.94 100.21 0.06 Allowed 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.019 -179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.91 130.04 1.75 Allowed Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' D' ' 20' ' ' PHE . 1.5 p90 -51.16 -37.58 47.19 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.79 -0.241 . . . . 0.0 111.479 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 39.9 p90 -60.55 -43.25 97.44 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.142 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.621 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 67.5 t-105 -60.57 -41.71 95.17 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 120.89 0.376 . . . . 0.0 111.016 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.05 -39.81 96.22 Favored Glycine 0 C--N 1.303 -1.293 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.533 ' O ' HG23 ' D' ' 27' ' ' THR . 6.9 mt -60.54 -39.84 89.36 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 58.4 tp -59.95 -43.84 94.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.16 -177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.58 -43.49 97.06 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 120.399 -0.52 . . . . 0.0 111.545 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.11 -41.61 93.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 120.932 0.396 . . . . 0.0 111.372 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.533 HG23 ' O ' ' D' ' 23' ' ' LEU . 51.8 p -62.34 -44.54 96.26 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.73 -43.64 98.27 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.49 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -63.4 -44.29 95.1 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.877 -0.729 . . . . 0.0 111.474 -179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -66.05 -39.89 90.52 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 44.9 t-80 -59.63 -41.38 90.34 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' E' ' 27' ' ' THR . 17.1 m -67.4 -2.59 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.319 -0.552 . . . . 0.0 112.043 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.419 ' CE ' ' O ' ' C' ' 39' ' ' GLY . 19.2 ttmm -48.81 -62.05 1.72 Allowed 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 120.714 -0.395 . . . . 0.0 109.936 179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.78 -37.35 90.01 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -59.81 -37.27 78.7 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.906 0.384 . . . . 0.0 111.328 -179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.582 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -60.4 -41.97 94.95 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 4.6 t -62.23 -46.42 90.76 Favored Pre-proline 0 C--N 1.304 -1.403 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 36.2 Cg_endo -62.55 -34.63 74.58 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 122.618 2.212 . . . . 0.0 112.02 177.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.78 -41.17 99.01 Favored Glycine 0 C--N 1.301 -1.362 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.789 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.82 -40.64 84.73 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 121.102 -0.239 . . . . 0.0 111.543 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 13.1 p -87.38 115.41 24.77 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 120.842 0.354 . . . . 0.0 111.296 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.7 p90 -172.31 104.54 0.17 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.039 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.553 HD22 ' N ' ' D' ' 43' ' ' LEU . 3.3 mm? -85.93 60.41 6.22 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.8 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 42.3 t -167.11 169.02 13.15 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.28 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt 59.79 46.45 11.44 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.83 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.8 -63.61 4.65 Favored Glycine 0 C--N 1.306 -1.1 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.681 -178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 m -127.44 -14.32 3.36 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -178.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.469 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 1.0 OUTLIER -52.5 -44.68 95.05 Favored Pre-proline 0 C--N 1.304 -1.375 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.285 -178.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.5 Cg_exo -51.14 -40.81 59.67 Favored 'Trans proline' 0 N--CA 1.499 1.812 0 C-N-CA 121.543 1.496 . . . . 0.0 112.408 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 65.7 mt -55.37 -36.28 66.17 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 -176.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.601 ' N ' HD12 ' D' ' 51' ' ' LEU . 9.4 mp -57.2 -44.76 83.97 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.71 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.2 -41.42 96.8 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.479 HG11 ' CE1' ' F' ' 19' ' ' PHE . 43.7 t -58.87 -30.65 43.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.247 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -54.41 -41.05 68.86 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.479 -0.488 . . . . 0.0 109.935 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.514 HD22 ' N ' ' D' ' 55' ' ' LEU . 3.8 mm? -60.61 -45.24 94.74 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.991 -1.084 . . . . 0.0 108.406 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 14.0 tp -66.86 -30.21 70.31 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 125.862 1.665 . . . . 0.0 115.047 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 39.4 ttt180 -53.59 -38.85 67.21 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -172.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 35.6 Cg_exo -60.42 -39.23 68.19 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 121.81 1.674 . . . . 0.0 110.837 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.419 ' O ' ' ND1' ' D' ' 59' ' ' HIS . 29.0 t-80 48.79 44.52 21.83 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.836 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.441 HH21 ' C ' ' D' ' 62' ' ' LEU . 15.4 ptm180 -51.14 177.39 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.054 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.45 -2.42 0.77 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.598 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.441 ' C ' HH21 ' D' ' 60' ' ' ARG . 17.1 mt -78.95 24.37 0.31 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.978 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.461 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.275 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.548 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.82 160.81 22.74 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.896 0.379 . . . . 0.0 110.672 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.482 ' O ' ' ND2' ' E' ' 4' ' ' ASN . 13.9 tptt 51.24 51.06 17.7 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.442 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' E' ' 3' ' ' LYS . 29.3 m120 -149.6 13.44 0.83 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.483 -0.781 . . . . 0.0 109.08 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.449 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -114.22 -62.42 2.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.789 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.603 ' H ' HD12 ' E' ' 6' ' ' ILE . 3.3 mp -59.42 -34.86 55.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 3.0 t -57.29 -40.82 76.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.14 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.523 HD22 ' HB1' ' D' ' 10' ' ' ALA . 7.2 mp -60.31 -40.23 89.81 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.163 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -61.2 -41.94 97.7 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.183 0.516 . . . . 0.0 110.011 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.3 76.29 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.834 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.68 80.12 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.311 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 5.2 p -60.83 -41.96 96.81 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.732 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -38.5 79.54 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.702 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.28 -40.87 91.97 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.53 -41.92 97.43 Favored Glycine 0 C--N 1.304 -1.207 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -61.54 -41.11 96.88 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 120.813 0.34 . . . . 0.0 110.692 179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -49.39 96.83 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.924 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -167.24 110.46 0.4 Allowed Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.5 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.4 -36.71 0.16 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.731 0.301 . . . . 0.0 111.199 -179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -59.36 -41.34 89.01 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.521 ' N ' ' O ' ' E' ' 18' ' ' GLY . 51.4 t90 -59.34 -41.18 88.58 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.858 -179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.18 -39.89 97.79 Favored Glycine 0 C--N 1.304 -1.226 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.61 -38.8 85.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.511 0.196 . . . . 0.0 111.138 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.23 -43.72 92.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -177.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 t -62.12 -44.11 98.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.33 -0.548 . . . . 0.0 112.318 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 98.9 t -64.16 -42.86 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 120.597 -0.441 . . . . 0.0 112.014 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.53 HG21 ' HB ' ' D' ' 32' ' ' VAL . 75.9 m -63.35 -44.18 95.58 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . 0.525 HD13 ' O ' ' E' ' 28' ' ' LEU . 0.2 OUTLIER -61.22 -43.22 99.23 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.221 -0.592 . . . . 0.0 109.963 -178.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.445 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.3 -41.39 98.47 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.527 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -42.86 96.24 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 55.7 t60 -62.26 -41.93 98.88 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.511 ' HB ' HG21 ' F' ' 27' ' ' THR . 15.8 m -62.44 -12.58 9.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttm -43.46 -58.58 2.53 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.437 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.29 -37.17 86.36 Favored Glycine 0 C--N 1.301 -1.389 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . 0.699 ' HE ' ' CD2' ' F' ' 31' ' ' HIS . 8.7 tpt180 -58.42 -36.86 74.26 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 120.934 0.397 . . . . 0.0 110.695 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.637 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.83 -43.28 99.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.13 88.97 Favored Pre-proline 0 N--CA 1.482 1.139 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.33 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.57 -35.79 94.53 Favored 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.748 2.298 . . . . 0.0 111.134 176.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -36.87 91.9 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.385 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.496 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -56.11 -39.9 72.9 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -177.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.4 ' C ' ' O ' ' E' ' 40' ' ' ALA . 41.1 p -41.66 108.07 0.09 Allowed 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 120.912 0.387 . . . . 0.0 110.802 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.496 ' CD2' ' O ' ' E' ' 40' ' ' ALA . 87.9 m-85 -90.85 77.07 6.26 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.574 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.577 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.7 mm? -59.6 -110.56 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.216 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 38.4 t -113.51 87.65 2.66 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.205 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 14.0 mt -137.16 22.83 3.02 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.293 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.05 -69.53 1.1 Allowed Glycine 0 C--N 1.299 -1.476 0 C-N-CA 121.069 -0.586 . . . . 0.0 111.746 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.84 -15.74 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -48.66 -47.53 71.03 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.763 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 48.7 Cg_exo -55.21 -42.26 70.36 Favored 'Trans proline' 0 N--CA 1.501 1.917 0 C-N-CA 121.935 1.757 . . . . 0.0 112.217 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 85.3 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.54 HD12 ' N ' ' E' ' 51' ' ' LEU . 10.3 mp -57.03 -43.57 82.04 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.301 -1.359 . . . . 0.0 108.938 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.7 mm? -60.04 -42.03 93.56 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 40.0 t -59.21 -32.31 47.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.002 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.04 -41.01 70.86 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.287 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . 0.524 ' N ' HD12 ' E' ' 55' ' ' LEU . 10.5 mp -59.08 -43.69 91.82 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.165 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.546 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 54.5 tp -67.21 -33.54 75.59 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 124.396 1.078 . . . . 0.0 113.243 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.52 -43.88 99.51 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -174.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 24.4 Cg_endo -59.86 -40.29 64.37 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.615 1.612 . . . . 0.0 112.754 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -39.59 162.84 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 120.96 0.409 . . . . 0.0 111.473 -178.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.49 177.15 11.75 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.972 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -73.73 -11.89 60.54 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.182 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.61 HD12 ' N ' ' E' ' 62' ' ' LEU . 7.5 mp -78.21 30.57 0.18 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.931 0.396 . . . . 0.0 109.985 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.272 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.688 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . 0.459 ' C ' HD22 ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.76 159.32 33.12 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.767 0.318 . . . . 0.0 110.463 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? 55.14 60.79 3.23 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.281 0.562 . . . . 0.0 109.834 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.459 HD22 ' C ' ' F' ' 1' ' ' GLY . 78.6 m-20 -154.69 -42.24 0.09 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.312 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.417 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.5 t -69.63 -51.95 36.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.403 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.1 mt -60.46 -35.15 61.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.328 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.2 t -58.04 -41.1 79.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 114.927 -1.033 . . . . 0.0 109.895 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.438 HD13 ' O ' ' F' ' 4' ' ' ASN . 7.1 mp -59.02 -39.89 83.28 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -61.27 -41.94 97.79 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 121.149 0.5 . . . . 0.0 110.183 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -39.7 76.05 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.998 -178.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.68 79.32 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.14 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.9 p -60.8 -42.49 97.73 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.86 82.33 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.243 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.89 -42.64 98.4 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.42 -42.24 97.42 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . 0.459 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 81.3 m-20 -61.77 -41.9 98.29 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.961 0.41 . . . . 0.0 110.369 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -69.48 128.28 35.98 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.315 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.74 -177.98 48.6 Favored Glycine 0 C--N 1.306 -1.133 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.306 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.479 ' CE1' HG11 ' D' ' 53' ' ' VAL . 0.2 OUTLIER -81.92 -62.21 1.7 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.667 -0.267 . . . . 0.0 111.607 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -58.42 -40.84 83.6 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.571 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.459 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 70.8 t-105 -59.53 -40.34 86.88 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.269 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.16 -40.63 98.82 Favored Glycine 0 C--N 1.304 -1.214 0 C-N-CA 121.137 -0.554 . . . . 0.0 111.83 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -60.65 -38.48 84.97 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 120.592 0.234 . . . . 0.0 111.309 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . 0.41 ' CD1' HG11 ' E' ' 32' ' ' VAL . 46.7 tp -59.28 -43.25 92.54 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 t -61.9 -44.1 98.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.457 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 5.8 t -64.11 -42.54 95.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 120.414 -0.514 . . . . 0.0 112.044 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.511 HG21 ' HB ' ' E' ' 32' ' ' VAL . 63.4 m -63.0 -43.79 97.81 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 54.1 mt -60.91 -42.94 99.05 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.753 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.87 -42.79 99.89 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.285 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.466 ' CH2' ' CE1' ' A' ' 20' ' ' PHE . 0.8 OUTLIER -64.75 -41.74 95.69 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.618 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . 0.699 ' CD2' ' HE ' ' E' ' 35' ' ' ARG . 86.3 t60 -60.72 -41.8 96.0 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.464 ' HB ' HG21 ' A' ' 27' ' ' THR . 15.9 m -68.08 -5.19 3.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.311 -177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -49.29 -63.28 1.15 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.014 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.36 88.66 Favored Glycine 0 C--N 1.3 -1.417 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.45 -37.03 79.66 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.938 0.399 . . . . 0.0 111.06 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.585 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.5 tt -60.49 -42.13 95.68 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.468 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -62.43 -46.4 89.82 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 115.146 1.535 . . . . 0.0 115.146 -176.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.4 Cg_endo -62.67 -34.68 73.17 Favored 'Trans proline' 0 N--CA 1.502 2.019 0 C-N-CA 122.569 2.18 . . . . 0.0 111.578 177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.537 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.78 -41.44 99.11 Favored Glycine 0 C--N 1.3 -1.437 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.294 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.81 -40.8 85.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.643 -0.278 . . . . 0.0 111.403 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' F' ' 41' ' ' THR . 4.8 p -91.81 103.6 16.14 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.544 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 7.2 p90 -154.01 -131.14 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.544 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 35.3 tp -141.37 114.59 8.71 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.497 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -37.74 123.0 1.01 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.107 0.479 . . . . 0.0 111.884 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . 0.498 ' O ' ' CD ' ' F' ' 49' ' ' PRO . 8.9 mt -138.75 31.95 2.25 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.276 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.3 -31.56 8.92 Favored Glycine 0 C--N 1.302 -1.314 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . 0.683 HG22 ' O ' ' F' ' 47' ' ' VAL . 8.9 p -86.37 41.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 CA-C-O 120.626 0.251 . . . . 0.0 111.228 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.605 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.7 OUTLIER -151.5 -49.34 0.02 OUTLIER Pre-proline 0 C--N 1.309 -1.165 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 176.039 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.605 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 18.4 Cg_endo -90.02 -33.17 0.1 OUTLIER 'Trans proline' 0 C--N 1.323 -0.812 0 C-N-CA 122.348 2.032 . . . . 0.0 112.072 -179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.455 ' H ' ' HD2' ' F' ' 49' ' ' PRO . 5.5 tp -57.67 -35.84 71.1 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.613 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.9 mp -56.74 -43.68 80.94 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 118.928 -1.109 . . . . 0.0 108.962 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.73 -41.46 95.38 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 33.3 t -60.91 -30.2 46.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.457 177.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.446 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 36.7 ttm180 -53.08 -39.07 63.07 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.768 -177.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 36.2 mt -53.87 -40.55 66.65 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.179 -178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.526 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 4.5 tp -67.65 -35.28 78.59 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 177.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 18.7 mmm-85 -54.94 -44.34 99.46 Favored Pre-proline 0 N--CA 1.488 1.434 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -172.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 24.3 Cg_exo -54.83 -39.26 90.77 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 CA-C-N 121.091 1.425 . . . . 0.0 111.098 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.526 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 9.5 m-70 58.7 170.73 0.06 Allowed 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.912 0.387 . . . . 0.0 110.114 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -162.68 117.16 1.76 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.95 -35.26 79.57 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.106 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' F' ' 63' ' ' ALA . 33.9 mt -68.49 -33.97 75.08 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 120.945 0.402 . . . . 0.0 110.205 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.412 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.268 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.49 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.98 -73.01 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.755 0.312 . . . . 0.0 110.52 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 15.3 mmtm -81.56 76.39 8.48 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.129 0.49 . . . . 0.0 110.684 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.455 ' O ' HD13 ' A' ' 8' ' ' LEU . 61.4 t30 -149.83 -54.45 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.017 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.7 t -54.84 -57.79 5.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.484 HG22 ' CG1' ' B' ' 5' ' ' VAL . 35.0 mt -59.45 -36.67 65.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.98 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.1 t -59.87 -40.39 82.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.192 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.3 mp -58.37 -39.86 80.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -61.32 -41.72 97.49 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.058 0.456 . . . . 0.0 110.111 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -41.21 83.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.007 -178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.26 79.35 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.362 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -60.37 -42.32 95.58 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.729 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -39.21 82.3 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.719 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -41.75 96.34 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.02 -41.99 96.72 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -61.39 -41.09 96.56 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 120.97 0.414 . . . . 0.0 110.468 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -48.9 98.13 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.023 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -169.15 120.22 0.87 Allowed Glycine 0 C--N 1.304 -1.233 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -42.24 -35.45 0.97 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 120.64 0.257 . . . . 0.0 110.478 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -60.74 -43.57 97.75 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.899 -0.72 . . . . 0.0 109.851 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.423 ' N ' ' O ' ' A' ' 18' ' ' GLY . 43.5 t90 -61.78 -42.63 99.24 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 120.978 0.418 . . . . 0.0 111.074 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.69 -39.37 97.33 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.735 ' O ' HG23 ' A' ' 27' ' ' THR . 3.1 tp -60.68 -39.42 88.36 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 tt -60.7 -43.45 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 25' ' ' VAL . 4.5 m -61.4 -42.34 93.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.573 -0.851 . . . . 0.0 111.462 -178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.02 -41.85 94.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.315 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.735 HG23 ' O ' ' A' ' 23' ' ' LEU . 60.6 p -61.61 -44.0 97.82 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.761 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -61.87 -42.15 98.72 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.493 -0.483 . . . . 0.0 109.873 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.06 -41.9 98.63 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.727 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.525 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.0 OUTLIER -64.45 -41.37 96.57 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.64 -41.33 94.69 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 29' ' ' ALA . 15.6 m -66.04 -6.69 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -47.39 -60.2 2.68 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.949 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.0 -37.67 91.87 Favored Glycine 0 C--N 1.302 -1.329 0 N-CA-C 111.042 -0.823 . . . . 0.0 111.042 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 52.4 mmt-85 -60.07 -36.96 78.51 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.948 0.404 . . . . 0.0 111.272 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.7 OUTLIER -59.94 -42.46 94.06 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -177.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.464 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.58 -46.55 89.13 Favored Pre-proline 0 C--N 1.306 -1.307 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 32.7 Cg_endo -62.54 -34.76 74.25 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.405 2.07 . . . . 0.0 111.708 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.486 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.42 -40.3 97.44 Favored Glycine 0 C--N 1.3 -1.448 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.557 179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.5 -41.21 84.86 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.926 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.0 p -97.54 110.71 23.22 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 120.785 0.326 . . . . 0.0 111.024 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.523 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.3 p90 -136.93 -122.93 0.14 Allowed 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.4 mt -126.15 -171.89 2.49 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.4 t -113.98 83.78 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.446 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.8 mt -68.45 -79.6 0.05 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.091 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 -56.32 0.47 Allowed Glycine 0 C--N 1.311 -0.848 0 N-CA-C 112.02 -0.432 . . . . 0.0 112.02 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.73 -8.79 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.109 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 19.3 t-105 -52.37 -43.86 92.36 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.937 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 90.5 Cg_endo -81.15 -42.73 0.12 Allowed 'Trans proline' 0 N--CA 1.489 1.261 0 C-N-CA 121.29 1.327 . . . . 0.0 112.095 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -54.66 -37.6 65.91 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -176.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.44 -44.96 89.38 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.501 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.8 mp -61.53 -41.96 98.1 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 57.3 t -58.76 -30.74 43.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.091 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -53.77 -40.63 66.41 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.5 mm? -60.78 -45.04 95.89 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.7 tp -66.52 -33.5 75.83 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 124.862 1.265 . . . . 0.0 113.764 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.499 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 58.0 ttm-85 -55.97 -43.53 99.27 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 115.311 1.596 . . . . 0.0 115.311 -174.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.3 Cg_endo -58.74 -40.05 76.45 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 CA-C-N 121.565 1.595 . . . . 0.0 110.908 178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.496 ' CE1' ' HB1' ' D' ' 11' ' ' ALA . 2.5 t-80 71.77 -61.27 0.49 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.834 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' O ' ' O ' ' A' ' 59' ' ' HIS . 54.0 ttm-85 59.14 145.09 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.648 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -122.58 78.5 1.53 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 121.014 0.435 . . . . 0.0 110.264 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.9 tp -158.37 -44.02 0.06 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.939 179.801 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.58 175.8 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.941 0.4 . . . . 0.0 110.645 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 32.4 mmtm 47.72 60.65 3.39 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.375 0.607 . . . . 0.0 110.716 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -146.75 22.64 1.26 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.493 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.484 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -136.61 -65.83 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.255 -1.339 . . . . 0.0 108.355 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.534 HD12 ' H ' ' B' ' 6' ' ' ILE . 3.0 mp -58.28 -36.95 60.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.06 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.5 m -61.02 -41.65 89.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 120.469 -0.493 . . . . 0.0 109.809 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.25 -40.46 86.04 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.141 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -61.29 -41.0 96.22 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.407 0.622 . . . . 0.0 109.494 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.85 77.26 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.038 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -39.28 80.16 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.468 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 48.1 t -60.5 -42.55 96.59 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.871 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.38 77.72 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.583 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.12 95.44 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.89 -41.2 96.07 Favored Glycine 0 C--N 1.304 -1.197 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.799 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 29.1 m120 -60.48 -42.19 95.76 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.359 0.579 . . . . 0.0 110.473 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.436 ' ND1' ' N ' ' B' ' 18' ' ' GLY . 7.4 t-80 58.24 163.16 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.514 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.436 ' N ' ' ND1' ' B' ' 17' ' ' HIS . . . -113.62 -6.16 21.71 Favored Glycine 0 N--CA 1.47 0.907 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.651 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 6.4 t80 -74.46 -98.17 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.702 0.287 . . . . 0.0 110.963 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.651 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 4.3 t80 -60.97 -42.64 98.71 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.866 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.456 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 65.7 t-105 -61.38 -40.83 95.79 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.627 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.77 -39.31 95.15 Favored Glycine 0 C--N 1.307 -1.072 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.877 ' O ' HG23 ' B' ' 27' ' ' THR . 13.2 mt -59.54 -38.59 81.45 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-N 115.834 -0.183 . . . . 0.0 110.995 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 24.9 tp -58.75 -42.25 88.41 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.265 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.91 -43.95 96.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 C-N-CA 119.475 -0.89 . . . . 0.0 110.927 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.64 -42.97 96.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.877 0.37 . . . . 0.0 111.714 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.877 HG23 ' O ' ' B' ' 23' ' ' LEU . 30.7 p -62.82 -44.75 95.33 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.052 -178.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.92 -43.09 99.75 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.674 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.822 ' O ' HG12 ' B' ' 32' ' ' VAL . . . -63.11 -41.74 99.42 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.969 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . 0.486 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.9 OUTLIER -63.8 -41.27 97.94 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -178.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -59.7 -39.57 85.01 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.822 HG12 ' O ' ' B' ' 29' ' ' ALA . 4.5 p -55.46 -20.05 6.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' B' ' 32' ' ' VAL . 6.1 tppt? -43.07 -58.37 2.48 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.02 94.44 Favored Glycine 0 C--N 1.297 -1.61 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -63.99 -38.6 91.66 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 117.694 0.747 . . . . 0.0 111.253 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.14 -41.85 93.6 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 68.0 t -62.63 -48.38 86.24 Favored Pre-proline 0 C--N 1.303 -1.418 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 42.8 Cg_endo -65.69 -39.45 20.68 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.084 1.856 . . . . 0.0 112.123 177.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.633 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -63.84 -45.78 93.38 Favored Glycine 0 C--N 1.304 -1.237 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.77 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' B' ' 41' ' ' THR . . . -62.26 -41.58 98.58 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.509 -0.345 . . . . 0.0 111.071 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . 0.476 ' C ' ' O ' ' B' ' 40' ' ' ALA . 5.5 m -15.34 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.962 0 O-C-N 124.004 0.815 . . . . 0.0 113.165 -179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' B' ' 42' ' ' TYR . 0.0 OUTLIER -69.46 64.26 0.17 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.642 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' B' ' 41' ' ' THR . 19.6 tp -74.95 90.42 2.43 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.974 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' B' ' 44' ' ' SER . 6.9 t -179.76 57.21 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.426 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.484 ' O ' ' CD ' ' B' ' 49' ' ' PRO . 16.0 mt -131.43 30.88 4.4 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.54 ' O ' HD23 ' B' ' 50' ' ' LEU . . . -89.07 -30.83 13.16 Favored Glycine 0 C--N 1.304 -1.223 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.17 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -99.55 44.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 116.978 0.389 . . . . 0.0 111.369 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.651 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.0 OUTLIER -144.27 -50.17 0.02 OUTLIER Pre-proline 0 C--N 1.308 -1.223 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 176.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 10.9 Cg_endo -87.52 -18.71 2.48 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 122.363 2.042 . . . . 0.0 111.902 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.54 HD23 ' O ' ' B' ' 46' ' ' GLY . 1.6 mm? -56.39 -36.73 69.21 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.919 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.681 HD22 ' N ' ' B' ' 51' ' ' LEU . 2.9 mm? -57.44 -44.77 85.0 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.627 -1.229 . . . . 0.0 109.218 -178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 6.9 mp -60.37 -41.85 94.6 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.605 ' CG2' HD21 ' D' ' 23' ' ' LEU . 33.8 t -60.95 -29.96 46.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.578 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -52.91 -39.0 62.43 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.838 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.525 ' O ' HD23 ' B' ' 55' ' ' LEU . 1.0 OUTLIER -57.18 -42.45 81.2 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 119.564 -0.854 . . . . 0.0 108.753 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tp -67.21 -33.93 76.42 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 124.332 1.053 . . . . 0.0 113.68 177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 13.2 mmm180 -56.53 -44.07 99.59 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.4 Cg_endo -60.05 -41.04 55.85 Favored 'Trans proline' 0 N--CA 1.496 1.664 0 CA-C-N 121.691 1.64 . . . . 0.0 111.886 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.451 ' O ' ' O ' ' B' ' 58' ' ' PRO . 0.0 OUTLIER 52.29 171.77 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.626 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 4.2 ptp85 -166.63 -49.84 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.849 0.357 . . . . 0.0 110.636 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.08 -5.26 1.25 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.547 HD22 ' N ' ' B' ' 62' ' ' LEU . 3.6 mm? -76.77 31.09 0.13 Allowed 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.503 ' H ' ' C ' ' B' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.325 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.507 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.419 ' O ' ' OD1' ' C' ' 4' ' ' ASN . . . -167.47 -88.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.756 0.313 . . . . 0.0 110.612 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.513 ' HZ1' ' HB2' ' D' ' 2' ' ' ALA . 1.6 mptm? -75.89 77.43 2.8 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.117 0.484 . . . . 0.0 110.151 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 6.1 p-10 -157.65 -47.78 0.07 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.494 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' C' ' 5' ' ' VAL . 1.7 t -65.17 -53.1 44.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.415 HG22 ' CG1' ' D' ' 5' ' ' VAL . 43.8 mt -59.22 -35.53 58.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.332 178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 12.2 t -58.88 -40.96 81.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.003 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -59.85 -40.31 88.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.506 -0.477 . . . . 0.0 109.771 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -61.53 -41.92 98.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.237 0.542 . . . . 0.0 109.963 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.74 82.71 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.756 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' F' ' 59' ' ' HIS . . . -58.8 -39.72 81.95 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.326 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 38.4 t -60.34 -42.21 95.22 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.925 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -39.48 84.14 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.16 96.28 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-O 121.326 0.584 . . . . 0.0 109.475 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.84 -41.18 97.56 Favored Glycine 0 C--N 1.305 -1.147 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.493 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -60.72 -41.79 95.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.744 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -53.46 107.29 0.23 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.28 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.72 157.18 27.97 Favored Glycine 0 C--N 1.308 -0.985 0 C-N-CA 120.942 -0.647 . . . . 0.0 111.645 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -80.14 -61.95 1.83 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.411 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -58.6 -40.13 82.36 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.002 -179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -59.41 -40.09 85.54 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.49 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . 0.432 ' O ' HG12 ' C' ' 25' ' ' VAL . . . -61.03 -39.33 96.93 Favored Glycine 0 C--N 1.306 -1.118 0 N-CA-C 112.058 -0.417 . . . . 0.0 112.058 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.13 -39.0 84.75 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 35.7 tp -59.99 -43.43 95.18 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -177.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.432 HG12 ' O ' ' C' ' 22' ' ' GLY . 2.3 p -63.37 -43.85 98.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.418 -0.913 . . . . 0.0 112.402 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 6.1 t -64.93 -43.52 96.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 C-N-CA 120.477 -0.489 . . . . 0.0 112.078 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.532 HG22 ' CH2' ' C' ' 30' ' ' TRP . 16.9 p -62.65 -43.84 97.79 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.847 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 42.7 tp -63.21 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.633 -178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.449 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.84 -47.18 84.48 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -177.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.633 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.3 OUTLIER -68.4 -38.83 81.65 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.476 -0.89 . . . . 0.0 112.112 179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.404 ' N ' ' CD1' ' C' ' 30' ' ' TRP . 75.1 t60 -59.56 -41.63 90.6 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.449 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.3 m -57.12 -9.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.575 -177.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.556 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 17.6 pttp -39.92 -53.01 2.38 Favored 'General case' 0 C--N 1.311 -1.093 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.114 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . 0.401 ' O ' ' CD ' ' C' ' 38' ' ' PRO . . . -58.41 -38.23 90.12 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -59.17 -35.81 74.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 120.904 0.383 . . . . 0.0 110.621 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.603 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.17 -43.75 98.39 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -177.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -46.42 88.2 Favored Pre-proline 0 N--CA 1.483 1.213 0 N-CA-C 113.558 0.948 . . . . 0.0 113.558 -176.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.401 ' CD ' ' O ' ' C' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.98 95.55 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 122.685 2.257 . . . . 0.0 111.421 176.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.67 -38.0 94.38 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.456 179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.524 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.55 -41.12 80.38 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 111.984 0.365 . . . . 0.0 111.984 -177.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 24.6 p -40.38 110.01 0.13 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.887 0.375 . . . . 0.0 111.397 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' C' ' 40' ' ' ALA . 58.0 m-85 -98.99 71.87 1.88 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.652 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -92.99 103.44 15.76 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.401 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 4.1 m 59.56 58.71 2.82 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.634 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 81.6 mt -142.64 24.87 1.86 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.135 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.21 -70.24 0.88 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 25.6 m -141.3 -12.8 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.444 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -48.03 -48.05 63.73 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.558 -179.34 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 37.1 Cg_exo -57.01 -38.87 94.97 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 C-N-CA 122.297 1.998 . . . . 0.0 112.698 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -55.05 -34.73 63.8 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -176.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 21.4 mt -56.32 -44.25 79.77 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 117.961 -1.495 . . . . 0.0 110.313 -178.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.1 mp -62.39 -45.16 94.41 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.415 ' H ' HG13 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -63.07 -30.72 50.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 178.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -53.42 -39.56 64.45 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.311 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 36.7 tp -56.43 -42.08 77.48 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.274 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.552 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 53.9 tp -67.62 -34.09 76.29 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.758 0.823 . . . . 0.0 112.451 177.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.9 ttp85 -55.02 -42.81 97.85 Favored Pre-proline 0 C--N 1.308 -1.226 0 N-CA-C 116.515 2.043 . . . . 0.0 116.515 -173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.4 Cg_endo -58.09 -37.71 94.62 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 CA-C-N 121.963 1.737 . . . . 0.0 112.019 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.552 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.3 OUTLIER -43.05 168.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.801 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.403 ' C ' ' CD ' ' C' ' 60' ' ' ARG . 0.0 OUTLIER -171.17 -79.09 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.413 179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -159.91 -161.25 0.88 Allowed 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.8 tp 57.27 9.9 0.79 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.134 0.492 . . . . 0.0 109.738 -179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.292 0 CA-C-O 117.98 -1.01 . . . . 0.0 110.532 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . 0.428 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.362 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.513 ' HB2' ' HZ1' ' C' ' 3' ' ' LYS . . . -165.01 34.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.801 0.334 . . . . 0.0 110.533 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.707 ' HZ2' ' CA ' ' E' ' 1' ' ' GLY . 70.0 tttt -165.73 -36.55 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.58 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.425 ' O ' HD13 ' D' ' 8' ' ' LEU . 96.2 m-20 -41.67 -34.14 0.57 Allowed 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.72 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.415 ' CG1' HG22 ' C' ' 6' ' ' ILE . 2.5 t -66.51 -52.72 43.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.474 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.8 mt -59.76 -35.46 60.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.053 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 91.2 t -58.35 -40.72 79.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.857 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.425 HD13 ' O ' ' D' ' 4' ' ' ASN . 7.2 mp -58.79 -39.86 82.33 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.812 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -61.3 -41.83 97.65 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.133 0.492 . . . . 0.0 109.928 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.522 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.72 -40.7 80.17 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.763 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 59' ' ' HIS . . . -58.91 -39.72 82.36 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.191 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 49.5 m -60.83 -42.82 98.5 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.973 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.64 -38.39 81.25 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.7 -41.77 95.85 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.17 -41.7 96.79 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -61.09 -41.23 96.27 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.892 0.377 . . . . 0.0 110.236 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -53.4 109.47 0.44 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.764 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.504 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -176.27 115.19 0.51 Allowed Glycine 0 C--N 1.304 -1.197 0 N-CA-C 110.532 -1.027 . . . . 0.0 110.532 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 27.6 p90 -35.94 -40.25 0.19 Allowed 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.612 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 29.1 p90 -60.23 -42.2 94.75 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.201 -0.6 . . . . 0.0 109.799 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.612 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 71.0 t90 -60.25 -42.4 95.21 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.2 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.6 -40.66 99.04 Favored Glycine 0 C--N 1.305 -1.157 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.605 HD21 ' CG2' ' B' ' 53' ' ' VAL . 46.1 mt -61.66 -39.75 92.48 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' D' ' 27' ' ' THR . 5.0 tt -60.26 -44.44 95.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.417 ' H ' HG22 ' D' ' 25' ' ' VAL . 4.5 m -62.13 -42.87 96.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.123 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.38 -42.25 95.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 120.975 0.416 . . . . 0.0 111.062 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.415 HG23 ' O ' ' D' ' 23' ' ' LEU . 23.8 p -62.49 -44.27 96.8 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.184 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -61.09 -42.15 97.99 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.078 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.491 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.6 -44.11 97.61 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.68 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.94 -41.62 95.34 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -61.39 -43.27 99.16 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.491 HG22 ' O ' ' D' ' 29' ' ' ALA . 22.8 m -62.22 -11.06 5.53 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 tppt? -46.56 -59.54 2.93 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.707 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.39 -37.11 79.96 Favored Glycine 0 C--N 1.302 -1.32 0 N-CA-C 111.264 -0.735 . . . . 0.0 111.264 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 88.5 mtt-85 -61.15 -37.6 83.44 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.959 0.379 . . . . 0.0 111.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.552 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.7 OUTLIER -60.35 -44.38 95.62 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -176.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.5 -44.52 81.84 Favored Pre-proline 0 CA--C 1.559 1.305 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -176.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 29.8 Cg_endo -61.49 -34.67 85.3 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 122.129 1.886 . . . . 0.0 111.365 178.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.14 94.98 Favored Glycine 0 C--N 1.299 -1.517 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.268 179.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.67 75.5 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -176.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.63 100.09 11.48 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 118.211 0.459 . . . . 0.0 110.541 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.502 ' C ' HD22 ' D' ' 43' ' ' LEU . 9.8 p90 -114.11 -132.08 0.33 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.092 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.502 HD22 ' C ' ' D' ' 42' ' ' TYR . 3.7 mm? -114.03 -86.19 0.59 Allowed 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.529 0.68 . . . . 0.0 110.304 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 58.3 p -142.66 128.63 19.56 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.182 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 87.9 mt -151.13 32.16 0.6 Allowed 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.859 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.07 -65.05 3.64 Favored Glycine 0 C--N 1.302 -1.313 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.585 -178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -114.27 -19.52 6.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.477 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.0 t-105 -52.37 -42.26 86.34 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.533 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.73 -48.72 19.75 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.271 1.314 . . . . 0.0 112.376 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -54.11 -37.89 64.8 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.909 -175.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.561 ' N ' HD12 ' D' ' 51' ' ' LEU . 8.7 mp -58.78 -45.09 90.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.325 -1.35 . . . . 0.0 109.369 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.5 mt -60.78 -41.83 96.31 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 49' ' ' PRO . 66.9 t -58.22 -32.23 44.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -55.07 -41.43 71.5 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.196 -178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.556 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.5 mp -60.47 -44.82 95.52 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.857 179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.549 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.02 -30.73 70.9 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 125.666 1.586 . . . . 0.0 114.694 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 29.7 ttt85 -54.02 -39.2 72.03 Favored Pre-proline 0 C--N 1.306 -1.322 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -172.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 28.9 Cg_exo -60.58 -40.48 55.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 121.677 1.584 . . . . 0.0 110.959 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.47 ' NE2' ' CD2' ' F' ' 17' ' ' HIS . 32.2 t-80 39.74 33.73 0.14 Allowed 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.95 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.432 ' O ' ' O ' ' D' ' 59' ' ' HIS . 21.8 ptt-85 -50.85 -176.35 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.4 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -145.09 -161.56 1.32 Allowed 'General case' 0 C--N 1.309 -1.194 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.252 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.534 HD12 ' N ' ' D' ' 62' ' ' LEU . 10.3 mp 50.97 28.11 3.62 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 118.017 -0.992 . . . . 0.0 110.554 179.942 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.707 ' CA ' ' HZ2' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.626 ' N ' ' NZ ' ' D' ' 3' ' ' LYS . . . 70.05 -39.09 0.43 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.693 0.283 . . . . 0.0 110.913 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' E' ' 1' ' ' GLY . 1.9 mptm? -91.54 -171.79 3.03 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 120.795 0.331 . . . . 0.0 110.446 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.461 ' H ' ' CG2' ' E' ' 7' ' ' VAL . 2.2 m120 70.81 1.61 3.82 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.522 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -117.23 -65.89 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 51.8 mt -58.89 -33.69 50.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.461 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 4.6 t -57.41 -40.95 77.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.19 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.564 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.6 mp -60.15 -40.38 89.64 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.287 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.3 -41.5 97.09 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.144 0.497 . . . . 0.0 110.089 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.25 80.39 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.655 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -40.52 82.62 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.085 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.0 p -61.35 -42.31 98.48 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.365 -0.534 . . . . 0.0 109.715 178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 -38.88 82.86 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.109 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.28 93.29 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.67 -42.34 97.83 Favored Glycine 0 C--N 1.305 -1.164 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -61.51 -40.9 96.29 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.856 0.36 . . . . 0.0 110.703 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -47.49 94.59 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.183 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -168.18 120.43 0.89 Allowed Glycine 0 C--N 1.304 -1.203 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -41.5 -31.58 0.27 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 120.723 0.297 . . . . 0.0 110.918 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 19.2 p90 -60.33 -42.16 95.04 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.709 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.632 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 14.3 t90 -61.02 -41.95 97.53 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.58 -40.15 98.33 Favored Glycine 0 C--N 1.305 -1.155 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.718 ' O ' HG23 ' E' ' 27' ' ' THR . 8.4 mt -61.3 -38.82 88.21 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.0 tp -60.02 -45.05 94.06 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 m -62.98 -42.77 97.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.894 -0.722 . . . . 0.0 112.188 -178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 92.5 t -63.47 -42.52 96.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.905 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.718 HG23 ' O ' ' E' ' 23' ' ' LEU . 61.5 p -62.31 -43.75 98.11 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.901 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 54.9 mt -61.36 -41.58 97.31 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.393 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.42 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.35 -42.07 98.09 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.095 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.21 -42.02 93.93 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -61.67 -42.04 98.37 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.551 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.7 m -62.32 -10.33 4.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -44.48 -57.09 3.78 Favored 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 120.098 -0.641 . . . . 0.0 110.364 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.97 -37.93 92.1 Favored Glycine 0 C--N 1.302 -1.341 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -59.11 -36.43 75.15 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.773 0.32 . . . . 0.0 111.092 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.91 -43.85 98.0 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -177.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -46.09 85.15 Favored Pre-proline 0 N--CA 1.484 1.227 0 C-N-CA 119.437 -0.905 . . . . 0.0 113.296 -176.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 32.4 Cg_exo -59.77 -35.81 93.29 Favored 'Trans proline' 0 N--CA 1.501 1.952 0 C-N-CA 122.928 2.419 . . . . 0.0 111.197 176.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.4 -37.4 93.12 Favored Glycine 0 C--N 1.301 -1.37 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.297 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.87 -39.91 75.21 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.412 ' C ' ' O ' ' E' ' 40' ' ' ALA . 22.4 p -39.91 109.58 0.12 Allowed 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.433 ' O ' ' O ' ' E' ' 43' ' ' LEU . 65.3 m-85 -90.28 69.63 7.09 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.214 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 42' ' ' TYR . 70.5 mt -55.61 -110.18 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.539 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 57.1 p -110.25 83.05 1.69 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.896 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . 0.473 HD13 ' HZ2' ' F' ' 33' ' ' LYS . 22.2 mt -135.26 21.8 3.44 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.789 -179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.82 -68.17 1.78 Allowed Glycine 0 C--N 1.3 -1.417 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 10.7 m -129.82 -14.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.48 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 4.1 t-105 -51.98 -45.26 93.07 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -178.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 38.6 Cg_endo -74.19 -39.97 1.43 Allowed 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 121.035 1.157 . . . . 0.0 112.93 -178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 98.8 mt -54.81 -36.05 64.56 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -56.9 -42.22 79.51 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.749 -1.18 . . . . 0.0 109.192 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -59.67 -40.7 88.62 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 20.8 t -57.93 -30.86 39.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.442 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -54.09 -39.35 66.26 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.177 -178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.5 mt -59.76 -44.56 93.79 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.898 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.543 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -66.76 -33.54 75.86 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 124.461 1.104 . . . . 0.0 113.503 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 32.0 ttm180 -56.71 -44.48 99.78 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 -174.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.4 Cg_endo -60.24 -41.39 51.19 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 CA-C-N 121.603 1.608 . . . . 0.0 111.786 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' E' ' 58' ' ' PRO . 0.0 OUTLIER 55.23 161.51 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.175 179.795 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -167.14 96.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.861 0.362 . . . . 0.0 110.437 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -61.52 -20.13 62.87 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.418 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' E' ' 63' ' ' ALA . 14.9 mt -75.88 17.98 0.29 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.088 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.466 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.339 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.782 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.7 -64.25 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.815 0.34 . . . . 0.0 110.533 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -82.7 68.88 9.34 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 121.052 0.453 . . . . 0.0 110.606 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -151.96 -36.87 0.12 Allowed 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.476 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.427 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.7 t -70.85 -57.65 7.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.247 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.5 mt -59.84 -35.29 59.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 t -58.85 -41.0 81.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.353 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.69 -40.62 88.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.116 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . 0.424 ' O ' ' OG ' ' F' ' 12' ' ' SER . 48.5 t30 -61.54 -41.78 97.85 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.153 0.502 . . . . 0.0 110.006 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.41 ' O ' ' HB3' ' F' ' 13' ' ' ALA . . . -57.98 -40.35 80.45 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.07 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.35 -39.56 79.85 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.393 -0.523 . . . . 0.0 110.042 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' F' ' 9' ' ' ASN . 52.2 p -60.49 -40.92 93.08 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' F' ' 10' ' ' ALA . . . -58.36 -38.61 77.56 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.931 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.43 -41.42 93.96 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.87 -42.85 98.34 Favored Glycine 0 C--N 1.304 -1.249 0 N-CA-C 111.189 -0.764 . . . . 0.0 111.189 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -61.82 -41.84 98.29 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.943 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . 0.47 ' CD2' ' NE2' ' D' ' 59' ' ' HIS . 1.7 m80 -67.43 122.61 18.31 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.712 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.37 177.97 48.52 Favored Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.635 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.472 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 4.3 t80 -80.28 -61.18 2.06 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.322 -0.439 . . . . 0.0 111.434 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.613 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 48.8 p90 -59.21 -41.12 87.86 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.576 -178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.613 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 82.4 t90 -59.59 -39.93 85.79 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.583 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.14 -39.77 96.31 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.01 -38.07 81.58 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 38.6 tp -59.5 -43.76 93.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 93.8 t -62.92 -44.92 99.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 11.6 m -64.4 -42.58 95.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 C-N-CA 120.322 -0.551 . . . . 0.0 112.167 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.551 HG21 ' HB ' ' E' ' 32' ' ' VAL . 88.1 m -62.18 -43.58 98.5 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.991 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 56.7 mt -61.36 -43.0 99.61 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.007 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.426 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.17 -42.26 99.36 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.581 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.79 -42.26 90.98 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -61.44 -42.14 98.29 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.426 HG22 ' O ' ' F' ' 29' ' ' ALA . 11.6 m -61.63 -13.3 8.58 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 120.446 -0.502 . . . . 0.0 112.117 -177.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.473 ' HZ2' HD13 ' E' ' 45' ' ' LEU . 53.8 mttm -45.21 -63.91 0.83 Allowed 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.929 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.9 -36.65 81.4 Favored Glycine 0 C--N 1.3 -1.462 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 12.4 tpp85 -60.0 -37.95 81.21 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 120.984 0.421 . . . . 0.0 111.003 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.584 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.2 tt -60.2 -42.64 95.56 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.7 t -62.13 -46.22 91.19 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -176.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 32.3 Cg_endo -62.65 -34.76 73.1 Favored 'Trans proline' 0 N--CA 1.501 1.961 0 C-N-CA 122.318 2.012 . . . . 0.0 111.294 178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.525 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.52 -39.77 96.85 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.701 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.27 -41.54 84.53 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.753 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 58.7 p -74.84 110.36 9.07 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.665 -0.414 . . . . 0.0 110.521 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.548 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 11.4 p90 -170.05 114.01 0.49 Allowed 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.992 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -86.74 161.57 18.33 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.298 0.571 . . . . 0.0 110.086 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 67.6 -179.39 0.22 Allowed 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.979 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt 69.05 38.78 1.89 Allowed 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.882 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.96 -57.06 6.55 Favored Glycine 0 CA--C 1.534 1.221 0 CA-C-N 115.734 -0.666 . . . . 0.0 113.017 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.7 -19.98 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 117.268 0.534 . . . . 0.0 111.871 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.48 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 1.0 OUTLIER -52.67 -41.85 85.88 Favored Pre-proline 0 C--N 1.302 -1.48 0 C-N-CA 120.636 -0.425 . . . . 0.0 110.55 -179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 31.8 Cg_exo -59.59 -49.85 9.44 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 C-N-CA 121.32 1.347 . . . . 0.0 111.141 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 75.9 mt -54.17 -36.5 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.41 -0.814 . . . . 0.0 113.025 -176.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.16 -44.18 87.79 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 117.775 -1.57 . . . . 0.0 109.072 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.76 -45.74 88.47 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.394 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . 0.426 ' H ' HG13 ' F' ' 53' ' ' VAL . 0.9 OUTLIER -63.59 -33.44 61.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 CA-C-O 120.654 0.264 . . . . 0.0 111.226 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.424 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 48.0 mmt-85 -54.65 -40.37 68.94 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 17.1 mt -58.45 -43.54 88.87 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.556 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.586 ' O ' HD23 ' F' ' 56' ' ' LEU . 0.8 OUTLIER -67.83 -35.3 78.35 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 124.21 1.004 . . . . 0.0 113.022 177.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 5.8 tpt180 -55.63 -43.82 99.35 Favored Pre-proline 0 C--N 1.303 -1.415 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 -173.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.6 Cg_endo -60.44 -40.5 56.94 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 122.002 1.751 . . . . 0.0 110.93 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.424 ' CE1' ' HB1' ' C' ' 11' ' ' ALA . 0.3 OUTLIER 69.01 161.39 0.2 Allowed 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.115 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 68.0 mtt-85 -139.65 -57.78 0.57 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.43 -179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 67.62 15.0 9.69 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.433 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' F' ' 63' ' ' ALA . 15.9 mt -100.98 19.6 17.06 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.211 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.592 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.449 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -170.21 12.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.783 0.325 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -163.22 59.98 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -148.83 -29.29 0.28 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.486 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.3 OUTLIER -75.24 -59.18 3.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.013 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 HG22 ' CG1' ' B' ' 5' ' ' VAL . 50.6 mt -59.19 -35.11 55.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.533 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 t -58.78 -40.9 81.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.289 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.14 -40.17 84.68 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.288 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -61.61 -41.67 97.79 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.175 0.512 . . . . 0.0 110.096 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.34 80.62 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.852 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.85 -39.23 77.21 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.645 -0.422 . . . . 0.0 109.936 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.6 t -60.35 -41.56 93.89 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.09 -38.2 75.95 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.645 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.37 94.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.65 -43.45 97.73 Favored Glycine 0 C--N 1.305 -1.174 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.699 HD21 ' HE1' ' A' ' 21' ' ' TRP . 23.5 t-20 -62.27 -41.41 98.45 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 120.891 0.377 . . . . 0.0 110.72 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -55.97 102.94 0.08 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.004 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.64 109.9 0.34 Allowed Glycine 0 C--N 1.303 -1.289 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -41.99 -37.38 1.34 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 122.845 -0.209 . . . . 0.0 111.437 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 32.7 p90 -60.66 -43.53 97.51 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.972 -0.691 . . . . 0.0 109.901 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.699 ' HE1' HD21 ' A' ' 16' ' ' ASN . 67.1 t-105 -61.67 -41.81 98.06 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.8 95.36 Favored Glycine 0 C--N 1.302 -1.328 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.841 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.84 -39.58 85.65 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 tt -60.53 -42.87 97.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -178.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.9 t -62.64 -44.79 99.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 C-N-CA 120.06 -0.656 . . . . 0.0 111.637 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.24 -43.14 97.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-O 121.212 0.53 . . . . 0.0 110.203 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.542 HG21 HG22 ' F' ' 32' ' ' VAL . 81.7 m -63.1 -41.9 99.46 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.01 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 45.1 tp -58.91 -41.25 86.79 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.507 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -59.91 -41.22 91.21 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.275 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -63.46 -41.12 98.62 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -61.67 -42.15 98.52 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 29' ' ' ALA . 18.4 m -63.31 -11.95 9.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -45.34 -59.07 2.87 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.243 -0.583 . . . . 0.0 110.201 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.26 -37.81 88.17 Favored Glycine 0 C--N 1.303 -1.304 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.617 ' NH2' ' CE1' ' B' ' 31' ' ' HIS . 46.5 mtp85 -59.86 -36.5 77.02 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.269 0.557 . . . . 0.0 110.59 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.893 HD12 HG22 ' B' ' 27' ' ' THR . 7.8 tt -59.2 -41.53 88.76 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -177.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.5 t -62.05 -46.84 91.72 Favored Pre-proline 0 C--N 1.307 -1.272 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -176.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 31.5 Cg_endo -61.79 -34.83 81.83 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.196 1.931 . . . . 0.0 111.387 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' B' ' 30' ' ' TRP . . . -60.5 -39.95 97.06 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.7 179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.79 -41.57 87.03 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.937 -0.305 . . . . 0.0 111.4 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.2 p -95.57 106.81 18.94 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.777 0.323 . . . . 0.0 111.505 -179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -137.51 -123.59 0.14 Allowed 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.63 -0.508 . . . . 0.0 109.63 179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.454 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 38.0 mt -125.32 -170.68 2.21 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 55.2 p -116.83 89.5 3.13 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.677 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.3 mp -73.94 -79.45 0.08 Allowed 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.153 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.58 -52.97 0.63 Allowed Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.327 -0.397 . . . . 0.0 112.957 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 47' ' ' VAL . 7.5 p -127.06 -13.57 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.469 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.3 t-105 -58.92 -40.65 83.5 Favored Pre-proline 0 C--N 1.304 -1.404 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.178 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 98.8 Cg_endo -82.02 -56.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.313 1.342 . . . . 0.0 112.641 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -54.88 -38.92 68.14 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -175.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.4 tp -60.08 -45.51 92.64 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.039 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 9.9 mp -61.31 -41.5 97.1 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.468 ' O ' ' N ' ' A' ' 57' ' ' ARG . 97.8 t -58.53 -30.17 40.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.096 179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -53.88 -40.96 67.05 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.717 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.75 -45.44 94.3 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -66.76 -33.22 75.14 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 124.827 1.251 . . . . 0.0 113.765 178.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.493 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.1 ttp180 -55.82 -43.46 99.21 Favored Pre-proline 0 C--N 1.308 -1.231 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -174.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.4 Cg_endo -58.86 -40.26 73.74 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 CA-C-N 121.599 1.607 . . . . 0.0 110.78 178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 44.95 45.08 8.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.915 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -50.23 164.96 0.1 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.228 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.53 3.79 5.07 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.377 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.4 mt -77.98 10.58 2.77 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.12 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.291 0 CA-C-O 118.043 -0.979 . . . . 0.0 110.708 -179.909 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' GLY . . . 56.69 161.02 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 120.888 0.375 . . . . 0.0 110.479 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.43 ' HZ3' ' C ' ' C' ' 1' ' ' GLY . 1.4 mptm? 55.43 22.87 5.31 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.036 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' B' ' 4' ' ' ASN . 9.1 p-10 -132.2 30.47 4.22 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.408 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -141.23 -63.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.655 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 32.4 mt -58.54 -37.22 63.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.448 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 3.2 m -61.01 -40.51 85.82 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.265 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 mp -58.78 -40.16 83.15 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -60.88 -39.82 90.68 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.388 0.613 . . . . 0.0 109.553 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.01 78.46 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.26 -178.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.14 -39.89 79.9 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 39.6 t -60.93 -42.03 97.38 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.421 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.49 -38.71 78.2 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.286 -178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.458 ' HB2' ' CB ' ' E' ' 63' ' ' ALA . . . -60.37 -40.27 90.19 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.329 0.585 . . . . 0.0 109.733 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.11 -41.07 96.39 Favored Glycine 0 C--N 1.304 -1.238 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.99 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -60.39 -41.85 94.66 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 117.235 0.517 . . . . 0.0 111.353 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.527 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER 53.33 -175.11 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.428 -179.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.527 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -133.13 -8.85 2.25 Favored Glycine 0 N--CA 1.472 1.044 0 CA-C-N 116.405 -0.361 . . . . 0.0 112.418 -179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 1.8 t80 -72.32 -92.14 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 117.172 0.486 . . . . 0.0 110.388 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 48.5 p90 -59.27 -41.52 89.04 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.242 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.61 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.6 t90 -60.31 -39.21 86.18 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.158 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.4 -39.34 96.09 Favored Glycine 0 C--N 1.308 -1.026 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.855 ' O ' HG23 ' B' ' 27' ' ' THR . 6.6 mt -60.37 -39.17 86.25 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 122.719 -0.283 . . . . 0.0 111.23 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp -59.89 -44.42 94.24 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.0 m -63.46 -42.21 95.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.611 -0.835 . . . . 0.0 111.641 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 93.7 t -63.73 -43.01 97.87 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 120.716 -0.393 . . . . 0.0 111.677 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.893 HG22 HD12 ' A' ' 36' ' ' LEU . 37.4 p -62.3 -43.63 98.37 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.611 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 mt -61.64 -42.61 99.14 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.61 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -41.87 98.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.0 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . 0.471 ' CD1' ' C ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -65.36 -42.36 92.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -179.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . 0.617 ' CE1' ' NH2' ' A' ' 35' ' ' ARG . 57.1 t60 -60.71 -41.19 94.74 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' B' ' 29' ' ' ALA . 15.5 m -64.9 -3.09 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 120.083 -0.647 . . . . 0.0 112.478 -177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 mttm -48.97 -62.82 1.32 Allowed 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 119.472 -0.891 . . . . 0.0 109.398 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.77 -38.0 91.21 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -60.2 -36.21 77.14 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.342 0.592 . . . . 0.0 110.68 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.451 HD12 HG21 ' C' ' 27' ' ' THR . 5.5 tt -59.6 -42.87 93.58 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 114.49 1.292 . . . . 0.0 114.49 -177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.11 -46.88 86.53 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -177.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.7 Cg_endo -62.72 -34.85 72.16 Favored 'Trans proline' 0 N--CA 1.502 2.008 0 C-N-CA 122.519 2.146 . . . . 0.0 111.564 177.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.443 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.88 -39.58 95.68 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.494 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.96 -40.42 88.99 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 41.7 p -78.1 121.53 24.41 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.875 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.626 ' CD1' ' NZ ' ' C' ' 33' ' ' LYS . 52.7 p90 -175.94 126.83 0.22 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.214 0.531 . . . . 0.0 109.895 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.58 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.2 mm? -91.22 156.0 18.16 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.495 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.7 m 64.81 -178.15 0.17 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.983 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt 71.03 35.84 1.55 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.694 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.0 -44.55 1.89 Allowed Glycine 0 C--N 1.307 -1.055 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.092 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.2 m -141.29 75.62 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.546 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -166.37 -52.81 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.24 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.545 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 40.6 Cg_endo -75.91 -28.7 7.5 Favored 'Trans proline' 0 N--CA 1.486 1.05 0 C-N-CA 120.962 1.108 . . . . 0.0 111.009 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.563 ' O ' HG22 ' B' ' 53' ' ' VAL . 1.2 mm? -54.32 -34.73 61.62 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.408 -178.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.55 HD22 ' N ' ' B' ' 51' ' ' LEU . 3.9 mm? -56.25 -39.93 73.37 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.215 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.95 -39.26 74.22 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.265 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.563 HG22 ' O ' ' B' ' 50' ' ' LEU . 0.8 OUTLIER -59.67 -29.75 43.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.056 0.455 . . . . 0.0 110.008 178.144 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.82 -39.9 62.83 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.798 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 35.4 mt -57.27 -42.91 82.53 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.424 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.508 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 45.9 tp -67.89 -34.14 76.07 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 123.98 0.912 . . . . 0.0 112.602 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 70.9 ttt180 -55.03 -43.4 99.04 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -173.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.4 Cg_endo -59.96 -39.28 72.41 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 122.037 1.763 . . . . 0.0 111.528 178.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 60.5 m-70 54.52 171.11 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.948 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -168.48 -29.25 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 61.56 77.32 0.33 Allowed 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.514 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 tp -158.54 -30.54 0.07 Allowed 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.966 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.283 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.862 179.852 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.43 ' C ' ' HZ3' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.381 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.53 -41.49 69.76 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.472 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 1.5 mptm? -91.66 -177.51 4.8 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.819 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 70.77 36.12 1.63 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.635 0.731 . . . . 0.0 109.44 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.67 -69.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' D' ' 5' ' ' VAL . 41.7 mt -59.15 -37.76 70.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.34 179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.45 ' H ' HG22 ' C' ' 7' ' ' VAL . 2.1 m -60.92 -40.77 86.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.088 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.151 179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.13 -39.9 87.91 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.21 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . 0.645 ' ND2' HD21 ' D' ' 9' ' ' ASN . 42.8 t30 -61.07 -42.14 97.93 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.223 0.535 . . . . 0.0 109.821 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.94 82.33 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.611 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.92 -39.29 77.63 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.322 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -60.12 -41.29 92.3 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.001 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -39.81 83.69 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.923 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -41.38 96.58 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.79 -41.69 99.22 Favored Glycine 0 C--N 1.305 -1.144 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.48 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . 0.537 ' ND2' ' CD1' ' C' ' 21' ' ' TRP . 2.8 t-20 -60.94 -41.91 97.16 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.946 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -52.86 104.89 0.1 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.234 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.96 157.91 28.66 Favored Glycine 0 C--N 1.309 -0.923 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.72 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -79.27 -62.71 1.61 Allowed 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.27 -0.465 . . . . 0.0 111.395 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -59.01 -40.45 84.95 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.346 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . 0.537 ' CD1' ' ND2' ' C' ' 16' ' ' ASN . 67.0 t-105 -59.63 -40.14 86.64 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.12 -40.59 98.75 Favored Glycine 0 C--N 1.303 -1.255 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.212 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.582 ' O ' HG23 ' C' ' 27' ' ' THR . 7.2 mp -60.03 -39.8 87.14 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 38.1 tp -59.86 -43.07 94.88 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 90.5 t -63.72 -45.0 98.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 74.5 t -65.26 -43.96 95.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.582 HG23 ' O ' ' C' ' 23' ' ' LEU . 81.0 p -63.42 -43.57 97.09 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.875 -0.602 . . . . 0.0 112.029 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 33.5 tp -63.09 -42.93 99.7 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.817 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.505 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.7 -47.01 85.5 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.485 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -68.76 -38.63 80.21 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.802 -0.561 . . . . 0.0 112.196 179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.48 ' C ' ' H ' ' C' ' 33' ' ' LYS . 84.8 t60 -59.19 -42.11 90.09 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.505 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.6 m -52.9 -7.1 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.121 -178.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CD1' ' B' ' 42' ' ' TYR . 2.2 mtpp -40.78 -58.04 1.77 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-O 120.679 0.276 . . . . 0.0 110.357 178.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.67 82.09 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -58.75 -35.83 73.36 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.967 0.413 . . . . 0.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.611 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.1 tt -60.61 -44.44 96.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.43 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -63.18 -46.54 86.01 Favored Pre-proline 0 N--CA 1.482 1.151 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 -175.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 -36.12 92.16 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.575 2.183 . . . . 0.0 111.296 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.48 -37.63 93.57 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.457 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -57.1 -41.27 78.6 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -177.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.407 ' C ' ' O ' ' C' ' 40' ' ' ALA . 22.6 p -39.14 106.89 0.06 Allowed 'General case' 0 C--N 1.31 -1.109 0 CA-C-O 120.876 0.369 . . . . 0.0 111.396 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.659 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 56.8 m-85 -93.08 70.85 4.56 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.765 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.481 ' C ' HD23 ' C' ' 43' ' ' LEU . 2.0 tt -83.53 97.74 9.19 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.14 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 68.9 m 54.94 68.8 0.81 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.674 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 88.9 mt -145.77 24.27 1.36 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.133 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.03 -70.96 0.69 Allowed Glycine 0 C--N 1.3 -1.419 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 36.0 m -138.43 -13.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.439 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.5 OUTLIER -47.61 -48.32 59.09 Favored Pre-proline 0 C--N 1.304 -1.406 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.458 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.439 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.7 Cg_exo -55.02 -39.28 91.7 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.242 1.961 . . . . 0.0 112.537 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.31 -35.77 65.48 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 16.7 mt -56.15 -42.93 77.74 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.597 -1.241 . . . . 0.0 109.126 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.6 mm? -60.27 -41.91 94.28 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' E' ' 19' ' ' PHE . 20.8 t -59.58 -31.9 47.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.827 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.18 -37.52 64.59 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.802 -178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 39.6 mt -54.51 -39.7 67.86 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 tp -66.2 -34.66 78.52 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 123.671 0.788 . . . . 0.0 112.853 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 66.3 ttp85 -57.41 -44.11 99.41 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 -174.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 22.4 Cg_endo -59.7 -40.52 63.76 Favored 'Trans proline' 0 N--CA 1.501 1.958 0 CA-C-N 121.695 1.641 . . . . 0.0 112.896 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' C' ' 59' ' ' HIS . 8.4 p80 -86.55 133.78 33.7 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 120.765 0.316 . . . . 0.0 110.656 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -158.87 96.62 1.36 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.315 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.39 71.66 0.53 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.793 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.538 HD12 ' C ' ' C' ' 62' ' ' LEU . 0.7 OUTLIER -171.28 6.85 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.403 179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.519 ' N ' HD12 ' C' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.314 0 CA-C-O 117.951 -1.024 . . . . 0.0 110.571 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . 0.511 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.67 -63.62 0.33 Allowed 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.782 0.325 . . . . 0.0 110.176 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.473 ' O ' HG13 ' D' ' 7' ' ' VAL . 13.6 mmtp -82.54 -32.91 28.38 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.19 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.01 46.93 0.25 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.26 0.552 . . . . 0.0 110.016 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.445 ' H ' ' C ' ' D' ' 3' ' ' LYS . 0.5 OUTLIER -145.71 -67.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.406 -0.816 . . . . 0.0 108.826 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.572 HG22 HG11 ' E' ' 5' ' ' VAL . 45.9 mt -58.54 -36.47 59.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.632 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.473 HG13 ' O ' ' D' ' 3' ' ' LYS . 19.9 m -60.23 -40.39 83.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.453 ' N ' HG23 ' D' ' 7' ' ' VAL . 8.0 mt -58.76 -40.01 82.66 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.319 -0.553 . . . . 0.0 110.322 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . 0.645 HD21 ' ND2' ' C' ' 9' ' ' ASN . 69.0 m-20 -61.75 -40.84 96.54 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-O 121.302 0.572 . . . . 0.0 110.37 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.489 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.05 -40.64 77.2 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.666 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -38.71 75.85 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.147 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 32.4 t -60.42 -41.67 94.44 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.83 -37.83 74.54 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.61 -40.37 87.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.82 -41.73 94.19 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.461 ' OD1' ' NE1' ' D' ' 21' ' ' TRP . 0.5 OUTLIER -60.7 -40.79 93.55 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.884 0.373 . . . . 0.0 110.522 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 15.6 t-80 -55.27 92.93 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.906 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.06 125.32 1.31 Allowed Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.474 ' O ' HD13 ' D' ' 23' ' ' LEU . 1.5 p90 -50.4 -37.02 35.43 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 121.001 -0.28 . . . . 0.0 111.041 -179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 47.0 p90 -60.07 -43.09 95.69 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.099 -0.64 . . . . 0.0 109.952 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.624 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 66.0 t-105 -60.45 -41.95 95.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.914 0.388 . . . . 0.0 110.58 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.83 96.77 Favored Glycine 0 C--N 1.304 -1.229 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.52 ' O ' HG23 ' D' ' 27' ' ' THR . 7.1 mp -60.81 -39.19 88.04 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.611 -0.295 . . . . 0.0 111.25 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . 0.522 ' O ' HD23 ' D' ' 24' ' ' LEU . 3.9 tt -59.36 -46.19 89.32 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -177.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.409 HG22 ' H ' ' D' ' 25' ' ' VAL . 6.9 m -64.34 -43.05 97.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.95 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -63.38 -42.36 96.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 120.868 0.366 . . . . 0.0 111.599 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.52 HG23 ' O ' ' D' ' 23' ' ' LEU . 37.2 p -62.39 -43.84 97.87 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.433 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 85.0 mt -62.03 -41.75 98.44 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.956 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.404 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.72 -43.79 98.17 Favored 'General case' 0 C--N 1.302 -1.478 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.192 -178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.659 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.57 -41.08 96.51 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -60.94 -41.77 96.89 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.404 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.1 m -69.28 -10.67 13.81 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -177.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtt -45.9 -60.32 2.32 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 120.242 -0.583 . . . . 0.0 109.974 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.66 92.13 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -60.19 -38.13 82.33 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-O 120.961 0.41 . . . . 0.0 111.13 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.516 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.9 OUTLIER -60.69 -41.3 94.88 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.218 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.7 t -61.75 -46.64 93.09 Favored Pre-proline 0 C--N 1.307 -1.248 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.4 Cg_endo -62.24 -34.84 77.14 Favored 'Trans proline' 0 N--CA 1.503 2.05 0 C-N-CA 122.415 2.076 . . . . 0.0 111.727 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.528 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.98 -41.62 99.48 Favored Glycine 0 C--N 1.3 -1.418 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.416 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.13 -41.0 87.19 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.698 -0.251 . . . . 0.0 111.293 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 6.9 p -89.2 112.81 23.93 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 120.927 0.394 . . . . 0.0 111.269 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.572 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 13.2 p90 -171.51 95.92 0.18 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.319 0.581 . . . . 0.0 109.97 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.61 59.18 0.62 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.324 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.2 m -164.74 166.51 19.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.387 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 14.7 mt 58.01 46.87 15.73 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.853 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -73.04 -55.61 6.23 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 113.308 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 10.6 t -111.27 -21.95 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 CA-C-N 117.375 0.588 . . . . 0.0 112.419 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.464 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 5.5 t-105 -55.05 -40.95 88.0 Favored Pre-proline 0 C--N 1.303 -1.455 0 CA-C-O 119.299 -0.382 . . . . 0.0 112.0 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 54.2 Cg_exo -52.85 -48.35 22.54 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 121.299 1.333 . . . . 0.0 112.211 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mt -54.52 -37.38 65.3 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.972 0.731 . . . . 0.0 112.972 -176.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.577 ' N ' HD12 ' D' ' 51' ' ' LEU . 10.1 mp -58.29 -45.09 88.6 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.509 -1.276 . . . . 0.0 109.701 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 13.8 mt -61.01 -41.76 97.15 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.82 -31.74 45.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.475 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -54.75 -41.04 69.97 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.421 -0.512 . . . . 0.0 110.164 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 37.4 mt -60.43 -44.44 95.77 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.762 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.56 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.5 mm? -66.91 -30.45 70.6 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 125.765 1.626 . . . . 0.0 114.71 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 27.2 ttt180 -53.8 -39.43 73.09 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.6 Cg_exo -60.56 -40.26 57.91 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 C-N-CA 121.652 1.568 . . . . 0.0 110.746 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 43.67 39.92 2.7 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.846 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -45.64 169.37 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.451 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.46 64.46 1.6 Allowed 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.039 0.447 . . . . 0.0 110.319 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.9 tp -162.53 27.65 0.1 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.987 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.605 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.63 -98.85 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.681 0.276 . . . . 0.0 110.602 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -79.41 65.11 4.48 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.285 0.564 . . . . 0.0 110.145 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -154.03 34.2 0.43 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.737 0.78 . . . . 0.0 109.21 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.572 HG11 HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -150.24 -66.18 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.214 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.411 HG22 ' CG1' ' F' ' 5' ' ' VAL . 46.7 mt -58.86 -37.34 66.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.475 HG23 ' N ' ' E' ' 8' ' ' LEU . 10.3 m -60.94 -41.23 88.19 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.341 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.475 ' N ' HG23 ' E' ' 7' ' ' VAL . 15.1 mt -60.52 -39.79 89.1 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.474 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -60.44 -42.33 95.9 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.224 0.535 . . . . 0.0 109.696 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.72 -39.96 82.35 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.027 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.37 -40.66 87.19 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.685 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 80.9 p -61.06 -42.14 97.93 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.199 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.23 -38.47 83.51 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.53 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.16 -41.07 92.02 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.81 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -41.77 98.16 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' E' ' 18' ' ' GLY . 2.6 m120 -61.3 -40.62 94.84 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.93 0.395 . . . . 0.0 110.53 179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -45.07 90.89 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.023 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.524 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.47 108.51 0.34 Allowed Glycine 0 C--N 1.304 -1.247 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.1 OUTLIER -37.01 -36.4 0.12 Allowed 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.7 0.286 . . . . 0.0 111.11 -179.322 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -59.89 -42.41 93.75 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.697 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.524 ' N ' ' O ' ' E' ' 18' ' ' GLY . 15.9 t90 -60.5 -42.14 95.73 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.403 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -62.08 -40.43 98.92 Favored Glycine 0 C--N 1.306 -1.116 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.485 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.1 mp -61.14 -37.57 83.31 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.686 -0.257 . . . . 0.0 111.595 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 38.0 tp -57.7 -43.29 85.06 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.424 ' H ' HG13 ' E' ' 25' ' ' VAL . 1.4 m -59.85 -41.11 84.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 120.014 -0.675 . . . . 0.0 112.0 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 71.9 t -62.03 -42.18 93.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.449 ' H ' HG23 ' E' ' 27' ' ' THR . 1.3 p -62.28 -44.63 96.09 Favored 'General case' 0 C--N 1.309 -1.178 0 C-N-CA 120.249 -0.581 . . . . 0.0 112.083 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -61.78 -42.41 98.97 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.071 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.36 -42.31 99.3 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.949 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.528 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.6 -42.8 91.22 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -62.09 -42.23 99.0 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' E' ' 29' ' ' ALA . 17.2 m -62.12 -12.05 7.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 112.964 0.728 . . . . 0.0 112.964 -177.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -46.06 -59.44 2.87 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.003 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.48 -37.75 89.18 Favored Glycine 0 C--N 1.303 -1.295 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -59.47 -36.31 75.74 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.582 ' O ' HD23 ' E' ' 36' ' ' LEU . 0.7 OUTLIER -61.49 -43.82 98.18 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 -177.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.403 HG23 ' H ' ' E' ' 37' ' ' VAL . 0.0 OUTLIER -63.04 -46.23 86.77 Favored Pre-proline 0 N--CA 1.484 1.226 0 CA-C-N 119.195 0.907 . . . . 0.0 113.325 -176.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.697 ' O ' HG22 ' E' ' 41' ' ' THR . 31.7 Cg_exo -59.57 -35.85 94.34 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 122.871 2.381 . . . . 0.0 110.99 176.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.483 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.32 -37.28 92.84 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.265 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.63 -40.34 75.23 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.697 HG22 ' O ' ' E' ' 38' ' ' PRO . 8.7 t -43.81 108.75 0.12 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.521 ' O ' ' N ' ' E' ' 44' ' ' SER . 1.2 m-85 -110.6 -73.28 0.69 Allowed 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.592 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 25.2 mt 63.35 -71.88 0.05 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.126 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . 0.521 ' N ' ' O ' ' E' ' 42' ' ' TYR . 54.5 m -105.33 -164.99 1.08 Allowed 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.249 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 8.2 mt 66.76 48.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.354 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.26 -47.42 5.48 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 121.42 -0.419 . . . . 0.0 113.521 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -103.55 -22.05 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-N 117.688 0.744 . . . . 0.0 112.684 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.561 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 12.0 t-105 -59.69 -37.02 45.65 Favored Pre-proline 0 C--N 1.299 -1.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.032 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 22.7 Cg_exo -64.46 -62.92 0.08 OUTLIER 'Trans proline' 0 N--CA 1.498 1.738 0 C-N-CA 121.812 1.675 . . . . 0.0 112.063 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.65 -37.15 65.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -58.02 -43.28 86.65 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.346 -1.341 . . . . 0.0 108.805 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.4 mp -60.65 -41.51 95.11 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 58.7 t -58.76 -32.55 46.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.172 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -55.25 -40.35 70.82 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.235 -178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.62 -43.31 89.62 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.895 -0.722 . . . . 0.0 109.232 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.531 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 44.3 tp -67.13 -33.24 75.03 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.452 1.101 . . . . 0.0 113.231 178.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.487 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 38.3 ttt85 -56.43 -43.84 99.48 Favored Pre-proline 0 C--N 1.307 -1.265 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 -174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 25.0 Cg_endo -59.84 -40.54 62.28 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 CA-C-N 121.559 1.592 . . . . 0.0 112.909 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.531 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 0.1 OUTLIER -40.84 164.16 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.742 0.306 . . . . 0.0 111.411 -178.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.552 ' N ' ' CD ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -172.22 175.99 3.54 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.035 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' E' ' 63' ' ' ALA . . . -62.81 -38.52 91.04 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.951 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' E' ' 63' ' ' ALA . 15.6 mt -62.56 1.35 0.37 Allowed 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.566 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' E' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.249 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.802 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -56.73 -49.87 73.92 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.802 0.334 . . . . 0.0 110.458 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 15.2 mmtp -95.64 -172.97 2.74 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.463 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.1 m-20 72.51 3.7 4.76 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.479 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.42 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.5 OUTLIER -113.91 -69.19 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . . . . . . . . . 46.5 mt -58.98 -33.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.247 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.407 ' CG2' ' H ' ' F' ' 4' ' ' ASN . 2.7 t -57.08 -40.85 75.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.927 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.549 HD12 ' N ' ' F' ' 8' ' ' LEU . 7.8 mp -59.28 -40.47 86.19 Favored 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 120.489 -0.484 . . . . 0.0 109.736 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.69 -40.8 96.26 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.136 0.493 . . . . 0.0 110.117 178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.441 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -57.6 -41.3 80.94 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.58 -178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.82 -40.0 78.97 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.962 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 27.7 p -61.52 -42.47 98.86 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -40.0 83.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.463 -178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -42.21 98.01 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.281 -0.636 . . . . 0.0 109.281 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.32 -43.38 97.35 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . 0.467 ' O ' ' CD1' ' F' ' 21' ' ' TRP . 11.8 m120 -62.22 -41.48 98.43 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 120.96 0.409 . . . . 0.0 110.625 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -71.72 124.6 25.14 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.563 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.15 -174.9 47.03 Favored Glycine 0 C--N 1.304 -1.227 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.833 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.421 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 27.2 t80 -79.29 -59.79 2.62 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.15 -0.525 . . . . 0.0 111.968 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -59.74 -41.32 90.69 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.795 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.467 ' CD1' ' O ' ' F' ' 16' ' ' ASN . 76.5 t-105 -60.31 -41.08 92.7 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.39 -40.86 99.23 Favored Glycine 0 C--N 1.304 -1.203 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.373 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.763 ' O ' HG23 ' F' ' 27' ' ' THR . 15.7 mt -60.84 -38.72 86.47 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.465 -0.367 . . . . 0.0 111.754 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.46 -43.22 93.25 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -177.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 11.7 t -62.68 -44.21 99.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.09 -42.81 96.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.763 HG23 ' O ' ' F' ' 23' ' ' LEU . 30.9 p -62.74 -43.73 98.05 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.147 -177.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 72.6 mt -62.06 -43.35 99.03 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.451 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.806 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.45 -42.86 98.65 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 120.141 -0.624 . . . . 0.0 111.706 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.483 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.9 OUTLIER -65.73 -42.36 91.14 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 59.4 t60 -61.03 -41.27 96.24 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.806 HG12 ' O ' ' F' ' 29' ' ' ALA . 6.1 p -51.55 -22.01 2.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -177.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.447 ' C ' ' O ' ' F' ' 32' ' ' VAL . 11.9 ttmm -40.54 -60.7 1.06 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.47 -37.99 84.92 Favored Glycine 0 C--N 1.297 -1.594 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.021 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -61.82 -36.51 81.37 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 118.093 0.946 . . . . 0.0 110.99 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.434 ' HG ' HG23 ' A' ' 27' ' ' THR . 1.9 tt -59.29 -43.42 92.58 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.6 t -62.22 -46.5 90.83 Favored Pre-proline 0 C--N 1.305 -1.336 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.2 Cg_endo -62.48 -35.38 71.86 Favored 'Trans proline' 0 N--CA 1.502 2.02 0 C-N-CA 122.255 1.97 . . . . 0.0 111.863 178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.41 -39.5 96.32 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.097 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.61 -42.31 83.02 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.864 -178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -73.19 104.23 4.17 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.834 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 10.1 p90 -157.8 113.94 2.83 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.323 0.582 . . . . 0.0 110.047 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -81.93 146.78 29.6 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.971 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t 63.3 -174.94 0.15 Allowed 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.812 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt 67.87 37.83 3.02 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.606 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.79 -45.44 2.46 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.317 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.5 m -143.41 74.38 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.662 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.8 t-105 -165.04 -42.11 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.007 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.662 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 12.5 Cg_exo -70.46 -30.05 19.61 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.722 1.615 . . . . 0.0 110.809 179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.735 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.49 -36.08 68.72 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.828 -178.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.64 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.3 mp -56.35 -43.81 79.47 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.958 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 8.3 mp -61.1 -41.86 97.44 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -60.56 -30.99 47.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.533 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 69.8 ttt180 -53.87 -39.16 65.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.934 -178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 37.5 mt -56.03 -42.19 76.13 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.519 -0.873 . . . . 0.0 108.919 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 5.1 tp -67.48 -34.25 76.76 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 124.094 0.958 . . . . 0.0 113.557 177.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -55.57 -44.55 99.71 Favored Pre-proline 0 C--N 1.306 -1.286 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -173.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' F' ' 59' ' ' HIS . 5.7 Cg_exo -56.54 -39.56 90.49 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 CA-C-N 121.706 1.645 . . . . 0.0 110.902 177.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' F' ' 60' ' ' ARG . 50.8 t-80 54.64 167.01 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.523 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . 0.599 ' N ' ' ND1' ' F' ' 59' ' ' HIS . 12.3 ptm180 -170.56 127.42 0.78 Allowed 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.694 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.59 -5.04 54.63 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 120.803 0.335 . . . . 0.0 110.508 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.595 HD22 ' N ' ' F' ' 62' ' ' LEU . 3.3 mm? -77.26 3.6 12.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.208 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.799 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.73 -88.57 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.715 0.293 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -75.85 -44.16 42.15 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.372 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' A' ' 8' ' ' LEU . 28.8 m-20 -46.38 -33.91 4.23 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.942 0.401 . . . . 0.0 110.427 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -61.69 -58.7 6.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.796 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.1 mt -58.68 -35.01 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.332 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.26 -40.57 78.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.973 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.0 mp -58.48 -40.19 82.03 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.824 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -61.28 -41.49 97.04 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.167 0.508 . . . . 0.0 110.268 179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.01 -41.0 82.2 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.615 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -58.18 -38.88 77.54 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.471 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.5 t -60.12 -41.58 92.93 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.12 -39.0 77.59 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.675 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.46 -40.74 92.27 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.59 -41.98 95.87 Favored Glycine 0 C--N 1.305 -1.146 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 18' ' ' GLY . 82.8 m-20 -60.85 -40.49 93.06 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.895 0.378 . . . . 0.0 110.333 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -50.78 85.75 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -160.21 119.29 0.88 Allowed Glycine 0 C--N 1.305 -1.159 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -48.35 -37.32 16.36 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 121.155 -0.218 . . . . 0.0 111.145 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.619 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 31.6 p90 -60.75 -43.94 97.34 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.026 -0.669 . . . . 0.0 109.924 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.619 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 64.1 t-105 -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.095 0.474 . . . . 0.0 110.523 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 25' ' ' VAL . . . -61.32 -39.0 96.63 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.835 ' O ' HG23 ' A' ' 27' ' ' THR . 2.8 tp -60.56 -39.89 89.64 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 115.364 -0.418 . . . . 0.0 111.738 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.6 tp -60.92 -43.9 97.95 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 22' ' ' GLY . 2.2 p -61.92 -43.11 97.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.455 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.19 -42.92 97.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.528 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.835 HG23 ' O ' ' A' ' 23' ' ' LEU . 44.1 p -62.92 -43.69 98.11 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 112.053 -178.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.5 tp -61.54 -42.38 98.74 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.401 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.65 -42.58 99.11 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.518 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.531 ' NE1' ' O ' ' F' ' 39' ' ' GLY . 0.3 OUTLIER -64.15 -41.77 97.04 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -179.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.688 ' CD2' HH12 ' A' ' 35' ' ' ARG . 11.7 t60 -61.63 -42.08 98.38 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.463 HG22 ' O ' ' A' ' 29' ' ' ALA . 19.3 m -65.49 -14.57 17.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' F' ' 42' ' ' TYR . 22.9 ttmt -46.63 -56.06 6.69 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.361 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.69 -38.39 91.64 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.688 HH12 ' CD2' ' A' ' 31' ' ' HIS . 70.1 mtt85 -60.25 -35.94 76.62 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.197 0.522 . . . . 0.0 110.823 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.875 HD12 HG22 ' B' ' 27' ' ' THR . 7.2 tt -59.55 -41.78 90.89 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -62.15 -47.02 91.23 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.2 Cg_endo -62.81 -35.44 67.94 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.324 2.016 . . . . 0.0 111.478 177.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.503 ' O ' ' NE1' ' B' ' 30' ' ' TRP . . . -60.75 -40.91 98.78 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.509 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.49 -41.47 89.9 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.464 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.1 p -96.32 112.01 23.89 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 120.93 0.395 . . . . 0.0 111.586 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.543 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.9 p90 -140.89 -128.88 0.1 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.543 HD22 ' C ' ' A' ' 42' ' ' TYR . 3.9 mm? -114.98 -168.1 1.33 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.0 t -115.47 86.33 2.44 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.093 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.9 mt -65.8 -79.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.027 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.73 -55.76 0.49 Allowed Glycine 0 C--N 1.31 -0.906 0 N-CA-C 112.314 -0.315 . . . . 0.0 112.314 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 m -138.29 -11.34 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 32.4 t-105 -57.23 -42.85 98.22 Favored Pre-proline 0 C--N 1.305 -1.341 0 C-N-CA 119.671 -0.812 . . . . 0.0 112.124 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.3 Cg_endo -79.16 -45.42 0.11 Allowed 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.141 1.228 . . . . 0.0 111.479 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 53.9 mt -52.08 -38.26 56.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.272 -175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 tp -62.22 -44.89 95.54 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.293 -0.963 . . . . 0.0 112.31 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.448 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.9 mm? -62.19 -45.76 91.94 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.659 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 57' ' ' ARG . 14.4 m -61.71 -30.08 47.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 120.908 0.385 . . . . 0.0 110.443 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -53.38 -40.97 65.42 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.7 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.5 mt -60.4 -44.78 95.37 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.122 -1.031 . . . . 0.0 108.512 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.0 mt -67.87 -32.76 73.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 124.824 1.25 . . . . 0.0 113.226 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 65.4 ttt-85 -55.22 -43.5 99.12 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.0 Cg_endo -59.32 -40.41 68.39 Favored 'Trans proline' 0 N--CA 1.495 1.569 0 CA-C-N 121.772 1.669 . . . . 0.0 110.516 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.447 ' CE1' ' HB1' ' D' ' 11' ' ' ALA . 1.8 t-160 74.0 -60.42 0.53 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.685 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 59' ' ' HIS . 52.5 ttt180 55.54 108.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.503 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.13 7.74 45.98 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.476 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 18.5 mt -77.94 7.98 5.29 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.254 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.329 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.539 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.29 151.13 15.15 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.891 0.377 . . . . 0.0 110.58 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.432 ' O ' HG23 ' B' ' 5' ' ' VAL . 35.3 mmtt 52.21 -177.81 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.74 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.468 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.0 t-20 71.11 3.81 4.81 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.002 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 3' ' ' LYS . 0.2 OUTLIER -119.48 -68.9 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.487 HG22 ' CG1' ' C' ' 5' ' ' VAL . 40.7 mt -58.1 -35.17 51.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.282 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.42 ' H ' HG23 ' B' ' 7' ' ' VAL . 2.9 t -58.97 -41.41 83.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.266 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.554 HD12 ' N ' ' B' ' 8' ' ' LEU . 8.0 mp -57.75 -38.98 76.31 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -60.51 -39.0 86.18 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.271 0.558 . . . . 0.0 109.54 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.72 -42.09 78.61 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.608 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -39.23 77.82 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.567 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.4 t -61.03 -43.14 99.32 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.293 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.7 -39.47 80.83 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.77 -40.72 93.57 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.88 -41.62 94.27 Favored Glycine 0 C--N 1.303 -1.296 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.095 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.429 ' O ' ' O ' ' B' ' 17' ' ' HIS . 16.3 t-20 -60.35 -41.26 93.28 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 117.057 0.428 . . . . 0.0 110.561 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 16' ' ' ASN . 5.5 t-80 51.19 173.86 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.647 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -122.42 -9.81 6.35 Favored Glycine 0 N--CA 1.471 1.029 0 CA-C-N 116.244 -0.435 . . . . 0.0 112.571 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.625 ' CE2' ' CD2' ' B' ' 20' ' ' PHE . 1.4 t80 -70.83 -93.94 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 117.355 0.578 . . . . 0.0 110.528 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.625 ' CD2' ' CE2' ' B' ' 19' ' ' PHE . 1.2 m-85 -59.65 -42.09 92.0 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.037 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.405 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 85.5 t90 -61.22 -40.14 92.9 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.727 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.52 -40.11 97.31 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.862 ' O ' HG23 ' B' ' 27' ' ' THR . 9.3 mt -60.1 -38.99 84.61 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 120.56 0.219 . . . . 0.0 110.775 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.3 tp -58.99 -42.25 89.58 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.431 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.56 -44.21 98.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.631 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 84.1 t -64.5 -42.76 96.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.453 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.875 HG22 HD12 ' A' ' 36' ' ' LEU . 30.2 p -62.7 -43.92 97.57 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.922 -178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.528 HD13 ' O ' ' B' ' 28' ' ' LEU . 0.2 OUTLIER -61.86 -43.73 98.25 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 120.184 -0.606 . . . . 0.0 110.238 -178.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.51 -43.1 98.17 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.461 -0.496 . . . . 0.0 111.726 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 39' ' ' GLY . 0.7 OUTLIER -64.37 -40.93 96.81 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.56 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -59.35 -41.25 88.8 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.45 HG22 ' O ' ' B' ' 29' ' ' ALA . 20.3 m -69.96 -0.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.767 -178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -52.58 -63.29 1.19 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.703 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -37.69 89.38 Favored Glycine 0 C--N 1.303 -1.263 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 17.7 mmm180 -60.4 -36.4 78.03 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.475 0.655 . . . . 0.0 110.225 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.4 tt -60.22 -42.53 95.38 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.48 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.61 -46.73 83.35 Favored Pre-proline 0 C--N 1.307 -1.239 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 -177.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.4 Cg_endo -63.25 -35.12 65.08 Favored 'Trans proline' 0 N--CA 1.505 2.184 0 C-N-CA 122.759 2.306 . . . . 0.0 111.914 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.557 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.35 -40.85 98.07 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.205 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.12 -41.08 91.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.1 p -83.17 119.55 24.67 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.712 0.292 . . . . 0.0 111.565 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.623 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.6 p90 -174.91 -54.57 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.088 0.471 . . . . 0.0 110.781 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.623 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 17.9 mt 59.68 99.7 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.379 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.586 ' O ' ' N ' ' B' ' 46' ' ' GLY . 57.3 m -173.52 -177.54 1.48 Allowed 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.25 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' B' ' 47' ' ' VAL . 0.6 OUTLIER 52.84 -84.18 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.235 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' B' ' 44' ' ' SER . . . 62.14 -47.61 0.06 OUTLIER Glycine 0 C--N 1.288 -2.104 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.171 177.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.487 HG13 ' O ' ' B' ' 46' ' ' GLY . 4.4 m -158.49 71.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-N 115.072 -0.564 . . . . 0.0 109.771 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.596 ' H ' ' CD ' ' B' ' 49' ' ' PRO . 0.6 OUTLIER -147.87 -48.76 0.02 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.596 ' CD ' ' H ' ' B' ' 48' ' ' TRP . 30.2 Cg_endo -84.31 -18.19 5.11 Favored 'Trans proline' 0 C--N 1.321 -0.882 0 C-N-CA 121.431 1.421 . . . . 0.0 111.969 -179.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 54.5 mt -54.66 -34.82 62.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.63 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.616 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.3 mp -56.81 -43.53 81.07 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.965 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -63.56 -45.89 88.39 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.7 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.4 ' H ' HG13 ' B' ' 53' ' ' VAL . 0.8 OUTLIER -63.68 -30.29 49.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-O 121.166 0.508 . . . . 0.0 110.353 178.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.9 ttp180 -53.42 -39.74 64.58 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.732 -178.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.511 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.7 mm? -58.19 -43.86 87.79 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.367 -0.933 . . . . 0.0 108.684 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.9 tp -67.55 -33.68 75.54 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 124.274 1.03 . . . . 0.0 112.92 177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 31.0 ttm180 -54.79 -43.7 98.79 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -173.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 21.0 Cg_endo -59.84 -39.11 75.06 Favored 'Trans proline' 0 N--CA 1.498 1.764 0 CA-C-N 121.878 1.706 . . . . 0.0 111.31 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.455 ' CE1' ' HB1' ' E' ' 11' ' ' ALA . 1.8 t-80 59.71 161.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.213 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 42.0 mtt-85 -147.23 -177.64 5.79 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.124 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.17 7.45 1.58 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.354 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.404 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 18.0 mt -83.75 -50.07 8.49 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.776 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.404 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.31 -1.14 0 CA-C-O 118.007 -0.997 . . . . 0.0 111.133 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.21 5.94 0.65 Allowed 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 120.662 0.268 . . . . 0.0 110.792 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.496 ' C ' ' H ' ' C' ' 5' ' ' VAL . 36.1 mmtm -139.53 -10.77 1.21 Allowed 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.584 179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.458 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 1.3 m-20 -76.46 42.07 0.27 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.425 0.631 . . . . 0.0 109.525 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.496 ' H ' ' C ' ' C' ' 3' ' ' LYS . 0.0 OUTLIER -147.01 -67.15 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.516 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 28.5 mt -58.23 -38.02 66.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.123 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.489 HG12 ' O ' ' C' ' 3' ' ' LYS . 9.7 p -60.86 -40.74 86.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.239 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.931 178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.456 ' N ' HG13 ' C' ' 7' ' ' VAL . 3.8 mp -59.8 -40.42 88.31 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.685 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -60.96 -40.42 93.31 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.45 0.643 . . . . 0.0 109.477 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -41.12 81.86 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.036 -179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.45 -40.63 83.15 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.132 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.6 t -61.38 -41.93 97.89 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.45 -38.48 77.6 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.073 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -40.7 91.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.192 0.52 . . . . 0.0 109.65 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.53 98.39 Favored Glycine 0 C--N 1.306 -1.137 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.568 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -61.45 -41.42 97.18 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 117.042 0.421 . . . . 0.0 110.941 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -52.68 100.9 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.705 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.15 159.4 31.9 Favored Glycine 0 C--N 1.307 -1.054 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.662 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . 0.463 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 1.1 t80 -75.25 -49.42 19.36 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.355 -0.422 . . . . 0.0 111.575 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -59.16 -40.12 84.59 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-O 120.658 0.266 . . . . 0.0 111.092 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 42.5 t90 -59.33 -40.28 85.85 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.769 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.04 -40.06 97.98 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.277 -0.487 . . . . 0.0 111.908 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.463 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 11.0 mt -60.49 -40.41 91.22 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 68.8 tp -61.31 -44.79 96.61 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.9 -44.79 96.16 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 78.1 t -64.93 -43.72 96.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 121.035 0.445 . . . . 0.0 112.031 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 36.2 m -62.97 -43.53 98.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.854 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 35.7 tp -63.37 -43.31 97.98 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.97 -178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.461 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -63.83 -48.09 78.19 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.513 -0.875 . . . . 0.0 113.094 -177.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.557 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.45 -37.64 80.41 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.704 178.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.581 ' HA ' ' HZ2' ' C' ' 33' ' ' LYS . 19.9 t60 -59.04 -42.12 89.47 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.461 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.9 m -58.44 -6.36 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.1 -0.64 . . . . 0.0 112.022 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.581 ' HZ2' ' HA ' ' C' ' 31' ' ' HIS . 11.2 pttm -42.99 -55.55 3.72 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.088 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.23 -38.21 89.26 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 111.757 -0.537 . . . . 0.0 111.757 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . 0.546 ' NH2' ' NE2' ' D' ' 31' ' ' HIS . 43.7 mtp85 -59.18 -35.97 74.51 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.874 0.369 . . . . 0.0 110.739 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.71 98.41 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 114.954 1.465 . . . . 0.0 114.954 -177.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.422 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.71 -46.28 88.42 Favored Pre-proline 0 N--CA 1.484 1.26 0 C-N-CA 119.481 -0.888 . . . . 0.0 113.358 -175.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' C' ' 41' ' ' THR . 31.3 Cg_exo -59.12 -35.72 97.38 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 122.756 2.304 . . . . 0.0 111.193 176.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.39 -37.59 93.4 Favored Glycine 0 C--N 1.302 -1.313 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.367 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -41.02 78.71 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 38' ' ' PRO . 33.1 p -42.91 109.64 0.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.937 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -88.46 68.99 8.93 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 20.9 mt -79.57 94.03 5.57 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.654 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 9.7 t 54.03 71.69 0.5 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.81 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 86.4 mt -144.8 25.37 1.45 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.025 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.68 -70.45 0.84 Allowed Glycine 0 C--N 1.302 -1.314 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 11.5 m -140.94 -11.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.451 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.4 OUTLIER -48.0 -48.34 62.91 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.281 -179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.451 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 38.4 Cg_exo -56.61 -39.36 91.85 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 122.274 1.983 . . . . 0.0 112.596 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -55.42 -35.68 65.64 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.587 HD12 ' N ' ' C' ' 51' ' ' LEU . 10.0 mp -56.72 -44.22 81.4 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 118.604 -1.239 . . . . 0.0 110.376 -177.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mp -60.85 -42.08 97.11 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.148 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -30.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.412 179.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -53.66 -39.32 64.97 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.767 -178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.513 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.7 mm? -58.52 -44.1 89.39 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.796 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.507 HD22 ' N ' ' C' ' 56' ' ' LEU . 3.7 mm? -67.47 -33.08 74.39 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 124.419 1.088 . . . . 0.0 112.994 177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.476 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 41.7 ttm180 -55.18 -43.68 99.21 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 115.764 1.765 . . . . 0.0 115.764 -173.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.8 Cg_endo -59.41 -39.85 72.68 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 CA-C-N 121.696 1.641 . . . . 0.0 111.377 178.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' C' ' 58' ' ' PRO . 22.5 t-80 52.03 168.15 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.981 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 2.1 ptp85 -169.44 101.24 0.34 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.148 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -66.91 -16.57 64.41 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.878 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 5.1 tp -77.72 30.38 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.925 0.393 . . . . 0.0 110.189 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.467 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.572 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.81 16.93 1.15 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 120.772 0.32 . . . . 0.0 110.638 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 17.0 mmtp -139.13 63.39 1.51 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.028 0.442 . . . . 0.0 110.282 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -151.48 -34.96 0.14 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.365 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . . . . . . . . . 1.4 t -73.26 -58.85 4.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.42 HG22 ' CG1' ' E' ' 5' ' ' VAL . 45.3 mt -58.89 -35.61 57.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.723 -0.672 . . . . 0.0 109.765 179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.43 ' H ' HG23 ' D' ' 7' ' ' VAL . 5.3 t -59.28 -41.15 83.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.366 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mt -59.49 -40.32 86.63 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.502 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.42 -41.81 97.74 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.177 0.513 . . . . 0.0 110.051 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.419 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.02 -40.76 81.62 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.766 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.447 ' HB1' ' CE1' ' A' ' 59' ' ' HIS . . . -58.27 -39.68 79.88 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.442 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.9 t -60.78 -42.18 97.02 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 120.393 -0.523 . . . . 0.0 109.738 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -39.21 81.7 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.03 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.93 -41.81 96.95 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.62 -42.29 97.73 Favored Glycine 0 C--N 1.304 -1.225 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.054 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -61.67 -41.7 97.91 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.835 0.35 . . . . 0.0 110.934 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -53.04 105.22 0.11 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.897 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.402 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -173.08 120.7 0.82 Allowed Glycine 0 C--N 1.305 -1.191 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -43.78 -33.4 1.27 Allowed 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.532 0.206 . . . . 0.0 110.622 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -60.58 -43.44 97.35 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.437 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.402 ' N ' ' O ' ' D' ' 18' ' ' GLY . 22.3 t90 -61.06 -41.58 96.88 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.939 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.67 -39.88 97.22 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.55 ' O ' HG23 ' D' ' 27' ' ' THR . 5.4 tp -61.02 -39.6 90.38 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 34.2 tp -60.4 -45.49 93.4 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.967 0.729 . . . . 0.0 112.967 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG22 ' D' ' 25' ' ' VAL . 6.2 m -63.38 -42.89 97.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.655 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.6 -42.85 97.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 120.928 0.394 . . . . 0.0 111.672 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.55 HG23 ' O ' ' D' ' 23' ' ' LEU . 54.3 p -63.05 -44.25 96.38 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.33 -178.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 mt -61.76 -42.83 99.49 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.822 -178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.84 -43.44 98.79 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.29 -178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -64.64 -41.58 96.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.546 ' NE2' ' NH2' ' C' ' 35' ' ' ARG . 26.4 t60 -60.99 -41.88 97.35 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.6 ' HB ' HG21 ' E' ' 27' ' ' THR . 21.8 m -66.89 -9.68 10.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -44.76 -59.88 2.3 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 120.564 -0.454 . . . . 0.0 110.15 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.02 -37.72 91.96 Favored Glycine 0 C--N 1.301 -1.402 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.537 HH21 ' CD2' ' E' ' 31' ' ' HIS . 10.7 tpt180 -59.75 -38.03 80.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 120.969 0.414 . . . . 0.0 111.323 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.564 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.26 -41.45 93.26 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -177.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.99 -46.58 91.94 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 33.1 Cg_endo -62.22 -34.92 77.13 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.416 2.077 . . . . 0.0 111.946 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.517 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.66 -41.12 98.8 Favored Glycine 0 C--N 1.301 -1.372 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.647 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.35 85.82 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.711 -0.245 . . . . 0.0 111.388 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 33.4 p -81.93 111.39 18.07 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.946 -0.301 . . . . 0.0 111.138 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.578 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 17.9 p90 -173.08 106.22 0.15 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.226 0.536 . . . . 0.0 109.913 178.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 tt -91.86 68.37 5.4 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 5.5 t -168.4 169.81 10.32 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.603 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . 0.461 HD12 ' N ' ' D' ' 45' ' ' LEU . 7.2 mp 57.48 49.26 13.13 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.972 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.86 -59.2 7.27 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-N 116.194 -0.457 . . . . 0.0 112.917 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -119.03 -17.95 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 6.3 t-105 -51.85 -44.16 90.42 Favored Pre-proline 0 C--N 1.302 -1.458 0 C-N-CA 120.584 -0.447 . . . . 0.0 111.32 -179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 76.7 Cg_exo -52.26 -42.74 58.29 Favored 'Trans proline' 0 N--CA 1.499 1.838 0 C-N-CA 121.412 1.408 . . . . 0.0 112.211 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.617 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.07 -37.91 64.71 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.608 -175.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -58.83 -45.01 91.03 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.671 -1.212 . . . . 0.0 110.35 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -61.21 -42.18 98.15 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.269 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' F' ' 19' ' ' PHE . 98.4 t -59.34 -32.04 47.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.247 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -54.81 -41.16 70.3 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.89 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.543 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.6 mp -60.6 -44.89 95.76 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.489 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -67.22 -30.59 70.55 Favored 'General case' 0 C--N 1.308 -1.217 0 C-N-CA 125.787 1.635 . . . . 0.0 115.219 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.413 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 7.5 ttm180 -54.08 -39.68 75.96 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 -172.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 30.8 Cg_exo -60.55 -40.43 56.53 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 121.752 1.635 . . . . 0.0 111.051 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.448 ' ND1' ' HB1' ' A' ' 11' ' ' ALA . 3.4 t-80 48.25 49.06 18.22 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.71 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.413 ' O ' ' O ' ' D' ' 59' ' ' HIS . 75.5 mtp180 -43.5 167.1 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.641 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.87 -6.9 2.41 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.416 ' CD2' ' H ' ' D' ' 62' ' ' LEU . 0.1 OUTLIER -89.1 25.01 1.95 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.9 0.381 . . . . 0.0 109.997 179.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.302 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.54 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.2 -79.55 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 120.771 0.319 . . . . 0.0 110.691 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -84.83 76.25 10.26 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.419 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.491 ' O ' HD13 ' E' ' 8' ' ' LEU . 63.8 m-80 -162.84 2.61 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.468 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.42 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.0 OUTLIER -116.18 -63.02 2.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.633 179.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 42.1 mt -60.08 -35.23 60.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.413 HG23 ' H ' ' E' ' 7' ' ' VAL . 2.8 t -57.18 -40.07 71.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.098 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.496 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.3 mp -59.19 -39.22 81.91 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 120.363 -0.535 . . . . 0.0 109.727 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -60.34 -42.23 95.25 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 121.036 0.446 . . . . 0.0 109.995 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . 0.495 ' HB2' HG12 ' F' ' 5' ' ' VAL . . . -57.3 -38.44 73.99 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.39 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.455 ' HB1' ' CE1' ' B' ' 59' ' ' HIS . . . -58.23 -39.13 78.31 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.425 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -59.96 -42.02 93.19 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.261 -0.576 . . . . 0.0 109.913 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.08 85.47 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.036 0.446 . . . . 0.0 110.138 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.86 92.08 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.604 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.98 97.9 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.42 ' OD1' ' NE1' ' E' ' 21' ' ' TRP . 2.0 t30 -60.79 -41.05 94.82 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.701 0.286 . . . . 0.0 110.899 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 49.9 m170 -46.61 98.11 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.017 0.437 . . . . 0.0 110.764 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -165.28 100.07 0.17 Allowed Glycine 0 C--N 1.304 -1.213 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.8 OUTLIER -33.31 -43.6 0.11 Allowed 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.48 -42.99 97.39 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.957 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.531 ' N ' ' O ' ' E' ' 18' ' ' GLY . 66.4 t-105 -61.06 -41.77 97.23 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.136 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.438 ' O ' HG12 ' E' ' 25' ' ' VAL . . . -61.12 -39.88 97.76 Favored Glycine 0 C--N 1.306 -1.132 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.41 -36.27 77.75 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.573 -0.313 . . . . 0.0 111.841 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . 0.502 ' CD1' HG11 ' D' ' 32' ' ' VAL . 37.9 tp -57.43 -42.98 83.45 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.438 HG12 ' O ' ' E' ' 22' ' ' GLY . 2.8 p -60.03 -41.52 86.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.668 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . 0.403 ' N ' ' CG1' ' E' ' 25' ' ' VAL . 97.7 t -62.68 -42.25 95.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.6 HG21 ' HB ' ' D' ' 32' ' ' VAL . 44.0 m -62.6 -44.82 95.34 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.6 -42.5 98.95 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.051 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.534 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.0 -41.14 97.73 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.749 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.517 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.9 OUTLIER -64.88 -42.08 95.12 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . 0.537 ' CD2' HH21 ' D' ' 35' ' ' ARG . 6.0 t60 -61.91 -42.34 98.98 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -177.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.534 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.7 m -59.38 -14.71 6.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -44.77 -62.66 1.13 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.497 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.18 -37.28 85.97 Favored Glycine 0 C--N 1.299 -1.496 0 N-CA-C 111.561 -0.616 . . . . 0.0 111.561 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . 0.612 ' NH2' ' CE1' ' F' ' 31' ' ' HIS . 68.7 mtp85 -59.68 -36.81 77.22 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.904 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.576 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.75 -43.5 98.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 -176.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.25 -46.03 85.34 Favored Pre-proline 0 N--CA 1.484 1.272 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.407 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.4 Cg_exo -59.14 -35.25 98.19 Favored 'Trans proline' 0 N--CA 1.501 1.942 0 C-N-CA 122.796 2.33 . . . . 0.0 111.035 176.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.554 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.87 -36.43 90.02 Favored Glycine 0 C--N 1.3 -1.459 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.406 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.67 -40.04 65.61 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.34 -177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 60.6 p -49.39 101.54 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.555 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.18 -43.67 14.72 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.412 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 46.3 mt 56.32 -103.64 0.19 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.153 0.501 . . . . 0.0 110.37 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.1 m -106.77 71.52 0.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.292 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 86.7 mt -149.42 27.53 0.82 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.421 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -67.48 -59.83 6.38 Favored Glycine 0 C--N 1.302 -1.355 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.768 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 16.9 m -109.9 -21.19 5.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.501 ' CD1' ' C ' ' E' ' 48' ' ' TRP . 3.1 t-105 -52.62 -42.02 86.45 Favored Pre-proline 0 C--N 1.303 -1.425 0 C-N-CA 120.25 -0.58 . . . . 0.0 111.258 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.469 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 27.0 Cg_exo -61.31 -49.77 7.08 Favored 'Trans proline' 0 N--CA 1.499 1.82 0 C-N-CA 121.493 1.462 . . . . 0.0 111.664 179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.615 ' O ' HG22 ' E' ' 53' ' ' VAL . 3.7 mm? -54.69 -37.8 66.25 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.964 -175.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 14.6 mt -58.59 -41.87 86.79 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.328 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' E' ' 52' ' ' LEU . 3.8 mm? -58.52 -40.1 81.96 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.47 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.615 HG22 ' O ' ' E' ' 50' ' ' LEU . 1.1 m -58.65 -30.81 42.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 120.846 0.355 . . . . 0.0 110.857 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 69.1 ttp85 -54.15 -40.76 67.72 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.669 -0.413 . . . . 0.0 110.24 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . 0.557 ' N ' HD12 ' E' ' 55' ' ' LEU . 9.9 mp -58.8 -43.2 90.49 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.613 -0.835 . . . . 0.0 109.145 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.551 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.2 mm? -67.59 -33.23 74.57 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 124.411 1.085 . . . . 0.0 113.049 177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 31.3 ttm180 -56.3 -43.9 99.49 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 -174.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 26.1 Cg_endo -59.92 -41.0 57.47 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.723 1.651 . . . . 0.0 112.651 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.504 ' ND1' ' N ' ' E' ' 60' ' ' ARG . 0.0 OUTLIER -38.85 156.75 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-O 120.958 0.409 . . . . 0.0 111.038 -178.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.504 ' N ' ' ND1' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -165.4 172.25 12.45 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.862 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.17 -176.93 0.11 Allowed 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 120.792 0.329 . . . . 0.0 110.959 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.551 HD12 ' N ' ' E' ' 62' ' ' LEU . 9.7 mp 52.7 19.94 1.41 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.043 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.592 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.63 -34.52 78.03 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.739 0.304 . . . . 0.0 110.577 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.13 20.8 6.46 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.091 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -120.12 45.69 2.13 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 121.443 0.64 . . . . 0.0 109.563 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.495 HG12 ' HB2' ' E' ' 10' ' ' ALA . 0.0 OUTLIER -151.96 -67.22 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.911 -1.04 . . . . 0.0 108.509 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.47 HG22 ' CG1' ' A' ' 5' ' ' VAL . 30.7 mt -58.34 -37.62 64.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.118 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.511 HG23 ' N ' ' F' ' 8' ' ' LEU . 12.1 m -60.72 -41.84 89.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.115 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.511 ' N ' HG23 ' F' ' 7' ' ' VAL . 14.6 mt -60.48 -40.74 92.37 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.348 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -61.63 -41.63 97.75 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-O 121.195 0.522 . . . . 0.0 110.017 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.21 82.31 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.033 -178.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.18 87.12 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.096 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 33.9 p -61.94 -42.79 99.51 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -38.99 80.39 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.188 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -42.25 97.9 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.47 -42.8 97.76 Favored Glycine 0 C--N 1.305 -1.162 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.74 -42.09 98.51 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.57 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 55.3 m170 -65.23 123.51 19.74 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.363 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.11 177.69 48.42 Favored Glycine 0 C--N 1.304 -1.218 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.777 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.412 ' CE2' HG21 ' D' ' 53' ' ' VAL . 25.0 t80 -80.02 -58.55 3.1 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.193 -0.504 . . . . 0.0 111.897 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' F' ' 21' ' ' TRP . 34.3 p90 -58.57 -39.9 81.61 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.761 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.635 ' N ' ' CD1' ' F' ' 20' ' ' PHE . 77.9 t90 -58.6 -38.98 79.11 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 120.607 0.241 . . . . 0.0 111.628 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.83 -39.17 93.49 Favored Glycine 0 C--N 1.303 -1.285 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.429 ' N ' HD12 ' F' ' 23' ' ' LEU . 10.2 mp -59.7 -38.18 80.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.58 0.229 . . . . 0.0 111.381 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . 0.558 ' O ' HD23 ' F' ' 24' ' ' LEU . 0.7 OUTLIER -59.64 -43.08 93.98 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.559 -0.457 . . . . 0.0 112.182 -177.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 8.2 t -61.56 -44.3 98.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 m -63.5 -41.59 93.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.524 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . . . . . . . . . 10.6 m -61.89 -44.39 96.91 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.11 -43.54 98.61 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.889 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.447 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.72 -41.33 98.1 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.303 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.554 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.1 OUTLIER -64.77 -43.42 93.3 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . 0.612 ' CE1' ' NH2' ' E' ' 35' ' ' ARG . 20.7 t60 -61.87 -40.54 95.72 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.447 HG22 ' O ' ' F' ' 29' ' ' ALA . 27.2 m -68.28 -11.23 14.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.435 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 7.4 pttp -48.32 -56.24 8.57 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.192 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . 0.435 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.59 -38.03 93.1 Favored Glycine 0 C--N 1.303 -1.276 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -59.9 -36.33 76.74 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 120.922 0.392 . . . . 0.0 111.239 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.554 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.7 OUTLIER -59.9 -42.22 93.35 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 -177.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.3 t -62.08 -46.5 91.51 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 115.103 1.52 . . . . 0.0 115.103 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 28.8 Cg_endo -61.84 -34.45 82.21 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 122.435 2.09 . . . . 0.0 111.13 177.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.531 ' O ' ' NE1' ' A' ' 30' ' ' TRP . . . -60.93 -38.2 95.03 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.17 -1.377 . . . . 0.0 111.24 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.79 -41.3 77.46 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.02 117.36 31.02 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.18 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 33' ' ' LYS . 20.9 p90 -150.76 100.78 2.86 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.44 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.557 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.7 mm? -59.67 141.05 55.87 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.674 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.4 m 69.46 174.99 0.29 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt 71.85 37.24 1.08 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.811 -178.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.68 -67.47 2.19 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.852 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 29.3 m -133.88 -3.78 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.526 ' N ' ' CD ' ' F' ' 49' ' ' PRO . 0.3 OUTLIER -58.94 -41.98 91.51 Favored Pre-proline 0 C--N 1.306 -1.324 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.251 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.0 Cg_exo -54.01 -41.91 71.32 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.675 1.584 . . . . 0.0 111.848 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 38.2 mt -56.49 -34.98 67.46 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -177.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.567 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.6 mp -55.63 -43.64 76.38 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.651 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.01 -41.84 97.31 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 t -60.11 -30.4 45.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.585 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -53.52 -38.83 64.13 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.667 -178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.553 HD12 ' N ' ' F' ' 55' ' ' LEU . 10.4 mp -58.35 -43.44 88.35 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.533 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.0 tp -67.28 -33.29 74.99 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.383 1.073 . . . . 0.0 113.672 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.478 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 13.9 mmt180 -55.27 -44.13 99.47 Favored Pre-proline 0 C--N 1.308 -1.234 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -174.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 18.3 Cg_endo -59.81 -41.01 58.34 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 121.584 1.601 . . . . 0.0 111.185 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 27.9 m-70 55.23 162.03 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.073 0.463 . . . . 0.0 110.477 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -175.55 131.78 0.28 Allowed 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.316 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.42 -11.38 59.88 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.286 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.572 ' N ' HD12 ' F' ' 62' ' ' LEU . 8.8 mp -73.44 -33.48 64.93 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.147 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.603 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.526 ' O ' ' NZ ' ' F' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.01 83.28 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 120.768 0.318 . . . . 0.0 110.623 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' HG2' ' HZ2' ' A' ' 3' ' ' LYS . 1.4 mptm? -87.95 73.91 9.06 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.071 0.462 . . . . 0.0 110.329 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -157.55 21.67 0.28 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.427 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.592 HG12 ' HB2' ' F' ' 10' ' ' ALA . 0.0 OUTLIER -142.48 -66.76 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.004 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' B' ' 5' ' ' VAL . 29.5 mt -58.87 -36.65 62.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 7' ' ' VAL . 0.3 OUTLIER -61.14 -41.2 88.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.938 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.2 mp -59.07 -40.42 85.16 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.418 -0.513 . . . . 0.0 109.905 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.68 -41.95 98.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.193 0.52 . . . . 0.0 110.182 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -39.94 76.57 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.004 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -39.67 79.71 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.254 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 t -60.94 -42.89 99.05 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.636 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.56 -38.83 82.17 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.048 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -42.91 97.39 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.37 -42.57 97.51 Favored Glycine 0 C--N 1.306 -1.087 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -61.95 -41.35 97.88 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.3 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -60.38 114.76 3.1 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.144 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.01 157.26 29.19 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE2' HG11 ' E' ' 53' ' ' VAL . 1.4 t80 -71.28 -49.27 44.67 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.237 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -59.13 -40.01 84.12 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 120.784 0.326 . . . . 0.0 110.463 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -58.99 -40.44 84.86 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 120.808 0.337 . . . . 0.0 110.629 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.66 -39.05 94.67 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.0 mp -59.55 -38.28 80.67 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.197 -179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 35.1 tp -59.58 -44.82 93.2 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.6 m -63.41 -43.45 98.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.459 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.1 t -63.79 -42.03 94.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-O 121.233 0.54 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 m -61.98 -43.16 99.43 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.831 -178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.9 mt -60.99 -41.61 96.8 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.39 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.62 ' O ' HG12 ' A' ' 32' ' ' VAL . . . -61.35 -41.32 96.86 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.197 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -63.11 -41.16 99.31 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -60.26 -40.61 90.93 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 29' ' ' ALA . 1.8 p -57.42 -20.09 12.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 32' ' ' VAL . 38.4 mttm -41.54 -56.78 2.45 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.106 -0.637 . . . . 0.0 109.309 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.59 -38.12 90.62 Favored Glycine 0 C--N 1.298 -1.554 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -61.96 -35.15 77.59 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 117.615 0.708 . . . . 0.0 111.146 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -58.59 -43.79 89.64 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.472 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -63.64 -46.87 83.22 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 36.7 Cg_endo -63.44 -36.17 56.5 Favored 'Trans proline' 0 N--CA 1.503 2.036 0 C-N-CA 122.381 2.054 . . . . 0.0 112.164 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.06 99.34 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.992 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.68 -41.22 90.18 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.347 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -95.43 109.72 21.87 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 120.802 0.334 . . . . 0.0 111.434 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.514 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -138.18 -122.03 0.13 Allowed 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 27.3 mt -131.68 -166.54 1.73 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 70.9 p -117.19 87.75 2.77 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.318 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -69.73 -79.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.925 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.76 -55.65 0.5 Allowed Glycine 0 CA--C 1.527 0.789 0 N-CA-C 112.383 -0.287 . . . . 0.0 112.383 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' O ' HG12 ' A' ' 47' ' ' VAL . 93.0 t -139.07 -11.86 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -177.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.421 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 33.5 t-105 -57.43 -42.77 97.59 Favored Pre-proline 0 C--N 1.305 -1.363 0 C-N-CA 119.98 -0.688 . . . . 0.0 112.649 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 56.1 Cg_endo -74.29 -45.99 0.31 Allowed 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.48 1.207 . . . . 0.0 112.346 -178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.4 mt -51.77 -36.35 47.17 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.69 -44.22 90.22 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.044 -1.462 . . . . 0.0 110.16 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.41 -47.2 82.98 Favored 'General case' 0 C--N 1.313 -1.001 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.962 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.43 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.8 OUTLIER -62.71 -31.14 51.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-O 120.819 0.342 . . . . 0.0 110.819 179.185 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 59.0 ttt180 -53.99 -41.41 67.87 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.78 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 39.8 mt -60.25 -45.05 94.62 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.144 -1.023 . . . . 0.0 108.54 179.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -67.69 -33.18 74.39 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 124.659 1.184 . . . . 0.0 113.597 178.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 59.3 ttp85 -55.55 -43.56 99.21 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -174.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 18.5 Cg_endo -59.47 -40.51 66.06 Favored 'Trans proline' 0 N--CA 1.495 1.561 0 CA-C-N 121.74 1.657 . . . . 0.0 110.763 178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.437 ' CB ' ' O ' ' A' ' 58' ' ' PRO . 6.1 t-80 78.33 -60.96 0.39 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.388 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' O ' ' A' ' 59' ' ' HIS . 17.1 ttt85 49.04 98.49 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.847 -0.341 . . . . 0.0 110.516 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.71 -176.52 6.12 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' O ' HD23 ' A' ' 62' ' ' LEU . 0.7 OUTLIER 70.47 -0.66 2.81 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.307 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.016 179.81 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.15 24.45 0.33 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.718 0.294 . . . . 0.0 110.561 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.434 ' HZ2' ' N ' ' C' ' 2' ' ' ALA . 19.4 mtpt -147.73 -40.61 0.18 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.551 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.453 ' O ' HD13 ' B' ' 8' ' ' LEU . 5.7 m120 -41.73 -31.05 0.27 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.059 0.457 . . . . 0.0 110.26 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 6' ' ' ILE . 1.4 t -67.66 -57.17 10.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.093 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.7 mt -59.26 -34.07 52.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.97 -40.63 77.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.884 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 4' ' ' ASN . 6.9 mp -58.33 -39.92 80.75 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -60.51 -39.75 88.9 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.05 -41.32 78.48 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.619 -178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.9 -38.7 76.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -60.02 -42.05 93.51 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.052 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.21 79.61 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.737 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.05 90.21 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.48 -41.33 95.31 Favored Glycine 0 C--N 1.304 -1.249 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.319 -178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 33.4 m120 -60.34 -41.31 93.32 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.834 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.426 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.3 t60 59.12 176.75 0.07 Allowed 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.276 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.426 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -129.04 -13.23 2.45 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 -179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.56 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 10.5 t80 -72.16 -95.83 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 117.135 0.468 . . . . 0.0 110.74 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.599 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 28.3 p90 -59.84 -42.05 92.76 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.587 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.599 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 73.3 t-105 -60.49 -40.6 91.95 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.235 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.05 -40.51 98.61 Favored Glycine 0 C--N 1.306 -1.127 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mt -61.65 -40.82 96.29 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.153 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 35.3 tp -61.02 -45.23 95.66 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -178.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.84 -44.66 96.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.948 -0.701 . . . . 0.0 112.041 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.439 HG22 ' CZ ' ' C' ' 20' ' ' PHE . 85.1 t -65.04 -44.02 95.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-O 121.204 0.526 . . . . 0.0 110.772 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 15.2 m -63.51 -42.26 98.49 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.037 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.4 -42.35 91.55 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.598 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.501 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.06 -41.96 98.69 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.553 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.87 -41.32 97.79 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -59.72 -41.66 91.35 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.501 HG22 ' O ' ' B' ' 29' ' ' ALA . 26.5 m -67.02 0.23 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.776 0 C-N-CA 119.898 -0.721 . . . . 0.0 111.982 -178.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -50.12 -65.41 0.57 Allowed 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.951 -0.699 . . . . 0.0 109.664 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.83 87.72 Favored Glycine 0 C--N 1.303 -1.262 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . 0.422 ' HE ' ' N ' ' B' ' 35' ' ' ARG . 4.4 mmp_? -60.89 -36.91 80.46 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.467 0.651 . . . . 0.0 110.211 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 5.2 tt -59.88 -41.49 91.69 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 -177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.45 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.89 -47.45 86.95 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 -177.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 37.1 Cg_endo -63.99 -36.94 46.26 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 122.404 2.069 . . . . 0.0 111.883 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.615 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.48 -41.16 98.55 Favored Glycine 0 C--N 1.302 -1.357 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -59.32 -40.5 86.47 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.482 -0.359 . . . . 0.0 111.939 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 30.8 p -78.27 121.33 24.27 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.774 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.547 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 50.1 p90 -177.22 -48.48 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.144 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.58 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.3 mm? 56.71 83.83 0.1 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.896 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' B' ' 43' ' ' LEU . 3.5 m -168.58 175.38 6.21 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.94 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.479 HD12 ' N ' ' B' ' 45' ' ' LEU . 7.2 mp 57.64 46.99 16.61 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.32 -45.36 3.28 Favored Glycine 0 C--N 1.308 -1.02 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.1 m -147.11 76.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.53 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.1 OUTLIER -159.98 -51.73 0.01 OUTLIER Pre-proline 0 C--N 1.31 -1.129 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 73.7 Cg_endo -84.73 -19.12 4.27 Favored 'Trans proline' 0 N--CA 1.482 0.811 0 C-N-CA 121.418 1.412 . . . . 0.0 111.669 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -55.47 -36.88 67.08 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.563 -177.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.647 ' N ' HD12 ' B' ' 51' ' ' LEU . 7.8 mp -58.08 -44.47 87.59 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 118.898 -1.121 . . . . 0.0 109.374 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 7.3 mp -60.95 -41.81 97.01 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 47.9 t -59.98 -31.52 47.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.65 178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -54.12 -39.97 66.9 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.071 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.05 -44.41 91.81 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.91 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 13.0 mt -67.66 -33.69 75.45 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 124.339 1.056 . . . . 0.0 113.22 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.45 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 1.4 tpm_? -55.61 -43.96 99.42 Favored Pre-proline 0 C--N 1.306 -1.318 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -173.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.9 Cg_endo -60.03 -40.02 65.14 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 CA-C-N 121.847 1.695 . . . . 0.0 111.496 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.441 ' O ' ' O ' ' B' ' 58' ' ' PRO . 3.6 t-80 52.02 172.53 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.375 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -173.11 -179.88 2.08 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.86 6.62 2.02 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.603 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.579 HD12 ' N ' ' B' ' 62' ' ' LEU . 10.2 mp -85.52 16.1 4.07 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.738 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.421 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.299 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.66 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.434 ' N ' ' HZ2' ' B' ' 3' ' ' LYS . . . -175.5 -90.61 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 120.713 0.292 . . . . 0.0 110.604 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 32.0 mmtt -73.79 84.27 1.66 Allowed 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.152 0.501 . . . . 0.0 110.722 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.439 ' O ' HD13 ' C' ' 8' ' ' LEU . 46.6 m-80 -159.01 -53.94 0.06 Allowed 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.349 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.406 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.6 OUTLIER -60.09 -55.37 24.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 52.6 mt -59.82 -35.98 63.55 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' C' ' 10' ' ' ALA . 14.6 t -58.95 -40.24 79.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.306 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.439 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.4 mp -58.49 -39.7 80.74 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -60.63 -39.78 89.54 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' F' ' 63' ' ' ALA . . . -57.6 -41.8 81.97 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.973 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -40.01 78.54 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.324 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 22.1 p -60.78 -42.25 97.16 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.044 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.57 -40.35 87.05 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -41.77 97.55 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.532 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.41 98.74 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.441 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -61.42 -41.81 97.75 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 120.837 0.351 . . . . 0.0 110.904 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -52.69 106.67 0.17 Allowed 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.5 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.91 160.36 32.37 Favored Glycine 0 C--N 1.307 -1.063 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.605 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -79.79 -57.79 3.49 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.33 -0.435 . . . . 0.0 111.603 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 22.3 p90 -58.94 -41.08 86.56 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.289 -178.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . 0.554 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 63.7 t-105 -60.0 -40.64 89.9 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.82 97.62 Favored Glycine 0 C--N 1.303 -1.291 0 C-N-CA 121.313 -0.47 . . . . 0.0 112.24 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -59.71 -38.77 82.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 37.2 tp -59.28 -42.79 92.08 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 91.5 t -63.98 -45.62 96.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.912 -0.715 . . . . 0.0 112.81 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 5.4 t -65.88 -44.0 92.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 CA-C-O 121.029 0.443 . . . . 0.0 112.001 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 84.7 m -63.09 -43.94 97.1 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.047 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.413 ' O ' HG13 ' C' ' 32' ' ' VAL . 47.8 tp -63.41 -42.01 98.75 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.793 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.642 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.01 -47.15 86.08 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 114.362 1.245 . . . . 0.0 114.362 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.615 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.7 OUTLIER -66.54 -36.5 82.82 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.455 -179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -57.29 -39.18 75.2 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.642 HG22 ' O ' ' C' ' 29' ' ' ALA . 2.7 m -53.32 -11.59 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.346 -178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -42.05 -57.58 2.41 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 120.52 -0.472 . . . . 0.0 110.681 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.87 -38.83 93.08 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.674 -0.57 . . . . 0.0 111.674 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.84 -37.1 78.29 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.988 0.423 . . . . 0.0 110.643 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.588 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.7 OUTLIER -61.79 -43.09 99.54 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -176.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.426 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.76 -46.21 88.17 Favored Pre-proline 0 N--CA 1.485 1.305 0 CA-C-N 119.284 0.947 . . . . 0.0 113.374 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.01 -36.05 97.4 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 122.685 2.256 . . . . 0.0 111.191 176.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.7 -36.89 92.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 114.568 -1.196 . . . . 0.0 111.372 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -55.47 -39.49 70.45 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.452 ' C ' ' O ' ' C' ' 40' ' ' ALA . 19.4 p -32.8 105.67 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.93 0.395 . . . . 0.0 111.297 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.596 ' HH ' ' HE1' ' D' ' 30' ' ' TRP . 55.9 m-85 -97.37 75.13 2.52 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.995 -179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' C' ' 45' ' ' LEU . 11.3 mt -81.13 -162.71 0.52 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.066 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 22.6 t -48.66 88.44 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.017 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . 0.504 ' N ' ' O ' ' C' ' 43' ' ' LEU . 30.9 mt -137.56 26.16 2.84 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.024 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -68.83 1.42 Allowed Glycine 0 C--N 1.303 -1.29 0 C-N-CA 121.255 -0.498 . . . . 0.0 111.875 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . 0.476 HG12 ' O ' ' C' ' 47' ' ' VAL . 91.2 t -134.07 -12.35 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.482 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 2.9 t-105 -51.59 -46.01 91.0 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.419 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 73.0 Cg_endo -79.02 -44.28 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.432 1.421 . . . . 0.0 112.454 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -55.15 -36.3 65.65 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -176.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 13.4 mt -57.01 -43.7 82.06 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 118.594 -1.242 . . . . 0.0 109.794 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.02 -41.32 96.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.48 HG11 ' CE2' ' E' ' 19' ' ' PHE . 45.6 t -58.58 -31.0 42.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.093 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.86 -39.53 65.75 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.527 HD22 ' N ' ' C' ' 55' ' ' LEU . 3.7 mm? -58.85 -43.86 90.87 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 11.5 tp -66.77 -33.06 74.78 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.559 1.144 . . . . 0.0 113.077 177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.488 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 44.6 ttt85 -55.33 -43.14 98.96 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -174.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.7 Cg_endo -57.83 -38.67 91.81 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 121.741 1.657 . . . . 0.0 111.227 178.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 68.19 -66.19 0.23 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.373 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 59.4 110.44 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.302 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.95 -4.04 58.86 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.581 0.229 . . . . 0.0 111.008 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 49.1 tp -65.57 -41.64 92.69 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.747 0.308 . . . . 0.0 110.285 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.5 -179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.54 18.75 0.06 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.794 0.33 . . . . 0.0 110.563 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.55 ' NZ ' ' H ' ' E' ' 2' ' ' ALA . 8.3 ttmt -152.68 64.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.194 0.521 . . . . 0.0 110.315 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.483 ' N ' ' OD1' ' D' ' 4' ' ' ASN . 2.1 p30 -143.73 -30.87 0.48 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.507 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.5 OUTLIER -77.36 -55.3 10.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.204 179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.453 HG22 ' CG1' ' E' ' 5' ' ' VAL . 31.2 mt -58.87 -36.49 61.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 51.6 t -59.55 -41.39 84.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.168 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.717 HD13 ' HB1' ' F' ' 63' ' ' ALA . 8.0 mt -59.65 -39.97 86.15 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.436 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -60.98 -42.06 97.64 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.231 0.539 . . . . 0.0 109.67 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.25 -40.61 82.22 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.638 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.49 79.91 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 120.646 -0.422 . . . . 0.0 110.384 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 46.8 t -60.36 -41.63 94.1 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.56 -38.53 78.03 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.04 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.45 94.59 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.51 -42.02 97.45 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.281 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -61.18 -41.81 97.46 Favored 'General case' 0 C--N 1.308 -1.228 0 O-C-N 122.562 -0.375 . . . . 0.0 110.647 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 19.3 m-70 -59.03 114.94 2.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.387 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.39 168.66 41.78 Favored Glycine 0 C--N 1.306 -1.098 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.649 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -78.07 -55.45 5.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.444 -0.378 . . . . 0.0 111.61 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -59.13 -40.29 84.99 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.575 0.226 . . . . 0.0 110.967 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 67.4 t-105 -59.03 -40.36 84.79 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.465 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.96 -38.67 94.53 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 111.359 -0.697 . . . . 0.0 111.359 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 66.1 mt -58.72 -38.31 78.08 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.02 -42.44 90.18 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 120.543 -0.463 . . . . 0.0 111.828 -178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.414 ' H ' HG23 ' D' ' 25' ' ' VAL . 4.6 t -63.8 -45.43 97.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 C-N-CA 119.357 -0.937 . . . . 0.0 112.098 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 23.3 t -66.68 -45.43 88.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -64.8 -43.07 94.36 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 20.3 mt -61.35 -42.75 99.21 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.009 -0.676 . . . . 0.0 110.527 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.3 -43.11 99.57 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.4 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.596 ' HE1' ' HH ' ' C' ' 42' ' ' TYR . 1.0 OUTLIER -65.03 -41.7 95.03 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.48 ' CE1' HH12 ' D' ' 35' ' ' ARG . 23.6 t-160 -61.41 -42.3 98.53 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' D' ' 29' ' ' ALA . 19.6 m -62.82 -7.08 2.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.346 -177.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -45.45 -60.56 2.09 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.27 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.55 -38.16 90.52 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.48 HH12 ' CE1' ' D' ' 31' ' ' HIS . 69.5 mtt85 -60.45 -36.52 78.44 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.861 0.362 . . . . 0.0 111.116 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.672 ' HG ' HG22 ' E' ' 27' ' ' THR . 0.9 OUTLIER -59.49 -42.27 91.75 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -177.019 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.481 ' H ' HG23 ' D' ' 37' ' ' VAL . 1.5 t -62.61 -46.56 88.97 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.8 Cg_endo -61.95 -34.62 80.7 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.528 2.152 . . . . 0.0 111.716 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.94 -38.93 94.88 Favored Glycine 0 C--N 1.3 -1.425 0 CA-C-N 114.898 -1.047 . . . . 0.0 110.755 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.28 -40.76 82.75 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.9 p -84.14 113.84 21.35 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.268 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.543 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 24.7 p90 -175.3 113.25 0.13 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.885 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tp -101.64 -179.35 3.99 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.123 0.487 . . . . 0.0 109.855 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m 51.45 75.26 0.21 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.07 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 tp -165.84 44.21 0.07 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.168 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -92.27 -33.17 7.8 Favored Glycine 0 CA--C 1.537 1.457 0 CA-C-O 119.592 -0.56 . . . . 0.0 113.91 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.54 -26.43 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 CA-C-N 118.201 1.0 . . . . 0.0 112.368 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.723 ' HE1' HD22 ' E' ' 36' ' ' LEU . 61.5 t-105 -61.56 -36.43 31.6 Favored Pre-proline 0 C--N 1.302 -1.49 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 85.1 Cg_endo -87.47 -58.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 121.505 1.47 . . . . 0.0 112.283 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 13.7 mt -54.92 -38.06 67.17 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.24 -44.9 92.33 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.656 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.8 -41.6 95.95 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 86.3 t -59.12 -32.67 48.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.146 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -54.79 -40.63 69.66 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.881 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.457 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 5.9 tp -59.86 -43.85 94.44 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.943 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.401 ' O ' ' CD2' ' D' ' 59' ' ' HIS . 50.3 tp -67.23 -31.19 71.38 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 125.568 1.547 . . . . 0.0 114.926 178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.409 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 15.3 ttm180 -54.69 -39.22 74.44 Favored Pre-proline 0 C--N 1.306 -1.325 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -172.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.6 Cg_exo -60.73 -39.75 60.57 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.075 1.85 . . . . 0.0 111.57 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' D' ' 56' ' ' LEU . 51.7 m-70 51.54 53.34 12.95 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.157 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.497 ' C ' ' H ' ' D' ' 62' ' ' LEU . 5.8 ptp85 -51.06 -23.93 3.48 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.927 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . 58.36 2.01 0.19 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.891 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.497 ' H ' ' C ' ' D' ' 60' ' ' ARG . 50.4 tp -79.46 -38.1 35.36 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.946 0.403 . . . . 0.0 109.993 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.416 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.233 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.144 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.55 ' H ' ' NZ ' ' D' ' 3' ' ' LYS . . . 47.26 89.76 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 120.733 0.301 . . . . 0.0 110.599 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -154.72 -56.71 0.1 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.279 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.449 ' O ' HD13 ' E' ' 8' ' ' LEU . 59.6 m-80 -43.14 -29.74 0.4 Allowed 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.107 0.479 . . . . 0.0 110.131 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' D' ' 6' ' ' ILE . 1.1 t -70.82 -52.61 26.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 59.3 mt -60.13 -35.36 61.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.515 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 72.9 t -57.59 -40.8 77.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.74 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.449 HD13 ' O ' ' E' ' 4' ' ' ASN . 7.1 mp -59.89 -40.11 87.62 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.666 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -60.96 -42.37 98.13 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.171 0.51 . . . . 0.0 109.886 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.16 -37.93 72.82 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.829 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.79 75.58 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.126 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 54.6 p -59.74 -40.83 89.4 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.84 -37.48 73.94 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.304 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.98 86.2 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.96 -41.31 96.25 Favored Glycine 0 C--N 1.306 -1.091 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' E' ' 18' ' ' GLY . 98.1 m-20 -60.4 -40.69 91.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.798 0.332 . . . . 0.0 110.346 179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -48.65 86.95 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.679 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.83 107.7 0.32 Allowed Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.48 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.3 OUTLIER -38.77 -38.35 0.41 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 120.602 0.239 . . . . 0.0 111.192 -179.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -60.42 -42.76 96.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.112 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.452 ' N ' ' O ' ' E' ' 18' ' ' GLY . 60.2 t-105 -59.5 -41.23 89.38 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.454 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.56 -39.96 97.17 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.648 ' O ' HG23 ' E' ' 27' ' ' THR . 7.1 mp -60.62 -39.31 87.74 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 111.603 0.223 . . . . 0.0 111.603 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.08 -44.34 91.87 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 44.8 t -61.56 -43.22 96.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.653 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 67.7 t -63.59 -42.75 97.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' D' ' 36' ' ' LEU . 45.7 p -63.07 -44.13 96.65 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 20.2 mt -62.09 -43.34 99.04 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.674 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.433 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.86 -43.68 98.15 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 120.336 -0.546 . . . . 0.0 112.041 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -64.65 -41.25 96.25 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -60.91 -42.0 97.22 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -177.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.433 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.1 m -66.13 -12.44 14.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -45.7 -61.23 1.8 Allowed 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.191 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.419 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.63 -36.91 87.87 Favored Glycine 0 C--N 1.301 -1.367 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 13.4 tpp180 -59.13 -37.51 77.4 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.92 0.391 . . . . 0.0 110.788 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.723 HD22 ' HE1' ' D' ' 48' ' ' TRP . 0.7 OUTLIER -62.13 -43.4 98.92 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -177.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.17 -46.14 85.86 Favored Pre-proline 0 N--CA 1.486 1.344 0 N-CA-C 113.588 0.958 . . . . 0.0 113.588 -175.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.37 -35.94 95.37 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.948 2.432 . . . . 0.0 111.52 177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.2 -39.58 97.37 Favored Glycine 0 C--N 1.3 -1.462 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.003 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CD2' ' E' ' 42' ' ' TYR . . . -57.11 -40.78 77.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 38.3 p -46.28 118.23 1.86 Allowed 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 120.284 -0.566 . . . . 0.0 110.571 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.52 ' OH ' ' NE1' ' F' ' 30' ' ' TRP . 28.4 m-85 -121.75 64.64 0.91 Allowed 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.331 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.533 ' CD2' ' H ' ' E' ' 43' ' ' LEU . 0.7 OUTLIER -74.88 16.87 0.25 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . 0.491 ' H ' ' C ' ' E' ' 42' ' ' TYR . 1.8 m 168.89 -166.06 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.848 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt 72.22 44.58 0.43 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.65 0.594 . . . . 0.0 110.264 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.55 -57.41 8.18 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 113.256 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.25 -16.55 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 CA-C-N 117.254 0.527 . . . . 0.0 112.333 -177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.41 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 3.0 t-105 -50.64 -44.7 84.78 Favored Pre-proline 0 C--N 1.305 -1.353 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.548 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 79.1 Cg_endo -79.85 -47.53 0.08 OUTLIER 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 120.895 1.063 . . . . 0.0 112.356 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 21.6 mt -57.2 -37.55 72.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 11.3 tp -58.65 -45.25 89.74 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 118.343 -1.343 . . . . 0.0 109.444 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 9.6 mp -60.2 -39.2 85.73 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.485 HG11 ' CE2' ' A' ' 19' ' ' PHE . 90.9 t -58.52 -30.71 41.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.376 179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -54.13 -38.63 65.65 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.25 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' E' ' 58' ' ' PRO . 31.1 tp -55.43 -40.2 71.23 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.786 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.516 ' O ' HD13 ' E' ' 56' ' ' LEU . 0.2 OUTLIER -65.88 -30.7 71.34 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 124.764 1.226 . . . . 0.0 113.214 178.002 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -55.01 -41.65 91.74 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 116.471 2.026 . . . . 0.0 116.471 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' E' ' 55' ' ' LEU . 24.5 Cg_exo -62.57 -41.52 31.62 Favored 'Trans proline' 0 N--CA 1.501 1.937 0 CA-C-N 121.823 1.687 . . . . 0.0 112.118 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.48 ' ND1' ' C ' ' E' ' 59' ' ' HIS . 0.0 OUTLIER -56.17 143.83 31.88 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.686 -179.023 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -179.66 97.01 0.03 OUTLIER 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.611 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . 41.75 46.68 3.36 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.01 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 2.0 pp -89.78 -15.82 31.57 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.236 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.883 -179.775 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . 0.465 ' N ' ' OD1' ' F' ' 4' ' ' ASN . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.85 30.75 0.25 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.699 0.285 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 1' ' ' GLY . 23.2 mtpt -150.67 -39.52 0.13 Allowed 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.906 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.465 ' OD1' ' N ' ' F' ' 1' ' ' GLY . 18.1 m120 -40.26 -33.24 0.23 Allowed 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.859 0.361 . . . . 0.0 110.735 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -67.98 -56.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.431 HG22 ' CG1' ' A' ' 5' ' ' VAL . 46.3 mt -58.83 -34.87 53.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.854 179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 72.6 t -58.48 -41.42 81.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.776 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 5.3 mp -58.66 -40.02 82.3 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 50.7 t30 -61.4 -40.27 93.78 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.286 0.565 . . . . 0.0 109.805 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.592 ' HB2' HG12 ' A' ' 5' ' ' VAL . . . -56.73 -41.28 77.21 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.655 -178.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -40.43 80.81 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 120.28 -0.568 . . . . 0.0 109.911 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 21.0 p -62.19 -43.65 98.35 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.621 178.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.03 87.48 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.64 -179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.09 99.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.48 -42.81 97.78 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.937 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 38.2 t-20 -61.91 -42.3 98.92 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.38 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -68.3 123.53 21.0 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -178.75 177.54 48.48 Favored Glycine 0 C--N 1.305 -1.18 0 C-N-CA 120.671 -0.776 . . . . 0.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.468 ' CE1' HD11 ' F' ' 23' ' ' LEU . 21.0 t80 -79.18 -57.12 3.88 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.304 -0.448 . . . . 0.0 111.935 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -59.59 -40.77 88.51 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.9 t90 -59.52 -40.33 86.78 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.578 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.67 -39.62 95.42 Favored Glycine 0 C--N 1.304 -1.24 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.66 ' O ' HG23 ' F' ' 27' ' ' THR . 35.9 mt -60.51 -37.74 82.11 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.67 -44.8 90.28 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . 0.41 ' H ' HG22 ' F' ' 25' ' ' VAL . 5.1 m -63.23 -42.68 97.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.471 -178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 47.1 t -63.32 -42.79 97.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.672 HG22 ' HG ' ' E' ' 36' ' ' LEU . 41.9 p -62.8 -43.72 98.07 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 7.7 mp -61.48 -42.49 98.86 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.915 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.508 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.99 -42.87 99.96 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.084 -0.646 . . . . 0.0 111.464 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.52 ' NE1' ' OH ' ' E' ' 42' ' ' TYR . 0.1 OUTLIER -65.33 -41.92 93.48 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 112.211 0.449 . . . . 0.0 112.211 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -60.44 -41.33 93.83 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 113.008 0.744 . . . . 0.0 113.008 -177.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.508 HG22 ' O ' ' F' ' 29' ' ' ALA . 25.9 m -65.14 -6.07 3.01 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.441 -177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' F' ' 33' ' ' LYS . 6.7 mtmp? -48.69 -60.6 2.59 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.57 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.91 -37.37 84.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 57.5 ttt180 -59.24 -36.35 75.31 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.424 0.63 . . . . 0.0 110.314 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.41 -41.15 93.3 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -177.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.474 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.0 OUTLIER -61.44 -46.67 94.57 Favored Pre-proline 0 C--N 1.307 -1.256 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -176.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.7 Cg_endo -62.57 -34.22 75.67 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.104 1.869 . . . . 0.0 110.948 177.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.93 -39.37 95.47 Favored Glycine 0 C--N 1.302 -1.346 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.451 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . 0.461 ' O ' ' CD1' ' F' ' 42' ' ' TYR . . . -58.68 -39.75 81.61 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.656 -0.272 . . . . 0.0 111.509 -178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 27.2 p -77.27 118.59 19.92 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 120.892 0.377 . . . . 0.0 111.637 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.616 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 52.4 p90 -169.44 -51.1 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.699 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.616 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 9.5 mp 55.93 77.09 0.25 Allowed 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.811 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 2.7 m 172.2 -173.21 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.752 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 17.2 mt 62.95 43.79 6.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.93 -44.09 2.31 Favored Glycine 0 C--N 1.308 -1.024 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.451 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -144.19 76.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.667 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 2.8 t-105 -170.15 -40.91 0.0 OUTLIER Pre-proline 0 C--N 1.312 -1.063 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.667 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.0 OUTLIER -80.09 -30.97 1.94 Allowed 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 121.993 1.795 . . . . 0.0 111.008 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 27.2 mt -55.59 -35.66 66.03 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.974 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.625 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -56.61 -44.18 80.91 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.293 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.82 -42.62 98.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 22.7 t -60.17 -29.84 44.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.64 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.401 ' O ' ' CD ' ' F' ' 58' ' ' PRO . 49.5 ttp180 -53.43 -40.88 65.53 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.869 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 38.1 mt -60.66 -45.96 92.14 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.782 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 20.1 mt -67.78 -34.06 76.04 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 124.641 1.176 . . . . 0.0 114.121 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.477 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 19.0 ttp180 -56.18 -44.23 99.62 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -173.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.3 Cg_endo -60.65 -40.87 51.76 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 CA-C-N 121.572 1.597 . . . . 0.0 111.271 178.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 67.08 82.52 0.18 Allowed 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.436 0.636 . . . . 0.0 110.126 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -53.26 -68.62 0.16 Allowed 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.535 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' F' ' 63' ' ' ALA . . . 63.68 16.24 9.56 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.449 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.736 HD22 ' C ' ' F' ' 62' ' ' LEU . 0.0 OUTLIER -51.63 -10.98 0.12 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.122 179.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.717 ' HB1' HD13 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 117.975 -1.012 . . . . 0.0 110.231 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . 60.33 142.27 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.918 0.389 . . . . 0.0 110.587 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp 50.28 52.49 14.67 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.212 0.529 . . . . 0.0 110.519 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' N ' ' OD1' ' A' ' 4' ' ' ASN . 6.8 p-10 -147.2 -40.96 0.18 Allowed 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.413 -0.812 . . . . 0.0 109.036 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.6 t -67.78 -55.27 17.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 65.6 mt -57.89 -35.43 51.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.56 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.18 -41.06 82.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.028 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.3 mp -59.31 -40.85 87.52 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.099 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -61.25 -41.88 97.67 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.2 0.524 . . . . 0.0 110.066 179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.26 -41.11 83.53 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.303 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.46 81.38 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.848 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.3 p -60.59 -42.59 97.06 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.97 -39.14 80.83 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.741 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.72 96.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -42.73 97.39 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.54 -41.13 96.89 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.971 0.415 . . . . 0.0 110.318 178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -51.28 101.75 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.85 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.61 121.32 0.85 Allowed Glycine 0 C--N 1.304 -1.24 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -38.61 -35.16 0.17 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.955 0.407 . . . . 0.0 110.975 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -60.75 -42.97 98.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.301 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.466 ' N ' ' O ' ' A' ' 18' ' ' GLY . 8.2 t90 -62.15 -40.02 94.58 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.426 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -58.4 -38.77 91.59 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.583 ' O ' HG23 ' A' ' 27' ' ' THR . 2.6 mt -60.1 -38.38 82.78 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -60.57 -48.11 83.22 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -177.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.5 p -65.02 -44.49 95.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.625 -0.83 . . . . 0.0 113.096 -177.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -64.45 -42.33 94.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-O 121.106 0.479 . . . . 0.0 111.445 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 23' ' ' LEU . 33.5 p -62.39 -43.78 98.01 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.989 -178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.538 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -62.17 -43.59 98.49 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.522 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.551 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.67 -43.53 98.57 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.248 -0.581 . . . . 0.0 112.034 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.504 ' CH2' HD12 ' E' ' 52' ' ' LEU . 0.1 OUTLIER -65.69 -40.57 92.48 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -60.45 -41.6 94.44 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.1 m -63.26 -9.0 4.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 120.365 -0.534 . . . . 0.0 112.366 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.581 ' HB2' ' HZ2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -46.47 -58.46 3.74 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.307 179.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.54 86.87 Favored Glycine 0 C--N 1.302 -1.349 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -59.89 -36.63 77.34 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.219 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.616 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -59.72 -42.48 93.16 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.2 t -62.3 -46.74 90.54 Favored Pre-proline 0 C--N 1.305 -1.348 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 -176.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 33.8 Cg_endo -62.69 -35.01 71.82 Favored 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.491 2.127 . . . . 0.0 111.72 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.22 -39.69 96.32 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.27 85.78 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.154 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 p -95.28 109.44 21.57 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 120.767 0.317 . . . . 0.0 111.314 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.515 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 2.7 p90 -139.28 -122.19 0.12 Allowed 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.415 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 25.4 mt -119.8 -179.98 4.07 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.3 p -106.02 81.52 1.65 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.174 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 45' ' ' LEU . 7.7 mp -71.78 -80.25 0.06 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.68 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.59 -58.44 0.39 Allowed Glycine 0 C--N 1.309 -0.97 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.115 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.7 m -148.52 -6.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.533 ' O ' ' CE3' ' A' ' 48' ' ' TRP . 4.6 t-105 -55.29 -45.07 99.92 Favored Pre-proline 0 C--N 1.303 -1.432 0 C-N-CA 119.573 -0.851 . . . . 0.0 112.188 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 59.2 Cg_endo -74.97 -41.17 0.71 Allowed 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.327 1.351 . . . . 0.0 111.98 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.967 ' O ' HG22 ' A' ' 53' ' ' VAL . 36.3 mt -54.37 -34.38 61.07 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.188 -177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 33.7 mt -54.82 -40.39 69.5 Favored 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.846 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 10.2 mt -57.06 -39.11 74.27 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.26 -0.576 . . . . 0.0 110.15 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.967 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.1 m -58.58 -28.93 37.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-O 120.873 0.368 . . . . 0.0 110.947 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -54.05 -40.72 67.38 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.45 -177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.0 tp -59.29 -44.56 92.5 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.058 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 56' ' ' LEU . 10.9 mp -68.04 -32.48 72.87 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.352 1.061 . . . . 0.0 112.992 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 43.6 ttt85 -54.9 -44.21 99.33 Favored Pre-proline 0 C--N 1.305 -1.369 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 -173.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 59' ' ' HIS . 23.6 Cg_endo -60.79 -42.06 41.28 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 CA-C-N 121.917 1.72 . . . . 0.0 110.719 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.474 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.4 OUTLIER 48.97 174.43 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.386 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -165.07 -32.4 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.832 0.349 . . . . 0.0 110.772 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . 54.46 66.85 1.12 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.34 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.6 tp -158.52 33.23 0.23 Allowed 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.926 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.368 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.578 -179.829 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.05 -50.09 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.818 0.342 . . . . 0.0 110.576 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -83.71 -172.51 4.19 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.503 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.555 ' N ' ' ND2' ' B' ' 4' ' ' ASN . 0.4 OUTLIER 73.93 0.55 3.65 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.625 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -111.2 -70.63 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 48.9 mt -58.18 -33.11 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.675 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.46 ' H ' HG23 ' B' ' 7' ' ' VAL . 2.8 t -57.39 -40.73 76.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.04 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 8' ' ' LEU . 7.3 mp -58.84 -40.38 84.05 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.744 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 21.7 t30 -61.25 -39.08 89.02 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 121.264 0.554 . . . . 0.0 109.817 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -42.25 78.84 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.711 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.99 -39.34 77.98 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.636 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 44.5 t -61.06 -42.86 99.29 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.051 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.92 -40.63 85.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.428 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.526 ' O ' ' CE1' ' B' ' 17' ' ' HIS . . . -61.75 -40.14 94.07 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.15 -41.05 94.5 Favored Glycine 0 C--N 1.304 -1.221 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.753 -178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 70.5 m-20 -60.05 -41.5 92.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.465 0.632 . . . . 0.0 110.571 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.526 ' CE1' ' O ' ' B' ' 14' ' ' ALA . 39.0 m80 52.02 -179.72 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -125.09 -8.23 5.64 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.912 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.585 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 11.6 t80 -72.01 -96.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.888 0.375 . . . . 0.0 110.956 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.585 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -59.74 -42.26 92.77 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.3 -178.905 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.438 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 80.2 t90 -60.8 -39.94 90.81 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.275 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.37 -39.69 96.53 Favored Glycine 0 C--N 1.306 -1.096 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mt -60.6 -38.95 86.36 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 120.558 0.218 . . . . 0.0 110.96 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 32' ' ' VAL . 34.0 tp -60.07 -44.81 94.47 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 m -63.96 -43.17 97.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.773 -0.771 . . . . 0.0 112.093 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 88.9 t -63.34 -42.31 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.951 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 18.6 m -61.59 -42.58 99.07 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.046 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 16.4 mt -60.65 -42.7 97.53 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.189 -0.604 . . . . 0.0 110.087 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.407 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.14 -42.77 99.52 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.521 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -66.06 -41.05 91.3 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 52.0 t60 -60.45 -42.03 95.3 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -177.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.407 HG22 ' O ' ' B' ' 29' ' ' ALA . 14.1 m -63.88 -4.06 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 C-N-CA 120.157 -0.617 . . . . 0.0 112.034 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -49.05 -65.58 0.54 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 120.057 -0.657 . . . . 0.0 109.248 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.06 -37.25 85.07 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -60.22 -37.12 79.33 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.297 0.57 . . . . 0.0 110.52 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 7.3 tt -59.65 -42.57 93.1 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.467 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.5 t -63.12 -46.68 86.39 Favored Pre-proline 0 C--N 1.307 -1.277 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 -176.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 34.9 Cg_endo -62.95 -35.58 65.53 Favored 'Trans proline' 0 N--CA 1.503 2.058 0 C-N-CA 122.461 2.107 . . . . 0.0 111.768 178.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.0 97.47 Favored Glycine 0 C--N 1.3 -1.433 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.78 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.41 ' O ' ' CD2' ' B' ' 42' ' ' TYR . . . -58.79 -41.73 87.38 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.67 -0.265 . . . . 0.0 111.331 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 70.5 p -77.51 43.78 0.41 Allowed 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.066 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.61 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 51.6 p90 -70.39 -41.31 73.2 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.772 0.32 . . . . 0.0 111.135 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.552 ' N ' ' CD1' ' B' ' 42' ' ' TYR . 26.3 mt 61.69 151.13 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.931 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 4.2 t 66.58 -173.29 0.19 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.043 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 63.13 45.98 4.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.2 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.42 -43.25 3.0 Favored Glycine 0 C--N 1.308 -1.005 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -147.89 76.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.554 ' H ' ' HD2' ' B' ' 49' ' ' PRO . 2.1 t-105 -165.63 -50.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 CA-C-O 119.353 -0.356 . . . . 0.0 110.422 178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.554 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 37.3 Cg_endo -75.5 -23.27 13.16 Favored 'Trans proline' 0 N--CA 1.488 1.153 0 CA-C-N 120.162 1.093 . . . . 0.0 111.232 -179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -56.27 -35.36 67.37 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.32 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.639 ' N ' HD12 ' B' ' 51' ' ' LEU . 8.1 mp -56.53 -43.31 79.71 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 118.939 -1.104 . . . . 0.0 109.037 -178.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.67 -42.05 96.3 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.3 -30.48 46.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.571 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -53.96 -40.03 66.48 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.016 -178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 tp -58.84 -44.28 90.9 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.856 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 4.8 tp -67.54 -33.18 74.54 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 124.484 1.113 . . . . 0.0 113.178 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 36.5 ttp180 -55.34 -43.8 99.3 Favored Pre-proline 0 C--N 1.306 -1.324 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.81 -40.04 67.13 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 CA-C-N 121.881 1.707 . . . . 0.0 111.278 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.429 ' O ' ' O ' ' B' ' 58' ' ' PRO . 14.2 t-80 53.33 169.5 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.369 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 ptt85 -175.52 -168.82 0.33 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.452 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.13 17.69 0.56 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.615 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.414 ' O ' ' OXT' ' B' ' 63' ' ' ALA . 17.0 mt -83.53 2.24 38.02 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.425 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.414 ' OXT' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.671 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.359 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.449 ' O ' ' CG2' ' C' ' 5' ' ' VAL . . . -74.75 -99.73 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.656 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' C' ' 5' ' ' VAL . 31.5 mmtm -77.65 -0.16 25.56 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.008 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -73.92 43.76 0.16 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.27 0.557 . . . . 0.0 109.879 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.526 HG23 HD12 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -141.49 -72.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.677 ' H ' HD12 ' C' ' 6' ' ' ILE . 1.1 mp -59.68 -37.14 69.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.066 0.46 . . . . 0.0 110.273 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.443 HG12 ' O ' ' C' ' 3' ' ' LYS . 5.5 p -60.58 -40.45 84.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.485 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.406 ' N ' HG13 ' C' ' 7' ' ' VAL . 12.5 mt -59.63 -40.38 87.44 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.277 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -60.73 -40.34 92.01 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.511 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -57.4 -40.97 79.4 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.448 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.92 86.63 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 24.8 p -61.45 -43.02 99.6 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.383 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.92 -39.81 86.7 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.359 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . 0.409 ' HB2' ' HB2' ' F' ' 63' ' ' ALA . . . -61.76 -42.08 98.53 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -61.09 -42.28 99.74 Favored Glycine 0 C--N 1.306 -1.091 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.372 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' C' ' 18' ' ' GLY . 25.4 t30 -60.97 -41.54 96.57 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.876 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . 0.438 ' O ' ' ND1' ' C' ' 17' ' ' HIS . 64.4 t-80 -60.14 70.44 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.877 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' C' ' 16' ' ' ASN . . . -112.14 163.19 12.21 Favored Glycine 0 C--N 1.311 -0.846 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.67 -68.06 0.72 Allowed 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 120.876 0.37 . . . . 0.0 110.985 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -59.45 -41.07 88.79 Favored 'General case' 0 C--N 1.309 -1.196 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.24 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 70.8 t-105 -60.21 -40.75 91.24 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 120.633 0.254 . . . . 0.0 111.524 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.41 -39.62 97.53 Favored Glycine 0 C--N 1.304 -1.239 0 N-CA-C 111.874 -0.49 . . . . 0.0 111.874 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.429 ' O ' HG23 ' C' ' 27' ' ' THR . 12.4 mt -60.74 -38.86 86.57 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tt -60.17 -43.54 95.73 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 -177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.433 ' H ' HG22 ' C' ' 25' ' ' VAL . 4.4 m -63.31 -44.91 99.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 119.525 -0.87 . . . . 0.0 112.849 -177.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.44 -43.99 94.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 C-N-CA 120.327 -0.549 . . . . 0.0 112.053 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.429 HG23 ' O ' ' C' ' 23' ' ' LEU . 74.1 p -63.54 -44.46 94.14 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.414 -177.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.574 ' O ' HD23 ' C' ' 28' ' ' LEU . 0.9 OUTLIER -63.14 -42.57 99.5 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.317 -178.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.794 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.76 -46.31 88.64 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.511 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -65.75 -37.71 87.1 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.156 -179.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.515 ' O ' ' N ' ' C' ' 33' ' ' LYS . 7.9 m-70 -57.07 -40.48 76.96 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.794 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.2 m -47.71 -11.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 C-N-CA 120.385 -0.526 . . . . 0.0 111.488 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.61 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 9.8 mtmt -41.03 -62.53 0.81 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-O 120.933 0.397 . . . . 0.0 110.221 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.25 -37.88 83.18 Favored Glycine 0 C--N 1.3 -1.431 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -59.4 -36.79 76.48 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.056 0.455 . . . . 0.0 110.477 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.602 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.8 OUTLIER -61.31 -43.96 98.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.455 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.83 -46.29 87.83 Favored Pre-proline 0 N--CA 1.483 1.215 0 CA-C-N 119.337 0.971 . . . . 0.0 113.612 -175.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.29 -36.3 95.06 Favored 'Trans proline' 0 N--CA 1.501 1.939 0 C-N-CA 122.543 2.162 . . . . 0.0 111.468 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.94 -37.73 94.28 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.491 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.441 ' O ' ' CD2' ' C' ' 42' ' ' TYR . . . -56.11 -41.97 76.09 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.698 -177.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.413 ' C ' ' O ' ' C' ' 40' ' ' ALA . 21.4 p -37.87 112.83 0.23 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.913 0.387 . . . . 0.0 111.308 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.53 ' OH ' ' NE1' ' D' ' 30' ' ' TRP . 22.6 m-85 -111.15 85.2 2.07 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.365 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.529 ' N ' HD12 ' C' ' 43' ' ' LEU . 9.8 mp -45.7 -99.79 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.643 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 33.2 t -116.93 11.7 14.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.47 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 15.8 mt -81.05 41.61 0.6 Allowed 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.24 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.02 -69.0 1.34 Allowed Glycine 0 C--N 1.3 -1.455 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.087 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -126.68 -12.95 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.454 ' CD1' ' C ' ' C' ' 48' ' ' TRP . 0.9 OUTLIER -49.86 -44.99 80.01 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.798 -179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.43 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 51.2 Cg_exo -54.1 -38.94 87.51 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.508 1.472 . . . . 0.0 112.401 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 87.7 mt -55.84 -37.02 68.17 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 113.599 0.962 . . . . 0.0 113.599 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.554 HD12 ' N ' ' C' ' 51' ' ' LEU . 10.3 mp -57.12 -43.03 81.95 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.409 -1.317 . . . . 0.0 109.322 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' C' ' 52' ' ' LEU . 3.4 mm? -60.71 -41.8 95.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.02 -32.92 51.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.987 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 ttp85 -54.88 -39.75 69.04 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 27.7 mt -58.35 -43.74 88.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.294 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 13.9 mt -67.7 -33.63 75.29 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 124.317 1.047 . . . . 0.0 112.927 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.457 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.2 ttt180 -55.18 -43.89 99.33 Favored Pre-proline 0 C--N 1.305 -1.351 0 N-CA-C 115.757 1.762 . . . . 0.0 115.757 -173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 23.6 Cg_endo -60.08 -40.16 63.41 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.902 1.715 . . . . 0.0 111.567 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 9.9 t-80 45.59 -175.51 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.882 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.6 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 33.5 ptt-85 -176.01 -166.4 0.18 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.432 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.39 12.17 0.46 Allowed 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.517 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 22.2 mt -73.99 -39.74 63.45 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.381 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.274 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.753 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.345 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.65 -76.08 0.12 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 120.652 0.263 . . . . 0.0 110.78 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.5 ' C ' ' H ' ' D' ' 5' ' ' VAL . 28.6 mmtm -93.55 -6.77 45.94 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.725 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -77.14 39.18 0.23 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.49 0.662 . . . . 0.0 109.703 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' C' ' 10' ' ' ALA . 0.0 OUTLIER -145.61 -67.87 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.43 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.483 HG22 ' CG1' ' E' ' 5' ' ' VAL . 26.3 mt -57.55 -36.93 55.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.447 HG13 ' N ' ' D' ' 8' ' ' LEU . 8.9 p -60.58 -40.93 86.08 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.393 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.447 ' N ' HG13 ' D' ' 7' ' ' VAL . 7.1 mt -59.27 -40.5 86.23 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -60.86 -41.53 96.06 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.156 0.503 . . . . 0.0 110.098 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.424 ' HB1' HD22 ' E' ' 8' ' ' LEU . . . -58.65 -41.78 86.84 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.23 86.32 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.053 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 59.6 p -60.83 -42.85 98.57 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 120.311 -0.555 . . . . 0.0 109.997 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -39.3 82.37 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.659 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.17 -41.23 96.4 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.56 -42.34 97.68 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -61.48 -41.26 97.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.851 0.357 . . . . 0.0 110.623 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 50.6 t60 -50.57 105.92 0.11 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.836 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -177.82 121.24 0.76 Allowed Glycine 0 C--N 1.306 -1.132 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.442 ' C ' ' CD1' ' D' ' 19' ' ' PHE . 0.0 OUTLIER -37.4 -36.56 0.16 Allowed 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 122.292 0.237 . . . . 0.0 111.005 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -59.77 -42.35 93.12 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.839 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.48 ' N ' ' O ' ' D' ' 18' ' ' GLY . 26.9 t90 -60.64 -40.52 92.26 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.073 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.5 -40.67 98.04 Favored Glycine 0 C--N 1.306 -1.086 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.415 HD11 ' CE2' ' D' ' 19' ' ' PHE . 8.8 mp -62.21 -40.35 95.79 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.48 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 42.1 tp -61.4 -47.15 87.11 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.449 HG13 ' N ' ' D' ' 26' ' ' VAL . 4.6 p -64.53 -45.17 96.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.32 -0.952 . . . . 0.0 112.318 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . 0.449 ' N ' HG13 ' D' ' 25' ' ' VAL . 82.5 t -65.02 -44.19 95.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.433 HG21 ' HB ' ' C' ' 32' ' ' VAL . 76.6 m -64.39 -44.24 91.95 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.47 -42.78 99.3 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.203 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.494 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.63 -42.66 99.21 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.932 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.53 ' NE1' ' OH ' ' C' ' 42' ' ' TYR . 0.0 OUTLIER -64.26 -40.95 97.04 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -60.88 -42.72 98.51 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -177.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.494 HG22 ' O ' ' D' ' 29' ' ' ALA . 15.8 m -61.92 -11.15 5.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.996 -177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -45.4 -61.67 1.58 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.899 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.16 -37.43 86.36 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? -60.01 -37.84 80.89 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.058 0.456 . . . . 0.0 110.914 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.588 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.2 tt -59.67 -41.85 91.59 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.454 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.5 t -62.0 -46.5 91.91 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -176.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 28.4 Cg_endo -61.63 -34.8 83.57 Favored 'Trans proline' 0 N--CA 1.502 1.987 0 C-N-CA 122.282 1.988 . . . . 0.0 111.444 177.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.491 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.19 -38.69 94.86 Favored Glycine 0 C--N 1.3 -1.454 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.543 179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.34 -41.83 80.77 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.83 -0.348 . . . . 0.0 111.039 -178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 14.8 p -86.16 105.81 16.83 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.923 -0.311 . . . . 0.0 110.817 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' D' ' 43' ' ' LEU . 44.7 p90 -151.04 -56.12 0.15 Allowed 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.539 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.628 ' N ' ' CD2' ' D' ' 42' ' ' TYR . 3.2 mm? 55.96 173.11 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.105 0.478 . . . . 0.0 110.011 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' D' ' 43' ' ' LEU . 28.1 p 57.59 68.07 0.89 Allowed 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.806 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 178.66 47.71 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.11 -33.99 5.55 Favored Glycine 0 CA--C 1.539 1.566 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.929 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 8.5 t -101.34 -32.06 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 118.205 1.002 . . . . 0.0 112.198 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.475 ' C ' ' CD1' ' D' ' 48' ' ' TRP . 8.6 t-105 -55.38 -39.85 80.18 Favored Pre-proline 0 C--N 1.302 -1.467 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.433 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 92.7 Cg_endo -83.49 -50.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.213 0 CA-C-N 120.53 1.225 . . . . 0.0 112.844 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.555 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.2 -40.98 71.4 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -175.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.24 -44.64 96.93 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.693 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 7.6 mp -61.02 -41.24 96.17 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -59.02 -34.11 52.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.822 179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -55.37 -40.65 71.58 Favored 'General case' 0 C--N 1.307 -1.273 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.751 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.549 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.6 mp -59.8 -43.77 94.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 23.8 tp -67.23 -31.71 72.26 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 125.651 1.581 . . . . 0.0 114.703 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -54.34 -39.74 77.23 Favored Pre-proline 0 C--N 1.305 -1.349 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -172.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' D' ' 59' ' ' HIS . 27.2 Cg_exo -60.83 -40.19 55.84 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 121.809 1.673 . . . . 0.0 111.179 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.458 ' O ' ' O ' ' D' ' 58' ' ' PRO . 14.9 t-80 54.0 161.15 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.583 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.429 ' N ' ' ND1' ' D' ' 59' ' ' HIS . 17.7 ptp180 -173.97 -174.65 0.95 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -144.01 11.95 1.6 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.857 0.361 . . . . 0.0 110.581 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 32.2 mt -68.86 -40.25 79.45 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.125 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.232 0 CA-C-O 117.98 -1.009 . . . . 0.0 110.901 179.798 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.249 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.4 -53.14 59.93 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 120.783 0.325 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.439 ' O ' HG23 ' E' ' 5' ' ' VAL . 38.1 mmtm -91.05 -169.56 2.39 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.563 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.478 ' O ' HD13 ' E' ' 8' ' ' LEU . 1.9 m-20 73.56 2.34 4.24 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.314 0.578 . . . . 0.0 109.475 -178.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.2 OUTLIER -115.67 -66.68 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -58.84 -33.53 49.78 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.896 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.428 ' CG2' ' H ' ' E' ' 4' ' ' ASN . 4.9 t -57.54 -40.85 77.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.111 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.571 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -60.1 -40.36 89.41 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.122 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.38 -41.44 97.11 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.173 0.511 . . . . 0.0 110.179 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.71 76.72 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.561 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -39.84 77.94 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.49 -0.484 . . . . 0.0 109.988 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 35.7 t -60.77 -41.74 96.1 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . 0.522 ' O ' ' ND1' ' E' ' 17' ' ' HIS . . . -58.04 -37.89 75.23 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.645 -179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -39.63 84.36 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.65 -41.33 95.66 Favored Glycine 0 C--N 1.302 -1.306 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' E' ' 18' ' ' GLY . 0.4 OUTLIER -60.59 -40.99 93.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 120.784 0.325 . . . . 0.0 110.767 179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . 0.522 ' ND1' ' O ' ' E' ' 13' ' ' ALA . 0.3 OUTLIER -52.33 87.11 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.754 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' E' ' 16' ' ' ASN . . . -162.56 112.97 0.54 Allowed Glycine 0 C--N 1.306 -1.097 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -42.66 -36.58 1.45 Allowed 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 32.7 p90 -60.48 -42.79 96.97 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.896 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.622 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 62.4 t-105 -61.12 -40.86 95.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.439 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -38.7 94.93 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.599 ' O ' HG23 ' E' ' 27' ' ' THR . 78.8 mt -59.03 -37.27 76.56 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . 0.575 ' O ' HD23 ' E' ' 24' ' ' LEU . 0.9 OUTLIER -57.56 -42.12 82.41 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 87.1 t -60.1 -42.0 88.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.96 -0.696 . . . . 0.0 111.419 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 64.2 t -63.16 -42.42 96.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.599 HG23 ' O ' ' E' ' 23' ' ' LEU . 11.3 p -62.78 -44.47 96.09 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 73.0 mt -62.29 -42.95 99.79 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.154 -0.619 . . . . 0.0 110.633 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.459 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.32 -42.02 98.95 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.178 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.491 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.7 OUTLIER -65.98 -42.66 89.56 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -62.1 -41.89 98.67 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.565 ' HB ' HG21 ' F' ' 27' ' ' THR . 14.0 m -60.35 -17.75 15.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -44.84 -62.35 1.25 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.1 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.412 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.5 -37.03 87.43 Favored Glycine 0 C--N 1.299 -1.477 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 38.5 ttt85 -59.49 -37.12 77.42 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.905 0.383 . . . . 0.0 110.823 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.632 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.2 tt -61.68 -43.62 98.5 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -46.41 84.83 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.412 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.78 -36.21 92.01 Favored 'Trans proline' 0 N--CA 1.502 2.017 0 C-N-CA 122.871 2.381 . . . . 0.0 111.755 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.91 94.1 Favored Glycine 0 C--N 1.302 -1.352 0 CA-C-N 114.873 -1.058 . . . . 0.0 111.141 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' E' ' 41' ' ' THR . . . -56.34 -40.27 74.2 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -177.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.401 ' C ' ' O ' ' E' ' 40' ' ' ALA . 19.5 p -40.92 112.39 0.29 Allowed 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.939 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.53 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 53.5 m-85 -88.68 70.76 8.81 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.068 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 tp -81.35 93.04 6.49 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.319 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 44.9 m 53.17 71.85 0.47 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.889 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 80.6 mt -143.0 25.15 1.78 Allowed 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.787 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.64 -70.41 0.85 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 m -139.26 -13.16 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.9 OUTLIER -50.06 -46.48 82.07 Favored Pre-proline 0 C--N 1.303 -1.426 0 C-N-CA 119.911 -0.715 . . . . 0.0 110.363 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.5 Cg_exo -58.87 -41.42 62.67 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.253 1.969 . . . . 0.0 112.299 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 53' ' ' VAL . 49.6 mt -54.58 -35.3 63.17 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.924 0.712 . . . . 0.0 112.924 -176.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.56 HD12 ' N ' ' E' ' 51' ' ' LEU . 10.4 mp -57.27 -44.19 83.75 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 118.215 -1.394 . . . . 0.0 110.583 -178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.539 HD22 ' N ' ' E' ' 52' ' ' LEU . 3.4 mm? -62.53 -45.01 94.92 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.419 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.424 HG22 ' O ' ' E' ' 50' ' ' LEU . 0.8 OUTLIER -62.76 -30.45 49.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-O 121.083 0.468 . . . . 0.0 110.661 178.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -53.53 -39.63 64.83 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.501 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 tp -56.88 -42.34 79.67 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tp -67.4 -33.65 75.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 124.385 1.074 . . . . 0.0 112.894 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 36.1 ttp180 -55.44 -43.63 99.23 Favored Pre-proline 0 C--N 1.306 -1.283 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -173.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 19.4 Cg_endo -59.28 -39.58 76.53 Favored 'Trans proline' 0 N--CA 1.498 1.745 0 CA-C-N 121.806 1.681 . . . . 0.0 111.627 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 28.8 t-80 51.52 174.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.481 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.472 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 9.5 ttm180 -168.98 87.92 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.018 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -16.32 29.13 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.355 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 19.8 mt -61.78 -38.75 89.23 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.623 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.206 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.941 179.388 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.74 -57.39 12.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 120.796 0.331 . . . . 0.0 110.549 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -84.97 68.92 10.72 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.065 0.459 . . . . 0.0 110.501 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -157.97 -35.98 0.07 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.287 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.46 -59.22 3.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.282 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.428 HG22 ' CG1' ' A' ' 5' ' ' VAL . 45.6 mt -59.8 -34.86 57.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 121.493 0.663 . . . . 0.0 109.471 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 22.2 t -58.2 -40.85 79.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.073 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.87 -40.8 89.89 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.051 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -61.97 -41.37 97.92 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 121.128 0.49 . . . . 0.0 110.179 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.24 -40.03 76.75 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.997 -178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.32 -39.65 76.28 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 120.337 -0.545 . . . . 0.0 109.866 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 26.8 p -60.75 -41.74 95.99 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.38 -38.84 78.14 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.419 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -41.0 94.49 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.31 -41.76 95.2 Favored Glycine 0 C--N 1.302 -1.311 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.983 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -60.92 -41.63 96.52 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.7 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -66.16 119.14 10.93 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.353 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.69 175.98 47.77 Favored Glycine 0 C--N 1.307 -1.078 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.851 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -79.79 -57.6 3.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.109 -0.545 . . . . 0.0 111.824 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -58.44 -40.6 83.03 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.672 -0.24 . . . . 0.0 111.454 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 79.7 t90 -59.52 -39.69 84.72 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.18 -39.54 96.04 Favored Glycine 0 C--N 1.304 -1.23 0 N-CA-C 111.575 -0.61 . . . . 0.0 111.575 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.95 -38.56 82.81 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 tp -59.85 -44.08 94.29 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -177.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 2.3 p -63.12 -44.15 99.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 C-N-CA 119.839 -0.745 . . . . 0.0 112.944 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . 0.427 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 10.9 m -64.56 -43.38 96.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 C-N-CA 120.293 -0.563 . . . . 0.0 112.308 -179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.565 HG21 ' HB ' ' E' ' 32' ' ' VAL . 97.7 m -62.78 -43.19 99.45 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.967 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 58.0 mt -61.04 -42.94 99.42 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 120.101 -0.639 . . . . 0.0 110.252 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.454 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.72 -43.92 97.57 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.764 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.615 ' NE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.1 OUTLIER -65.06 -41.44 95.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -61.04 -42.48 98.55 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.454 HG22 ' O ' ' F' ' 29' ' ' ALA . 19.5 m -65.42 -5.41 2.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.184 -177.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.615 ' NZ ' ' NE1' ' F' ' 30' ' ' TRP . 82.0 mttt -46.8 -62.86 1.2 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 120.434 -0.506 . . . . 0.0 110.267 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.41 -37.71 88.67 Favored Glycine 0 C--N 1.302 -1.348 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -60.68 -37.04 80.27 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 121.022 0.439 . . . . 0.0 111.098 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.561 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.7 OUTLIER -60.21 -41.99 94.19 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 -177.085 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.4 t -62.03 -46.43 91.73 Favored Pre-proline 0 C--N 1.308 -1.208 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 -176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 30.5 Cg_endo -62.17 -34.35 79.19 Favored 'Trans proline' 0 N--CA 1.501 1.935 0 C-N-CA 122.334 2.023 . . . . 0.0 111.009 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.1 -39.68 96.11 Favored Glycine 0 C--N 1.3 -1.421 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.366 179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.02 -41.67 88.31 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.868 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.97 114.5 24.64 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 120.939 0.4 . . . . 0.0 110.995 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.553 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 36.3 p90 -162.11 108.93 1.32 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.217 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.56 HD22 ' N ' ' F' ' 43' ' ' LEU . 3.4 mm? -74.13 151.3 40.12 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.551 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 1.1 m 72.68 170.82 0.31 Allowed 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.683 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.0 mt 69.29 36.48 2.32 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.927 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.4 -67.36 2.22 Favored Glycine 0 C--N 1.305 -1.184 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.684 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -133.14 -7.28 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 116.626 0.213 . . . . 0.0 111.392 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.8 OUTLIER -54.95 -43.7 99.11 Favored Pre-proline 0 C--N 1.306 -1.311 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.748 -179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 57.2 Cg_exo -51.4 -33.87 48.32 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 121.221 1.281 . . . . 0.0 110.823 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.692 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.4 OUTLIER -55.25 -36.42 66.03 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.323 -177.272 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.576 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.8 mp -57.61 -43.91 85.11 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.784 -1.167 . . . . 0.0 110.014 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 15.6 mt -60.8 -42.54 97.83 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -60.42 -31.26 48.22 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.503 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.441 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 62.7 ttt-85 -53.34 -39.33 64.02 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.678 -178.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.54 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.7 mm? -58.78 -44.1 90.58 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.761 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.48 HD12 ' N ' ' F' ' 56' ' ' LEU . 9.3 mp -68.69 -34.85 76.36 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.16 -45.2 99.94 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -172.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.471 ' O ' ' O ' ' F' ' 59' ' ' HIS . 33.2 Cg_exo -57.06 -42.38 64.55 Favored 'Trans proline' 0 C--N 1.299 -2.066 0 C-N-CA 121.446 1.431 . . . . 0.0 110.676 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.471 ' O ' ' O ' ' F' ' 58' ' ' PRO . 1.1 t-80 48.0 177.53 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.649 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -177.97 -169.73 0.22 Allowed 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.377 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -150.49 -165.36 2.25 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.34 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.568 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.2 mp 51.12 26.48 2.87 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.417 ' OXT' ' O ' ' F' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.288 0 CA-C-O 117.967 -1.016 . . . . 0.0 110.633 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.65 62.26 0.26 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 120.834 0.35 . . . . 0.0 110.712 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.0 ttmp? -163.63 -48.07 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.659 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' O ' HD13 ' A' ' 8' ' ' LEU . 10.2 m120 -46.64 -27.18 1.08 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 120.992 0.425 . . . . 0.0 109.91 179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.458 ' H ' HG23 ' A' ' 5' ' ' VAL . 1.5 t -68.79 -54.87 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.433 HG22 ' CG1' ' B' ' 5' ' ' VAL . 48.2 mt -58.45 -35.22 53.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.539 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.46 -40.63 79.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.048 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.9 mp -59.04 -40.41 84.98 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.362 -0.535 . . . . 0.0 109.633 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -61.12 -41.06 96.02 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.231 0.539 . . . . 0.0 110.183 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.67 -40.62 79.81 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.301 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.51 -39.87 77.44 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.214 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.4 p -61.04 -42.4 98.4 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.141 -0.624 . . . . 0.0 109.472 178.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.15 84.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.068 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' D' ' 63' ' ' ALA . . . -60.82 -41.12 95.08 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.19 -42.7 97.31 Favored Glycine 0 C--N 1.305 -1.163 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.526 ' O ' ' N ' ' A' ' 18' ' ' GLY . 27.9 t-20 -61.37 -40.8 95.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.369 178.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.1 t-80 -48.93 86.85 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.846 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 16' ' ' ASN . . . -161.81 122.9 1.15 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -48.44 -35.17 12.32 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 122.807 -0.231 . . . . 0.0 111.312 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.596 ' CD1' ' N ' ' A' ' 21' ' ' TRP . 25.6 p90 -59.61 -41.7 90.94 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.876 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.596 ' N ' ' CD1' ' A' ' 20' ' ' PHE . 57.9 t90 -59.94 -40.81 90.21 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 120.922 0.391 . . . . 0.0 110.568 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.03 -39.57 95.88 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.59 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.4 mp -59.96 -39.43 85.55 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.739 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -60.62 -45.37 94.29 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 96.5 t -63.65 -44.68 98.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.687 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.9 t -64.34 -42.11 94.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-O 121.1 0.476 . . . . 0.0 111.065 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.476 HG21 ' HB ' ' F' ' 32' ' ' VAL . 30.2 m -62.49 -43.49 98.69 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.212 -178.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 13.6 mt -61.6 -42.9 99.54 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.342 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.55 -43.21 99.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.712 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.32 -41.98 93.44 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -61.44 -41.56 97.39 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.49 HG22 ' O ' ' A' ' 29' ' ' ALA . 22.2 m -64.43 -10.65 8.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -177.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.595 ' NZ ' ' CE2' ' F' ' 42' ' ' TYR . 3.5 tppt? -45.48 -58.85 3.06 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.273 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.44 -37.26 87.62 Favored Glycine 0 C--N 1.302 -1.354 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -59.26 -37.0 76.54 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 120.946 0.403 . . . . 0.0 111.043 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.583 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.2 tt -60.09 -42.02 93.73 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 -177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.461 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.4 t -61.78 -46.49 92.92 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -176.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 28.7 Cg_endo -61.99 -34.7 80.07 Favored 'Trans proline' 0 N--CA 1.503 2.064 0 C-N-CA 122.349 2.033 . . . . 0.0 111.543 177.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.95 -38.01 94.76 Favored Glycine 0 C--N 1.3 -1.434 0 CA-C-N 114.366 -1.288 . . . . 0.0 111.439 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.55 -41.51 81.12 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.13 115.04 29.71 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.967 0.413 . . . . 0.0 111.012 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 3.1 p90 -134.26 -124.94 0.17 Allowed 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.754 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' C ' ' A' ' 42' ' ' TYR . 11.1 mp -111.47 173.99 6.08 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.4 m -102.79 83.6 2.27 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.025 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -82.85 -77.12 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.735 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.82 -59.01 0.37 Allowed Glycine 0 C--N 1.309 -0.939 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.425 178.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.8 t -144.77 -5.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 10.4 t-105 -55.91 -43.07 99.04 Favored Pre-proline 0 C--N 1.304 -1.403 0 C-N-CA 119.647 -0.821 . . . . 0.0 112.183 -178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 73.5 Cg_endo -79.06 -45.48 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.388 1.392 . . . . 0.0 112.218 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.1 mt -55.72 -35.61 66.32 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.8 tp -56.6 -42.53 78.9 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.212 -0.995 . . . . 0.0 109.785 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.3 mm? -59.32 -40.85 87.56 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.3 t -59.3 -29.91 42.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.934 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -53.56 -39.53 64.84 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 28.2 mt -58.43 -44.09 89.0 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.783 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.8 tp -67.2 -33.26 75.0 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.548 1.139 . . . . 0.0 113.296 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 60.3 ttt180 -55.52 -43.85 99.35 Favored Pre-proline 0 C--N 1.306 -1.305 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -174.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 20.7 Cg_endo -59.91 -40.18 64.94 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 CA-C-N 121.731 1.654 . . . . 0.0 111.221 178.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.422 ' O ' ' O ' ' A' ' 58' ' ' PRO . 7.9 t-80 52.89 170.38 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.633 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -176.27 112.51 0.11 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.288 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.41 5.69 16.78 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 120.801 0.334 . . . . 0.0 110.424 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 62' ' ' LEU . 9.0 mp -82.43 13.64 3.5 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.987 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.25 0 CA-C-O 118.061 -0.971 . . . . 0.0 110.567 -179.91 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.436 ' C ' ' H ' ' B' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.79 7.15 0.36 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-O 120.713 0.292 . . . . 0.0 110.736 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.436 ' H ' ' C ' ' B' ' 1' ' ' GLY . 41.4 mmtt -130.36 65.62 1.52 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.178 0.513 . . . . 0.0 110.274 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.49 ' N ' ' OD1' ' B' ' 4' ' ' ASN . 1.4 p-10 -149.95 -34.43 0.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.042 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.461 HG23 ' H ' ' B' ' 5' ' ' VAL . 1.6 t -72.65 -57.29 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.132 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 53.9 mt -59.65 -35.38 59.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.828 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 60.1 t -58.76 -41.48 82.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.122 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.67 -40.54 88.13 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -61.56 -39.68 91.99 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.46 0.648 . . . . 0.0 109.427 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 -40.99 75.83 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.097 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.7 -38.93 76.06 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 120.76 -0.376 . . . . 0.0 110.344 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.504 ' O ' ' ND2' ' B' ' 16' ' ' ASN . 8.1 t -60.51 -42.28 96.08 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.371 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.68 -39.12 79.79 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.211 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.11 -40.34 93.39 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.428 0.633 . . . . 0.0 109.477 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.53 -40.67 94.78 Favored Glycine 0 C--N 1.305 -1.177 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.806 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' B' ' 12' ' ' SER . 5.7 m-80 -60.1 -41.61 92.92 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 117.324 0.562 . . . . 0.0 110.832 -179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.594 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.7 t60 54.22 -177.0 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.79 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.594 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.7 -7.12 4.35 Favored Glycine 0 N--CA 1.47 0.954 0 CA-C-N 116.063 -0.517 . . . . 0.0 112.283 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -72.57 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.175 0.487 . . . . 0.0 110.362 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -61.23 -42.06 97.95 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.837 0.351 . . . . 0.0 111.057 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -61.17 -40.49 94.08 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.085 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.89 -40.82 98.86 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 83.7 mt -60.56 -39.1 86.74 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.6 0.238 . . . . 0.0 111.006 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.66 -43.01 94.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.648 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.29 -43.89 98.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 120.433 -0.507 . . . . 0.0 111.888 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -63.68 -42.89 97.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 120.552 -0.459 . . . . 0.0 111.127 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.473 HG21 ' HB ' ' A' ' 32' ' ' VAL . 71.0 m -62.76 -43.0 99.94 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.883 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 17.1 mt -60.49 -42.54 96.53 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.753 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.47 -42.26 99.35 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.193 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -41.61 95.65 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -61.19 -42.04 97.87 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.988 0.736 . . . . 0.0 112.988 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.8 m -64.43 -8.76 5.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 C-N-CA 120.216 -0.594 . . . . 0.0 112.384 -177.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -47.71 -61.57 1.88 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.914 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.49 -37.76 89.22 Favored Glycine 0 C--N 1.303 -1.305 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -60.77 -35.87 77.53 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.273 0.559 . . . . 0.0 110.751 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . . . . . . . . . 6.3 tt -59.46 -42.9 93.07 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -177.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.465 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.2 t -63.45 -46.81 84.34 Favored Pre-proline 0 C--N 1.307 -1.271 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 32.5 Cg_endo -62.87 -35.1 69.41 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.7 2.267 . . . . 0.0 111.805 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.552 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.19 -39.7 96.28 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.06 -40.66 85.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.487 -0.356 . . . . 0.0 111.782 -178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 21.8 p -78.29 121.23 24.16 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 120.829 0.347 . . . . 0.0 111.834 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.646 ' CZ ' ' NZ ' ' C' ' 33' ' ' LYS . 55.2 p90 -174.74 -44.45 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.134 179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.601 ' N ' HD22 ' B' ' 43' ' ' LEU . 3.3 mm? 63.53 -64.22 0.12 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.114 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.488 ' O ' ' O ' ' B' ' 43' ' ' LEU . 16.0 m -47.16 -176.76 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.296 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 60.54 47.42 8.51 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.71 -43.35 3.15 Favored Glycine 0 C--N 1.309 -0.925 0 N-CA-C 111.618 -0.593 . . . . 0.0 111.618 -179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.11 76.52 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.55 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.2 OUTLIER -165.87 -53.82 0.01 OUTLIER Pre-proline 0 C--N 1.312 -1.031 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.344 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 67.6 Cg_endo -80.05 -28.97 2.85 Favored 'Trans proline' 0 N--CA 1.486 1.073 0 C-N-CA 121.323 1.349 . . . . 0.0 112.067 -178.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.856 ' O ' HG22 ' B' ' 53' ' ' VAL . 11.5 mt -55.82 -34.65 65.55 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -54.39 -39.6 67.4 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.054 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 5.6 mp -57.89 -38.01 75.02 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . 0.856 HG22 ' O ' ' B' ' 50' ' ' LEU . 1.3 m -58.23 -26.98 31.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.151 0.5 . . . . 0.0 110.399 178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -52.61 -39.44 61.68 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.986 -177.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.55 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.9 mm? -59.51 -45.37 91.91 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.363 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.4 mm? -67.24 -32.32 73.28 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 124.733 1.213 . . . . 0.0 113.184 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.484 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.1 ttp85 -54.93 -43.54 98.95 Favored Pre-proline 0 C--N 1.305 -1.339 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -174.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 18.8 Cg_endo -58.52 -39.51 82.6 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 CA-C-N 121.625 1.616 . . . . 0.0 111.062 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.509 ' CE1' ' O ' ' E' ' 11' ' ' ALA . 14.2 t-80 48.21 50.72 15.92 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.954 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.461 ' O ' ' CB ' ' E' ' 14' ' ' ALA . 5.7 ptp85 -55.62 153.29 8.08 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.194 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -101.86 0.75 36.1 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.675 0.274 . . . . 0.0 110.705 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.529 HD12 ' N ' ' B' ' 62' ' ' LEU . 8.0 mp -64.82 -40.88 95.9 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.279 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.86 179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.41 -125.55 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.549 0.214 . . . . 0.0 110.519 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' D' ' 1' ' ' GLY . 26.7 mmtp -78.23 68.43 4.25 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.201 0.524 . . . . 0.0 110.726 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -147.35 -27.69 0.37 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.11 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.454 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.5 OUTLIER -78.36 -55.27 10.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.236 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 37.2 mt -59.56 -36.28 64.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.06 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -59.8 -40.95 83.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.465 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.52 -39.23 83.22 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.088 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -60.0 -41.19 91.53 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.31 79.72 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.58 80.08 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.539 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 45.9 t -60.69 -41.64 95.58 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.125 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.16 88.28 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.57 -41.32 97.22 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.55 -40.94 98.5 Favored Glycine 0 C--N 1.304 -1.199 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.226 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.39 -41.8 94.59 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.589 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 57.9 t60 -46.98 102.72 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.872 0.368 . . . . 0.0 110.2 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.79 153.74 25.06 Favored Glycine 0 C--N 1.308 -0.981 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -82.21 -61.81 1.8 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.538 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -59.49 -40.63 87.66 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.35 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 54.4 t-105 -58.76 -40.38 83.74 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.648 0.261 . . . . 0.0 111.189 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.42 -39.24 95.97 Favored Glycine 0 C--N 1.301 -1.39 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 6.7 mt -60.45 -39.54 87.91 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 tt -60.2 -43.91 95.56 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.59 -45.36 97.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 C-N-CA 119.883 -0.727 . . . . 0.0 112.319 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.62 -44.1 93.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.104 0.478 . . . . 0.0 111.967 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 78.6 m -63.85 -44.35 93.41 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.396 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 5.8 tp -62.96 -43.38 98.96 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.913 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.52 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.94 -46.59 87.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 113.515 0.931 . . . . 0.0 113.515 -176.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.552 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -67.02 -38.75 86.49 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.795 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -58.84 -42.23 88.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.52 HG22 ' O ' ' C' ' 29' ' ' ALA . 9.9 m -58.02 -6.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.338 -178.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.646 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 26.9 mtmt -39.66 -54.57 2.02 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.609 0.242 . . . . 0.0 110.461 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.67 -37.53 83.8 Favored Glycine 0 C--N 1.304 -1.244 0 N-CA-C 111.764 -0.534 . . . . 0.0 111.764 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 38.9 mmt-85 -58.48 -36.14 73.28 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 120.919 0.39 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.691 HD23 ' O ' ' C' ' 36' ' ' LEU . 1.9 tt -61.54 -44.0 97.84 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 -177.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.63 -45.96 88.73 Favored Pre-proline 0 N--CA 1.484 1.252 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -175.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.705 ' O ' HG22 ' C' ' 41' ' ' THR . 32.0 Cg_exo -59.03 -35.37 98.53 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.855 2.37 . . . . 0.0 111.366 176.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . 0.51 ' O ' ' CD1' ' D' ' 30' ' ' TRP . . . -60.74 -38.28 94.93 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.259 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.44 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.77 -41.41 81.96 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.705 HG22 ' O ' ' C' ' 38' ' ' PRO . 15.2 t -32.47 113.05 0.12 Allowed 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 120.918 0.389 . . . . 0.0 111.934 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -94.57 75.25 3.78 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.505 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -88.22 96.28 10.49 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.286 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . 0.413 ' O ' ' OG ' ' C' ' 44' ' ' SER . 40.8 p 42.29 91.46 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.08 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -142.3 31.76 1.53 Allowed 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.381 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -53.25 -69.77 1.12 Allowed Glycine 0 C--N 1.301 -1.401 0 C-N-CA 121.29 -0.481 . . . . 0.0 112.257 -179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.36 -9.89 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.412 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 5.0 t-105 -52.54 -45.59 95.78 Favored Pre-proline 0 C--N 1.301 -1.5 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.613 -179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 60.2 Cg_endo -75.9 -45.56 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.139 1.226 . . . . 0.0 112.459 -178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -55.03 -36.24 65.3 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -177.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 mt -57.09 -43.95 82.71 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.66 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -59.59 -41.99 91.52 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -60.21 -31.43 48.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.703 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -53.23 -38.7 63.17 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.38 -41.98 77.14 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.468 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 52.7 tp -67.52 -34.34 76.91 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.947 0.899 . . . . 0.0 113.35 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.482 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.1 mtp180 -56.71 -42.73 97.8 Favored Pre-proline 0 N--CA 1.483 1.2 0 N-CA-C 116.243 1.942 . . . . 0.0 116.243 -174.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.5 Cg_endo -58.03 -38.55 91.42 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 CA-C-N 121.9 1.714 . . . . 0.0 112.326 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 0.1 OUTLIER -40.14 156.42 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.744 0.307 . . . . 0.0 110.865 -179.764 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.43 162.93 33.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -60.34 -172.39 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 120.726 -0.389 . . . . 0.0 110.49 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 tp 76.18 -22.57 0.27 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.507 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.311 -1.099 0 CA-C-O 117.978 -1.011 . . . . 0.0 111.408 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.25 -79.65 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.704 0.288 . . . . 0.0 110.549 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -84.42 -44.21 13.92 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.474 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.485 ' O ' HD13 ' D' ' 8' ' ' LEU . 14.6 m120 -44.26 -32.93 1.41 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.491 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.468 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.6 OUTLIER -63.98 -55.18 23.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.658 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.679 HG22 ' CG1' ' E' ' 5' ' ' VAL . 56.0 mt -59.56 -36.14 63.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.484 0.659 . . . . 0.0 110.125 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 92.9 t -58.88 -40.44 80.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.145 179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.485 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.68 -39.29 80.26 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.057 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -60.55 -41.77 95.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.228 0.537 . . . . 0.0 109.659 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.51 ' HB2' HG13 ' E' ' 5' ' ' VAL . . . -57.63 -39.42 76.91 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.851 -179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.22 73.84 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 120.531 -0.468 . . . . 0.0 109.832 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 51.3 p -60.83 -41.84 96.55 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.682 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.511 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -59.31 -38.97 81.61 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.161 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -42.46 96.91 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.86 -42.77 98.3 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -62.14 -41.69 98.52 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-O 120.898 0.38 . . . . 0.0 110.597 179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 0.3 OUTLIER -53.43 113.09 1.03 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.841 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.0 159.72 33.2 Favored Glycine 0 C--N 1.303 -1.257 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.408 ' CE2' HG21 ' B' ' 53' ' ' VAL . 1.5 t80 -72.95 -50.94 20.48 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.519 0.2 . . . . 0.0 111.324 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -59.12 -39.87 83.64 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.344 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . . . . . . . . . 41.0 t90 -59.01 -41.16 87.06 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 120.628 0.251 . . . . 0.0 111.326 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.49 -40.67 98.04 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 10.2 mp -60.79 -38.47 85.43 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.536 0.208 . . . . 0.0 111.176 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.01 -44.23 91.64 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -177.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.04 -45.06 99.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.389 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.36 -43.59 94.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.037 0.446 . . . . 0.0 111.353 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 25.7 m -63.82 -44.27 93.75 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.724 -178.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.18 -43.53 98.73 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.105 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.41 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.26 -43.26 99.22 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.366 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . 0.51 ' CD1' ' O ' ' C' ' 39' ' ' GLY . 0.4 OUTLIER -63.6 -40.21 96.35 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.128 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.436 ' O ' ' ND1' ' D' ' 31' ' ' HIS . 1.5 t60 -60.63 -41.82 95.63 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.592 ' HB ' HG21 ' E' ' 27' ' ' THR . 19.6 m -71.78 -6.86 8.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -49.12 -59.97 3.19 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.107 -179.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.05 -37.48 91.67 Favored Glycine 0 C--N 1.302 -1.353 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 91.1 mtt180 -59.74 -36.81 77.35 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.006 -179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.609 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.3 tt -60.32 -41.34 93.33 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 1.6 t -61.62 -46.61 93.73 Favored Pre-proline 0 C--N 1.307 -1.283 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 -176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 31.5 Cg_endo -62.05 -34.1 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.114 0 C-N-CA 122.476 2.117 . . . . 0.0 111.657 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.527 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.62 97.86 Favored Glycine 0 C--N 1.301 -1.389 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.342 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.92 -40.96 81.67 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.567 -0.316 . . . . 0.0 111.383 -178.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 28.9 p -81.76 114.17 20.22 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 120.795 0.331 . . . . 0.0 111.42 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 29.3 p90 -172.88 108.89 0.18 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.948 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 12.6 tp -91.67 62.62 4.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.801 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -167.75 170.07 11.17 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.491 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 9.0 mt 62.34 45.44 6.65 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.91 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.25 -59.16 5.55 Favored Glycine 0 CA--C 1.532 1.143 0 CA-C-N 115.987 -0.551 . . . . 0.0 113.423 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 20.9 m -108.72 -21.75 5.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 CA-C-N 117.276 0.538 . . . . 0.0 112.365 -178.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.447 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 9.2 t-105 -54.15 -40.97 85.99 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 111.946 0.351 . . . . 0.0 111.946 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.447 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 50.2 Cg_exo -54.39 -49.45 16.86 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 121.346 1.364 . . . . 0.0 112.156 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.629 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -54.58 -38.14 66.35 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.897 -175.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 33.1 mt -58.99 -45.35 90.83 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.982 -179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.3 mp -60.64 -41.81 95.68 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 93.0 t -58.69 -31.31 43.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.173 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -54.22 -40.7 67.9 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.794 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 27.0 mt -59.9 -44.35 94.32 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.304 -0.958 . . . . 0.0 108.825 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 13.5 mt -66.85 -30.65 70.89 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 125.557 1.543 . . . . 0.0 114.873 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.412 ' N ' ' CD ' ' D' ' 58' ' ' PRO . 31.7 ttt180 -53.86 -39.32 72.39 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 -172.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 33.6 Cg_exo -60.33 -39.97 62.58 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 C-N-CA 121.713 1.609 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 46.26 40.73 7.98 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.856 179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -48.18 121.44 4.32 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.225 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.56 -10.86 24.45 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.801 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 22.1 mt -61.53 -37.7 84.7 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.445 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 C--N 1.309 -1.182 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.098 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' E' ' 2' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' E' ' 1' ' ' GLY . . . 65.63 138.89 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.498 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.496 ' O ' HG23 ' E' ' 5' ' ' VAL . 0.4 OUTLIER 49.27 -171.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.049 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 1.2 p30 42.07 22.0 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.046 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.679 ' CG1' HG22 ' D' ' 6' ' ' ILE . 60.4 t -128.95 -70.31 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 71.7 mt -58.54 -33.3 47.97 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.41 HG23 ' H ' ' E' ' 7' ' ' VAL . 9.4 t -57.91 -41.08 79.2 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.305 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mt -59.96 -40.02 87.59 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.367 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -61.13 -41.62 97.07 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.14 0.495 . . . . 0.0 110.037 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.11 77.57 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.543 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . 0.509 ' O ' ' CE1' ' B' ' 59' ' ' HIS . . . -58.22 -39.91 80.3 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.344 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 40.7 p -60.82 -42.07 96.99 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 120.486 -0.486 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.54 -37.96 76.78 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.949 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' B' ' 60' ' ' ARG . . . -60.2 -41.12 92.33 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.22 -42.32 97.18 Favored Glycine 0 C--N 1.305 -1.141 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -61.27 -41.18 96.49 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 120.877 0.37 . . . . 0.0 110.534 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -57.84 109.85 0.8 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.059 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 179.5 116.64 0.52 Allowed Glycine 0 C--N 1.304 -1.195 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' E' ' 19' ' ' PHE . 0.6 OUTLIER -34.25 -42.46 0.13 Allowed 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 122.615 0.366 . . . . 0.0 111.455 -179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.2 -42.98 96.22 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.148 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.525 ' N ' ' O ' ' E' ' 18' ' ' GLY . 64.5 t-105 -60.55 -41.25 94.15 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.322 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.34 96.12 Favored Glycine 0 C--N 1.303 -1.282 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.441 HD13 ' O ' ' E' ' 19' ' ' PHE . 7.3 mp -59.85 -38.22 81.51 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.762 -0.219 . . . . 0.0 111.524 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 65.2 tp -58.84 -43.71 90.81 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 58.2 t -61.85 -44.07 98.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.825 -178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 50.9 t -64.39 -42.68 96.06 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.724 -0.39 . . . . 0.0 112.042 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.592 HG21 ' HB ' ' D' ' 32' ' ' VAL . 33.1 m -62.69 -43.88 97.67 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 34.0 tp -61.51 -43.18 99.33 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.382 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.31 -40.78 98.3 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.225 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.527 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.6 OUTLIER -64.34 -42.86 96.04 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.24 -41.7 98.66 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.424 ' H ' HG22 ' E' ' 32' ' ' VAL . 6.0 m -64.16 -10.99 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -177.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -46.64 -58.35 3.92 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.221 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.409 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.73 -37.96 90.93 Favored Glycine 0 C--N 1.302 -1.325 0 N-CA-C 111.323 -0.711 . . . . 0.0 111.323 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -59.79 -35.96 75.72 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 120.927 0.394 . . . . 0.0 110.594 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.631 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.1 tt -61.93 -43.62 98.47 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -45.97 86.63 Favored Pre-proline 0 N--CA 1.486 1.33 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -176.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.409 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.3 Cg_exo -59.38 -35.14 97.23 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 122.973 2.449 . . . . 0.0 111.13 176.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.518 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -60.19 -37.95 93.71 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.897 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.08 -40.4 73.56 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -177.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' E' ' 38' ' ' PRO . 29.3 p -44.54 112.41 0.41 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 120.373 -0.531 . . . . 0.0 109.842 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -108.92 83.53 1.77 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.395 0.617 . . . . 0.0 110.843 -178.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' E' ' 45' ' ' LEU . 30.1 mt -80.23 -149.27 0.06 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.133 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 28.5 m -54.07 87.29 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.869 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . 0.47 ' N ' ' O ' ' E' ' 43' ' ' LEU . 18.2 mt -141.4 31.35 1.71 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.52 -68.26 1.78 Allowed Glycine 0 C--N 1.304 -1.207 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.45 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . 0.487 HG22 ' O ' ' E' ' 47' ' ' VAL . 2.8 p -132.47 -11.59 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.518 ' O ' ' CE3' ' E' ' 48' ' ' TRP . 2.9 t-105 -51.82 -45.39 92.24 Favored Pre-proline 0 C--N 1.304 -1.408 0 C-N-CA 120.336 -0.546 . . . . 0.0 111.128 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 91.8 Cg_endo -83.65 -50.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 121.672 1.581 . . . . 0.0 112.442 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 70.0 mt -55.96 -36.42 67.8 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.493 HD13 ' O ' ' E' ' 51' ' ' LEU . 0.2 OUTLIER -57.28 -43.86 83.49 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.378 -1.329 . . . . 0.0 108.941 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -60.32 -40.71 91.55 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 45.2 t -59.09 -31.99 46.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.061 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -54.93 -40.42 69.88 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.283 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.56 -43.61 89.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.734 -0.786 . . . . 0.0 109.187 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 tp -67.4 -33.49 75.29 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 124.336 1.054 . . . . 0.0 113.094 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.455 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 2.8 tpt180 -55.97 -43.88 99.43 Favored Pre-proline 0 C--N 1.306 -1.319 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.94 -40.7 59.87 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 CA-C-N 121.824 1.687 . . . . 0.0 111.601 178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.446 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.6 t-80 52.69 169.45 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.581 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -171.47 111.03 0.32 Allowed 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.184 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -72.9 -0.67 14.23 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.734 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.411 ' O ' ' OXT' ' E' ' 63' ' ' ALA . 26.4 mt -64.94 -42.68 94.45 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.097 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.411 ' OXT' ' O ' ' E' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.916 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.25 155.83 38.9 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 120.785 0.326 . . . . 0.0 110.554 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . 0.412 ' O ' HG23 ' F' ' 5' ' ' VAL . 3.9 mmpt? 54.44 173.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.533 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.416 ' O ' HD13 ' F' ' 8' ' ' LEU . 8.8 t-20 67.86 16.08 9.63 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.697 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.412 HG23 ' O ' ' F' ' 3' ' ' LYS . 0.4 OUTLIER -120.44 -73.06 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.673 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.604 ' H ' HD12 ' F' ' 6' ' ' ILE . 3.4 mp -59.2 -33.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.231 177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.412 ' H ' HG23 ' F' ' 7' ' ' VAL . 3.2 t -56.8 -40.82 73.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.95 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.587 HD12 ' N ' ' F' ' 8' ' ' LEU . 9.7 mp -59.77 -40.77 89.32 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.819 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -61.82 -40.7 96.21 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.288 0.566 . . . . 0.0 109.976 178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -40.63 77.05 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.445 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.56 -40.34 78.71 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.933 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -62.0 -43.15 99.44 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.697 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.16 88.27 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.568 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.24 -43.27 99.15 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 120.046 -0.661 . . . . 0.0 109.234 179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.59 -43.01 98.01 Favored Glycine 0 C--N 1.303 -1.261 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -62.13 -41.92 98.74 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.995 0.426 . . . . 0.0 110.574 179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -71.84 129.5 38.76 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.584 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 171.72 -171.48 44.11 Favored Glycine 0 C--N 1.304 -1.211 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.688 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' F' ' 20' ' ' PHE . 3.3 t80 -79.07 -57.78 3.57 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.319 -0.441 . . . . 0.0 111.598 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' F' ' 19' ' ' PHE . 32.4 p90 -59.18 -40.69 86.47 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 31.5 t90 -59.93 -38.03 81.2 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.576 -178.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.73 -38.52 88.51 Favored Glycine 0 C--N 1.306 -1.103 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.564 ' O ' HG22 ' F' ' 27' ' ' THR . 10.3 mp -59.46 -35.85 74.86 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 120.524 0.202 . . . . 0.0 110.473 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -46.8 84.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 6.1 m -66.56 -46.53 86.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 4.2 t -65.95 -45.74 90.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.564 HG22 ' O ' ' F' ' 23' ' ' LEU . 12.8 t -65.08 -44.58 88.42 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . 0.483 ' N ' HG23 ' F' ' 27' ' ' THR . 3.2 tp -62.97 -43.5 98.63 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.704 -0.799 . . . . 0.0 110.519 -179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.98 -42.02 99.72 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.68 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.518 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 1.2 t-105 -64.45 -43.56 93.85 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -62.79 -41.37 99.23 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 27' ' ' THR . 23.7 m -65.39 -18.73 24.38 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.486 ' CG ' ' N ' ' F' ' 34' ' ' GLY . 15.3 pttp -41.77 -49.85 4.34 Favored 'General case' 0 C--N 1.309 -1.168 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.405 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . 0.486 ' N ' ' CG ' ' F' ' 33' ' ' LYS . . . -59.78 -38.42 93.9 Favored Glycine 0 C--N 1.307 -1.047 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -59.22 -36.58 75.66 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.175 0.512 . . . . 0.0 110.761 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.405 HD12 ' OG1' ' A' ' 27' ' ' THR . 7.4 tt -60.18 -41.73 93.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.46 ' H ' HG23 ' F' ' 37' ' ' VAL . 1.6 t -62.26 -46.71 90.71 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 33.5 Cg_endo -62.39 -34.31 77.17 Favored 'Trans proline' 0 N--CA 1.501 1.963 0 C-N-CA 122.459 2.106 . . . . 0.0 111.155 177.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.547 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -59.97 -39.52 95.73 Favored Glycine 0 C--N 1.302 -1.349 0 CA-C-N 114.491 -1.231 . . . . 0.0 110.272 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.91 -40.57 80.67 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 121.078 -0.249 . . . . 0.0 110.768 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 37.3 p -87.17 108.2 18.8 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-O 120.767 0.318 . . . . 0.0 110.697 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.595 ' CE2' ' NZ ' ' A' ' 33' ' ' LYS . 21.5 p90 -165.09 45.31 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.314 179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -44.45 86.95 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.023 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . 0.665 ' O ' ' N ' ' F' ' 46' ' ' GLY . 13.7 p -163.01 161.48 25.5 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.341 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 mp 49.56 -74.94 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.173 0 O-C-N 123.97 0.794 . . . . 0.0 110.305 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . 0.665 ' N ' ' O ' ' F' ' 44' ' ' SER . . . 104.77 -63.47 0.34 Allowed Glycine 0 C--N 1.29 -2.023 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.284 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 15.9 m -154.46 7.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -178.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' C ' ' F' ' 48' ' ' TRP . 0.4 OUTLIER -51.75 -43.13 87.46 Favored Pre-proline 0 C--N 1.303 -1.428 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.962 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' F' ' 48' ' ' TRP . 52.5 Cg_exo -55.39 -29.64 69.29 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 121.592 1.528 . . . . 0.0 111.652 179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.721 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -55.74 -36.48 67.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.081 -177.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.574 HD12 ' N ' ' F' ' 51' ' ' LEU . 9.2 mp -56.67 -43.3 80.26 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.763 -1.175 . . . . 0.0 109.401 -178.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.9 -42.2 97.58 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 60.7 t -59.51 -30.26 44.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.74 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -52.84 -38.61 61.64 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 mt -58.13 -43.77 87.46 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . 0.536 ' O ' ' CD2' ' F' ' 59' ' ' HIS . 5.7 tp -67.17 -33.29 75.09 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 124.347 1.059 . . . . 0.0 113.543 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.483 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 29.2 ttm-85 -55.13 -44.0 99.38 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.277 1.584 . . . . 0.0 115.277 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 22.8 Cg_endo -59.75 -39.05 76.65 Favored 'Trans proline' 0 N--CA 1.497 1.726 0 CA-C-N 121.427 1.546 . . . . 0.0 111.748 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.536 ' CD2' ' O ' ' F' ' 56' ' ' LEU . 12.5 m-70 59.2 69.51 0.72 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.121 0.486 . . . . 0.0 110.028 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -48.23 -46.03 34.93 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.356 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . 65.42 3.68 2.43 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.859 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 57.7 tp -79.79 -43.96 21.5 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.252 0 CA-C-O 118.027 -0.987 . . . . 0.0 111.17 179.764 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.33 -55.6 32.92 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.815 0.34 . . . . 0.0 110.53 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.443 ' NZ ' HG21 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -96.74 70.24 2.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.044 0.449 . . . . 0.0 110.433 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.457 ' O ' HD13 ' A' ' 8' ' ' LEU . 68.6 m-80 -154.69 -41.94 0.09 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.474 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.429 ' CG1' HG22 ' F' ' 6' ' ' ILE . 2.1 t -66.17 -54.9 21.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG22 ' CG1' ' B' ' 5' ' ' VAL . 45.2 mt -60.3 -35.12 60.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.529 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -58.02 -40.48 76.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.022 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 4' ' ' ASN . 6.8 mp -59.96 -40.42 88.96 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.048 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -61.23 -42.08 97.98 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.131 0.491 . . . . 0.0 109.954 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.82 74.77 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.765 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HB1' ' ND1' ' D' ' 59' ' ' HIS . . . -57.83 -39.67 78.19 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.151 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.6 p -60.39 -41.95 94.88 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.401 ' O ' ' ND1' ' A' ' 17' ' ' HIS . . . -59.25 -39.28 82.34 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.72 -41.52 95.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.89 -42.28 98.13 Favored Glycine 0 C--N 1.305 -1.148 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 -61.65 -41.52 97.64 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.821 0.343 . . . . 0.0 110.834 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.401 ' ND1' ' O ' ' A' ' 13' ' ' ALA . 0.8 OUTLIER -51.15 105.58 0.11 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -158.91 154.34 25.43 Favored Glycine 0 C--N 1.305 -1.139 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CE2' HG11 ' E' ' 53' ' ' VAL . 0.4 OUTLIER -78.39 -55.28 5.35 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 121.284 -0.166 . . . . 0.0 111.292 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -58.37 -40.03 81.18 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 120.788 0.327 . . . . 0.0 110.341 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -59.31 -40.88 87.64 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.779 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.14 96.61 Favored Glycine 0 C--N 1.304 -1.246 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.825 ' O ' HG23 ' A' ' 27' ' ' THR . 8.3 mp -59.11 -37.58 77.52 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 120.555 0.217 . . . . 0.0 110.864 -179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -57.77 -41.94 83.06 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -177.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -60.87 -43.96 96.77 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 C-N-CA 119.494 -0.883 . . . . 0.0 111.297 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.9 t -64.41 -41.58 92.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.074 0.464 . . . . 0.0 111.102 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.825 HG23 ' O ' ' A' ' 23' ' ' LEU . 68.8 p -61.82 -44.76 96.21 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.351 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.5 mp -61.48 -41.46 97.29 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.016 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.487 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -61.0 -42.64 98.84 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.247 -0.581 . . . . 0.0 111.846 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -65.16 -42.75 93.43 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -62.23 -42.33 99.21 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 113.048 0.759 . . . . 0.0 113.048 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 29' ' ' ALA . 24.5 m -62.99 -12.88 11.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -45.16 -56.86 4.35 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.431 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.14 -37.92 87.89 Favored Glycine 0 C--N 1.301 -1.379 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -60.13 -36.28 77.15 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 120.907 0.384 . . . . 0.0 111.392 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 36' ' ' LEU . 1.6 tt -59.32 -42.98 92.68 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.463 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.3 t -62.71 -46.91 88.64 Favored Pre-proline 0 C--N 1.304 -1.38 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -177.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 34.8 Cg_endo -62.75 -35.19 70.13 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 122.525 2.15 . . . . 0.0 111.984 177.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.2 -39.48 95.99 Favored Glycine 0 C--N 1.302 -1.312 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.987 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.6 -41.06 84.95 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.082 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.4 p -95.76 108.31 20.62 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 120.897 0.38 . . . . 0.0 111.368 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.554 ' C ' HD22 ' A' ' 43' ' ' LEU . 4.4 p90 -139.94 -128.4 0.11 Allowed 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.554 HD22 ' C ' ' A' ' 42' ' ' TYR . 4.1 mm? -116.09 -178.91 3.51 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.6 t -109.62 83.29 1.73 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.214 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.9 mt -73.26 -78.31 0.09 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.694 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.77 -38.53 1.72 Allowed Glycine 0 C--N 1.306 -1.086 0 CA-C-N 116.202 -0.453 . . . . 0.0 112.993 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG13 ' N ' ' A' ' 48' ' ' TRP . 15.0 p -103.66 -37.63 4.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 48.1 t-105 -65.07 -34.84 10.87 Favored Pre-proline 0 C--N 1.3 -1.581 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 -177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 71.7 Cg_endo -90.53 -57.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.308 0 C-N-CA 122.001 1.801 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 53' ' ' VAL . 13.7 mt -53.5 -39.74 64.83 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -175.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.3 mp -61.36 -41.18 96.64 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.322 -0.951 . . . . 0.0 110.525 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.98 -40.68 81.26 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.948 -177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -59.3 -31.55 46.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 120.591 0.234 . . . . 0.0 110.793 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.407 ' O ' ' CD ' ' A' ' 58' ' ' PRO . 71.7 ttp85 -53.95 -41.23 67.56 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.9 mm? -59.61 -44.25 93.47 Favored 'General case' 0 C--N 1.301 -1.543 0 C-N-CA 119.301 -0.96 . . . . 0.0 108.482 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.6 mt -67.89 -33.63 75.09 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 124.515 1.126 . . . . 0.0 113.412 177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.444 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 50.3 ttm-85 -55.92 -44.13 99.54 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -173.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' HIS . 26.5 Cg_endo -61.09 -41.39 43.92 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 CA-C-N 121.828 1.689 . . . . 0.0 111.019 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 50.81 171.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.471 179.792 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 16.1 ptm180 -160.86 -35.62 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.37 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 60' ' ' ARG . . . 71.35 -12.19 0.63 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.806 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 60' ' ' ARG . 56.6 mt -86.18 33.24 0.61 Allowed 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.224 179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' O ' HD11 ' E' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.321 0 CA-C-O 118.082 -0.961 . . . . 0.0 110.615 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.65 156.47 38.93 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 120.865 0.364 . . . . 0.0 110.608 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp 57.35 49.06 13.74 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.391 0.615 . . . . 0.0 110.597 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.44 ' O ' HD13 ' B' ' 8' ' ' LEU . 71.6 m-80 -148.97 -38.16 0.16 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.455 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.443 HG21 ' NZ ' ' A' ' 3' ' ' LYS . 2.0 t -68.79 -52.74 32.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.7 mt -59.23 -35.58 58.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.509 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' B' ' 10' ' ' ALA . 46.2 t -58.73 -41.52 82.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.026 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.44 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.2 mp -58.98 -40.05 83.64 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -61.06 -39.56 90.3 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.371 0.605 . . . . 0.0 109.554 178.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' B' ' 7' ' ' VAL . . . -56.24 -40.63 74.44 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.961 -178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.36 -38.85 74.84 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.438 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 8.3 t -60.6 -41.98 95.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.954 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.4 -39.11 78.82 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.301 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . 0.519 ' O ' ' CD2' ' B' ' 17' ' ' HIS . . . -60.58 -39.8 89.41 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.72 -40.51 92.88 Favored Glycine 0 C--N 1.304 -1.235 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.518 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.6 ' ND2' ' CD1' ' B' ' 21' ' ' TRP . 16.4 t30 -59.57 -41.56 90.48 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 117.16 0.48 . . . . 0.0 110.803 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' B' ' 14' ' ' ALA . 38.9 m80 51.81 -178.74 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -131.27 -10.39 2.45 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 116.296 -0.411 . . . . 0.0 112.103 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.611 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 3.3 t80 -72.44 -97.21 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 117.037 0.419 . . . . 0.0 110.675 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.611 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.18 -41.5 93.02 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.223 -179.247 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.6 ' CD1' ' ND2' ' B' ' 16' ' ' ASN . 73.1 t-105 -59.29 -40.07 84.96 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.005 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.43 -39.85 96.82 Favored Glycine 0 C--N 1.304 -1.196 0 N-CA-C 111.065 -0.814 . . . . 0.0 111.065 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 8.4 mt -61.28 -40.89 95.8 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 121.148 -0.221 . . . . 0.0 111.426 -179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 tp -61.06 -45.32 95.24 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 2.8 p -64.52 -43.54 96.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 120.046 -0.662 . . . . 0.0 112.049 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -63.96 -43.35 97.65 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.15 0.5 . . . . 0.0 110.751 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.42 ' OG1' HD12 ' A' ' 36' ' ' LEU . 17.3 m -62.78 -42.5 99.73 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.395 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.83 -41.54 91.55 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.674 -178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -60.94 -41.83 97.01 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 120.296 -0.561 . . . . 0.0 111.079 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -41.0 96.34 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 111.979 0.363 . . . . 0.0 111.979 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -60.56 -42.72 97.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.467 HG22 ' O ' ' B' ' 29' ' ' ALA . 9.9 m -58.9 -7.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 119.718 -0.793 . . . . 0.0 111.38 -178.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 39.7 mmtt -46.65 -63.27 1.06 Allowed 'General case' 0 C--N 1.311 -1.067 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.482 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.8 -37.86 85.96 Favored Glycine 0 C--N 1.304 -1.238 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -60.13 -36.68 78.04 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.413 0.625 . . . . 0.0 110.298 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.68 ' O ' HD23 ' B' ' 36' ' ' LEU . 3.6 tt -59.42 -42.96 93.06 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -62.07 -46.47 91.57 Favored Pre-proline 0 C--N 1.306 -1.302 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 -177.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.14 -34.94 77.91 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 122.386 2.057 . . . . 0.0 111.606 177.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.411 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.89 -39.1 95.06 Favored Glycine 0 C--N 1.302 -1.326 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.708 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.57 -41.12 84.97 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.764 -0.218 . . . . 0.0 111.248 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 6.6 p -89.14 109.16 20.05 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 120.851 0.358 . . . . 0.0 111.302 -179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.596 ' CG ' ' N ' ' B' ' 43' ' ' LEU . 35.1 p90 -159.21 -52.31 0.06 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.302 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.596 ' N ' ' CG ' ' B' ' 42' ' ' TYR . 9.9 mp 59.94 173.59 0.09 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.123 0.487 . . . . 0.0 110.308 -179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' B' ' 43' ' ' LEU . 0.9 OUTLIER 79.04 179.28 0.12 Allowed 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.715 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 35.1 mt 57.07 50.62 11.69 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.376 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.97 -62.21 5.42 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 116.099 -0.501 . . . . 0.0 113.076 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 16.2 m -113.96 -10.38 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 CA-C-O 121.314 0.578 . . . . 0.0 110.334 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.432 ' N ' ' CD ' ' B' ' 49' ' ' PRO . 36.5 t90 -51.1 -41.6 75.44 Favored Pre-proline 0 C--N 1.3 -1.564 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.157 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.432 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 37.8 Cg_endo -74.3 -39.01 1.73 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 120.386 1.174 . . . . 0.0 110.692 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.589 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.2 OUTLIER -53.87 -39.07 65.38 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.857 -176.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mp -59.97 -43.8 94.85 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.862 -1.135 . . . . 0.0 109.357 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.28 -42.54 95.65 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 82.7 t -59.6 -32.98 50.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.85 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -54.6 -41.09 69.54 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.912 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 40.5 mt -59.96 -44.23 94.56 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 119.523 -0.871 . . . . 0.0 108.809 179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.6 mm? -67.31 -33.76 75.96 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 124.594 1.157 . . . . 0.0 113.383 178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.536 HH21 HD11 ' B' ' 50' ' ' LEU . 58.7 ttm-85 -56.12 -43.92 99.47 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -174.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 26.8 Cg_endo -60.55 -40.83 53.15 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 CA-C-N 121.696 1.642 . . . . 0.0 111.502 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.48 76.01 0.38 Allowed 'General case' 0 C--N 1.306 -1.314 0 CA-C-O 121.546 0.689 . . . . 0.0 109.586 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 76.3 mtt180 -63.13 -39.7 95.44 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.709 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . 55.52 66.15 1.29 Allowed 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.416 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 37.8 tp -160.94 -17.99 0.05 Allowed 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.549 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.24 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.896 179.689 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.44 -114.74 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.625 0.25 . . . . 0.0 110.462 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.28 71.89 3.8 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.327 0.584 . . . . 0.0 110.262 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' C' ' 8' ' ' LEU . 60.0 t30 -151.36 -53.58 0.13 Allowed 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.278 -0.874 . . . . 0.0 108.816 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -54.29 -57.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.264 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.407 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.1 mt -59.65 -36.52 65.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.835 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 6.5 t -59.99 -40.54 83.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.465 -0.788 . . . . 0.0 110.313 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.419 HD13 ' O ' ' C' ' 4' ' ' ASN . 7.5 mp -59.17 -40.13 84.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -60.83 -40.01 91.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.98 -40.79 77.19 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.035 -178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.53 -39.32 76.33 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.477 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.46 -41.64 94.54 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.467 -0.493 . . . . 0.0 109.952 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.48 81.4 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.276 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.07 -41.21 96.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -42.6 98.55 Favored Glycine 0 C--N 1.306 -1.104 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.606 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.25 -41.62 97.21 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.585 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -58.83 111.38 1.27 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.342 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.38 165.52 38.32 Favored Glycine 0 C--N 1.307 -1.079 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.609 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . 0.42 ' CZ ' HD11 ' C' ' 23' ' ' LEU . 27.5 t80 -79.92 -60.31 2.39 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.466 -0.367 . . . . 0.0 111.422 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -58.84 -40.81 85.34 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 120.575 0.226 . . . . 0.0 111.162 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 78.2 t90 -59.4 -40.63 87.25 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.489 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.54 -40.42 98.68 Favored Glycine 0 C--N 1.303 -1.251 0 C-N-CA 121.213 -0.518 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.42 HD11 ' CZ ' ' C' ' 19' ' ' PHE . 48.9 mt -61.88 -40.27 94.81 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.31 -45.19 95.46 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.452 HG23 ' N ' ' C' ' 26' ' ' VAL . 2.4 m -65.63 -45.2 92.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.831 -178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.452 ' N ' HG23 ' C' ' 25' ' ' VAL . 70.1 t -65.79 -45.35 91.88 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 28.1 p -64.77 -44.13 91.02 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.399 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 36.7 tp -63.39 -42.39 98.81 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.994 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.492 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.46 -45.73 91.74 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 -176.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.495 ' CD1' ' C ' ' C' ' 30' ' ' TRP . 0.0 OUTLIER -67.3 -37.48 83.44 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.168 179.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' C' ' 31' ' ' HIS . 0.6 OUTLIER -58.25 -41.24 83.79 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.492 HG22 ' O ' ' C' ' 29' ' ' ALA . 3.0 m -56.01 -6.68 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.156 -178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.576 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 8.8 mtmt -41.02 -55.15 2.63 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.607 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.02 -37.79 86.84 Favored Glycine 0 C--N 1.303 -1.281 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -58.44 -35.52 72.24 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.943 0.401 . . . . 0.0 110.314 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.603 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.07 -43.66 98.55 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 -177.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . 0.438 HG23 ' H ' ' C' ' 37' ' ' VAL . 0.0 OUTLIER -62.37 -46.31 90.04 Favored Pre-proline 0 N--CA 1.481 1.108 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -175.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.05 -35.56 98.11 Favored 'Trans proline' 0 N--CA 1.5 1.871 0 C-N-CA 122.575 2.183 . . . . 0.0 110.943 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.21 -37.35 92.82 Favored Glycine 0 C--N 1.3 -1.42 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.208 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.02 76.56 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.726 -0.237 . . . . 0.0 111.501 -177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . . . . . . . . . 30.9 p -41.43 109.44 0.12 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.884 0.373 . . . . 0.0 111.047 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -94.31 71.26 3.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.574 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.75 99.3 10.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.523 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t 58.35 62.47 1.98 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 76.5 mt -144.35 22.49 1.68 Allowed 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.992 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -48.37 -71.36 0.59 Allowed Glycine 0 C--N 1.301 -1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 19.7 m -138.37 -14.98 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.45 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.9 OUTLIER -49.15 -47.41 75.72 Favored Pre-proline 0 C--N 1.303 -1.438 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.636 -179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 35.4 Cg_exo -56.91 -39.63 90.03 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 122.045 1.83 . . . . 0.0 112.475 -179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.8 mt -55.07 -35.98 65.13 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -176.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' C' ' 51' ' ' LEU . 14.9 mt -56.46 -44.05 80.17 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.978 -1.089 . . . . 0.0 110.252 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.32 -42.17 95.05 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.371 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.511 HG11 ' CE2' ' E' ' 19' ' ' PHE . 3.2 t -60.81 -30.71 47.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.674 178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -53.43 -39.17 64.17 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.732 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.565 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.5 mp -57.12 -42.42 80.86 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.199 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 49.8 tp -67.58 -33.68 75.5 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 124.036 0.934 . . . . 0.0 112.621 177.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 57.3 ttt-85 -55.56 -43.41 99.14 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.9 Cg_endo -58.73 -39.29 83.49 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.913 1.719 . . . . 0.0 111.693 179.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.544 ' CG ' ' N ' ' C' ' 60' ' ' ARG . 58.2 t-80 50.17 173.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.002 178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' CG ' ' C' ' 59' ' ' HIS . 6.5 ptm180 -172.52 96.45 0.14 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.388 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.84 -10.33 5.41 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.977 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 14.7 mt -68.63 -32.05 71.63 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 120.929 0.395 . . . . 0.0 109.947 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.224 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.755 179.873 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.5 -103.98 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 120.777 0.322 . . . . 0.0 110.524 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -77.05 -38.11 53.34 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.425 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' D' ' 4' ' ' ASN . 1.7 m120 -44.2 -36.42 2.67 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.796 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.439 ' H ' HG23 ' D' ' 5' ' ' VAL . 1.3 t -64.89 -54.91 24.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . 0.455 HG22 ' CG1' ' E' ' 5' ' ' VAL . 40.5 mt -59.23 -35.31 57.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.114 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 60.3 t -58.72 -40.77 80.53 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.796 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.423 HD13 ' O ' ' D' ' 4' ' ' ASN . 6.2 mp -58.99 -40.01 83.55 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.092 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -61.17 -41.89 97.58 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.976 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.41 80.03 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.845 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.57 -40.42 83.06 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.431 -0.508 . . . . 0.0 110.277 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 41.1 t -61.65 -43.44 98.86 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.84 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.06 -39.62 86.66 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.03 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.32 -43.24 99.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -42.69 98.63 Favored Glycine 0 C--N 1.303 -1.258 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.437 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 39.0 t30 -62.09 -42.17 98.95 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.717 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -65.23 132.0 47.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.612 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -179.22 179.23 48.91 Favored Glycine 0 C--N 1.305 -1.14 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.447 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -80.83 -61.09 2.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.425 -0.388 . . . . 0.0 111.511 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -58.98 -40.56 85.19 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.686 -0.234 . . . . 0.0 111.145 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.437 ' CE2' ' OD1' ' D' ' 16' ' ' ASN . 69.9 t90 -59.22 -40.52 86.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.24 -40.46 97.37 Favored Glycine 0 C--N 1.304 -1.241 0 N-CA-C 110.989 -0.845 . . . . 0.0 110.989 -179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.556 ' O ' HG23 ' D' ' 27' ' ' THR . 56.7 mt -60.9 -37.78 83.43 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 32.4 tp -57.9 -43.17 85.98 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 14.6 t -61.0 -43.79 96.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 C-N-CA 119.784 -0.766 . . . . 0.0 111.268 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.15 -42.17 94.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.456 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.556 HG23 ' O ' ' D' ' 23' ' ' LEU . 73.8 p -62.6 -44.17 96.97 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.243 -178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 14.7 mt -61.44 -42.9 99.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.444 -179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -62.49 -44.94 95.16 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.876 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -64.46 -41.22 96.65 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . 0.492 ' CE1' ' NH2' ' D' ' 35' ' ' ARG . 18.1 t-160 -60.6 -42.66 97.21 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.3 m -65.04 -7.89 4.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 120.179 -0.608 . . . . 0.0 112.324 -177.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -47.29 -63.04 1.15 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.712 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.63 -37.34 82.67 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.492 ' NH2' ' CE1' ' D' ' 31' ' ' HIS . 55.9 mmt-85 -60.03 -37.65 80.43 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.179 0.514 . . . . 0.0 110.693 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.583 ' O ' HD23 ' D' ' 36' ' ' LEU . 0.8 OUTLIER -59.99 -42.35 94.02 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -177.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.482 ' H ' HG23 ' D' ' 37' ' ' VAL . 2.0 t -62.02 -46.31 91.74 Favored Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -176.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.5 Cg_endo -61.96 -34.65 80.54 Favored 'Trans proline' 0 N--CA 1.502 2.025 0 C-N-CA 122.457 2.105 . . . . 0.0 111.663 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.42 -40.19 97.28 Favored Glycine 0 C--N 1.3 -1.432 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.47 -42.84 88.39 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.103 -178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 62.6 p -68.55 108.24 3.24 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.947 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.542 ' O ' ' CD1' ' D' ' 42' ' ' TYR . 5.6 p90 -175.16 115.84 0.16 Allowed 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . 0.487 ' O ' HD12 ' D' ' 43' ' ' LEU . 0.3 OUTLIER -89.28 170.66 10.39 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.214 0.53 . . . . 0.0 109.742 179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 57.26 -166.52 0.14 Allowed 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.76 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt 58.18 48.08 13.37 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.546 -179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.17 -39.12 4.91 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 116.159 -0.473 . . . . 0.0 113.481 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 m -102.73 -28.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 117.91 0.855 . . . . 0.0 112.474 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.507 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 16.6 t-105 -57.41 -37.92 62.15 Favored Pre-proline 0 C--N 1.302 -1.458 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 32.4 Cg_exo -57.99 -50.61 9.71 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.169 1.246 . . . . 0.0 111.274 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.595 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -52.49 -38.57 59.79 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.604 -175.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.471 ' N ' HD12 ' D' ' 51' ' ' LEU . 11.3 mp -61.94 -45.31 94.26 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.003 -1.079 . . . . 0.0 112.284 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 12.0 mt -62.33 -45.09 94.78 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 120.079 -0.649 . . . . 0.0 112.119 -177.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -61.63 -31.22 50.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-O 120.891 0.377 . . . . 0.0 110.737 178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -53.92 -41.45 67.71 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.738 -177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.508 HD12 ' N ' ' D' ' 55' ' ' LEU . 11.0 mp -60.79 -44.6 96.61 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.061 -1.055 . . . . 0.0 108.535 178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.74 -30.83 70.4 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 125.759 1.623 . . . . 0.0 114.976 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -54.15 -39.58 75.36 Favored Pre-proline 0 C--N 1.305 -1.366 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 -172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.444 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 27.0 Cg_exo -60.82 -40.16 56.29 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.68 1.587 . . . . 0.0 110.647 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.424 ' O ' ' O ' ' D' ' 60' ' ' ARG . 6.9 t-80 44.97 47.38 9.37 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.831 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' D' ' 59' ' ' HIS . 19.5 ptt-85 -53.21 -170.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.322 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . -145.84 -1.3 0.78 Allowed 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 14.9 mt -79.39 27.33 0.26 Allowed 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.018 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.45 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.248 0 CA-C-O 117.961 -1.018 . . . . 0.0 110.558 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.71 -17.06 63.44 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.845 0.355 . . . . 0.0 110.51 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -79.64 64.92 4.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.357 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' E' ' 4' ' ' ASN . 5.3 p-10 -138.44 22.02 2.74 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.477 0.656 . . . . 0.0 109.492 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.455 ' CG1' HG22 ' D' ' 6' ' ' ILE . 0.0 OUTLIER -136.47 -67.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.552 ' H ' HD12 ' E' ' 6' ' ' ILE . 2.5 mp -58.47 -37.27 63.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.601 178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 9.7 p -60.8 -39.58 82.28 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.086 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.088 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 63' ' ' ALA . 4.0 mp -58.49 -40.09 81.85 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -61.32 -41.43 97.01 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.08 0.467 . . . . 0.0 110.323 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.21 79.8 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.609 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.81 -39.43 77.58 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.426 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.6 t -60.36 -41.44 93.71 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 120.354 -0.538 . . . . 0.0 109.816 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -39.03 78.94 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.956 -179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -40.7 93.01 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.46 -42.05 97.4 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.644 HD21 ' HE1' ' E' ' 21' ' ' TRP . 13.0 t-20 -60.79 -40.85 94.16 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.408 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -51.49 90.85 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.836 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -163.36 104.36 0.23 Allowed Glycine 0 C--N 1.303 -1.258 0 N-CA-C 110.609 -0.996 . . . . 0.0 110.609 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.511 ' CE2' HG11 ' C' ' 53' ' ' VAL . 0.8 OUTLIER -34.69 -39.88 0.1 Allowed 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 120.772 0.32 . . . . 0.0 111.689 -179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -60.63 -42.69 97.4 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.083 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.644 ' HE1' HD21 ' E' ' 16' ' ' ASN . 59.7 t-105 -60.97 -41.66 96.83 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.087 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . 0.404 ' O ' HG22 ' E' ' 25' ' ' VAL . . . -61.37 -39.46 97.29 Favored Glycine 0 C--N 1.304 -1.206 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.456 ' O ' HG23 ' E' ' 27' ' ' THR . 2.8 mt -60.24 -37.23 79.73 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.547 -0.326 . . . . 0.0 111.688 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 34.8 tp -57.33 -41.92 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.413 HG13 ' H ' ' E' ' 25' ' ' VAL . 1.1 m -59.82 -41.19 84.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 C-N-CA 119.895 -0.722 . . . . 0.0 111.949 -178.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.23 -42.63 96.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.456 HG23 ' O ' ' E' ' 23' ' ' LEU . 1.5 p -62.87 -43.66 98.19 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 120.466 -0.494 . . . . 0.0 111.952 -178.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 21.0 mt -61.51 -42.71 99.22 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.489 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -62.39 -41.97 99.07 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.123 -179.224 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.514 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.4 OUTLIER -65.18 -41.99 94.07 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -62.06 -42.25 99.0 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' E' ' 29' ' ' ALA . 16.5 m -59.84 -16.09 10.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -45.42 -58.0 3.67 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.631 -0.827 . . . . 0.0 109.911 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.05 -37.3 85.24 Favored Glycine 0 C--N 1.303 -1.283 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . 0.435 ' NH1' ' ND1' ' F' ' 31' ' ' HIS . 11.8 mmt85 -59.06 -36.31 74.83 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.867 0.365 . . . . 0.0 110.646 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.636 ' O ' HD23 ' E' ' 36' ' ' LEU . 1.0 OUTLIER -61.58 -44.24 97.39 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 115.297 1.592 . . . . 0.0 115.297 -177.046 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.81 -45.95 87.82 Favored Pre-proline 0 N--CA 1.483 1.218 0 O-C-N 121.174 -0.954 . . . . 0.0 113.53 -176.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.413 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.14 -35.42 97.86 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.806 2.337 . . . . 0.0 111.191 176.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.459 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . . . -60.3 -37.38 92.96 Favored Glycine 0 C--N 1.301 -1.415 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.411 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.18 -41.6 79.6 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 121.054 -0.258 . . . . 0.0 111.656 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 33.7 p -42.45 108.6 0.1 Allowed 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.779 -0.368 . . . . 0.0 110.981 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.572 ' CE1' ' NZ ' ' F' ' 33' ' ' LYS . 29.3 m-85 -100.88 73.72 1.58 Allowed 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.303 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' E' ' 43' ' ' LEU . 3.6 mm? -68.35 -103.07 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.24 0.543 . . . . 0.0 109.72 178.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 5.8 t -100.55 63.61 1.09 Allowed 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.841 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 24.9 mt -137.82 20.26 2.86 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.334 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.95 -69.6 1.08 Allowed Glycine 0 C--N 1.301 -1.376 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.704 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.85 -15.18 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.436 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 1.3 t-105 -47.83 -47.3 62.96 Favored Pre-proline 0 C--N 1.304 -1.382 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.523 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 43.2 Cg_exo -56.77 -40.96 80.52 Favored 'Trans proline' 0 N--CA 1.5 1.905 0 C-N-CA 122.077 1.851 . . . . 0.0 112.565 179.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 92.6 mt -55.56 -36.38 66.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.507 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -57.15 -43.45 82.49 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.462 -1.295 . . . . 0.0 109.005 -178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . 0.453 HD22 ' N ' ' E' ' 52' ' ' LEU . 3.6 mm? -60.16 -41.57 93.07 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.496 HG11 ' CE2' ' A' ' 19' ' ' PHE . 39.7 t -59.32 -31.84 47.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.224 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -54.45 -40.05 68.02 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.12 -178.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.36 -43.44 88.36 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.09 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 28.9 tp -67.16 -33.42 75.39 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 124.443 1.097 . . . . 0.0 113.217 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 37.9 ttm180 -56.42 -44.05 99.57 Favored Pre-proline 0 C--N 1.307 -1.264 0 N-CA-C 116.118 1.896 . . . . 0.0 116.118 -174.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.89 -41.01 57.62 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 CA-C-N 121.811 1.683 . . . . 0.0 111.811 179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.507 ' CG ' ' H ' ' E' ' 60' ' ' ARG . 21.4 t-80 48.24 177.04 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.507 ' H ' ' CG ' ' E' ' 59' ' ' HIS . 12.7 ptt85 -175.63 104.38 0.08 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.137 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -71.67 -10.51 59.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 39.7 mt -81.43 35.11 0.39 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.362 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 118.005 -0.997 . . . . 0.0 110.591 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.339 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.61 28.48 15.74 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 120.667 0.27 . . . . 0.0 110.661 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -162.43 -46.9 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.787 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -44.29 -28.16 0.5 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.218 0.532 . . . . 0.0 109.914 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.48 ' H ' HG23 ' F' ' 5' ' ' VAL . 1.6 t -66.43 -57.83 8.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.61 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.429 HG22 ' CG1' ' A' ' 5' ' ' VAL . 47.0 mt -59.36 -35.4 58.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.797 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 95.4 t -58.7 -40.81 80.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.156 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.68 -40.4 87.71 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.184 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -61.81 -41.56 97.92 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.149 0.5 . . . . 0.0 110.102 178.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.31 78.3 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.732 -178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.74 -39.39 77.22 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.329 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 42.3 t -60.79 -42.03 96.76 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.621 178.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.81 83.51 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.21 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.438 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.03 -41.82 97.3 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.12 -42.23 96.99 Favored Glycine 0 C--N 1.305 -1.169 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 62.7 m-20 -61.4 -41.56 97.34 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.478 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -64.18 122.35 16.42 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.67 176.16 47.82 Favored Glycine 0 C--N 1.306 -1.107 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.889 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CZ ' HD11 ' F' ' 23' ' ' LEU . 24.3 t80 -79.7 -60.57 2.3 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.335 -0.433 . . . . 0.0 111.708 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -59.78 -41.93 92.22 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.504 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.6 t-105 -60.94 -41.13 95.67 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . 0.403 ' O ' HG12 ' F' ' 25' ' ' VAL . . . -62.04 -40.87 99.48 Favored Glycine 0 C--N 1.305 -1.183 0 N-CA-C 111.61 -0.596 . . . . 0.0 111.61 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.413 HD11 ' CZ ' ' F' ' 19' ' ' PHE . 9.8 mt -60.52 -38.15 83.48 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tt -58.01 -42.23 84.81 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 113.858 1.058 . . . . 0.0 113.858 -176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . 0.419 ' CG1' ' N ' ' F' ' 26' ' ' VAL . 3.3 p -61.85 -43.41 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.709 -0.796 . . . . 0.0 112.646 -177.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' F' ' 25' ' ' VAL . 68.7 t -64.27 -43.76 97.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.618 HG22 HD12 ' E' ' 36' ' ' LEU . 75.3 p -63.46 -43.1 98.31 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 32.2 tp -61.03 -42.98 99.5 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.024 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.586 ' O ' HG12 ' F' ' 32' ' ' VAL . . . -63.16 -42.84 99.5 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.684 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.654 ' HE1' ' NZ ' ' F' ' 33' ' ' LYS . 0.5 OUTLIER -64.9 -42.54 94.67 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 112.621 0.601 . . . . 0.0 112.621 -179.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . 0.435 ' ND1' ' NH1' ' E' ' 35' ' ' ARG . 11.9 t-80 -61.28 -41.42 96.92 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.586 HG12 ' O ' ' F' ' 29' ' ' ALA . 2.2 p -58.57 -17.07 9.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.654 ' NZ ' ' HE1' ' F' ' 30' ' ' TRP . 28.3 mtpt -46.71 -60.41 2.41 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.96 -38.09 87.64 Favored Glycine 0 C--N 1.299 -1.475 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 8.1 tpp85 -61.31 -37.3 82.76 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 117.846 0.823 . . . . 0.0 110.807 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.566 ' O ' HD23 ' F' ' 36' ' ' LEU . 0.6 OUTLIER -59.42 -41.41 89.45 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -176.321 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.441 ' H ' HG23 ' F' ' 37' ' ' VAL . 2.3 t -60.74 -46.8 97.07 Favored Pre-proline 0 C--N 1.306 -1.304 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 27.9 Cg_endo -61.8 -34.78 81.85 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 121.801 1.668 . . . . 0.0 110.979 176.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.88 -37.98 93.38 Favored Glycine 0 C--N 1.303 -1.304 0 CA-C-N 114.623 -1.171 . . . . 0.0 111.0 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.3 79.98 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.17 -178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -91.34 97.67 11.24 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 121.031 -0.268 . . . . 0.0 111.298 -179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' F' ' 42' ' ' TYR . 4.5 p90 -120.02 -125.09 0.28 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.1 tp -175.05 118.89 0.18 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 19.9 p 61.44 -165.22 0.23 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.672 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 8.4 mt 76.23 31.25 0.65 Allowed 'General case' 0 C--N 1.31 -1.115 0 O-C-N 123.818 0.699 . . . . 0.0 110.132 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.91 -49.95 2.19 Favored Glycine 0 C--N 1.307 -1.053 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 4.6 m -140.31 71.89 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.693 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.6 t-105 -159.82 -43.32 0.0 OUTLIER Pre-proline 0 C--N 1.31 -1.13 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.5 Cg_exo -70.64 -28.73 20.67 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.869 1.712 . . . . 0.0 110.638 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.72 HD13 ' O ' ' F' ' 50' ' ' LEU . 0.7 OUTLIER -56.08 -36.57 68.27 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.481 -178.068 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.58 HD22 ' N ' ' F' ' 51' ' ' LEU . 3.7 mm? -57.27 -43.63 83.24 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 118.732 -1.187 . . . . 0.0 108.917 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.53 -41.66 94.89 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.19 -31.55 48.43 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.565 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.461 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 56.2 ttp180 -53.58 -38.9 64.36 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.995 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.532 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.8 mm? -56.33 -42.09 77.1 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.137 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 62.6 mt -67.99 -35.33 78.15 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 10.3 mmt180 -56.1 -45.43 99.91 Favored Pre-proline 0 N--CA 1.483 1.202 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 -172.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 27.4 Cg_exo -56.57 -41.07 79.89 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.284 1.322 . . . . 0.0 111.091 176.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.7 169.6 0.21 Allowed 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.292 -0.413 . . . . 0.0 109.916 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 37.1 mtp180 -144.83 -51.52 0.28 Allowed 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.506 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' F' ' 63' ' ' ALA . . . 57.99 -176.97 0.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.279 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.567 HD22 ' N ' ' F' ' 62' ' ' LEU . 3.5 mm? 52.87 18.28 1.03 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.421 ' N ' ' C ' ' F' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.259 0 CA-C-O 118.064 -0.97 . . . . 0.0 110.617 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.38 -2.9 30.66 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 120.729 0.3 . . . . 0.0 110.524 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 7' ' ' VAL . 6.1 tptm -160.3 -25.54 0.06 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.53 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -74.66 52.32 0.51 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.317 0.579 . . . . 0.0 110.151 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.0 OUTLIER -153.79 -70.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 32.5 mt -57.81 -36.94 57.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.431 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 8' ' ' LEU . 11.0 p -60.24 -41.66 87.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.041 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.512 ' N ' HG13 ' A' ' 7' ' ' VAL . 19.1 mt -60.36 -40.7 91.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.426 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 t30 -61.3 -41.9 97.75 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.188 0.518 . . . . 0.0 109.723 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.77 -41.33 86.37 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.631 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -40.21 83.63 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.385 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.9 t -60.86 -41.81 96.64 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.46 -38.78 78.26 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.587 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.48 -41.56 94.46 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.92 -42.63 96.85 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -61.59 -40.91 96.48 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 58.0 t-80 -58.19 108.58 0.62 Allowed 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . 178.84 117.89 0.55 Allowed Glycine 0 C--N 1.303 -1.253 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.598 ' CE1' HD11 ' A' ' 23' ' ' LEU . 2.5 t80 -34.61 -41.08 0.12 Allowed 'General case' 0 C--N 1.309 -1.171 0 C-N-CA 122.536 0.335 . . . . 0.0 111.499 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -60.79 -43.28 98.32 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.183 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.526 ' N ' ' O ' ' A' ' 18' ' ' GLY . 65.4 t-105 -60.95 -40.49 93.5 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.602 -179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.21 -39.25 94.31 Favored Glycine 0 C--N 1.302 -1.339 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.598 HD11 ' CE1' ' A' ' 19' ' ' PHE . 89.6 mt -59.78 -39.77 86.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.6 tp -60.23 -44.2 95.4 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.487 -0.485 . . . . 0.0 111.951 -178.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.9 t -62.58 -44.63 99.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.587 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.47 -42.72 96.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.071 0.463 . . . . 0.0 111.587 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.421 HG22 ' HG ' ' F' ' 36' ' ' LEU . 18.3 p -62.9 -44.24 96.62 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.322 -178.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 30.6 tp -62.45 -43.42 98.85 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.097 -0.641 . . . . 0.0 110.412 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.16 99.18 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.926 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' F' ' 39' ' ' GLY . 0.5 OUTLIER -65.07 -41.85 94.72 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -61.27 -41.08 96.32 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -177.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' H ' HG22 ' A' ' 32' ' ' VAL . 4.5 m -62.72 -13.57 11.76 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -46.39 -58.94 3.27 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.954 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.0 -37.5 85.63 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 79.8 mtt180 -60.44 -36.49 78.33 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.962 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.671 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.1 tt -59.65 -42.91 93.85 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 2.2 t -62.29 -46.2 90.44 Favored Pre-proline 0 C--N 1.307 -1.275 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.5 Cg_endo -61.78 -33.96 84.03 Favored 'Trans proline' 0 N--CA 1.501 1.946 0 C-N-CA 122.334 2.023 . . . . 0.0 111.269 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.87 -39.15 95.09 Favored Glycine 0 C--N 1.302 -1.354 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.633 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.03 -42.13 84.66 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.693 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 45.6 p -67.9 112.37 4.89 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.731 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.504 ' CD1' ' O ' ' A' ' 43' ' ' LEU . 3.7 p90 -172.68 135.32 0.66 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' TYR . 4.7 tp -56.09 -140.12 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.206 -179.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.448 ' H ' ' CG ' ' A' ' 43' ' ' LEU . 67.0 m -138.52 121.63 16.83 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.121 0.486 . . . . 0.0 111.654 -179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 45' ' ' LEU . 6.6 mp -85.95 -74.21 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.184 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.02 -50.43 0.8 Allowed Glycine 0 C--N 1.311 -0.853 0 CA-C-N 116.326 -0.397 . . . . 0.0 113.155 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.6 -14.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.488 ' CD1' ' C ' ' A' ' 48' ' ' TRP . 9.2 t-105 -57.37 -40.96 88.27 Favored Pre-proline 0 C--N 1.306 -1.306 0 C-N-CA 119.718 -0.793 . . . . 0.0 112.452 -178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 89.4 Cg_endo -83.85 -51.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.293 1.329 . . . . 0.0 112.219 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -54.84 -39.67 68.82 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.457 -175.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.7 tp -60.5 -46.7 89.17 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 118.709 -1.196 . . . . 0.0 110.74 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 52' ' ' LEU . 9.2 mp -61.94 -42.84 99.56 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 57' ' ' ARG . 96.5 t -60.12 -31.18 47.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.849 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -54.54 -41.17 69.42 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.071 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.547 ' N ' HD22 ' A' ' 55' ' ' LEU . 3.6 mm? -60.68 -45.1 95.42 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.186 -1.006 . . . . 0.0 108.519 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 56' ' ' LEU . 3.3 mm? -67.34 -33.25 74.86 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.81 1.244 . . . . 0.0 113.266 178.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.465 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 55.0 ttp180 -55.88 -44.01 99.48 Favored Pre-proline 0 C--N 1.306 -1.303 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 59' ' ' HIS . 22.6 Cg_endo -60.25 -41.4 51.13 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 CA-C-N 121.809 1.682 . . . . 0.0 111.362 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.466 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 t-160 52.59 166.21 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.685 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' D' ' 14' ' ' ALA . 13.9 ptp180 -175.17 134.93 0.33 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.68 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.92 1.1 57.47 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.667 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.42 ' O ' ' OXT' ' A' ' 63' ' ' ALA . 14.3 mt -82.34 8.46 11.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.475 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.42 ' OXT' ' O ' ' A' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.304 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.682 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.09 174.75 1.84 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.892 0.377 . . . . 0.0 110.65 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mmtm 48.47 -169.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.413 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 73.29 -56.2 0.66 Allowed 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -178.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.419 HG23 ' H ' ' B' ' 5' ' ' VAL . 3.6 t -59.46 -57.08 13.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.76 -35.46 55.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.468 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 39.8 t -58.69 -41.1 81.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.948 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.413 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.8 mp -57.41 -39.53 76.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.67 -39.63 89.1 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.374 0.607 . . . . 0.0 109.567 178.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.8 -41.91 78.59 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.377 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.62 74.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.584 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 52.0 p -60.73 -42.42 97.29 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.339 -0.545 . . . . 0.0 109.939 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.63 -39.89 81.8 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.098 -178.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -40.59 94.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -41.71 95.04 Favored Glycine 0 C--N 1.305 -1.172 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.338 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.431 ' O ' ' CB ' ' B' ' 21' ' ' TRP . 84.8 m-20 -60.51 -41.47 94.43 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 117.228 0.514 . . . . 0.0 110.395 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 1.4 t60 47.21 -175.2 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.833 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -128.12 -7.41 4.52 Favored Glycine 0 N--CA 1.471 1.027 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.13 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.667 ' CG ' ' N ' ' B' ' 20' ' ' PHE . 2.9 t80 -69.5 -98.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.066 0.433 . . . . 0.0 110.538 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.667 ' N ' ' CG ' ' B' ' 19' ' ' PHE . 0.1 OUTLIER -60.26 -41.72 93.84 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.388 -179.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.431 ' CB ' ' O ' ' B' ' 16' ' ' ASN . 62.9 t-105 -60.38 -40.64 91.6 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.388 -179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.88 -39.88 97.52 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.78 -39.01 83.47 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.81 -0.195 . . . . 0.0 110.998 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 27.2 tp -58.85 -42.56 89.61 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 t -64.19 -45.09 97.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.857 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 22.5 t -65.53 -45.5 92.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 9.7 t -64.58 -41.56 96.2 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.975 -178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 27.6 tp -59.99 -43.8 94.92 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.937 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.537 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.67 -44.46 93.68 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.401 -0.92 . . . . 0.0 110.295 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.71 -41.01 92.81 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 111.976 0.362 . . . . 0.0 111.976 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -59.4 -42.38 91.61 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.845 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.537 HG22 ' O ' ' B' ' 29' ' ' ALA . 28.4 m -65.16 2.73 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.377 -178.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -49.95 -65.89 0.49 Allowed 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.27 -37.52 81.33 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.767 -0.933 . . . . 0.0 110.767 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 81.4 mtt180 -61.8 -36.86 82.33 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.409 0.623 . . . . 0.0 110.298 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.473 ' CD1' HG21 ' C' ' 27' ' ' THR . 5.3 tt -60.26 -44.16 95.53 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.2 OUTLIER -64.02 -45.4 80.09 Favored Pre-proline 0 CA--C 1.561 1.38 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -177.148 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 36.8 Cg_endo -63.2 -35.67 62.3 Favored 'Trans proline' 0 N--CA 1.503 2.031 0 C-N-CA 122.133 1.889 . . . . 0.0 111.196 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.628 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.3 -38.99 95.47 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.339 -1.301 . . . . 0.0 110.666 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.477 ' O ' ' CD1' ' B' ' 42' ' ' TYR . . . -57.65 -40.33 79.02 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 47.7 p -71.7 120.36 17.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.687 -0.405 . . . . 0.0 111.925 -179.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.538 ' CD2' ' O ' ' B' ' 42' ' ' TYR . 50.6 p90 178.68 111.62 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.882 178.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.57 85.29 2.14 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.989 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.0 m 173.11 -170.64 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.399 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 65.93 43.45 3.03 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.5 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.89 -41.02 3.18 Favored Glycine 0 C--N 1.309 -0.965 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.504 HG22 ' O ' ' B' ' 47' ' ' VAL . 2.8 p -151.08 78.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.54 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 0.5 OUTLIER -168.3 -53.95 0.0 OUTLIER Pre-proline 0 C--N 1.313 -0.998 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.235 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.486 ' HD2' ' H ' ' B' ' 48' ' ' TRP . 94.5 Cg_endo -84.37 -32.28 0.4 Allowed 'Trans proline' 0 N--CA 1.487 1.102 0 C-N-CA 121.796 1.664 . . . . 0.0 111.109 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . 0.656 ' O ' HD13 ' B' ' 50' ' ' LEU . 0.3 OUTLIER -56.3 -37.33 69.74 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.713 -177.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.604 ' N ' HD12 ' B' ' 51' ' ' LEU . 9.4 mp -58.76 -45.04 90.65 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.11 -178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.04 -41.74 97.16 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.37 -30.23 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.448 177.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 50.1 ttm-85 -53.96 -39.9 66.36 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.159 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.7 -44.05 90.21 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.034 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 tp -67.59 -33.15 74.42 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 124.489 1.115 . . . . 0.0 113.198 177.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 61.6 ttt-85 -55.38 -43.76 99.29 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 -174.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 20.6 Cg_endo -59.61 -40.16 67.84 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 CA-C-N 121.747 1.66 . . . . 0.0 111.405 178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 64.17 159.88 0.1 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -143.21 -173.39 3.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.35 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 75.47 0.58 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.497 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 2.7 pp -159.54 -21.38 0.07 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.837 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.216 0 CA-C-O 117.962 -1.018 . . . . 0.0 111.008 179.664 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' C' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.68 14.19 0.29 Allowed 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 120.798 0.333 . . . . 0.0 110.621 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . 0.477 ' H ' ' C ' ' C' ' 1' ' ' GLY . 2.4 mmpt? -134.19 -34.04 0.99 Allowed 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.218 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -74.84 55.43 0.69 Allowed 'General case' 0 C--N 1.307 -1.282 0 CA-C-O 121.297 0.57 . . . . 0.0 110.026 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.62 -73.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.451 HG22 ' CG1' ' D' ' 5' ' ' VAL . 47.1 mt -59.12 -36.66 63.89 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.806 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . 0.472 HG13 ' N ' ' C' ' 8' ' ' LEU . 7.9 p -59.85 -40.76 83.62 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.129 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.55 HD22 ' HB3' ' E' ' 63' ' ' ALA . 39.3 mt -59.65 -40.16 86.77 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.482 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -61.1 -41.71 97.18 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.185 0.517 . . . . 0.0 109.854 179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' D' ' 5' ' ' VAL . . . -58.78 -41.54 86.89 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.828 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.43 85.18 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.417 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 58.2 p -61.1 -42.09 97.88 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.58 79.09 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.891 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.53 -41.62 94.81 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.81 -42.24 98.0 Favored Glycine 0 C--N 1.306 -1.114 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.427 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . 0.458 ' ND2' ' CE2' ' C' ' 21' ' ' TRP . 0.9 OUTLIER -61.55 -41.71 97.76 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.852 0.358 . . . . 0.0 110.878 179.73 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 45.0 m170 -61.8 117.18 5.53 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.566 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.09 169.11 41.96 Favored Glycine 0 C--N 1.306 -1.091 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.751 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -80.02 -60.14 2.45 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.448 -0.376 . . . . 0.0 111.517 179.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -57.71 -39.82 78.1 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.783 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . 0.458 ' CE2' ' ND2' ' C' ' 16' ' ' ASN . 79.7 t90 -59.17 -39.56 82.87 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.091 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.07 -38.95 96.4 Favored Glycine 0 C--N 1.305 -1.17 0 N-CA-C 112.107 -0.397 . . . . 0.0 112.107 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.63 ' O ' HG23 ' C' ' 27' ' ' THR . 9.7 mp -58.67 -39.54 80.94 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.655 0.264 . . . . 0.0 111.351 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.465 ' CD1' HG11 ' B' ' 32' ' ' VAL . 15.7 tp -60.0 -42.85 95.15 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.35 -46.07 94.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 8.1 t -65.86 -44.11 92.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 120.386 -0.525 . . . . 0.0 112.128 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.63 HG23 ' O ' ' C' ' 23' ' ' LEU . 70.0 p -62.73 -42.83 99.86 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.364 -0.834 . . . . 0.0 111.607 -178.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.28 -41.08 98.18 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.917 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' D' ' 24' ' ' LEU . . . -61.26 -48.41 81.54 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.786 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.628 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.6 OUTLIER -68.74 -38.35 80.08 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.999 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -59.0 -42.57 90.39 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' C' ' 29' ' ' ALA . 4.5 m -55.91 -9.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.686 -0.806 . . . . 0.0 111.205 -178.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -43.59 -57.18 3.28 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.618 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.58 -37.66 83.87 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.581 -0.607 . . . . 0.0 111.581 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -58.52 -36.77 74.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.09 0.472 . . . . 0.0 110.336 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.62 HD23 ' O ' ' C' ' 36' ' ' LEU . 0.9 OUTLIER -61.77 -43.89 97.97 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.095 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.59 -46.06 88.95 Favored Pre-proline 0 N--CA 1.483 1.201 0 CA-C-N 119.331 0.969 . . . . 0.0 113.533 -175.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.64 -35.75 94.22 Favored 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 122.616 2.21 . . . . 0.0 111.016 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.97 -37.08 93.24 Favored Glycine 0 C--N 1.3 -1.423 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.552 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.488 ' O ' ' O ' ' C' ' 41' ' ' THR . . . -56.29 -41.1 75.36 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 111.833 0.308 . . . . 0.0 111.833 -177.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.55 ' O ' ' CD2' ' C' ' 42' ' ' TYR . 56.2 p -48.97 -104.99 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.759 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' C' ' 41' ' ' THR . 0.7 OUTLIER 52.43 114.8 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.477 0.656 . . . . 0.0 111.558 179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' C' ' 42' ' ' TYR . 20.3 mt -59.18 -141.6 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.213 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 59.6 p -62.91 145.67 54.67 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.505 -179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 171.89 49.22 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -98.02 -37.8 4.28 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 115.945 -0.57 . . . . 0.0 113.935 -178.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 17.5 m -105.44 -32.48 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 CA-C-N 118.147 0.974 . . . . 0.0 112.976 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.537 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 7.3 t-105 -56.87 -37.45 57.96 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 22.3 Cg_exo -64.44 -53.45 1.07 Allowed 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.687 1.591 . . . . 0.0 111.72 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . 0.452 HD22 ' N ' ' C' ' 50' ' ' LEU . 3.9 mm? -52.92 -37.66 61.04 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.753 -175.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.38 -43.84 92.85 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 117.758 -1.577 . . . . 0.0 109.185 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . 0.501 ' N ' HD22 ' C' ' 52' ' ' LEU . 3.4 mm? -63.2 -46.15 88.39 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 120.615 -0.434 . . . . 0.0 111.956 -179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.429 HG13 ' O ' ' C' ' 49' ' ' PRO . 1.0 OUTLIER -62.29 -32.45 54.89 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.054 0 CA-C-O 120.771 0.32 . . . . 0.0 111.077 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 57.7 ttt85 -54.79 -41.12 70.18 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.812 -178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.18 -43.91 92.16 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.908 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . 0.519 ' O ' ' CD2' ' C' ' 59' ' ' HIS . 45.7 tp -68.01 -33.23 74.22 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 124.419 1.088 . . . . 0.0 112.998 177.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.472 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 60.1 ttm-85 -55.42 -43.59 99.21 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 115.902 1.816 . . . . 0.0 115.902 -173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 21.1 Cg_endo -59.69 -39.71 71.16 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 CA-C-N 121.834 1.691 . . . . 0.0 111.793 178.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.519 ' CD2' ' O ' ' C' ' 56' ' ' LEU . 59.5 m-70 54.4 165.51 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.041 0.448 . . . . 0.0 110.214 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -175.49 89.11 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.246 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -48.2 -32.15 6.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.477 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.423 ' O ' ' OXT' ' C' ' 63' ' ' ALA . 23.6 mt -77.58 31.76 0.16 Allowed 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.175 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.474 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.643 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.1 63.69 0.7 Allowed 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.839 0.352 . . . . 0.0 110.573 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 29.8 mmtt -139.72 -177.83 5.14 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.318 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 66.35 32.09 7.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.346 0.593 . . . . 0.0 110.214 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.451 ' CG1' HG22 ' C' ' 6' ' ' ILE . 0.0 OUTLIER -146.84 -68.02 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 51.4 mt -58.89 -37.56 67.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . 0.433 HG13 ' N ' ' D' ' 8' ' ' LEU . 13.9 p -60.9 -39.93 83.65 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.965 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.434 HD21 ' N ' ' F' ' 63' ' ' ALA . 4.2 mp -59.8 -40.42 88.29 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.845 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.26 -41.66 97.31 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.171 0.51 . . . . 0.0 110.274 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.64 -39.74 77.68 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.73 -178.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.67 -40.63 84.1 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.425 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -61.34 -42.46 98.72 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.859 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.51 79.1 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.47 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 60' ' ' ARG . . . -60.32 -41.09 92.8 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.58 97.81 Favored Glycine 0 C--N 1.305 -1.176 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.427 ' OD1' ' CE2' ' D' ' 21' ' ' TRP . 11.7 t30 -61.82 -41.18 97.47 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 120.753 0.311 . . . . 0.0 110.931 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 48.6 m170 -49.7 101.57 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.893 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . . . . . . . . . . . -172.02 119.55 0.78 Allowed Glycine 0 C--N 1.303 -1.276 0 N-CA-C 110.267 -1.133 . . . . 0.0 110.267 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -44.31 -34.83 2.08 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 122.871 -0.194 . . . . 0.0 111.238 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.587 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 26.3 p90 -60.01 -41.39 92.03 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.841 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.587 ' N ' ' CD1' ' D' ' 20' ' ' PHE . 34.9 t90 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.261 0.553 . . . . 0.0 110.366 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.63 -37.67 92.61 Favored Glycine 0 C--N 1.298 -1.546 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.639 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 65.0 mt -58.4 -39.79 80.64 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . 0.715 ' H ' HD12 ' D' ' 24' ' ' LEU . 6.0 mp -59.31 -42.41 91.31 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.542 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.405 HG23 ' H ' ' D' ' 25' ' ' VAL . 3.7 t -62.41 -45.96 97.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 120.256 -0.578 . . . . 0.0 112.427 -177.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 87.2 t -66.21 -44.29 91.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.772 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 61.9 m -63.82 -44.96 91.7 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.581 -178.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.61 -42.45 99.59 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.408 -178.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.473 ' HB2' HD21 ' E' ' 24' ' ' LEU . . . -62.0 -42.25 98.95 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.501 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -42.25 95.95 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 120.893 0.378 . . . . 0.0 111.97 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -62.04 -42.36 99.1 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 14.0 m -63.65 -15.26 16.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -177.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -46.18 -59.9 2.62 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.567 179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.18 -37.0 85.03 Favored Glycine 0 C--N 1.302 -1.334 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' D' ' 38' ' ' PRO . 8.8 tpm_? -61.4 -38.69 88.0 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.998 0.428 . . . . 0.0 111.327 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.601 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.3 tt -61.13 -44.13 97.81 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -176.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.458 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 0.2 OUTLIER -63.01 -44.87 86.15 Favored Pre-proline 0 C--N 1.305 -1.33 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -177.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 32.7 Cg_endo -62.34 -34.56 76.92 Favored 'Trans proline' 0 N--CA 1.5 1.904 0 C-N-CA 122.048 1.832 . . . . 0.0 110.876 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.17 -39.48 95.95 Favored Glycine 0 C--N 1.302 -1.334 0 CA-C-N 114.384 -1.28 . . . . 0.0 110.384 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.1 87.89 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.884 -0.326 . . . . 0.0 111.648 -178.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . 0.49 ' O ' ' CG ' ' D' ' 42' ' ' TYR . 47.4 p -65.42 123.53 19.88 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.024 0.44 . . . . 0.0 112.136 -178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.49 ' CG ' ' O ' ' D' ' 41' ' ' THR . 15.8 m-85 -168.52 105.1 0.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.251 178.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -89.32 44.6 1.22 Allowed 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.958 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 11.9 p -177.75 179.99 0.84 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.818 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 26.2 mt 62.63 46.9 5.14 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.231 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -80.19 -51.25 5.08 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 113.088 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 t -110.3 -25.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.474 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 2.1 t-105 -55.12 -41.46 90.77 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-O 119.488 -0.291 . . . . 0.0 111.735 -179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.474 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 47.7 Cg_exo -55.81 -49.63 15.1 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.478 1.452 . . . . 0.0 111.914 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.648 ' O ' HD13 ' D' ' 50' ' ' LEU . 0.2 OUTLIER -55.23 -38.11 68.05 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.478 -176.662 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.67 -44.23 90.15 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.74 -1.184 . . . . 0.0 109.816 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' D' ' 52' ' ' LEU . 3.4 mm? -60.42 -41.91 94.95 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 96.4 t -59.96 -31.62 48.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.847 178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . 0.407 ' O ' ' HD3' ' D' ' 58' ' ' PRO . 17.0 tpt180 -54.26 -40.39 67.74 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.92 -178.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' D' ' 58' ' ' PRO . 36.0 mt -60.11 -44.43 94.87 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 118.967 -1.093 . . . . 0.0 108.967 179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . . . . . . . . . 61.5 mt -68.36 -32.68 72.95 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 115.546 1.684 . . . . 0.0 115.546 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.522 ' NE ' ' O ' ' D' ' 57' ' ' ARG . 0.0 OUTLIER -55.72 -42.54 96.57 Favored Pre-proline 0 C--N 1.308 -1.233 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 -172.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.46 ' O ' ' O ' ' D' ' 59' ' ' HIS . 33.5 Cg_exo -59.74 -41.84 51.62 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 121.606 1.537 . . . . 0.0 111.368 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' D' ' 58' ' ' PRO . 1.9 t-80 50.47 170.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.684 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -173.49 -162.8 0.16 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.416 -179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -160.36 4.59 0.08 Allowed 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.648 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.577 HD22 ' N ' ' D' ' 62' ' ' LEU . 3.5 mm? -86.22 30.23 0.7 Allowed 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.049 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.427 ' OXT' ' O ' ' D' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.306 -1.293 0 CA-C-O 118.011 -0.995 . . . . 0.0 110.67 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.28 -45.86 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.785 0.326 . . . . 0.0 110.476 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.4 ' O ' HG23 ' E' ' 5' ' ' VAL . 0.6 OUTLIER -89.87 -177.49 5.24 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.01 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . 0.48 ' O ' HD13 ' E' ' 8' ' ' LEU . 7.5 t-20 70.11 11.41 7.6 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.083 -179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.4 HG23 ' O ' ' E' ' 3' ' ' LYS . 0.2 OUTLIER -118.99 -69.93 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 49.9 mt -58.56 -34.33 50.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 t -58.48 -41.15 80.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.086 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.566 ' N ' HD12 ' E' ' 8' ' ' LEU . 7.9 mp -59.64 -40.7 88.54 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.888 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -61.38 -39.79 91.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.454 0.645 . . . . 0.0 109.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.02 -41.35 78.41 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.832 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.89 -39.86 78.87 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.034 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 33.3 t -61.27 -41.69 97.36 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.0 -38.74 76.7 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.18 -41.69 93.42 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.93 96.71 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -61.51 -40.94 96.42 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.235 178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -70.46 116.68 11.08 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.868 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . 170.24 124.42 0.74 Allowed Glycine 0 C--N 1.304 -1.236 0 N-CA-C 110.764 -0.934 . . . . 0.0 110.764 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.41 ' C ' ' O ' ' E' ' 18' ' ' GLY . 0.0 OUTLIER -33.32 -41.73 0.08 Allowed 'General case' 0 C--N 1.31 -1.127 0 C-N-CA 122.648 0.379 . . . . 0.0 111.702 -179.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . 0.405 ' N ' ' CD1' ' E' ' 19' ' ' PHE . 10.4 m-85 -59.64 -42.88 93.73 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.775 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.539 ' N ' ' O ' ' E' ' 18' ' ' GLY . 53.8 t-105 -61.72 -38.13 86.78 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.848 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -57.32 -37.69 82.58 Favored Glycine 0 C--N 1.302 -1.335 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.54 ' O ' HG23 ' E' ' 27' ' ' THR . 9.9 mp -58.43 -36.42 73.61 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 122.972 -0.134 . . . . 0.0 111.213 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . 0.495 HD22 ' N ' ' E' ' 24' ' ' LEU . 3.5 mm? -57.41 -45.34 84.69 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -177.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . 0.435 ' CG2' ' N ' ' E' ' 26' ' ' VAL . 1.2 m -63.51 -45.01 98.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.607 -0.837 . . . . 0.0 112.746 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . 0.435 ' N ' ' CG2' ' E' ' 25' ' ' VAL . 91.8 t -65.08 -43.3 95.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.54 HG23 ' O ' ' E' ' 23' ' ' LEU . 67.0 p -63.09 -45.5 91.82 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 46.5 mt -63.32 -43.52 97.55 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.148 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.46 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -63.77 -43.56 96.03 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.508 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.5 OUTLIER -65.57 -42.72 91.48 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -61.75 -41.62 97.91 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 -177.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.548 ' HB ' HG21 ' F' ' 27' ' ' THR . 20.7 m -64.79 -14.12 15.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -177.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . 0.412 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 28.9 ttmt -44.89 -57.51 3.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.03 -0.668 . . . . 0.0 110.251 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.416 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.96 -37.73 91.72 Favored Glycine 0 C--N 1.302 -1.333 0 N-CA-C 111.286 -0.726 . . . . 0.0 111.286 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -59.21 -36.93 76.27 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.587 ' O ' HD23 ' E' ' 36' ' ' LEU . 0.9 OUTLIER -62.42 -43.4 98.9 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -177.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -46.08 87.44 Favored Pre-proline 0 N--CA 1.484 1.273 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.416 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.2 Cg_exo -59.33 -35.51 96.63 Favored 'Trans proline' 0 N--CA 1.501 1.921 0 C-N-CA 123.041 2.494 . . . . 0.0 111.405 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.553 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -61.0 -38.94 96.35 Favored Glycine 0 C--N 1.299 -1.48 0 CA-C-N 114.689 -1.142 . . . . 0.0 110.881 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.04 76.59 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -177.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . 0.449 ' O ' ' NZ ' ' F' ' 33' ' ' LYS . 37.0 p -45.78 119.2 2.1 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.302 -0.559 . . . . 0.0 110.589 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . 0.403 ' CD2' ' NZ ' ' F' ' 33' ' ' LYS . 2.0 m-85 -126.52 83.3 2.15 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.089 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.554 HD22 ' N ' ' E' ' 43' ' ' LEU . 3.4 mm? -66.5 -82.49 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.691 0.757 . . . . 0.0 109.344 178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 11.9 m -101.91 -147.48 0.37 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.654 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . . . . . . . . . 5.3 mt 70.75 46.83 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -54.91 -70.98 0.79 Allowed Glycine 0 C--N 1.303 -1.26 0 N-CA-C 111.985 -0.446 . . . . 0.0 111.985 -179.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 33.8 m -140.37 -6.36 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.462 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.8 OUTLIER -50.71 -47.61 84.93 Favored Pre-proline 0 C--N 1.303 -1.453 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.113 -179.7 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.462 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 32.1 Cg_exo -55.65 -40.79 83.27 Favored 'Trans proline' 0 N--CA 1.5 1.863 0 C-N-CA 121.96 1.773 . . . . 0.0 112.611 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 5.1 mt -55.77 -35.49 66.3 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -176.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 16.5 mt -56.45 -43.92 80.0 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.818 -178.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 14.9 mt -60.84 -42.48 97.84 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.29 -31.22 47.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.861 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -54.76 -40.56 69.47 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.405 -177.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.43 -44.34 92.93 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.264 -0.974 . . . . 0.0 108.951 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.543 HD22 ' N ' ' E' ' 56' ' ' LEU . 3.4 mm? -67.53 -33.15 74.47 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 124.547 1.139 . . . . 0.0 113.138 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.466 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 44.0 ttp180 -55.98 -43.77 99.38 Favored Pre-proline 0 C--N 1.304 -1.377 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -174.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 22.1 Cg_endo -59.96 -40.74 59.36 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 CA-C-N 121.794 1.676 . . . . 0.0 111.79 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' E' ' 58' ' ' PRO . 2.0 t-80 54.89 162.59 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.564 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 38.9 mtt85 -147.43 -177.64 5.81 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.431 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -147.14 4.05 0.81 Allowed 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . 0.539 HD22 ' N ' ' E' ' 62' ' ' LEU . 3.3 mm? -79.13 -54.85 5.58 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.55 ' HB3' HD22 ' C' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.309 -1.195 0 CA-C-O 118.087 -0.958 . . . . 0.0 111.036 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . -176.55 -86.15 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 120.79 0.329 . . . . 0.0 110.559 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? 52.98 177.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.169 -0.468 . . . . 0.0 109.943 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.424 ' H ' HG23 ' F' ' 7' ' ' VAL . 2.0 m120 70.07 -61.85 0.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.476 ' H ' HG23 ' F' ' 5' ' ' VAL . 2.0 t -60.27 -52.34 62.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.436 HG22 ' CG1' ' A' ' 5' ' ' VAL . 51.6 mt -60.11 -36.38 67.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.089 179.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . 0.424 HG23 ' H ' ' F' ' 4' ' ' ASN . 33.3 t -58.63 -40.35 78.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.983 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 8.0 mp -58.19 -39.73 79.73 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -61.45 -41.51 97.32 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.1 0.476 . . . . 0.0 110.228 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.9 -40.87 81.38 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.221 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.19 -39.49 79.08 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.151 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 51.4 p -60.85 -42.16 97.26 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 120.53 -0.468 . . . . 0.0 109.758 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.17 -38.79 80.63 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.178 -179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.29 -42.1 94.77 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.33 -41.91 97.14 Favored Glycine 0 C--N 1.304 -1.201 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.327 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -61.5 -41.82 97.87 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.916 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -67.85 124.61 23.82 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.536 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.15 -179.29 48.91 Favored Glycine 0 C--N 1.308 -1.023 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.844 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -78.33 -58.6 3.17 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.274 -0.463 . . . . 0.0 111.571 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -59.29 -40.92 87.68 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -178.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . . . . . . . . . 74.1 t90 -59.85 -39.96 86.94 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 121.006 -0.278 . . . . 0.0 111.68 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.38 97.25 Favored Glycine 0 C--N 1.305 -1.193 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -60.66 -38.5 85.08 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 120.538 0.209 . . . . 0.0 111.202 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 40.3 tp -59.53 -44.99 93.04 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 m -63.68 -43.47 98.1 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 C-N-CA 119.904 -0.718 . . . . 0.0 112.755 -178.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 93.8 t -64.04 -43.7 97.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.548 HG21 ' HB ' ' E' ' 32' ' ' VAL . 89.2 m -63.66 -43.06 97.84 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 22.7 mt -60.85 -43.24 98.58 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.083 -179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.451 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.32 -42.22 98.97 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.141 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.8 OUTLIER -65.44 -41.87 93.03 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 56.9 t60 -60.95 -41.81 97.03 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.451 HG22 ' O ' ' F' ' 29' ' ' ALA . 16.4 m -64.12 -5.35 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 C-N-CA 120.176 -0.609 . . . . 0.0 112.165 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . 0.449 ' NZ ' ' O ' ' E' ' 41' ' ' THR . 28.8 ttpt -48.95 -61.99 1.77 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.537 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.1 -36.76 83.34 Favored Glycine 0 C--N 1.302 -1.338 0 N-CA-C 110.624 -0.991 . . . . 0.0 110.624 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -61.05 -37.63 83.3 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 120.919 0.39 . . . . 0.0 111.457 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.651 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.9 tt -60.59 -44.79 95.85 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -176.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.47 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 0.2 OUTLIER -63.73 -44.91 81.53 Favored Pre-proline 0 CA--C 1.562 1.411 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 34.2 Cg_endo -62.45 -34.56 75.81 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.329 2.019 . . . . 0.0 111.214 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . 0.54 ' O ' ' CD1' ' A' ' 30' ' ' TRP . . . -60.36 -40.03 96.96 Favored Glycine 0 C--N 1.299 -1.497 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.282 179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.97 -40.89 81.72 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.653 -0.273 . . . . 0.0 111.404 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 34.7 p -86.9 110.99 20.37 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 120.806 0.336 . . . . 0.0 110.977 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' F' ' 42' ' ' TYR . 35.5 p90 -163.45 108.43 1.07 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.119 0.485 . . . . 0.0 110.28 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.38 148.86 50.1 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.8 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . . . . . . . . . 7.7 p 68.57 173.64 0.29 Allowed 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.77 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 11.8 mt 69.18 36.36 2.42 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.784 -0.643 . . . . 0.0 109.731 -178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.58 -46.69 2.27 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.3 m -143.6 74.06 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.679 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 1.9 t-105 -163.21 -42.34 0.0 OUTLIER Pre-proline 0 C--N 1.309 -1.175 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.679 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 13.1 Cg_exo -70.76 -29.43 19.1 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.933 1.756 . . . . 0.0 110.392 178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . . . . . . . . . 30.4 mt -55.67 -35.4 65.95 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.998 -178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . 0.638 HD12 ' N ' ' F' ' 51' ' ' LEU . 8.2 mp -56.15 -42.94 77.77 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.853 -1.139 . . . . 0.0 109.038 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.14 -41.7 97.21 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -59.41 -30.48 44.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.177 178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -53.61 -39.74 65.16 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.534 HD22 ' N ' ' F' ' 55' ' ' LEU . 3.6 mm? -59.62 -45.18 92.72 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 90.7 mt -67.32 -33.14 74.64 Favored 'General case' 0 C--N 1.308 -1.219 0 C-N-CA 124.495 1.118 . . . . 0.0 113.461 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.468 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 24.3 ttm180 -54.89 -44.0 99.18 Favored Pre-proline 0 C--N 1.306 -1.298 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -174.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 21.5 Cg_endo -60.28 -40.33 59.92 Favored 'Trans proline' 0 N--CA 1.495 1.566 0 CA-C-N 121.719 1.65 . . . . 0.0 110.622 177.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 56.95 65.25 1.44 Allowed 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.785 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . 0.4 ' HG2' ' H ' ' F' ' 60' ' ' ARG . 32.7 ptt85 -61.17 -168.26 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.36 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -159.46 -152.22 0.3 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.417 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.529 ' N ' HD12 ' F' ' 62' ' ' LEU . 10.0 mp 49.22 34.66 6.36 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 110.065 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . 0.434 ' N ' HD21 ' D' ' 8' ' ' LEU . . . . . . . . 0 C--N 1.308 -1.214 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.803 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.08 21.21 1.69 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 120.628 0.251 . . . . 0.0 110.652 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' NZ ' ' N ' ' B' ' 2' ' ' ALA . 74.6 tttt -164.13 -34.89 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.833 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.602 HD22 ' N ' ' A' ' 4' ' ' ASN . 1.1 m120 -47.93 -29.92 3.78 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.081 0.467 . . . . 0.0 109.826 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' CG1' HG22 ' F' ' 6' ' ' ILE . 0.6 OUTLIER -66.89 -54.41 25.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.273 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.447 HG22 ' CG1' ' B' ' 5' ' ' VAL . 44.1 mt -58.38 -35.8 55.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.732 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 79.7 t -59.05 -40.76 81.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.076 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.1 mp -58.73 -40.02 82.55 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.254 -0.579 . . . . 0.0 109.743 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.403 ' ND2' ' OD1' ' B' ' 9' ' ' ASN . 0.5 OUTLIER -61.2 -41.25 96.5 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-O 121.092 0.472 . . . . 0.0 110.173 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.45 -40.48 78.58 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.365 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' D' ' 59' ' ' HIS . . . -57.73 -38.84 76.0 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.762 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.4 t -60.05 -42.5 94.58 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.176 -0.61 . . . . 0.0 110.02 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.511 ' O ' ' CE1' ' A' ' 17' ' ' HIS . . . -59.4 -40.02 85.28 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.3 -40.0 92.53 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.412 0.625 . . . . 0.0 109.332 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.81 -41.04 95.83 Favored Glycine 0 C--N 1.303 -1.26 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.983 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -60.4 -41.08 93.1 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 120.849 0.357 . . . . 0.0 110.759 179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.511 ' CE1' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -48.43 97.43 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.033 0.444 . . . . 0.0 110.828 -179.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.81 118.04 0.73 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.41 ' CZ ' HG11 ' E' ' 53' ' ' VAL . 0.3 OUTLIER -44.68 -38.23 4.23 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.554 0.216 . . . . 0.0 110.929 -179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -60.91 -44.53 97.04 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.872 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 68.0 t-105 -61.57 -42.28 98.62 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.928 0.394 . . . . 0.0 110.991 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.33 -40.36 98.51 Favored Glycine 0 C--N 1.304 -1.235 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.89 -39.7 92.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 -179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' CD1' HG11 ' F' ' 32' ' ' VAL . 37.2 tp -60.94 -45.34 95.11 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' A' ' 26' ' ' VAL . 2.3 p -62.81 -44.21 99.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.456 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' A' ' 25' ' ' VAL . 57.6 t -64.43 -42.02 94.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 CA-C-O 120.991 0.424 . . . . 0.0 110.841 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.501 HG21 ' HB ' ' F' ' 32' ' ' VAL . 77.0 m -62.16 -43.87 97.87 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.798 -178.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 28' ' ' LEU . 0.2 OUTLIER -61.55 -41.97 98.14 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.992 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -60.91 -41.66 96.56 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.47 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.405 ' CH2' ' CE2' ' B' ' 20' ' ' PHE . 1.1 m-90 -63.52 -41.7 98.48 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -61.55 -42.04 98.25 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 29' ' ' ALA . 16.0 m -63.72 -13.75 13.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -45.61 -60.18 2.33 Favored 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 120.016 -0.674 . . . . 0.0 110.069 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.21 -37.62 87.31 Favored Glycine 0 C--N 1.301 -1.388 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -60.27 -36.97 79.03 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.587 ' O ' HD23 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -59.28 -42.34 91.02 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 -176.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.8 t -62.29 -46.57 90.53 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 115.168 1.544 . . . . 0.0 115.168 -176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 30.6 Cg_endo -62.01 -34.71 79.89 Favored 'Trans proline' 0 N--CA 1.504 2.111 0 C-N-CA 122.384 2.056 . . . . 0.0 111.612 177.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' O ' ' CD1' ' B' ' 30' ' ' TRP . . . -59.96 -39.05 95.08 Favored Glycine 0 C--N 1.301 -1.387 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.25 84.69 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.814 -0.355 . . . . 0.0 110.733 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 41' ' ' THR . 5.0 p -99.24 95.64 7.21 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 120.717 0.294 . . . . 0.0 110.582 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.498 ' N ' ' CD1' ' A' ' 42' ' ' TYR . 5.7 p90 -110.48 -129.11 0.29 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.438 -179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.529 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.8 mm? -97.49 -94.06 0.22 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.212 0.53 . . . . 0.0 111.094 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 43' ' ' LEU . 2.0 m 162.79 77.07 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.312 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.674 ' N ' HD12 ' A' ' 45' ' ' LEU . 8.0 mp -94.26 -67.27 0.86 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.67 -39.06 1.94 Allowed Glycine 0 C--N 1.305 -1.149 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.75 178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.9 m -97.95 -27.76 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 117.095 0.447 . . . . 0.0 112.18 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.48 ' CB ' HD23 ' A' ' 45' ' ' LEU . 74.3 t-105 -65.53 -38.8 28.28 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -178.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 64.8 Cg_endo -76.97 -65.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 121.168 1.245 . . . . 0.0 112.4 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.9 mt -54.92 -38.73 68.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -176.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.0 tp -60.43 -45.55 93.22 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.082 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 52' ' ' LEU . 80.5 mt -60.76 -40.67 93.36 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.428 ' O ' ' N ' ' A' ' 57' ' ' ARG . 90.4 t -58.62 -33.1 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.058 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.7 ttp180 -55.17 -41.73 72.24 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.336 -0.545 . . . . 0.0 109.986 -178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.1 tp -60.86 -45.09 95.89 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.4 mt -67.4 -33.36 75.02 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 124.718 1.207 . . . . 0.0 113.575 178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 47.3 ttp180 -56.03 -44.25 99.61 Favored Pre-proline 0 C--N 1.306 -1.309 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -174.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 24.4 Cg_endo -60.72 -41.56 45.7 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 121.735 1.655 . . . . 0.0 111.067 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 58' ' ' PRO . 0.5 OUTLIER 51.35 169.12 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.803 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.5 ptt85 -173.75 179.92 1.92 Allowed 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.044 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.11 -1.52 4.05 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.547 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 39.4 mt -69.41 -39.6 77.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.253 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.253 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.805 179.88 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.444 ' C ' ' HZ2' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.513 ' N ' ' NZ ' ' A' ' 3' ' ' LYS . . . -172.12 -39.99 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 CA-C-O 120.795 0.331 . . . . 0.0 110.561 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.401 ' O ' HG23 ' B' ' 5' ' ' VAL . 39.5 mmtm -83.65 -164.05 0.85 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.476 ' O ' HD13 ' B' ' 8' ' ' LEU . 0.8 OUTLIER 75.47 -2.72 2.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.061 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.447 ' CG1' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.97 -65.25 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.528 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 49.1 mt -58.4 -33.93 49.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.299 178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.438 ' CG2' ' H ' ' B' ' 4' ' ' ASN . 3.5 t -58.36 -41.96 82.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.214 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.563 HD12 ' N ' ' B' ' 8' ' ' LEU . 8.5 mp -59.36 -40.93 88.05 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.093 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . 0.403 ' OD1' ' ND2' ' A' ' 9' ' ' ASN . 36.7 m-20 -61.45 -39.2 89.99 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-O 121.469 0.652 . . . . 0.0 109.601 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' E' ' 63' ' ' ALA . . . -56.58 -41.97 77.86 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.766 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.4 -39.43 76.11 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.921 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 7.9 t -60.9 -43.0 99.11 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.363 178.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.73 -40.43 88.0 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.088 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -41.57 95.38 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . 0.518 ' O ' ' ND1' ' B' ' 17' ' ' HIS . . . -59.37 -41.99 97.23 Favored Glycine 0 C--N 1.304 -1.206 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.775 -178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.538 ' O ' ' CG ' ' B' ' 17' ' ' HIS . 6.6 m-20 -60.95 -41.56 96.53 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 117.124 0.462 . . . . 0.0 111.052 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.538 ' CG ' ' O ' ' B' ' 16' ' ' ASN . 10.1 p-80 42.74 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.035 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -129.27 -3.13 5.33 Favored Glycine 0 N--CA 1.472 1.097 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.564 -178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.426 ' HB3' ' H ' ' B' ' 20' ' ' PHE . 1.4 t80 -73.35 -93.04 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 117.327 0.563 . . . . 0.0 110.33 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.426 ' H ' ' HB3' ' B' ' 19' ' ' PHE . 65.9 m-85 -61.0 -42.0 97.58 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.797 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.429 ' H ' ' CD2' ' B' ' 17' ' ' HIS . 68.8 t90 -60.71 -39.82 90.01 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.565 -179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . 0.411 ' O ' HG12 ' B' ' 25' ' ' VAL . . . -60.27 -39.98 96.77 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . 0.812 ' O ' HG23 ' B' ' 27' ' ' THR . 12.6 mt -60.95 -39.93 91.38 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 121.104 -0.239 . . . . 0.0 111.064 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . . . . . . . . . 31.4 tp -60.65 -45.08 95.45 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.411 HG12 ' O ' ' B' ' 22' ' ' GLY . 3.2 p -63.52 -41.7 93.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 112.039 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.59 -42.08 94.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 120.932 0.396 . . . . 0.0 111.316 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 23' ' ' LEU . 44.7 p -61.5 -43.0 99.65 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.596 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 6.4 mp -61.87 -42.07 98.62 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.183 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.458 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -62.45 -41.78 98.99 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.438 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . 0.465 ' CD1' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -65.8 -41.14 92.28 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -60.56 -41.42 94.53 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.458 HG22 ' O ' ' B' ' 29' ' ' ALA . 6.5 m -58.96 -7.85 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 C-N-CA 119.95 -0.7 . . . . 0.0 111.746 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -46.84 -62.8 1.23 Allowed 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.487 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.25 -37.43 86.88 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 12.1 tpp85 -59.84 -36.31 76.58 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.348 0.594 . . . . 0.0 110.583 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.466 HD12 HG21 ' C' ' 27' ' ' THR . 6.2 tt -59.4 -42.66 92.28 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 -177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.46 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 0.8 OUTLIER -62.46 -46.82 89.79 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -177.055 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 29.7 Cg_endo -62.25 -34.64 77.61 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 122.51 2.14 . . . . 0.0 111.483 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.512 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -59.42 -38.29 93.25 Favored Glycine 0 C--N 1.302 -1.317 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.421 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.68 -40.34 79.21 Favored 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.66 -0.27 . . . . 0.0 111.273 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 34.3 p -88.76 112.73 23.52 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 120.854 0.359 . . . . 0.0 110.765 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.631 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.4 p90 -151.95 -54.73 0.13 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.631 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 9.6 mp 58.42 169.62 0.05 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.243 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m 66.87 -171.37 0.19 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt 65.14 47.76 2.38 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -64.76 3.9 Favored Glycine 0 CA--C 1.534 1.251 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.993 -179.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 24.4 m -125.34 -6.59 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 117.027 0.413 . . . . 0.0 111.275 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.46 ' CD1' ' C ' ' B' ' 48' ' ' TRP . 1.8 t-105 -54.97 -43.55 99.06 Favored Pre-proline 0 C--N 1.304 -1.396 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.875 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . 0.444 ' CD ' ' N ' ' B' ' 48' ' ' TRP . 57.8 Cg_endo -74.66 -47.27 0.23 Allowed 'Trans proline' 0 N--CA 1.488 1.202 0 CA-C-N 119.905 1.002 . . . . 0.0 111.19 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 85.5 mt -55.52 -37.14 67.52 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.56 -44.85 89.83 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.752 -1.179 . . . . 0.0 110.184 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.47 -41.48 97.31 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.85 -29.99 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.809 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -53.14 -40.08 63.98 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.547 ' N ' HD12 ' B' ' 55' ' ' LEU . 9.6 mp -59.71 -45.13 93.07 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.534 ' O ' ' CD2' ' B' ' 59' ' ' HIS . 5.7 tp -67.12 -33.66 75.93 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 124.624 1.17 . . . . 0.0 113.651 178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.492 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.5 ttp85 -55.22 -43.43 99.09 Favored Pre-proline 0 C--N 1.307 -1.282 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 19.2 Cg_endo -59.24 -39.35 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 CA-C-N 121.646 1.624 . . . . 0.0 111.799 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.534 ' CD2' ' O ' ' B' ' 56' ' ' LEU . 37.5 m-70 53.12 58.73 5.0 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 121.043 0.449 . . . . 0.0 110.111 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.631 ' O ' ' HB3' ' B' ' 61' ' ' ALA . 29.8 ptt-85 -47.87 -52.28 19.81 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.814 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' B' ' 60' ' ' ARG . . . 83.91 -9.98 0.95 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.913 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.492 HD22 ' N ' ' B' ' 62' ' ' LEU . 4.1 mm? -84.87 37.47 0.66 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.084 0.469 . . . . 0.0 109.813 179.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.575 -179.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.71 2.07 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.562 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 1.5 tpmt? -157.89 66.49 0.47 Allowed 'General case' 0 C--N 1.306 -1.315 0 CA-C-O 121.214 0.531 . . . . 0.0 110.316 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.499 ' OD1' ' N ' ' C' ' 4' ' ' ASN . 5.2 p-10 -153.14 -39.55 0.1 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.322 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . 0.445 ' H ' HG23 ' C' ' 5' ' ' VAL . 0.2 OUTLIER -67.49 -58.12 7.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.216 179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . . . . . . . . . 49.4 mt -59.71 -35.09 57.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.888 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 87.4 t -58.46 -40.78 79.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.602 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.401 HD13 ' O ' ' C' ' 4' ' ' ASN . 4.6 mp -59.91 -39.62 86.04 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.316 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -59.95 -41.05 91.04 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.53 -41.02 84.55 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.838 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.16 85.45 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.476 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 60.2 p -60.36 -41.78 94.42 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.704 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.43 -38.88 81.82 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.652 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.74 92.72 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.643 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.44 98.06 Favored Glycine 0 C--N 1.306 -1.122 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.329 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.94 -41.49 96.37 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 120.754 0.312 . . . . 0.0 111.056 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -51.76 104.23 0.08 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.94 0.4 . . . . 0.0 110.518 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -161.42 158.61 30.38 Favored Glycine 0 C--N 1.305 -1.145 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' C' ' 20' ' ' PHE . 0.3 OUTLIER -78.65 -54.28 6.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' C' ' 21' ' ' TRP . 31.4 p90 -59.19 -41.28 88.13 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-O 120.549 0.214 . . . . 0.0 111.45 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . 0.63 ' N ' ' CD1' ' C' ' 20' ' ' PHE . 60.4 t-105 -59.96 -40.31 88.6 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 120.673 0.273 . . . . 0.0 111.668 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.1 -39.57 97.31 Favored Glycine 0 C--N 1.302 -1.316 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.092 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . 0.624 ' O ' HG23 ' C' ' 27' ' ' THR . 64.6 mt -60.84 -39.86 90.69 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 tt -60.92 -43.89 97.97 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . 0.426 ' CG1' ' N ' ' C' ' 26' ' ' VAL . 2.5 p -63.76 -44.46 98.3 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 C-N-CA 119.588 -0.845 . . . . 0.0 112.277 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . 0.426 ' N ' ' CG1' ' C' ' 25' ' ' VAL . 53.2 t -65.26 -44.48 95.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 CA-C-O 121.14 0.495 . . . . 0.0 111.927 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . 0.624 HG23 ' O ' ' C' ' 23' ' ' LEU . 73.6 p -63.62 -44.07 94.98 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.137 -178.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.559 ' O ' HD23 ' C' ' 28' ' ' LEU . 0.8 OUTLIER -63.23 -43.15 98.88 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.568 -178.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.424 ' O ' ' CG2' ' C' ' 32' ' ' VAL . . . -63.68 -46.55 85.01 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.512 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.13 -40.12 82.53 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 0.0 112.164 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.486 ' CD2' ' CA ' ' B' ' 39' ' ' GLY . 13.1 t-80 -59.22 -41.75 89.38 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -177.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' C' ' 29' ' ' ALA . 4.2 m -57.36 -8.65 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 119.827 -0.749 . . . . 0.0 111.289 -178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.6 ' NZ ' ' CZ ' ' B' ' 42' ' ' TYR . 33.9 mtmt -44.07 -59.02 2.51 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.227 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -57.97 -38.12 87.83 Favored Glycine 0 C--N 1.303 -1.275 0 N-CA-C 111.771 -0.531 . . . . 0.0 111.771 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -59.62 -36.57 76.59 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.029 0.442 . . . . 0.0 110.558 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.725 HD23 ' O ' ' C' ' 36' ' ' LEU . 2.8 tt -61.83 -43.48 98.77 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -177.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -46.4 89.52 Favored Pre-proline 0 N--CA 1.483 1.204 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.491 ' O ' HG23 ' C' ' 41' ' ' THR . 31.8 Cg_exo -59.77 -35.88 93.03 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.543 2.162 . . . . 0.0 111.206 176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.02 -38.51 95.65 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.395 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.502 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -57.35 -42.9 82.89 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.502 ' C ' ' O ' ' C' ' 40' ' ' ALA . 0.9 OUTLIER 25.3 -93.76 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.144 0.497 . . . . 0.0 111.074 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' C' ' 40' ' ' ALA . 1.0 OUTLIER 80.34 114.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.036 178.604 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -158.59 -80.18 0.06 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.0 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 52.0 p -100.83 69.89 1.37 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.367 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 62.8 mt -143.51 23.09 1.81 Allowed 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.083 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -47.26 -71.47 0.54 Allowed Glycine 0 C--N 1.303 -1.301 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 15.0 t -140.02 -16.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 -178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.466 ' N ' ' CD ' ' C' ' 49' ' ' PRO . 0.1 OUTLIER -48.24 -47.9 66.06 Favored Pre-proline 0 C--N 1.303 -1.436 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.837 -178.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.466 ' CD ' ' N ' ' C' ' 48' ' ' TRP . 30.1 Cg_exo -60.4 -41.18 51.57 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 122.476 2.117 . . . . 0.0 113.134 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -55.58 -35.91 66.3 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -176.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.478 HD22 ' N ' ' C' ' 51' ' ' LEU . 3.7 mm? -56.57 -43.95 80.51 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.593 -1.243 . . . . 0.0 110.209 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 10.3 mp -61.1 -42.95 99.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.514 -0.874 . . . . 0.0 108.999 179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' E' ' 19' ' ' PHE . 7.7 t -61.0 -30.8 48.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.797 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -53.2 -39.9 64.03 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' C' ' 55' ' ' LEU . 32.9 mt -58.62 -44.01 89.82 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.506 -0.877 . . . . 0.0 108.788 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 53.3 tp -67.72 -33.19 74.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 124.481 1.112 . . . . 0.0 112.949 177.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 67.6 ttt-85 -55.02 -43.47 99.07 Favored Pre-proline 0 C--N 1.307 -1.267 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 -173.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 18.0 Cg_endo -58.84 -38.53 88.03 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 CA-C-N 121.784 1.673 . . . . 0.0 111.32 178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.583 ' CG ' ' H ' ' C' ' 60' ' ' ARG . 19.4 t-80 48.48 179.1 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.817 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.583 ' H ' ' CG ' ' C' ' 59' ' ' HIS . 37.5 ttm180 -161.9 165.25 27.88 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.934 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' C' ' 63' ' ' ALA . . . -139.9 -23.57 0.85 Allowed 'General case' 0 C--N 1.314 -0.963 0 C-N-CA 121.165 -0.214 . . . . 0.0 111.411 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . 0.661 ' H ' HD23 ' C' ' 62' ' ' LEU . 0.2 OUTLIER -79.11 37.96 0.33 Allowed 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.462 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.264 0 CA-C-O 117.9 -1.048 . . . . 0.0 110.568 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.17 -83.12 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.793 0.33 . . . . 0.0 110.479 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -82.59 -34.69 27.58 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.44 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . 0.419 ' O ' HD13 ' D' ' 8' ' ' LEU . 9.1 m120 -39.94 -37.83 0.62 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.126 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.421 HG23 ' H ' ' D' ' 5' ' ' VAL . 2.0 t -65.91 -55.02 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.04 -34.69 53.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.057 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 74.6 t -58.5 -41.12 80.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.869 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . 0.435 ' CD2' ' O ' ' F' ' 61' ' ' ALA . 7.2 mp -59.7 -40.43 87.9 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.158 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.25 -41.42 96.87 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.15 0.5 . . . . 0.0 109.932 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.443 ' HB2' ' CG1' ' E' ' 5' ' ' VAL . . . -56.72 -39.5 74.01 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.505 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.31 -39.72 76.4 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.064 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -61.07 -41.98 97.63 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.53 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . 0.427 ' O ' ' ND1' ' D' ' 17' ' ' HIS . . . -58.21 -38.28 76.47 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.812 -179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.36 92.17 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.723 HD21 ' HE1' ' D' ' 21' ' ' TRP . 25.1 t-20 -61.41 -41.33 96.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.918 0.39 . . . . 0.0 110.7 179.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . 0.427 ' ND1' ' O ' ' D' ' 13' ' ' ALA . 58.7 m80 -57.8 107.22 0.43 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.819 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' D' ' 21' ' ' TRP . . . -175.39 108.51 0.27 Allowed Glycine 0 C--N 1.304 -1.225 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.449 ' CG ' ' N ' ' D' ' 20' ' ' PHE . 11.6 p90 -35.61 -40.62 0.17 Allowed 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' D' ' 21' ' ' TRP . 34.9 p90 -60.2 -42.6 95.44 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.706 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.723 ' HE1' HD21 ' D' ' 16' ' ' ASN . 66.5 t-105 -60.74 -41.25 94.99 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.913 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.3 -39.46 96.11 Favored Glycine 0 C--N 1.304 -1.205 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . . . . . . . . . 12.4 mt -60.91 -38.11 84.62 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 33.6 tp -58.55 -44.05 89.52 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -177.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -64.61 -42.74 95.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 119.424 -0.91 . . . . 0.0 112.189 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 56.1 t -64.14 -45.14 97.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -178.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . 0.402 HG23 ' N ' ' D' ' 28' ' ' LEU . 7.5 t -63.76 -41.91 97.9 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.739 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.402 ' N ' HG23 ' D' ' 27' ' ' THR . 57.8 tp -60.37 -41.53 93.94 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 120.646 -0.421 . . . . 0.0 110.172 -179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.488 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -60.31 -42.26 95.2 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.324 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -63.56 -40.35 96.76 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.48 -42.23 95.82 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.488 HG22 ' O ' ' D' ' 29' ' ' ALA . 17.1 m -65.03 -8.64 5.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.956 -178.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -45.79 -60.34 2.28 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.218 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.36 -38.03 89.36 Favored Glycine 0 C--N 1.301 -1.397 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . 0.474 HH21 ' CE1' ' E' ' 31' ' ' HIS . 46.6 mtp85 -60.41 -37.05 79.62 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 121.071 0.462 . . . . 0.0 110.956 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.633 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.1 tt -59.76 -41.97 92.2 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.466 ' H ' HG23 ' D' ' 37' ' ' VAL . 2.1 t -62.18 -46.5 91.05 Favored Pre-proline 0 C--N 1.308 -1.228 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -176.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 30.6 Cg_endo -61.93 -34.76 80.59 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.383 2.055 . . . . 0.0 111.584 177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' E' ' 30' ' ' TRP . . . -60.27 -40.0 96.8 Favored Glycine 0 C--N 1.301 -1.393 0 CA-C-N 114.881 -1.054 . . . . 0.0 110.596 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.06 -41.49 83.43 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.272 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . . . . . . . . . 64.3 p -77.12 111.51 12.8 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.765 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.54 ' CG ' ' O ' ' D' ' 42' ' ' TYR . 20.4 p90 -173.77 112.16 0.19 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 120.994 0.426 . . . . 0.0 109.972 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 44.0 mt -91.61 174.5 7.33 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.192 0.52 . . . . 0.0 110.174 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t 59.89 -168.85 0.15 Allowed 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.12 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 mt 58.94 53.43 5.67 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.411 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -91.15 -34.75 7.4 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.807 -178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -102.34 -18.82 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 CA-C-N 118.067 0.934 . . . . 0.0 111.799 -178.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.443 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 64.4 t-105 -63.73 -39.74 49.8 Favored Pre-proline 0 C--N 1.298 -1.657 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 59.2 Cg_endo -74.3 -60.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.545 1.23 . . . . 0.0 112.208 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . . . . . . . . . 15.7 mt -54.32 -36.22 63.51 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.523 ' O ' HD23 ' D' ' 51' ' ' LEU . 1.1 tt -58.02 -44.24 87.16 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.17 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.6 -41.52 94.92 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . . . . . . . . . 90.1 t -58.23 -32.83 45.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.149 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 -54.1 -40.44 67.29 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.948 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . . . . . . . . . 9.8 tp -60.11 -44.3 94.95 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.882 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.58 ' O ' HD23 ' D' ' 56' ' ' LEU . 0.8 OUTLIER -66.83 -34.72 78.42 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 124.472 1.109 . . . . 0.0 113.536 178.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . 0.473 ' N ' ' HD2' ' D' ' 58' ' ' PRO . 62.3 ttt180 -56.63 -43.86 99.51 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -174.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' D' ' 57' ' ' ARG . 22.3 Cg_endo -60.48 -41.12 51.26 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 CA-C-N 121.684 1.637 . . . . 0.0 111.32 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . 0.422 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 59.58 73.55 0.48 Allowed 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.494 0.664 . . . . 0.0 110.377 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -59.7 -53.08 62.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.89 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' D' ' 63' ' ' ALA . . . 55.09 -173.29 0.05 Allowed 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.48 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' D' ' 63' ' ' ALA . 37.2 mt 57.85 8.38 0.71 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 120.94 0.4 . . . . 0.0 109.991 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' D' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.306 -1.322 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.813 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.63 -46.98 70.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 120.641 0.257 . . . . 0.0 110.782 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . 0.431 ' HZ1' ' C ' ' F' ' 2' ' ' ALA . 29.2 mmtt -102.98 62.57 0.81 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.084 0.468 . . . . 0.0 110.761 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -156.15 15.35 0.33 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.443 ' CG1' ' HB2' ' D' ' 10' ' ' ALA . 0.2 OUTLIER -124.75 -67.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.35 179.484 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . . . . . . . . . 53.8 mt -59.65 -34.6 55.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.415 HG23 ' H ' ' E' ' 7' ' ' VAL . 3.3 t -58.51 -40.67 79.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.151 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.579 ' N ' HD12 ' E' ' 8' ' ' LEU . 8.6 mp -60.08 -40.03 88.17 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.169 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -61.01 -42.07 97.76 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 121.127 0.489 . . . . 0.0 109.908 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.37 75.96 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.897 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.83 -40.14 83.3 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.428 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 18.8 p -61.16 -42.93 99.44 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 120.347 -0.541 . . . . 0.0 109.982 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.08 -38.53 83.18 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.716 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.55 -41.23 94.12 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.73 -41.71 97.64 Favored Glycine 0 C--N 1.304 -1.215 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.455 ' OD1' ' CG ' ' E' ' 21' ' ' TRP . 34.6 t30 -61.38 -41.54 97.28 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 120.772 0.32 . . . . 0.0 110.528 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -48.52 101.45 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.615 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.533 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -169.45 111.67 0.43 Allowed Glycine 0 C--N 1.302 -1.309 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' C' ' 53' ' ' VAL . 1.3 t80 -34.31 -39.64 0.08 Allowed 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 122.576 0.35 . . . . 0.0 111.923 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . 0.638 ' CD1' ' N ' ' E' ' 21' ' ' TRP . 30.4 p90 -60.32 -41.08 92.78 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.15 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.638 ' N ' ' CD1' ' E' ' 20' ' ' PHE . 47.1 t90 -60.1 -41.68 93.03 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.432 -178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.71 -39.65 96.95 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.584 ' O ' HG23 ' E' ' 27' ' ' THR . 2.5 mt -60.05 -38.43 82.76 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.496 -0.352 . . . . 0.0 111.629 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 35.5 tp -58.61 -43.03 89.45 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.85 -42.56 93.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.244 -0.582 . . . . 0.0 111.853 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -63.13 -42.57 97.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.584 HG23 ' O ' ' E' ' 23' ' ' LEU . 27.3 p -63.22 -43.46 98.05 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 43.7 mt -61.18 -42.68 99.01 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.289 -179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . 0.516 ' O ' HG22 ' E' ' 32' ' ' VAL . . . -61.94 -43.01 99.74 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.789 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' D' ' 39' ' ' GLY . 0.2 OUTLIER -65.45 -41.49 93.39 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . 0.474 ' CE1' HH21 ' D' ' 35' ' ' ARG . 50.9 t60 -61.39 -43.06 99.52 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -177.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . 0.516 HG22 ' O ' ' E' ' 29' ' ' ALA . 10.4 m -54.57 -17.97 2.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 C-N-CA 119.842 -0.743 . . . . 0.0 112.362 -177.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . . . . . . . . . 4.7 tppt? -44.93 -61.11 1.74 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 120.181 -0.608 . . . . 0.0 109.751 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . 0.453 ' O ' ' CD ' ' E' ' 38' ' ' PRO . . . -58.35 -39.7 93.08 Favored Glycine 0 C--N 1.296 -1.64 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.027 -179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' F' ' 35' ' ' ARG . 49.6 mtp85 -62.62 -38.19 89.24 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-O 121.458 0.647 . . . . 0.0 110.784 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.676 HD13 ' C ' ' E' ' 36' ' ' LEU . 2.3 tm? -63.08 -43.62 98.05 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . 0.434 ' N ' ' CD ' ' E' ' 38' ' ' PRO . 0.0 OUTLIER -62.72 -45.11 88.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 CA-C-N 120.104 1.32 . . . . 0.0 112.969 -177.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' E' ' 34' ' ' GLY . 31.8 Cg_exo -58.43 -34.89 99.11 Favored 'Trans proline' 0 N--CA 1.502 1.972 0 C-N-CA 123.335 2.69 . . . . 0.0 111.435 176.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.62 -37.16 91.86 Favored Glycine 0 C--N 1.299 -1.479 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.109 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.64 -41.01 76.42 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.473 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 36.2 p -45.58 106.66 0.08 Allowed 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.723 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -108.23 82.71 1.67 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.379 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' E' ' 45' ' ' LEU . 22.9 mt -78.95 -152.89 0.07 Allowed 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.907 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 18.2 m -51.9 88.3 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.73 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . 0.481 ' N ' ' O ' ' E' ' 43' ' ' LEU . 87.3 mt -151.19 35.14 0.58 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.713 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.82 -67.53 2.14 Favored Glycine 0 C--N 1.303 -1.266 0 CA-C-N 115.914 -0.584 . . . . 0.0 113.215 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 28.7 m -129.73 -12.06 2.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.431 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 18.4 t-105 -54.43 -43.05 97.34 Favored Pre-proline 0 C--N 1.303 -1.43 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.817 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 71.7 Cg_endo -78.14 -45.44 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.149 1.089 . . . . 0.0 111.742 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.82 -36.78 65.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.043 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . . . . . . . . . 20.8 mt -58.14 -42.84 86.73 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.147 -179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -57.66 -39.39 76.94 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . 0.41 HG11 ' CZ ' ' A' ' 19' ' ' PHE . 9.6 t -58.68 -30.19 41.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.647 178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -53.46 -39.62 64.63 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.747 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 22.9 mt -57.3 -42.12 81.16 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.361 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.34 -33.05 74.44 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.856 177.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.475 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 35.1 ttm180 -56.1 -43.77 99.4 Favored Pre-proline 0 C--N 1.307 -1.281 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -174.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 20.9 Cg_endo -59.74 -40.54 63.22 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 CA-C-N 121.86 1.7 . . . . 0.0 111.892 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.526 ' CG ' ' N ' ' E' ' 60' ' ' ARG . 82.6 t60 -45.26 164.85 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 120.839 0.352 . . . . 0.0 111.128 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . 0.526 ' N ' ' CG ' ' E' ' 59' ' ' HIS . 0.1 OUTLIER -172.71 -166.8 0.4 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . 0.507 ' O ' ' N ' ' E' ' 63' ' ' ALA . . . -73.84 64.96 1.0 Allowed 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.722 -0.391 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 54.2 mt -44.94 -17.56 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.064 0.459 . . . . 0.0 110.106 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . 0.538 ' HB1' ' HB1' ' B' ' 10' ' ' ALA . . . . . . . . 0 C--N 1.303 -1.418 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.631 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . 0.431 ' C ' ' HZ1' ' E' ' 3' ' ' LYS . . . -163.01 -52.49 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.873 0.368 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -84.52 -162.95 0.73 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.487 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 67.33 31.14 6.66 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.365 0.602 . . . . 0.0 110.397 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.46 -70.68 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.425 HG22 ' CG1' ' A' ' 5' ' ' VAL . 35.7 mt -59.41 -36.81 66.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.954 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 p -61.15 -40.67 86.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.858 178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 mp -59.15 -40.37 85.32 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -61.94 -41.59 98.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.133 0.492 . . . . 0.0 110.138 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.94 -41.06 82.02 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.135 -178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.9 85.36 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.036 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -62.25 -43.77 98.06 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.956 -0.698 . . . . 0.0 109.398 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.29 -41.09 96.39 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.51 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.51 -43.4 98.93 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.82 -41.84 97.82 Favored Glycine 0 C--N 1.305 -1.182 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.756 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . 0.609 ' ND2' ' NE1' ' F' ' 21' ' ' TRP . 6.8 t-20 -61.7 -42.17 98.58 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 120.968 0.413 . . . . 0.0 110.435 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.6 138.43 40.12 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . . . . . . . . . . . 166.3 -164.13 37.37 Favored Glycine 0 C--N 1.304 -1.232 0 C-N-CA 120.848 -0.692 . . . . 0.0 111.956 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.413 ' CD2' ' N ' ' F' ' 20' ' ' PHE . 43.1 t80 -82.7 -67.46 0.78 Allowed 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.413 ' N ' ' CD2' ' F' ' 19' ' ' PHE . 17.3 p90 -59.67 -41.41 90.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.96 -178.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.609 ' NE1' ' ND2' ' F' ' 16' ' ' ASN . 84.5 t90 -60.22 -39.97 88.52 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.01 -40.71 98.87 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.621 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.487 ' O ' HG23 ' F' ' 27' ' ' THR . 60.6 mt -60.45 -39.13 86.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 5.0 tt -59.34 -42.97 92.75 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.51 -44.32 99.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 119.997 -0.681 . . . . 0.0 112.642 -178.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.19 -43.27 97.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 120.536 -0.466 . . . . 0.0 111.981 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.487 HG23 ' O ' ' F' ' 23' ' ' LEU . 81.6 p -63.34 -42.86 98.98 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.375 -178.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -60.79 -42.98 98.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.049 -0.66 . . . . 0.0 109.558 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.519 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -62.82 -42.44 99.72 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.18 -0.608 . . . . 0.0 111.02 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -64.82 -42.13 95.2 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 47.9 t60 -60.99 -42.08 97.71 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.519 HG22 ' O ' ' F' ' 29' ' ' ALA . 29.2 m -64.2 -5.59 2.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 C-N-CA 120.22 -0.592 . . . . 0.0 112.118 -177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 ttpp -47.39 -62.77 1.28 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.283 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.52 -37.38 88.43 Favored Glycine 0 C--N 1.302 -1.331 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . 0.5 HH21 HH21 ' E' ' 35' ' ' ARG . 77.5 mtt180 -60.08 -36.64 77.81 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.057 0.455 . . . . 0.0 110.873 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.565 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.17 -41.15 92.21 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -177.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.446 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 2.0 t -61.65 -46.78 93.61 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 31.7 Cg_endo -62.35 -34.56 76.82 Favored 'Trans proline' 0 N--CA 1.502 1.995 0 C-N-CA 122.301 2.0 . . . . 0.0 111.169 177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.61 -39.0 94.54 Favored Glycine 0 C--N 1.303 -1.305 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.437 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.22 -39.17 74.93 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.63 -0.285 . . . . 0.0 111.403 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 32.7 p -81.44 114.38 20.15 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 120.799 0.333 . . . . 0.0 111.062 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.626 ' CD2' ' N ' ' F' ' 43' ' ' LEU . 51.3 p90 -165.67 -55.36 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.626 ' N ' ' CD2' ' F' ' 42' ' ' TYR . 20.6 mt 57.3 74.53 0.41 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.854 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' F' ' 45' ' ' LEU . 11.2 t -178.86 -177.12 0.48 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.672 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . 0.531 ' N ' ' OG ' ' F' ' 44' ' ' SER . 4.7 mp 57.66 44.24 21.0 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.85 -45.43 2.45 Favored Glycine 0 C--N 1.307 -1.033 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.35 73.02 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.55 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 0.0 OUTLIER -164.3 -48.59 0.0 OUTLIER Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.306 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.55 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 1.3 Cg_endo -81.39 -33.98 0.63 Allowed 'Trans proline' 0 N--CA 1.489 1.206 0 C-N-CA 122.607 2.205 . . . . 0.0 111.411 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.449 ' O ' ' N ' ' F' ' 54' ' ' ARG . 57.7 mt -55.25 -34.54 64.11 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.774 -177.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.18 -43.79 78.75 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.798 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -63.22 -46.9 84.8 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.376 179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' F' ' 53' ' ' VAL . 0.7 OUTLIER -65.24 -31.91 55.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-O 121.118 0.485 . . . . 0.0 110.381 177.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HD3' ' F' ' 58' ' ' PRO . 59.8 ttp85 -54.29 -40.39 67.84 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.618 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . . . . . . . . . 29.6 tp -53.82 -39.88 65.91 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.437 -178.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 tp -67.59 -38.31 83.83 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 177.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . . . . . . . . . 8.7 ttt-85 -54.75 -43.24 98.33 Favored Pre-proline 0 N--CA 1.486 1.363 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' F' ' 54' ' ' ARG . 22.2 Cg_exo -55.5 -40.17 86.96 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 CA-C-N 121.16 1.45 . . . . 0.0 110.934 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . . . . . . . . . 2.4 m170 53.19 -170.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 120.984 0.421 . . . . 0.0 110.406 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . 0.554 ' O ' ' HB3' ' F' ' 61' ' ' ALA . 11.9 ptm180 -171.46 -28.9 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' F' ' 60' ' ' ARG . . . 74.31 -13.17 0.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.741 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . 0.429 ' H ' ' C ' ' F' ' 60' ' ' ARG . 42.1 mt -84.03 33.47 0.49 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.224 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.317 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.621 -179.908 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.527 ' O ' ' N ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.689 ' H ' ' NZ ' ' F' ' 3' ' ' LYS . . . 54.95 -83.02 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 120.74 0.305 . . . . 0.0 110.58 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 1' ' ' GLY . 11.8 mptt -80.56 79.16 7.22 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.271 0.558 . . . . 0.0 110.37 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.542 HD22 ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -155.3 -46.1 0.08 Allowed 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.236 179.529 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' F' ' 10' ' ' ALA . 0.2 OUTLIER -63.12 -56.57 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 38.9 mt -59.65 -35.19 58.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.112 179.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.4 t -58.09 -40.95 79.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.983 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 4' ' ' ASN . 7.2 mp -59.36 -40.32 86.08 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 120.544 -0.463 . . . . 0.0 109.933 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -61.44 -41.64 97.51 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.125 0.488 . . . . 0.0 110.048 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.48 -40.21 78.07 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.603 -178.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -39.1 78.25 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.428 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.9 p -60.32 -42.41 95.53 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 120.33 -0.548 . . . . 0.0 109.735 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.2 78.23 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.735 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.25 -41.7 93.76 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.78 -42.61 96.55 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.3 m120 -62.22 -40.92 97.72 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 120.901 0.382 . . . . 0.0 110.618 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -51.83 103.09 0.06 Allowed 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.174 -179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' N ' ' A' ' 21' ' ' TRP . . . -173.12 120.25 0.8 Allowed Glycine 0 C--N 1.305 -1.189 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.561 ' CE2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -41.49 -32.95 0.38 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.757 0.313 . . . . 0.0 110.455 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -61.02 -43.26 99.15 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.833 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CZ3' HG21 ' A' ' 25' ' ' VAL . 52.1 t90 -61.2 -41.54 97.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.536 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -59.85 -39.68 95.76 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.561 HD11 ' CE2' ' A' ' 19' ' ' PHE . 19.2 mt -60.04 -39.26 85.3 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.518 0.199 . . . . 0.0 111.108 -179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.5 tp -60.17 -44.21 95.22 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.472 HG21 ' CZ3' ' A' ' 21' ' ' TRP . 63.5 t -62.6 -44.45 99.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.514 -179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.18 -42.14 94.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.104 0.478 . . . . 0.0 111.133 179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.505 HG21 ' HB ' ' F' ' 32' ' ' VAL . 31.7 m -62.28 -43.35 99.02 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.778 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.5 mt -61.52 -42.73 99.25 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 120.309 -0.557 . . . . 0.0 110.327 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' O ' HG22 ' A' ' 32' ' ' VAL . . . -62.08 -43.05 99.68 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.676 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -64.67 -41.71 95.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.535 ' CE1' ' NH2' ' F' ' 35' ' ' ARG . 53.2 t-80 -61.23 -41.48 96.95 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.527 HG22 ' O ' ' A' ' 29' ' ' ALA . 27.3 m -65.48 -12.08 13.12 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mttm -46.24 -56.01 6.35 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.206 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.31 -37.58 87.7 Favored Glycine 0 C--N 1.302 -1.326 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -59.49 -36.44 76.03 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 120.979 0.418 . . . . 0.0 111.068 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.668 ' O ' HD23 ' A' ' 36' ' ' LEU . 2.0 tt -59.78 -42.2 92.79 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 -177.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 1.5 t -61.81 -46.61 92.8 Favored Pre-proline 0 C--N 1.306 -1.31 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 37' ' ' VAL . 29.7 Cg_endo -62.22 -34.2 79.15 Favored 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.278 1.985 . . . . 0.0 111.031 177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.08 93.35 Favored Glycine 0 C--N 1.301 -1.412 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.603 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.9 -40.49 76.36 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.978 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 58.4 p -79.2 111.7 15.69 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.721 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 42' ' ' TYR . 36.3 p90 -166.62 116.93 0.93 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.109 0.48 . . . . 0.0 110.203 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD22 ' N ' ' A' ' 43' ' ' LEU . 4.1 mm? -40.67 111.53 0.22 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.462 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.5 t -38.78 128.9 1.54 Allowed 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 29.8 mt -86.04 -72.26 0.5 Allowed 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.655 179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.21 -54.85 0.55 Allowed Glycine 0 C--N 1.309 -0.956 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.396 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.8 m -142.73 -13.28 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.407 ' N ' ' CD ' ' A' ' 49' ' ' PRO . 30.4 t-105 -52.88 -44.5 96.53 Favored Pre-proline 0 C--N 1.307 -1.245 0 C-N-CA 119.697 -0.801 . . . . 0.0 112.308 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 48' ' ' TRP . 72.9 Cg_endo -78.8 -39.24 0.39 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.187 1.258 . . . . 0.0 111.55 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.594 HD13 ' O ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -52.52 -38.2 59.17 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.711 -176.056 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.29 -45.48 93.08 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.495 -179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 3.7 mm? -62.27 -45.33 93.78 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.75 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 57' ' ' ARG . 17.0 m -61.76 -29.61 46.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 120.938 0.399 . . . . 0.0 110.469 178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -52.91 -40.75 63.81 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.494 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.6 tp -60.03 -44.83 94.37 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.491 178.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 tt -67.54 -32.78 73.8 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 124.769 1.228 . . . . 0.0 113.135 177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.47 ' N ' ' HD2' ' A' ' 58' ' ' PRO . 52.4 ttt85 -55.07 -43.71 99.21 Favored Pre-proline 0 C--N 1.307 -1.261 0 N-CA-C 115.677 1.732 . . . . 0.0 115.677 -173.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 57' ' ' ARG . 17.9 Cg_endo -58.95 -40.02 75.48 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 CA-C-N 121.652 1.626 . . . . 0.0 110.705 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 61.08 144.99 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.735 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -159.58 128.99 5.33 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.126 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.41 0.34 55.64 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 120.84 0.352 . . . . 0.0 110.473 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.58 HD22 ' N ' ' A' ' 62' ' ' LEU . 3.4 mm? -71.11 -39.91 71.8 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.051 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.786 179.864 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.25 -91.58 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 120.777 0.322 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.15 81.01 5.46 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.221 0.534 . . . . 0.0 110.378 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ASN . . . . . 0.445 ' O ' HD13 ' B' ' 8' ' ' LEU . 29.2 m-80 -155.07 -52.16 0.09 Allowed 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.126 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' VAL . . . . . 0.451 ' H ' HG22 ' B' ' 5' ' ' VAL . 0.0 OUTLIER -59.47 -57.28 12.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 52.4 mt -58.16 -35.68 54.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.775 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 12.5 t -59.34 -41.24 83.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.202 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.445 HD13 ' O ' ' B' ' 4' ' ' ASN . 7.6 mp -59.6 -40.88 88.92 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 120.617 -0.433 . . . . 0.0 109.942 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -61.3 -40.21 93.32 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-O 121.394 0.616 . . . . 0.0 109.663 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.17 -41.31 79.02 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.984 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.99 -40.52 85.09 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.626 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 71.7 p -61.34 -42.93 99.49 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.187 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.72 78.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.031 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.82 -40.15 91.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.52 -41.22 95.33 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.906 -178.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -60.25 -41.89 94.16 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 117.456 0.628 . . . . 0.0 110.719 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' B' ' 18' ' ' GLY . 2.0 t60 55.1 -176.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.641 ' H ' ' CG ' ' B' ' 17' ' ' HIS . . . -124.93 -5.58 6.8 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.424 -178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' F' ' 50' ' ' LEU . 54.0 t80 -74.61 -93.45 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 117.326 0.563 . . . . 0.0 110.91 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' B' ' 21' ' ' TRP . 27.3 p90 -61.05 -43.03 99.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.901 -0.319 . . . . 0.0 111.119 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' TRP . . . . . 0.538 ' N ' ' CD1' ' B' ' 20' ' ' PHE . 63.2 t90 -61.83 -41.08 97.35 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.524 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.28 -40.44 98.61 Favored Glycine 0 C--N 1.307 -1.079 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mt -60.05 -39.53 86.28 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.477 ' CD1' HG11 ' A' ' 32' ' ' VAL . 37.3 tp -60.2 -43.14 96.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 t -62.5 -45.18 99.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 120.069 -0.652 . . . . 0.0 112.42 -178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 41.3 t -64.92 -43.12 96.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.385 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 70.7 m -63.11 -44.06 96.71 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.16 -178.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 36.1 tp -61.6 -43.77 98.25 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.35 -178.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.56 ' O ' HG22 ' B' ' 32' ' ' VAL . . . -63.55 -43.31 97.44 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.006 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.08 -40.97 95.41 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -60.01 -41.76 92.84 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.56 HG22 ' O ' ' B' ' 29' ' ' ALA . 29.8 m -63.74 -1.07 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 119.799 -0.76 . . . . 0.0 111.733 -178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -47.01 -64.89 0.66 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.144 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.3 -38.35 90.0 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -61.13 -36.54 80.02 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.39 0.614 . . . . 0.0 110.467 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.554 ' O ' HD23 ' B' ' 36' ' ' LEU . 1.7 tt -59.57 -42.54 92.71 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' B' ' 38' ' ' PRO . 1.6 t -63.21 -46.86 85.89 Favored Pre-proline 0 C--N 1.308 -1.213 0 N-CA-C 114.86 1.43 . . . . 0.0 114.86 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' B' ' 37' ' ' VAL . 35.7 Cg_endo -63.13 -35.44 64.5 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.364 2.043 . . . . 0.0 111.511 178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLY . . . . . 0.586 ' C ' ' HE1' ' C' ' 30' ' ' TRP . . . -60.12 -40.12 96.75 Favored Glycine 0 C--N 1.299 -1.485 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.395 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.503 ' O ' ' CE1' ' B' ' 42' ' ' TYR . . . -59.93 -41.47 91.84 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' THR . . . . . . . . . . . . . 43.9 p -78.06 126.13 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 120.844 0.354 . . . . 0.0 111.802 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . 0.622 ' CD2' ' N ' ' B' ' 43' ' ' LEU . 44.9 p90 -177.57 -51.24 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.612 179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' LEU . . . . . 0.622 ' N ' ' CD2' ' B' ' 42' ' ' TYR . 10.2 mp 54.55 86.57 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.825 -179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 2.4 p 174.16 -168.29 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.343 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . . . . . . . . . 23.7 mt 66.16 47.87 1.8 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.334 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.18 -68.61 1.6 Allowed Glycine 0 C--N 1.306 -1.135 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.82 -10.62 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' TRP . . . . . 0.437 ' CE3' ' O ' ' B' ' 48' ' ' TRP . 1.6 t-105 -47.54 -48.87 57.54 Favored Pre-proline 0 C--N 1.307 -1.263 0 C-N-CA 120.721 -0.392 . . . . 0.0 111.497 -178.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.35 -34.47 12.56 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 120.885 1.056 . . . . 0.0 111.593 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -55.49 -36.19 66.38 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.044 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 28.7 mt -57.47 -44.05 84.54 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.792 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.46 -42.56 96.44 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.59 -30.83 47.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.638 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -53.92 -40.61 66.87 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.857 -177.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 3.6 mm? -59.94 -44.85 94.13 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.104 -1.039 . . . . 0.0 108.601 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.552 HD22 ' N ' ' B' ' 56' ' ' LEU . 3.3 mm? -67.55 -33.79 75.76 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 124.671 1.188 . . . . 0.0 113.244 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . 0.463 ' N ' ' HD2' ' B' ' 58' ' ' PRO . 53.2 ttp180 -55.72 -43.78 99.35 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -173.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' B' ' 57' ' ' ARG . 22.2 Cg_endo -59.95 -40.51 61.59 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 CA-C-N 121.87 1.704 . . . . 0.0 111.269 178.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' HIS . . . . . 0.445 ' O ' ' O ' ' B' ' 58' ' ' PRO . 2.1 t-80 51.91 170.56 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.392 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -171.83 179.82 2.65 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.646 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . . . . . . . . . . . -139.55 11.84 2.52 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.358 179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 63' ' ' ALA . 17.0 mt -90.7 6.09 45.44 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.347 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' B' ' 62' ' ' LEU . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 117.99 -1.005 . . . . 0.0 110.582 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.61 -51.34 35.97 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.765 0.317 . . . . 0.0 110.604 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -78.51 72.52 5.04 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.082 0.468 . . . . 0.0 110.17 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' ASN . . . . . 0.403 ' O ' HD13 ' C' ' 8' ' ' LEU . 20.1 m120 -156.16 -39.43 0.08 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.638 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -72.2 -54.41 16.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ILE . . . . . 0.452 HG22 ' CG1' ' D' ' 5' ' ' VAL . 44.4 mt -59.33 -36.22 62.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.333 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 9.1 t -59.13 -40.66 81.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.058 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' LEU . . . . . 0.403 HD13 ' O ' ' C' ' 4' ' ' ASN . 3.3 mp -59.4 -40.31 86.21 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.734 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' ASN . . . . . . . . . . . . . 36.6 t30 -61.39 -41.75 97.62 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-O 121.173 0.511 . . . . 0.0 109.826 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.75 84.17 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.643 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.51 81.79 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.931 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' SER . . . . . . . . . . . . . 11.7 t -60.19 -41.5 93.05 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.248 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . 0.456 ' O ' ' ND1' ' C' ' 17' ' ' HIS . . . -59.48 -39.49 83.88 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.682 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.84 -41.17 95.3 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.12 -40.88 97.75 Favored Glycine 0 C--N 1.304 -1.233 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.6 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -60.73 -41.77 96.0 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.008 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' C' ' 13' ' ' ALA . 1.9 m80 -52.89 108.69 0.34 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.305 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.44 159.03 30.15 Favored Glycine 0 C--N 1.309 -0.936 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.793 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -79.59 -60.97 2.15 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.18 -0.51 . . . . 0.0 111.414 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -59.15 -40.8 86.7 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 120.692 0.282 . . . . 0.0 111.367 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' TRP . . . . . . . . . . . . . 63.5 t-105 -59.88 -40.5 88.9 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.829 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.05 -40.66 99.21 Favored Glycine 0 C--N 1.303 -1.289 0 C-N-CA 121.058 -0.591 . . . . 0.0 112.318 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.5 -39.21 86.91 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.493 ' CD1' HG11 ' B' ' 32' ' ' VAL . 37.0 tp -59.72 -43.23 94.27 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -177.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.41 -45.52 95.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 N-CA-C 113.442 0.904 . . . . 0.0 113.442 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.78 -44.26 93.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' THR . . . . . . . . . . . . . 74.4 p -63.32 -42.81 99.01 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.972 -178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' LEU . . . . . 0.538 HD13 ' O ' ' C' ' 28' ' ' LEU . 0.2 OUTLIER -62.43 -42.15 99.24 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.196 -178.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.443 ' O ' HG22 ' C' ' 32' ' ' VAL . . . -62.37 -47.37 84.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 113.364 0.876 . . . . 0.0 113.364 -177.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' TRP . . . . . 0.586 ' HE1' ' C ' ' B' ' 39' ' ' GLY . 0.0 OUTLIER -68.56 -37.93 80.32 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.511 -0.743 . . . . 0.0 112.199 179.307 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' HIS . . . . . 0.428 ' C ' ' H ' ' C' ' 33' ' ' LYS . 34.9 t60 -59.38 -41.37 89.2 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.443 HG22 ' O ' ' C' ' 29' ' ' ALA . 5.1 m -59.77 -2.8 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.023 -178.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' LYS . . . . . 0.428 ' H ' ' C ' ' C' ' 31' ' ' HIS . 18.6 pttp -40.69 -54.38 2.61 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 120.743 -0.383 . . . . 0.0 111.105 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.17 94.02 Favored Glycine 0 C--N 1.303 -1.271 0 C-N-CA 121.222 -0.513 . . . . 0.0 111.884 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ARG . . . . . . . . . . . . . 83.0 mtt-85 -60.2 -36.08 76.85 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.908 0.385 . . . . 0.0 110.534 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.715 HD23 ' O ' ' C' ' 36' ' ' LEU . 4.1 tt -61.93 -44.55 96.55 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -177.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -44.32 80.62 Favored Pre-proline 0 N--CA 1.484 1.275 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.67 -34.6 99.01 Favored 'Trans proline' 0 N--CA 1.5 1.911 0 C-N-CA 122.144 1.896 . . . . 0.0 110.851 176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.45 -37.69 93.62 Favored Glycine 0 C--N 1.3 -1.466 0 CA-C-N 114.343 -1.299 . . . . 0.0 111.195 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' C' ' 41' ' ' THR . . . -56.47 -40.11 74.32 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' THR . . . . . 0.49 ' O ' ' NZ ' ' D' ' 33' ' ' LYS . 22.0 p -40.32 108.49 0.09 Allowed 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.283 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -99.9 38.02 1.53 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.999 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tp -44.77 108.44 0.12 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t 57.02 -155.41 0.32 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.323 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt 70.35 40.72 1.09 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.262 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.25 -47.96 2.94 Favored Glycine 0 C--N 1.305 -1.182 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' VAL . . . . . . . . . . . . . 3.0 m -144.74 77.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' TRP . . . . . 0.531 ' O ' ' CE3' ' C' ' 48' ' ' TRP . 1.7 t-105 -168.25 -50.53 0.0 OUTLIER Pre-proline 0 C--N 1.313 -1.006 0 O-C-N 122.181 -0.324 . . . . 0.0 110.577 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' PRO . . . . . 0.513 ' HD2' ' H ' ' C' ' 48' ' ' TRP . 42.2 Cg_endo -76.86 -28.62 6.08 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 121.065 1.177 . . . . 0.0 112.112 -178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' LEU . . . . . . . . . . . . . 9.4 mt -55.96 -34.11 65.39 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.841 -178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.591 HD12 ' N ' ' C' ' 51' ' ' LEU . 9.1 mp -55.21 -41.39 71.95 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.124 -1.031 . . . . 0.0 109.642 -178.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.18 -41.39 88.36 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' VAL . . . . . 0.431 HG11 ' CE2' ' E' ' 19' ' ' PHE . 10.6 t -59.51 -29.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.627 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ARG . . . . . . . . . . . . . 48.9 ttm-85 -53.42 -37.91 62.99 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.985 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' LEU . . . . . 0.535 HD12 ' N ' ' C' ' 55' ' ' LEU . 9.6 mp -55.51 -41.3 72.88 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' LEU . . . . . . . . . . . . . 44.0 tp -67.09 -33.15 74.86 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 123.973 0.909 . . . . 0.0 112.687 177.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' ARG . . . . . 0.5 ' N ' ' HD2' ' C' ' 58' ' ' PRO . 58.6 ttt-85 -55.79 -42.51 96.47 Favored Pre-proline 0 N--CA 1.483 1.182 0 N-CA-C 116.564 2.061 . . . . 0.0 116.564 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' C' ' 57' ' ' ARG . 17.4 Cg_endo -56.98 -37.4 98.55 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 CA-C-N 121.652 1.626 . . . . 0.0 112.129 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' HIS . . . . . 0.676 ' NE2' ' HB3' ' F' ' 14' ' ' ALA . 8.3 t-80 -34.74 151.82 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.99 179.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.54 ' N ' ' ND1' ' C' ' 59' ' ' HIS . 0.0 OUTLIER -164.46 177.2 8.36 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 120.624 0.25 . . . . 0.0 110.492 -179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' F' ' 11' ' ' ALA . . . -81.14 -142.91 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 120.843 0.354 . . . . 0.0 111.32 -179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' LEU . . . . . . . . . . . . . 4.3 tp 53.92 10.08 0.25 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . 0.468 ' H ' ' C ' ' C' ' 61' ' ' ALA . . . . . . . . 0 C--N 1.307 -1.277 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.535 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' GLY . . . . . 0.474 ' C ' ' H ' ' D' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.9 2.42 0.39 Allowed 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 120.767 0.318 . . . . 0.0 110.628 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' D' ' 1' ' ' GLY . 11.1 tptm -164.87 -53.53 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.383 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 -46.3 -20.29 0.1 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.403 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' VAL . . . . . 0.461 ' H ' HG23 ' D' ' 5' ' ' VAL . 0.4 OUTLIER -72.05 -58.34 5.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.741 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ILE . . . . . . . . . . . . . 48.4 mt -59.44 -35.73 60.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.768 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 85.9 t -58.18 -40.73 78.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.99 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' LEU . . . . . . . . . . . . . 12.4 mt -59.3 -39.19 82.23 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.489 -0.484 . . . . 0.0 110.118 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -60.65 -42.09 96.27 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.157 0.503 . . . . 0.0 109.806 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' ALA . . . . . 0.405 ' HB2' HG12 ' E' ' 5' ' ' VAL . . . -57.26 -39.09 74.91 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.301 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.35 -39.19 75.42 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.022 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t -60.25 -41.66 93.69 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 120.422 -0.511 . . . . 0.0 109.75 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.05 -38.49 79.47 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.871 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.81 95.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.38 -41.95 97.22 Favored Glycine 0 C--N 1.306 -1.112 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ASN . . . . . 0.548 ' O ' ' N ' ' D' ' 18' ' ' GLY . 4.4 t30 -61.11 -41.13 96.12 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.771 0.32 . . . . 0.0 110.426 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -60.63 71.24 0.01 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.889 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' D' ' 16' ' ' ASN . . . -135.5 106.24 0.57 Allowed Glycine 0 C--N 1.307 -1.043 0 N-CA-C 110.649 -0.98 . . . . 0.0 110.649 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' PHE . . . . . 0.481 ' CZ ' HD11 ' D' ' 23' ' ' LEU . 1.0 OUTLIER -29.01 -47.63 0.06 Allowed 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 123.191 0.596 . . . . 0.0 112.318 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -60.28 -42.45 95.49 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.099 -0.64 . . . . 0.0 110.463 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' D' ' 18' ' ' GLY . 67.5 t-105 -60.42 -41.15 93.38 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.541 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.38 97.4 Favored Glycine 0 C--N 1.304 -1.216 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' LEU . . . . . 0.481 HD11 ' CZ ' ' D' ' 19' ' ' PHE . 9.7 mt -61.74 -39.33 91.21 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.55 -44.78 93.14 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' VAL . . . . . 0.435 ' H ' HG22 ' D' ' 25' ' ' VAL . 6.1 m -64.1 -43.25 97.43 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 C-N-CA 119.669 -0.812 . . . . 0.0 112.308 -178.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.52 -44.91 96.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' THR . . . . . . . . . . . . . 8.4 t -64.51 -42.14 95.98 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' LEU . . . . . 0.554 ' O ' HD23 ' D' ' 28' ' ' LEU . 1.0 OUTLIER -60.4 -43.32 96.78 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.824 -178.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.424 ' O ' HG22 ' D' ' 32' ' ' VAL . . . -61.92 -42.54 99.21 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.515 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -63.89 -41.43 97.71 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -61.09 -42.53 98.69 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 -177.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . 0.424 HG22 ' O ' ' D' ' 29' ' ' ALA . 16.1 m -65.02 -10.74 10.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.209 -0.596 . . . . 0.0 111.938 -177.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' LYS . . . . . 0.49 ' NZ ' ' O ' ' C' ' 41' ' ' THR . 15.5 ttpp -46.35 -61.45 1.79 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.616 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.45 -37.39 88.06 Favored Glycine 0 C--N 1.3 -1.424 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -60.19 -37.91 81.66 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.983 0.421 . . . . 0.0 111.046 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' LEU . . . . . 0.57 ' O ' HD23 ' D' ' 36' ' ' LEU . 1.0 OUTLIER -60.11 -41.27 92.24 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' VAL . . . . . 0.444 ' N ' ' HD2' ' D' ' 38' ' ' PRO . 2.5 t -62.2 -46.64 90.98 Favored Pre-proline 0 C--N 1.307 -1.27 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 -176.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' D' ' 37' ' ' VAL . 34.6 Cg_endo -62.57 -35.39 70.92 Favored 'Trans proline' 0 N--CA 1.504 2.108 0 C-N-CA 122.425 2.083 . . . . 0.0 111.516 177.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLY . . . . . 0.529 ' O ' ' NE1' ' E' ' 30' ' ' TRP . . . -60.27 -39.4 95.99 Favored Glycine 0 C--N 1.3 -1.429 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.573 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' D' ' 41' ' ' THR . . . -56.05 -40.07 72.97 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' THR . . . . . 0.428 ' O ' ' O ' ' D' ' 40' ' ' ALA . 39.5 p -49.51 -103.62 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.636 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' TYR . . . . . 0.42 ' CD2' ' CE ' ' E' ' 33' ' ' LYS . 3.7 m-85 64.0 122.12 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.755 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -107.86 149.43 28.28 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.179 -0.918 . . . . 0.0 108.831 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' SER . . . . . . . . . . . . . 35.1 m 42.04 88.58 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.203 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 165.77 51.66 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' GLY . . . . . . . . . . . . . . . -102.56 -34.36 4.16 Favored Glycine 0 CA--C 1.539 1.572 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.668 -178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' VAL . . . . . . . . . . . . . 4.9 p -95.42 -35.83 6.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 117.992 0.896 . . . . 0.0 112.599 -178.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' TRP . . . . . 0.472 ' N ' ' CD ' ' D' ' 49' ' ' PRO . 5.4 t-105 -53.81 -40.83 84.11 Favored Pre-proline 0 C--N 1.304 -1.371 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' D' ' 48' ' ' TRP . 31.5 Cg_exo -58.23 -55.96 1.89 Allowed 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.242 1.295 . . . . 0.0 111.903 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' LEU . . . . . 0.63 ' O ' HG22 ' D' ' 53' ' ' VAL . 83.8 mt -54.13 -38.09 65.06 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.65 -42.46 92.86 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 119.596 1.089 . . . . 0.0 110.586 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' LEU . . . . . . . . . . . . . 9.7 mt -58.27 -38.52 77.14 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.491 -178.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' VAL . . . . . 0.63 HG22 ' O ' ' D' ' 50' ' ' LEU . 1.0 OUTLIER -57.28 -30.69 35.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 120.55 0.214 . . . . 0.0 111.192 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -54.08 -40.98 67.7 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.038 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' LEU . . . . . 0.533 HD12 ' N ' ' D' ' 55' ' ' LEU . 10.4 mp -59.95 -44.02 94.67 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.705 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' LEU . . . . . 0.545 HD22 ' N ' ' D' ' 56' ' ' LEU . 3.3 mm? -67.23 -31.09 71.22 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 125.663 1.585 . . . . 0.0 114.872 178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' ARG . . . . . . . . . . . . . 31.5 ttp180 -54.42 -39.65 76.73 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 115.525 1.676 . . . . 0.0 115.525 -172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' PRO . . . . . 0.452 ' HD2' ' O ' ' D' ' 55' ' ' LEU . 29.0 Cg_exo -60.39 -40.34 58.85 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 121.629 1.553 . . . . 0.0 110.855 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 52.12 53.08 13.07 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.538 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 71.6 mtp180 -46.04 164.65 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.504 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ALA . . . . . . . . . . . . . . . -153.65 72.08 0.9 Allowed 'General case' 0 C--N 1.306 -1.292 0 CA-C-O 121.002 0.43 . . . . 0.0 110.549 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' LEU . . . . . . . . . . . . . 5.3 tp -166.84 29.09 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.752 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.238 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.916 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.04 -55.61 19.51 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtt -92.52 51.7 1.78 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 120.914 0.388 . . . . 0.0 110.838 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 4' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -143.9 33.84 1.25 Allowed 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.627 0.727 . . . . 0.0 109.324 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' D' ' 10' ' ' ALA . 0.0 OUTLIER -147.62 -67.7 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 114.467 -1.242 . . . . 0.0 108.063 179.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 6' ' ' ILE . . . . . 0.416 HG22 ' CG1' ' F' ' 5' ' ' VAL . 48.4 mt -58.61 -36.97 62.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.355 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . 0.486 HG23 ' N ' ' E' ' 8' ' ' LEU . 11.1 m -60.71 -41.21 87.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.353 179.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 8' ' ' LEU . . . . . 0.486 ' N ' HG23 ' E' ' 7' ' ' VAL . 12.0 mt -60.26 -40.36 90.06 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.448 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 9' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -61.09 -41.66 97.08 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 121.213 0.53 . . . . 0.0 109.952 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.04 -40.3 80.58 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.651 -179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.94 -40.34 84.36 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.586 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 12' ' ' SER . . . . . . . . . . . . . 38.5 t -61.0 -42.35 98.28 Favored 'General case' 0 C--N 1.309 -1.184 0 C-N-CA 120.355 -0.538 . . . . 0.0 109.98 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.96 -38.15 78.4 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.63 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.24 88.67 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.97 -41.6 96.42 Favored Glycine 0 C--N 1.304 -1.22 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 16' ' ' ASN . . . . . 0.549 ' ND2' ' NE1' ' E' ' 21' ' ' TRP . 15.7 t-20 -60.91 -40.59 93.74 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.538 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 17' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -51.17 93.89 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' E' ' 21' ' ' TRP . . . -166.56 107.18 0.28 Allowed Glycine 0 C--N 1.304 -1.23 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 19' ' ' PHE . . . . . 0.452 ' O ' HD13 ' E' ' 23' ' ' LEU . 0.2 OUTLIER -36.68 -38.7 0.18 Allowed 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.593 0.235 . . . . 0.0 111.4 -179.267 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 20' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -59.92 -42.62 94.31 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 21' ' ' TRP . . . . . 0.549 ' NE1' ' ND2' ' E' ' 16' ' ' ASN . 61.9 t-105 -60.83 -41.05 94.98 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.766 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.93 96.22 Favored Glycine 0 C--N 1.304 -1.204 0 N-CA-C 111.344 -0.703 . . . . 0.0 111.344 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 23' ' ' LEU . . . . . 0.594 ' O ' HG23 ' E' ' 27' ' ' THR . 7.3 mp -59.25 -37.57 77.9 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.784 -0.208 . . . . 0.0 110.978 -178.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 24' ' ' LEU . . . . . . . . . . . . . 41.6 tp -57.69 -41.23 81.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 25' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.95 -42.61 90.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 C-N-CA 120.166 -0.614 . . . . 0.0 111.796 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 26' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.24 -42.52 96.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 27' ' ' THR . . . . . 0.594 HG23 ' O ' ' E' ' 23' ' ' LEU . 5.1 p -63.41 -44.96 93.12 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 28' ' ' LEU . . . . . . . . . . . . . 70.0 mt -62.52 -43.62 98.35 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.765 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.11 99.17 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.863 -179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 30' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' D' ' 39' ' ' GLY . 1.0 OUTLIER -64.49 -42.67 95.71 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.002 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 31' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -61.51 -41.4 97.24 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 15.1 m -70.67 -8.31 10.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 33' ' ' LYS . . . . . 0.42 ' CE ' ' CD2' ' D' ' 42' ' ' TYR . 21.5 ttpt -48.27 -55.02 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 120.078 -0.649 . . . . 0.0 110.333 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 34' ' ' GLY . . . . . . . . . . . . . . . -60.16 -38.53 94.57 Favored Glycine 0 C--N 1.302 -1.328 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 35' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -59.09 -34.93 72.58 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 120.777 0.322 . . . . 0.0 111.191 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 36' ' ' LEU . . . . . 0.714 ' O ' HD23 ' E' ' 36' ' ' LEU . 3.6 tt -61.66 -45.13 95.35 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 115.093 1.516 . . . . 0.0 115.093 -177.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.91 -44.37 78.6 Favored Pre-proline 0 N--CA 1.484 1.261 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -176.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 38' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.52 -33.65 98.19 Favored 'Trans proline' 0 N--CA 1.503 2.056 0 C-N-CA 122.434 2.089 . . . . 0.0 111.126 175.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 39' ' ' GLY . . . . . 0.536 ' O ' ' CD1' ' F' ' 30' ' ' TRP . . . -59.75 -37.69 92.79 Favored Glycine 0 C--N 1.299 -1.505 0 CA-C-N 114.084 -1.416 . . . . 0.0 110.845 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.23 75.5 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -43.28 117.58 1.14 Allowed 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.677 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 42' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -105.77 75.32 1.12 Allowed 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.033 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 43' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' E' ' 45' ' ' LEU . 36.5 mt -77.63 -148.6 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 44' ' ' SER . . . . . . . . . . . . . 43.3 t -55.34 80.82 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.543 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 45' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' E' ' 43' ' ' LEU . 80.1 mt -148.62 32.22 0.79 Allowed 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 46' ' ' GLY . . . . . . . . . . . . . . . -51.71 -71.36 0.67 Allowed Glycine 0 C--N 1.301 -1.383 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.8 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 47' ' ' VAL . . . . . . . . . . . . . 26.4 m -139.78 -10.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 48' ' ' TRP . . . . . 0.479 ' N ' ' CD ' ' E' ' 49' ' ' PRO . 0.7 OUTLIER -51.1 -45.83 88.6 Favored Pre-proline 0 C--N 1.304 -1.393 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.115 -179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' E' ' 48' ' ' TRP . 31.7 Cg_exo -59.28 -42.3 51.01 Favored 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 122.263 1.975 . . . . 0.0 112.257 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 50' ' ' LEU . . . . . . . . . . . . . 81.7 mt -53.59 -34.87 59.9 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 51' ' ' LEU . . . . . 0.49 HD22 ' N ' ' E' ' 51' ' ' LEU . 3.6 mm? -56.52 -44.12 80.46 Favored 'General case' 0 C--N 1.294 -1.827 0 C-N-CA 117.88 -1.528 . . . . 0.0 109.993 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 52' ' ' LEU . . . . . . . . . . . . . 11.0 mp -63.87 -46.59 84.27 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.079 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 53' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.15 54.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-O 120.916 0.389 . . . . 0.0 110.743 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 54' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -54.98 -41.1 70.77 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.936 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 mt -59.39 -44.37 92.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.434 -0.906 . . . . 0.0 108.934 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 56' ' ' LEU . . . . . 0.528 ' O ' ' CD2' ' E' ' 59' ' ' HIS . 48.2 tp -67.68 -33.65 75.34 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 124.57 1.148 . . . . 0.0 113.192 177.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 57' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' E' ' 58' ' ' PRO . 49.8 ttp180 -55.63 -43.61 99.25 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -173.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' E' ' 57' ' ' ARG . 21.5 Cg_endo -59.56 -40.02 69.63 Favored 'Trans proline' 0 N--CA 1.499 1.837 0 CA-C-N 121.701 1.643 . . . . 0.0 112.014 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 59' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' E' ' 56' ' ' LEU . 39.1 m-70 49.47 178.62 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.29 0 CA-C-O 120.964 0.411 . . . . 0.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 60' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -174.75 139.13 0.52 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.2 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 61' ' ' ALA . . . . . . . . . . . . . . . -103.16 61.35 0.78 Allowed 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 120.91 0.386 . . . . 0.0 110.391 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 62' ' ' LEU . . . . . . . . . . . . . 4.7 tp -165.95 15.49 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.108 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.303 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.517 179.964 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.0 11.23 0.92 Allowed 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.6 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 3' ' ' LYS . . . . . 0.689 ' NZ ' ' H ' ' A' ' 2' ' ' ALA . 14.2 mmtp -83.63 76.03 10.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 4' ' ' ASN . . . . . 0.45 ' O ' HD13 ' F' ' 8' ' ' LEU . 1.3 p30 -158.49 2.64 0.1 Allowed 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.586 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 5' ' ' VAL . . . . . 0.416 ' CG1' HG22 ' E' ' 6' ' ' ILE . 0.5 OUTLIER -113.27 -66.38 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.185 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 6' ' ' ILE . . . . . 0.619 ' H ' HD12 ' F' ' 6' ' ' ILE . 2.8 mp -59.55 -33.11 50.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.518 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.05 -40.91 76.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.01 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 8' ' ' LEU . . . . . 0.536 HD12 ' N ' ' F' ' 8' ' ' LEU . 7.6 mp -59.33 -40.81 87.53 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 120.531 -0.467 . . . . 0.0 109.864 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 9' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -61.44 -40.19 93.55 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.243 0.544 . . . . 0.0 109.707 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 10' ' ' ALA . . . . . 0.505 ' HB2' ' CG1' ' A' ' 5' ' ' VAL . . . -56.74 -40.75 76.29 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.525 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 11' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' C' ' 61' ' ' ALA . . . -58.05 -40.97 82.3 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.055 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -61.8 -43.84 98.05 Favored 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.499 178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -41.52 94.74 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.709 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 14' ' ' ALA . . . . . 0.676 ' HB3' ' NE2' ' C' ' 59' ' ' HIS . . . -61.87 -41.22 97.58 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 178.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 15' ' ' GLY . . . . . 0.507 ' N ' ' NE2' ' C' ' 59' ' ' HIS . . . -58.53 -41.43 95.46 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.296 -1.121 . . . . 0.0 110.296 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 16' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -60.89 -40.92 94.9 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.201 179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 17' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -59.19 110.08 0.99 Allowed 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.455 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 18' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' F' ' 21' ' ' TRP . . . 178.5 115.85 0.47 Allowed Glycine 0 C--N 1.303 -1.305 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 19' ' ' PHE . . . . . 0.524 ' CG ' ' N ' ' F' ' 20' ' ' PHE . 2.8 p90 -31.54 -43.41 0.06 Allowed 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 20' ' ' PHE . . . . . 0.524 ' N ' ' CG ' ' F' ' 19' ' ' PHE . 0.1 OUTLIER -60.14 -42.77 95.55 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.002 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 21' ' ' TRP . . . . . 0.517 ' N ' ' O ' ' F' ' 18' ' ' GLY . 86.6 t90 -60.93 -40.47 93.34 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.367 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 22' ' ' GLY . . . . . . . . . . . . . . . -60.01 -38.91 94.94 Favored Glycine 0 C--N 1.303 -1.296 0 N-CA-C 111.474 -0.651 . . . . 0.0 111.474 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 23' ' ' LEU . . . . . 0.471 ' O ' HG22 ' F' ' 27' ' ' THR . 93.3 mt -59.5 -39.36 83.55 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 24' ' ' LEU . . . . . . . . . . . . . 37.1 tp -60.2 -44.01 95.47 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 25' ' ' VAL . . . . . . . . . . . . . 7.2 t -65.13 -45.21 94.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 26' ' ' VAL . . . . . . . . . . . . . 6.4 t -65.15 -45.13 94.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 -178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 27' ' ' THR . . . . . 0.471 HG22 ' O ' ' F' ' 23' ' ' LEU . 8.1 t -64.69 -41.96 95.66 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 28' ' ' LEU . . . . . 0.429 ' N ' HG23 ' F' ' 27' ' ' THR . 57.3 tp -59.97 -43.28 95.19 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.494 -0.883 . . . . 0.0 109.321 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 29' ' ' ALA . . . . . 0.411 ' O ' HG22 ' F' ' 32' ' ' VAL . . . -63.55 -41.37 98.43 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.848 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 30' ' ' TRP . . . . . 0.536 ' CD1' ' O ' ' E' ' 39' ' ' GLY . 0.7 OUTLIER -64.56 -41.66 96.18 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.335 -179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' F' F ' 31' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -60.86 -41.04 95.12 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . 0.505 ' HB ' HG21 ' A' ' 27' ' ' THR . 16.5 m -68.27 -4.37 3.25 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -177.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -47.93 -62.15 1.61 Allowed 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 119.8 -0.76 . . . . 0.0 109.628 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 34' ' ' GLY . . . . . . . . . . . . . . . -58.71 -37.19 89.23 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 35' ' ' ARG . . . . . 0.535 ' NH2' ' CE1' ' A' ' 31' ' ' HIS . 52.5 ttt85 -59.17 -37.42 77.31 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.001 0.429 . . . . 0.0 110.944 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 36' ' ' LEU . . . . . 0.623 ' O ' HD23 ' F' ' 36' ' ' LEU . 1.3 tt -60.23 -41.58 93.42 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 37' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' F' ' 38' ' ' PRO . 1.5 t -61.73 -46.41 93.18 Favored Pre-proline 0 C--N 1.306 -1.291 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -176.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 38' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' F' ' 37' ' ' VAL . 29.3 Cg_endo -61.86 -34.08 82.98 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.408 2.072 . . . . 0.0 111.203 177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.01 -39.72 96.05 Favored Glycine 0 C--N 1.301 -1.385 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.451 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.85 -40.99 81.42 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.073 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -80.22 114.13 18.9 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 42' ' ' TYR . . . . . 0.561 ' CD1' ' O ' ' F' ' 42' ' ' TYR . 30.7 p90 -166.12 119.02 1.08 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.28 0.562 . . . . 0.0 110.123 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 43' ' ' LEU . . . . . 0.552 ' N ' HD12 ' F' ' 43' ' ' LEU . 10.0 mp -81.04 148.53 29.65 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.502 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 44' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' F' ' 43' ' ' LEU . 13.1 p 66.6 176.52 0.23 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.016 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt 72.63 34.24 1.25 Allowed 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.742 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.27 -46.88 2.3 Favored Glycine 0 C--N 1.307 -1.07 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.202 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 47' ' ' VAL . . . . . . . . . . . . . 3.6 m -143.9 73.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 48' ' ' TRP . . . . . 0.663 ' H ' ' CD ' ' F' ' 49' ' ' PRO . 3.6 t-105 -164.61 -42.02 0.0 OUTLIER Pre-proline 0 C--N 1.311 -1.088 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 49' ' ' PRO . . . . . 0.663 ' CD ' ' H ' ' F' ' 48' ' ' TRP . 11.7 Cg_exo -71.68 -31.48 13.19 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.901 1.734 . . . . 0.0 110.585 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 50' ' ' LEU . . . . . 0.565 HD21 ' CE1' ' B' ' 19' ' ' PHE . 6.3 mt -57.61 -34.89 69.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.087 -0.96 . . . . 0.0 112.169 -178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 51' ' ' LEU . . . . . . . . . . . . . 7.7 mt -55.5 -42.97 75.18 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.78 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.72 -41.69 95.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 53' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.99 -30.2 45.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.581 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 54' ' ' ARG . . . . . . . . . . . . . 65.0 ttt-85 -53.35 -39.68 64.34 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.536 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 55' ' ' LEU . . . . . 0.549 HD12 ' N ' ' F' ' 55' ' ' LEU . 10.0 mp -57.95 -43.7 86.55 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.618 -0.833 . . . . 0.0 108.944 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.62 -33.42 74.94 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 124.208 1.003 . . . . 0.0 112.891 177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 57' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' F' ' 58' ' ' PRO . 45.4 ttp180 -54.72 -44.01 98.88 Favored Pre-proline 0 C--N 1.306 -1.321 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' F' ' 57' ' ' ARG . 23.9 Cg_endo -60.94 -40.29 53.98 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 CA-C-N 121.805 1.68 . . . . 0.0 110.995 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 59' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' F' ' 58' ' ' PRO . 2.7 t-80 50.02 175.76 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.624 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 60' ' ' ARG . . . . . . . . . . . . . 17.2 ptp180 -173.37 -160.53 0.12 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.209 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 61' ' ' ALA . . . . . . . . . . . . . . . -156.34 6.9 0.19 Allowed 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.682 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 62' ' ' LEU . . . . . . . . . . . . . 34.7 mt -85.63 23.83 1.32 Allowed 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.225 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 63' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.489 -179.915 . . . . . . . . 0 0 . 1 stop_ save_